tsawon lokacin da alamun suka kasance?
Kuma duk wani ciwon kirji ya kamata a bi da shi ta wannan hanyar, musamman ma saboda shekarunka.
kuma tare da high zafin jiki
Kuma za a bincika matakin cholesterol da hawan jini.
kuma kuna da zazzabi a yanzu?
kuma kuna jin wannan ciwon kirji a yanzu?
kuma, shin kuna da wahalar numfashi
kuma za ku iya gaya mani wasu alamun da kuke da su ban da waɗannan?
kuma yawan zafin jikinka
Kuma ina da tari.
Kuma ina da ɗan sanyi da tari.
Kuma ina da ciwon kirji mai tsanani a yau.
kuma ko wannan lokaci ya yi daidai da lokacin da kake da zazzabin hayaki
Kuma akwai ciwo a cikin ƙirjinka.
Kuma ina tsammanin zazzabi na ɗan tashi.
Kuma ina so ku bayyana inda kuke jin zafi a cikin kirjinku.
kuma suna da kadan high zazzabi
da kuma tarihin ciwon sukari
Kuma kun san, yana jin kamar ƙirjina za a murƙushe shi.
Kuma, ka sani, mutane suna yawan yin tari a kaina.
kuma kuna jin zafi a cikin kirji
Kuma kun ce wannan matsin ne a cikin kirji.
wani a cikin iyalinka yana da ciwon zuciya, rashin lafiya na zuciya, ciwon zuciya, hawan cholesterol, hawan jini
wani ciwo ko kuma wata matsala da kuka lura da ita da ke da nasaba da ciwon tsoka?
Shin akwai wasu marasa lafiya a gidanku da suke da irin wannan cutar?
kuna da wasu alamun cutar?
Kuna jin cewa ba ku da numfashi a yanzu?
har yanzu kuna jin ciwon kirji
saboda lokacin mura ne
Amma kuma bai kamata mu manta da ciwon kirji ba, wanda ke da alaka da zuciya.
Amma yanzu, babban abin da ke damunmu shi ne ciwon kirji.
Amma ina da wahalar numfashi.
Amma na san mutane da yawa suna yin tari a kaina.
Amma dole ne mu bi da duk wani ciwon kirji da tsanani.
Amma kana numfashi sosai, ko ba haka ba?
Domin wannan ciwon kirji na daina tunawa.
Shin yana kama da wani yana matsawa kirjinka
har yanzu kana jin ƙarancin numfashi
suna gunaguni game da rashin lafiya?
Shin kuna da wasu cututtuka na kullum kamar hawan jini ko wani abu makamancin haka?
kana da wasu cututtuka na kullum ko kuma matsalar lafiya kamar ciwon sukari?
Kuna jin ƙarancin numfashi a cikin wannan ciwon kirji?
Shin kana da hawan jini?
Shin kana da matsalar numfashi?
Shin kun san alamun da take da su?
Kuna ganin wannan hoton?
Ku sha ruwa mai yawa yau.
Amma ina yin gwajin ciwon sukari.
Amma ta na da alamun cutar kamar yadda nake da su.
Yaya zafin zafin jikinka?
Yaya yawan hawan jini?
idan har yanzu kuna da zazzabi
idan zafin jikinka 38 da 9 ko sama da haka
idan kana ganin cewa alamun ko matsalarka na da tabbacin cewa za ka kyautata bayyanarka
Na yi zazzabi jiya.
Na kuma samu ɗan zafin jiki a jiya.
Ina da zazzabi jiya
Ina jin zafi sosai a nan cikin kirji.
Ina kuma da ɗan wahalar numfashi.
Zan aiko muku da hoton.
Ina jin wani ciwon kirji a yau.
Ina da ciwon kai da zazzabi a yau.
Ina tsammanin mura ce.
Ina ganin cewa, cutar mura ce mai saurin kamuwa da cutar.
Shin wannan yana kama da mutum mai nauyi a wuyanka?
Hakan ya fara ne kusan a lokaci guda da ciwon kai da zafin jiki.
Ina jin zafi a tsakiyar kirji.
Yana damuna kamar ciwon kirji.
Ina da shi a cikin ƙirjina.
Wannan yana tsakiyar ƙirjina.
Wannan yana tsakiyar ƙirjinka.
Ina da ciwon kirji
Ina matukar damuwa da wannan ciwon kirji.
Ina so ku bayyana mini wannan ciwon kirji.
kamar hawan jini ko ciwon sukari
kamar yadda daidai a tsakiyar ƙirjin
Za ka iya shan takipirinin a cikin wani irin magani mai suna "Leducin".
Yanzu, Maryamu, ka gaya mini, kwana nawa ne ka yi da irin wannan ciwo?
yanzu kun ce kuna jin zafi a kirji
Wani lokaci ina jin wani ɗan ciwo a cikin kirji.
To, shin kuna da wasu alamun bayyanar cututtuka banda ciwo?
Ko kuwa wani yana zaune a kan kirjinka?
Zafi da tari, ciwon kai da kuma ciwon tsoka.
ciwo kai tsaye a tsakiyar kirji na
Ku nuna mini a wannan hoton inda kuke jin zafi.
saboda kuna da zazzabi
To, kana ganin wasu daga cikin waɗannan alamun suna da nasaba da ciki?
To, yaranku suna da wasu daga cikin waɗannan alamun?
Ka gaya mini game da ciwon kirji
zafin jiki yana hawa da dare
zazzabi da na yi a cikin kwanaki biyu da suka gabata
Zafin jiki ya fara tashi a daren jiya.
Wannan Dr. Porter ne a wurin kula da marasa lafiya.
To, za ku iya ba mu ƙarin bayani game da ciwon kirjinku?
Ina jin zafi a gaban jikina, a nan, a cikin kirji.
Ina jin zafi sosai a kirji.
To, idan na ji ciwon kirji
wane irin ciwo kake ji a cikin kirjinka?
Yaushe ne kuka fara jin wannan ciwon a kirjinku?
A ina ne kake jin ciwon kirji?
inda kake jin wannan ciwon kirji
kuna jin wani abu kamar wannan a cikin kirjinku
Ka sani, ina da ciwon sukari da sauran abubuwa
kun ce kuna da wannan ciwon a cikin kirji
Yawan masu kamuwa da cutar coronavirus (COVID-19) a Tarayyar Turai da Burtaniya ya karu sosai a tsakanin 1 ga Janairu zuwa 15 ga Maris na 2020.
Cutar cutar coronavirus (COVID-19) tana da irin wannan yanayin a cikin EU / Yankin Tattalin Arzikin Turai da kuma Burtaniya, wanda ke tabbatar da cewa duk da matakai daban-daban na ci gabanta a cikin ƙasashe daban-daban, cutar ta COVID-19 tana ƙaruwa cikin sauri a duk ƙasashe.
Bisa ga abin da Italiya ta fuskanta, ya kamata ƙasashe, asibitoci da kuma ma'aikatun kulawa mai tsanani su ƙara kasancewa a shirye don samun masu cutar COVID-19 da ke bukatar magani, musamman ma kulawa mai tsanani.
A ranar 31 ga watan Disamba na shekarar 2019 an samu wasu mutane da suka kamu da cutar huhu a birnin Wuhan na lardin Hubei na kasar Sin.
A ranar 9 ga Janairu, 2020, Cibiyar Kula da Cututtuka da Rigakafin Cutar Sin ta sanar da cewa sabon nau'in kwayar cutar coronavirus ne ke haifar da kamuwa da cutar, wanda yanzu aka sani da nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in
Tun daga wannan lokacin, cutar da ke haifar da SARS-CoV-2 an fara kiranta da cutar coronavirus (COVID-19).
Bisa ga bayanan da ake da su a yau, kusan kashi 80 cikin ɗari na mutanen da ke da COVID-19 suna da ƙananan cututtuka, wato, cututtukan numfashi tare da ciwon huhu ko kuma ba tare da ciwon huhu ba, kuma yawancin mutane suna warkewa.
Kimanin kashi 14 cikin ɗari na COVID-19 suna samun ciwo mai tsanani wanda ke bukatar asibiti, kuma kashi 6 cikin ɗari na ciwo yana samun ciwo mai tsanani wanda ke bukatar kulawa mai tsanani.
Yawan mutuwar marasa lafiya da aka kwantar da su a asibiti da COVID-19 ya kai kusan kashi 4%.
Wannan binciken ya bincika yanayin kamuwa da cutar COVID-19 a kowace ƙasa ta Tarayyar Turai (EU) / Yankin Tattalin Arzikin Turai (EEA) da kuma a Burtaniya kuma ya kwatanta shi da yanayin lardin Hubei na kasar Sin.
Mun kuma gwada adadin masu kamuwa da cutar COVID-19 a EU/EEA da kuma Birtaniya da kuma Italiya daga 31 ga Janairu zuwa 15 ga Maris, 2020.
Al'amuran COVID-19 a EU/EEA da kuma Birtaniya
Bayan barkewar cutar a China, COVID-19 ya bazu zuwa wasu ƙasashe, kuma yanzu a sauran sassan duniya, cutar ta COVID-19 tana ci gaba daidai da yadda ta faru a China.
A ranar 11 ga Maris na shekarar 2020, babban daraktan Hukumar Lafiya ta Duniya (WHO) ya sanar da annobar COVID-19.
A cikin mujallar Eurosurveillance na 5 ga Maris, 2020, Mista Spiteri da abokan aikinsa sun ba da rahoton farkon tabbatar da cutar COVID-19 a Turai, wanda ya cika ka'idodin WHO don gano cutar.
An samu mutane uku na farko da aka tabbatar da cutar a EU/EEA a Faransa a ranar 24 ga Janairu, 2020  dukkansu uku sun dawo daga Wuhan, lardin Hubei na kasar Sin.
A ranar 15 ga Maris na shekarar 2020, an gano masu kamuwa da COVID-19 a duk ƙasashe 30 na EU/EEA da kuma Burtaniya, tare da a cikin lokacin daga 31 ga Disamba, 2019 zuwa wannan kwanan wata an sami kamuwa da cutar 39,768 da mutuwar 1,727, daga cikinsu akwai 17,750, ciki har da 1,441 da suka mutu, a Italiya kadai.
Ƙayyade yawan cutar COVID-19 da kuma yawan masu kamuwa da cutar
Cibiyar Kula da Cututtuka ta Turai (ECDC) tana sabunta adadin masu kamuwa da cutar COVID-19 a kowace kasa a kowace rana da karfe 8:00 na safe, daga tushe na hukuma, kamar ma'aikatar kiwon lafiya na waɗannan ƙasashe, hukumomin kula da kiwon lafiya na ƙasa da na yanki da WHO.
Ana amfani da wannan bayanin don bincika yanayin yaduwar COVID-19 a EU/EEA da kuma Birtaniya da kuma kwatanta shi da na Italiya.
A matsayin mai nuna yawan yaduwar cutar COVID-19, an ƙididdige yawan kamuwa da cutar COVID-19 a cikin kwanaki 14 bisa ga yadda COVID-19 ke gudana a kowace ƙasa ta EU/EEA da kuma Burtaniya a tsakanin 1 ga Janairu zuwa 15 ga Maris, 2020.
Mun kuma gabatar da adadin masu kamuwa da cutar a kowace ƙasa a karfe 8:00 na ranar 15 ga Maris, 2020, idan aka kwatanta da na Italiya daga 31 ga Janairu zuwa 15 ga Maris, 2020.
Yanayin COVID-19 a ƙasashen EU/EEA da kuma Birtaniya
Yanayin ci gaban cututtukan cutar COVID-19 a cikin kwanaki 14 a cikin ƙasashen EU/EEA da kuma a cikin Burtaniya gaba ɗaya sun yi daidai da yanayin da aka gani a lardin Hubei na China (Figure 1).
Cutar COVID-19 mai yawa a cikin EU/EEA da kuma Birtaniya gaba ɗaya ta fara ƙaruwa a kusan ranar 21 ga Fabrairu, kuma a ranar 28 ga Fabrairu, 2020 an sami tsalle mai girma a wannan adadin (karin bayani).
Wannan ya samo asali ne daga karuwar yawan mutanen da suka kamu da cutar a Italiya, amma duk sauran ƙasashen EU/EEA da Birtaniya sun ga irin wannan karuwar cutar COVID-19 (karin bayani).
Hoto na 2 ya nuna adadin masu kamuwa da cutar COVID-19 a cikin EU/EEA da kuma Birtaniya idan aka kwatanta da irin wannan adadin a Italiya a tsakanin 31 ga Janairu zuwa 15 ga Maris, 2020.
Bisa ga wannan, jimillar adadin waɗanda aka riga aka samu a ranar 15 ga Maris da karfe 8:00 na safe a wasu ƙasashe 15 na EU/EEA da kuma a Burtaniya, ya yi daidai da adadin da aka samu a Italiya makonni uku da suka gabata.
Sakamakonmu ya nuna cewa adadin mutanen da aka samu da cutar COVID-19 a EU/EEA da kuma Birtaniya na ƙaruwa sosai.
Yanayin da ake gani na kamuwa da cutar COVID-19 ya nuna cewa cutar ta na yaduwa a cikin sauri a duk ƙasashe.
Kuma wannan duk da cewa akwai matakai daban-daban a cikin ƙasashe daban-daban, da bambancin matakan amsawa da hukumomin kiwon lafiyar ƙasa ke ɗauka, da kuma yiwuwar bambancin ƙa'idodin ganewar cutar da kuma ƙa'idodin zaɓin marasa lafiya don yin gwajin COVID-19, gami da gwajin "inversor".
A farkon watan Maris na shekarar 2020, likitoci a yankunan da cutar ta shafa a Italiya sun ruwaito cewa kusan kashi 10 cikin 100 na marasa lafiya da ke fama da COVID-19 na bukatar kulawa mai tsanani, kuma kafofin watsa labarai sun lura cewa asibitoci da sassan kulawa mai tsanani a wadannan yankuna sun cika sosai.
A halin yanzu, ana samun bayanai game da shigar da marasa lafiya da COVID-19 asibitoci da (ko) sashen kulawa mai tsanani a cikin EU/EEA ne kawai game da kashi 6 cikin ɗari da kuma kashi 1 cikin ɗari na shari'o'i daidai da haka (ba a gabatar da bayanai ba).
Amma, ya kamata a riƙa tattara wannan bayanin a kai a kai don a ƙara yawan mutanen da suka kamu da cutar da kuma waɗanda suka mutu.
Bisa ga sakamakon bincike da aka yi a shekara ta 2010-2011 a Turai, akwai bambanci mai yawa a yawan gadaje a sashen jinya mai tsanani da kuma sashen kula da marasa lafiya mai tsanani: daga 29.2 a Jamus zuwa 4.2 gadaje ga mutane 100,000 a Portugal.
Wannan yana nufin cewa wasu ƙasashe na iya samun wadata ko ƙarancin wadata fiye da Italiya (12.5 gadaje a cikin ɗakunan kulawa mai tsanani da ɗakunan kulawa mai tsanani a kowace 100,000 a cikin 2010-2011).
Rahoton ECDC na shida da aka sabunta na sakamakon kimanta hadarin COVID-19 ya gabatar da yanayin yin kwaikwayon kayan aiki na tsarin kiwon lafiya tare da kimanta bayanan asibiti na COVID-19 a kowace ƙasa ta EU/EEA da kuma Burtaniya, lokacin da haɗarin rashin isassun gadaje a sashen kulawa mai tsanani ya wuce 90%.
Tun da yake a yanzu an rarraba masu kamuwa da cutar zuwa wasu yankuna na EU/EEA da kuma Birtaniya, kuma asibitoci da kuma asibitocin jinya suna kula da yawan jama'a na wani yanki, ana ba da shawarar a ba da bayanai game da kamuwa da cutar da kuma adadin gadaje a asibitocin jinya a matakin 2 na Ƙididdigar Ƙididdigar Ƙididdigar Ƙididdigar Ƙididdigar Ƙididdigar Ƙididdigar Ƙididdigar Ƙididdigar Ƙididdigar Ƙididdigar Ƙididdigar Ƙididdigar Ƙididdigar Ƙididdigar Ƙididdigar Ƙididdigar Ƙididdigar Ƙididdigar Ƙididdigar Ƙididdigar Ƙididdigar Ƙididdigar Ƙididdigar Ƙididdigar Ƙididdigar Ƙididdigar Ƙididdigar Ƙididdigar Ƙididdigar Ƙididdigar Ƙididdigar Ƙididdigar Ƙididdigar (NUTS-2).
Kwarewar Italiya da kuma abubuwan da ke faruwa a yanzu a wasu ƙasashe sun nuna cewa cutar COVID-19 tana ci gaba da sauri a EU/EEA da kuma Birtaniya.
Saboda haka, ya kamata kasashe, asibitoci da kuma ma'aikatun kulawa mai zurfi su kasance a shirye don yanayin kamuwa da SARS-CoV-2 na dogon lokaci, da kuma karuwar adadin marasa lafiya da ke fama da COVID-19, waɗanda ke buƙatar kulawa ta likita da kuma musamman kulawa mai zurfi, kamar yadda ake gani a yankunan da cutar ta shafa na Italiya.
Kamar yadda rahoton ECDC na kwanan nan ya nuna, gaggawa, tsinkaya da kuma tsarin da aka tsara don hana yaduwar SARS-COV-2 yana da mahimmanci, tare da sauyawa daga hanawa zuwa rage sakamako, saboda, bisa ga ƙididdigar ƙaruwar ƙaruwar cututtuka, masu yanke shawara da asibitoci na iya samun isasshen lokaci don yin tunani, ɗauka da daidaita amsoshin su idan ba a ɗauki irin waɗannan matakan ba.
Rahoton na gaggawa na tantance hadarin ya kuma lissafa matakan kiwon lafiya na jama'a da ake so a rage tasirin cutar.
Kasashe suna da ɗan lokaci kaɗan da za su iya ƙara ƙoƙarin sarrafawa don rage yaduwar SARS-CoV-2 da rage nauyin tsarin kiwon lafiyarsu.
Idan ba a yi haka ba, a cikin kwanaki ko makonni masu zuwa, tsarin kiwon lafiya a wasu ƙasashe na EU/EEA zai fuskanci yawan marasa lafiya da ke bukatar kulawa mai tsanani.
Cutar cutar korona ta 2019 (COVID-19), wadda ta samo asali daga cutar korona mai saurin numfashi (SARS) ta nau'i na 2 (SARS-CoV-2), ta zama bala'i ga bil'adama: a halin yanzu fiye da mutane 3,000 ne suka mutu a China da sauran kasashen duniya, kuma adadin wadanda suka kamu da cutar ya zarce 80,000.
Kamar SARS-CoV da ya haifar da ciwon numfashi mai tsanani a dubban mutane a shekara ta 2003, SARS-CoV-2 na iya samun cutar daga batsa kuma yana haifar da irin wannan alamun ta hanyar amfani da irin wannan hanyar.
Ko da yake COVID-19 ba shi da tsanani sosai kuma ba ya kashe mutane sosai kamar SARS, amma yana da saurin yaɗuwa kuma yana shafar tsofaffi fiye da matasa, maza fiye da mata.
A cikin amsa ga karuwar littattafai game da sabon cutar, wannan talifin ya ba da cikakken bayani game da batun bincike mai saurin bunƙasa.
Za mu bincika fannoni na asali na kamuwa da cuta, ilmin cuta, ilmin ƙwayoyin cuta, ganewar asali, magani, tsinkaya da kuma rigakafin cutar.
Ko da yake akwai tambayoyi da yawa da za a amsa, muna fatan cewa wannan bincike zai taimaka wajen fahimtar da kuma kawar da wannan cuta mai haɗari.
Bikin bazara (Sinanci Sabuwar Shekara) wanda ya faɗi a ranar 25 ga Janairu, 2020 ya zama abin tunawa da ba a taɓa gani ba ga duk Sinawa, waɗanda saboda barkewar sabon kamuwa da kwayar cutar, an bukaci su zauna a gida a duk lokacin bikin da makonni da yawa bayan haka.
Bisa la'akari da irin kamannin da ke tsakanin cutar coronavirus (CoV) da ta haifar da barkewar cutar SARS a shekarar 2003, Hukumar Lafiya ta Duniya (WHO) a ranar 11 ga Fabrairu, 2020 ta sanya wa wannan cutar suna SARS-CoV-2, kuma cutar da ke tattare da shi  cutar coronavirus 19 (COVID-19).
Cutar ta fara ne a birnin Wuhan na kasar Sin, kuma ta yadu cikin sauri a duk fadin kasar, daga nan kuma zuwa kusan kasashe 50 na duniya.
A ranar 2 ga Maris, 2020, an gano sama da mutane 80,000 da aka tabbatar da cutar COVID-19, sama da marasa lafiya 40,000 sun warke, sama da marasa lafiya 3,000 sun mutu.
WHO ta yi gargadin cewa COVID-19 shine "magabcin farko na al'umma" kuma yana iya zama mafi haɗari fiye da ta'addanci.
A cewar PubMed (https://www.ncbi.nlm.nih.gov/pubmed/), a cikin ƙasa da watanni biyu, an sami wallafe-wallafe sama da 200 game da COVID-19, gami da labarai game da kwayar cutar, cutar, ilimin halitta, ganewar asali da magani, tun daga rahoton farko na Janairu 7, 2020, wanda ya gano jerin kwayar cutar da aka ware daga wasu marasa lafiya.
Wannan bita na ƙoƙari ne na taƙaita sakamakon bincike a cikin sabon da kuma saurin bunkasa fannin.
A duk inda za mu iya, za mu gwada COVID-19 da SARS da kuma wasu cututtukan coronavirus  Coronavirus na Gabas ta Tsakiya (MERS), wanda ya barke a shekarar 2012.
Za mu kuma tattauna abubuwan da aka sani a yanzu game da rigakafi da kuma yadda ake tsinkayar cutar, da kuma wasu batutuwa masu muhimmanci.
Kwayar cutar korona ta kasance a cikin masu cutar da ba ta da haɗari ga mutum kuma galibi tana haifar da kusan kashi 15 cikin ɗari na cututtukan numfashi na kowacce shekara 4.
Duk da haka, mun sha fama da cututtukan korona masu saurin yaduwa a cikin wannan karni sau biyu, wato SARS-CoV-2 da kuma MERS-CoV, wadanda suka fara bullowa a China a 2003 da Saudi Arabiya a 2012 kuma nan da nan suka bazu zuwa wasu ƙasashe da ke da yawan cutar da kuma mutuwa.
Saboda haka, COVID-19 na yanzu shine fashewar cutar coronavirus ta uku a tarihin ɗan adam.
Kamar yadda aka nuna a hoto na 1.1, rahoton farko game da tarin cututtukan cutar huhu da ba a san asalin su ba ya shiga Hukumar Kula da Lafiya ta kasa ta kasar Sin daga birnin Wuhan a ranar 31 ga watan Disamba na shekarar 2019.
Bayan kwana bakwai, sai aka fitar da tsarin kwayoyin cutar.
A ranar 15 ga Janairu, 2020, an samu mace-mace ta farko a birnin Wuhan.
A halin yanzu, annobar ta bazu cikin sauri zuwa garuruwa, larduna da ƙasashe makwabta.
A ranar 20 ga watan Janairu, an gano cewa ma'aikatan lafiya sun kamu da cutar, wanda hakan ya ba da damar yin tunanin yiwuwar kamuwa da cutar daga mutum zuwa mutum.
A ranar 23 ga watan Janairu, an kafa dokar hana fita a birnin Wuhan, kuma an dakatar da zirga-zirgar jama'a a birnin.
A ranar 24 ga watan Janairu, an gano cewa 21 daga cikin 41 da suka kamu da cutar coronavirus sun yi hulɗa kai tsaye da kasuwar abincin teku a birnin Wuhan, wanda aka ɗauka cewa wurin da cutar ta fito daga dabba ce da ba a san ko ta fito daga ina ba.
A ranar 30 ga watan Janairu, WHO ta ayyana annobar coronavirus a matsayin gaggawa ta duniya a fannin kiwon lafiyar jama'a.
A lokacin da ake shirya wannan rahoton, cutar ta yadu a duk fadin kasar Sin kuma ta riga ta shiga wasu kasashe 50 a duniya (hoto na 2).
Idan aka yi la'akari da yadda yanayin yake, ba a san ainihin yadda za a iya kai hari ba.
A ranar 11 ga Fabrairu, 2020, sakamakon binciken asibiti da aka yi a cibiyoyi da dama, wanda ya shafi marasa lafiya 8,866, ciki har da marasa lafiya 4,021 da aka tabbatar da cutar COVID-19, an gabatar da wannan sabon hoto na ci gaban annobar (https://mp.weixin.qq.com/s/UlBi-HX_rHPXa1qHA2bhdA).
An gano cewa SARS-CoV-2 ya kamu da cutar a duk shekarun mutane, amma yawanci mutane ne masu shekaru 30 zuwa 65.
Kusan rabin (47.7%) na waɗanda suka kamu da cutar sun haura shekaru 50, kaɗan  ne ƙanana da shekaru 20, kuma 14 ne kawai suka kamu da cutar ba su kai shekara 10 ba.
Cutar SARS-CoV-2 ta fi yawa a tsakanin maza (0,31/100 000), fiye da mata (0,27/100 000).
COVID-19 ya yadu a cikin rukuni a lardin Hubei da yankuna da ke kusa.
A matsakaita, kwanaki 5 (29) suka wuce tun lokacin da aka fara nuna alamun cutar COVID-19 har sai an gano cutar.
Lokacin da aka yi amfani da shi a cikin yanayin da aka yi amfani da shi a cikin yanayin da aka yi amfani da shi a cikin yanayin da aka yi amfani da shi a cikin yanayin da aka yi amfani da shi a cikin yanayin da aka yi amfani da shi a cikin yanayin da aka yi amfani da shi a cikin yanayin da aka yi amfani da shi a cikin yanayin da aka yi amfani da shi a cikin yanayin da aka yi amfani da shi a cikin yanayin da aka yi amfani da shi a cikin yanayin da aka yi amfani da shi.
Daga lokacin bayyanar cututtuka zuwa lokacin mutuwa, a matsakaita, kwana 9.5 (4,813) suka wuce.
Matsayin asali na sake haifuwa (R0) ya kai 3,77 (95 % CI: 3,514,05), kuma gyara R0 ya kai 2,234,82.
A ranar 23 ga Janairu, 2020, an samu karuwar masu kamuwa da cutar, wanda ya yi daidai da lokacin da aka yi manyan motocin sufuri a ranar bikin Sabuwar Shekarar kasar Sin.
Mutuwa tsakanin marasa lafiya tare da tabbatar da ganewar asali ya kai 1,44 % (95 % CI: 1,101,86 %), kuma daidaitaccen alamar mutuwa tsakanin marasa lafiya  3,06 % (95 % CI: 2,024,59 %).
Abubuwa uku na haɗari a cikin kamuwa da COVID-19 sune: jinsi (maza), shekaru (≥60) da kuma mummunan cutar huhu.
Kwayar cutar korona wani nau'i ne na manyan kwayar cuta masu dauke da zaren RNA guda.
Za a iya raba su zuwa nau'i hudu, wato alpha, beta, gamma da delta, wanda aka san cewa alpha da beta suna cutar da mutane.
A cikin cutar SARS da MERS, glycoprotein na shinge na spiro (S) yana haɗuwa da masu karɓar kwayar cutar mai canza angiotensin na nau'in 2 (ACE2) da dipoptidylpeptidaze-4 (DPP4), bi da bi, bayan haka ana yin sinadarin membrane.
A cikin cytoplasm, an saki kwayar cutar RNA; bayan kwayar cutar ta kwayar cutar, RNA tare da glicoprotein da nucleocapsid sun hada da kwayar cutar ta haifar da kwayar cutar da ke dauke da kwayar cutar, wanda daga bisani ya haɗu da kwayar halitta, yana sakin kwayar cutar.
Rahotanni na farko game da jerin kwayoyin SARS-CoV-2 sun bayyana a ranar 10 ga Janairu, 2020.
An gano cewa SARS-CoV-2 wani sabon nau'in kwayar cutar beta ne, wanda kwayoyin halittarsa sun yi daidai da kashi 99.98 cikin 100 na samfurori 10 da aka tattara a kasuwar abincin teku ta Huanan a Wuhan.
SARS-CoV-2 ya fi kusa da SARS-CoV a cikin kwayoyin halitta fiye da MERS-CoV.
Ta hanyar amfani da hasken lantarki, an gano SARS-CoV-2 a cikin ƙananan ɓangarorin jikin mutum.
An gano cewa enzyme na mutum ACE2 shine mai karɓa ga SARS-CoV-2, kamar yadda yake ga SARS-CoV.
Duk da haka, S-protein SARS-CoV-2 yana da rauni a haɗe da enzyme na ACE2 na ɗan adam fiye da SARS-CoV, wanda ke bayyana gaskiyar cewa SARS-CoV-2 yana haifar da rashin lafiya a cikin marasa lafiya fiye da SARS-CoV.
SARS-CoV-2 na iya samar da wani furotin mai ɗan gajeren lokaci wanda ba a san shi ba, wanda aka tsara shi da orf3b, da kuma wani furotin da ake iya ɓoyewa wanda aka tsara shi da orf8.
Kwayar cutar SARS-CoV-2 orf3b na iya taka rawa a yanayin cutar cutar kuma ta hana bayyana IFNβ; duk da haka orf8 ba ta da wani sanannen yanki na aiki ko dalili.
A ranar 18 ga Fabrairu, 2020, ƙungiyar marubuta karkashin jagorancin Zhou sun gabatar da rahotanni game da cryophone tomography na tsarin enzymes na mutum mai girma ACE2 tare da ƙuduri 2,9 Å a cikin hadaddun tare da mai jigilar amino acid B0AT1.
Sun gano cewa wannan hadadden, wanda ya hada da bayyanar da kuma rufewa, an hada shi kamar dimer kuma cewa hadadden ACE2-B0AT1 na iya hada sunadarai biyu na S, wanda hakan ya zama hujja wajen ganewa da kamuwa da cutar coronavirus.
B0AT1 na iya zama abin da ake so a yi amfani da shi wajen yin gwajin magani don hana kamuwa da cutar SARS-CoV-2.
Tushen da kuma mai shi na ɗan lokaci
An san cewa SARS-CoV da MERS-CoV sun samo asali ne daga beraye, wanda daga gare su ne cutar ta yadu ga mutane ta hanyar tsirrai da raƙuma.
Ta hanyar kwatanta SARS-CoV-2 da sauran kwayar cutar korona, an gano cewa SARS-CoV-2 na farko da aka fara amfani da shi shi ne batsa, saboda sabon kwayar cutar ta yi daidai da kashi 96 cikin dari na kwayar cutar SARS guda biyu, wato SL-CoVZX45 da SL-CoVZX21.
Amma ba a san ko wane irin nau'in ne ya zama mai masaukin baki ba, wanda ya sa cutar ta iya tsallake shingen nau'in kuma ta iya kamuwa da mutane; hanyar watsawa kuma har yanzu ba a gano ba.
Ji da abokan aikinsa sun ce macizai ne suka ɗauki kwayar cutar daga batutuwan zuwa ga mutane, kuma sun yi amfani da S-protein don yin hakan.
Bisa ga binciken da suka yi, masana kimiyya na kasar Sin daga Guangzhou sun yi hasashen cewa pangolins  dabbobi masu shayarwa masu dogon baki, waɗanda suke cin nama da kuma waɗanda ake amfani da su a cikin maganin gargajiya na kasar Sin  su ne masu iya daukar bakuncin SARS-CoV-2; wannan hasashen ya dogara ne akan kamannin kwayoyin kashi 99 cikin dari tsakanin kwayar cutar coronavirus ta pangolins da SARS-CoV-2.
Duk da haka, bambancin 1%, wanda aka rarraba tsakanin kwayoyin halittar biyu, duk da haka, yana da girma sosai, saboda haka an yi la'akari da cewa ba a sami sakamako na ƙarshe tare da takamaiman shaida ba tukuna (siffa 33).
Ba a san ainihin yanayin jiki da kuma sinadarin SARS-CoV-2 ba.
A cikin yanayin dakin gwaje-gwaje, SARS-CoV da MERS-CoV na iya rayuwa na tsawon sa'o'i 48 a cikin bushewar yanayi da kuma har zuwa kwanaki 5 a yanayin zafi da ke ƙasa da 20 °C da 4050 % na danshi.
SARS-CoV-2 na iya samun irin wannan halayen.
An san cewa SARS-CoV-2 yana da saukin kamuwa da hasken ultraviolet da kuma zafin jiki har zuwa 56 °C na tsawon minti 30; ether, kashi 75 cikin dari na barasa, sinadarin kashe ƙwayoyin cuta masu dauke da chlorine, peruxous acid, chloroform da sauran mai narkewa na iya toshe tasirin kwayar cutar, amma ba chlorhexidine ba.
Yawan mutane ba su da kariya ga SARS-CoV-2 saboda haka mutane suna iya kamuwa da sabon kwayar cutar.
A halin yanzu babu bayanai game da cikakken binciken da aka yi na yadda ƙwayar cutar ke amsa cutar SARS-CoV-2.
Saboda haka, za mu iya komawa ga binciken da aka yi a baya game da wasu ƙwayoyin cuta, musamman SARS-CoV da MERS-CoV (siffa 4).
A yadda aka saba, kwayar cutar da ta shiga jikin mai gida tana gane ta farko ta hanyar tsarin garkuwar jiki ta hanyar masu karɓar hoto (ORP), gami da masu karɓar lectin na nau'in C, masu karɓar Toll, masu karɓar NOD, da masu karɓar RIG-I.
Ta hanyar hanyoyi daban-daban, kwayar cutar tana haifar da bayyanar cututtukan kumburi, tsufa na kwayoyin dendrites da kuma hadawar nau'in interferons na I, wanda ke hana yaduwar kwayar cutar kuma yana hanzarta fashocytosis na macrophages game da kwayoyin cutar.
Amma, saboda N-protein SARS-CoV zai iya kaucewa amsawar garkuwar jiki.
Ba da daɗewa ba, rigakafin jiki zai iya yaƙi da cutar.
T-Lymphocytes, ciki har da T-cell CD4+ da CD8+, suna taka muhimmiyar rawa wajen kare jiki.
CD4+ T-cell suna motsa kwayar cutar ta B ta samar da kwayoyin cutar, kuma CD8+ T-cell suna kashe kwayoyin cutar kai tsaye.
T-helper suna samar da sinadarin cytokines da ke hana kumburi, wanda ke taimaka wa ƙwayoyinmu su guje wa kumburi.
Koyaya, kwayar cutar korona na iya hana ayyukan ƙwayoyin T, ta sa su mutu bisa tsari.
Tsarin rigakafin jiki, wanda ya ƙunshi abubuwa kamar C3a da C5a da kuma ƙwayoyin cuta, yana da muhimmanci wajen yaƙi da kamuwa da ƙwayoyin cuta.
Alal misali, ƙwayoyin cuta da aka cire daga mai ciwon da ya warke sun kawar da cutar MERS-CoV.
A wani ɓangare kuma, ƙwayar cuta tana sa mu kamu da ƙwayoyin cuta da yawa a gida, kuma hakan zai iya sa mu yi ciwon huhu da kuma wasu gabobin jiki, kuma idan aka yi mugun abu, zai iya sa mu kamu da rashin aiki da kuma mutuwa.
Cutar SARS-CoV-2 wadda ke nuna tarin cututtuka, tana iya shafar tsofaffi da ke da cututtuka da kuma mata masu juna biyu.
Mutane da suke da ƙwayoyin cuta da yawa ko kuma waɗanda suke da ƙwayoyin cuta masu guba suna da haɗarin kamuwa da cuta.
Bisa ga binciken da aka yi na mutane 425 da suka kamu da cutar a birnin Wuhan, ana kiyasta matsakaicin lokacin da cutar SARS-CoV-2 ke kwance a cikin jiki daga kwana 1 zuwa 14, yawanci kwanaki 3.
Amma binciken da aka yi na mutane 1,099 ya nuna cewa lokacin da suka yi juna biyu ya kai kwanaki uku, kuma ya kai kwanaki 24 a kowane lokaci.
Wani bincike da aka yi a baya, wanda ya yi amfani da bayanan alƙaluma na mutane 8,866, ya nuna cewa lokacin da ake yi wa mutum ciki ya kai kwanaki 4.8 (3.07.2).
Yana da muhimmanci ga hukumomin kiwon lafiya su daidaita lokacin da aka kafa matakan killacewa bisa cikakken lissafin tsawon lokacin da ake yi na kwantar da cutar, don hana yaduwar cutar a cikin waɗanda ke da cutar ba tare da bayyanar cututtuka ba.
An yi amfani da keɓewar kwanaki 14 ga mutanen da suka sadu da cutar ko kuma waɗanda suka kamu da ita.
Ya kamata a tsawaita lokacin keɓewa zuwa kwanaki 24?
Babban alama na COVID-19 sau da yawa zazzabi ne, wanda zai iya zama bayyanar kawai ko kuma ya zo tare da wasu alamun kamar tari mai bushe, wahalar numfashi, ciwon tsoka, zazzaɓi, ciwon kai, ciwon makogwaro, kumburi, ciwon kirji, zawo, rashin jin daɗi da amai.
Wasu marasa lafiya sun yi rashin numfashi da kuma (ko) hypoxia bayan mako guda bayan fara cutar.
A cikin mawuyacin hali, cutar ta ci gaba da sauri, kuma marasa lafiya sun sami cututtukan numfashi, haɗarin haɗari, acid mai maye gurbi, da coagulopathy.
Ya kamata a gwada marasa lafiya masu zazzabi da (ko) alamun cututtukan numfashi da zazzabi mai tsanani don gano cutar da wuri, ko da ba a sami wata cuta ba a hotunan kirji.
Binciken alƙaluma da aka gudanar a ƙarshen Disamba na 2019 ya gano alamun bayyanar cututtuka kamar haka: 98  zazzabi, 76  tari mai bushe, 55  numfashi mai guba da 3%  zawo; 8  % na marasa lafiya sun buƙaci yin amfani da iska mai iska.
An samu irin wannan sakamako a cikin bincike biyu na baya-bayan nan na kamuwa da cutar a cikin iyali da kuma kamuwa da cutar daga marasa cutar.
An samu irin wannan sakamako a shekarar 2012 a cikin binciken marasa lafiya da ke dauke da cutar MERS-CoV, wadanda kuma manyan alamun cutar su ne zazzabi (98%), tari mai bushe (47%) da kuma rashin numfashi (55%).
Amma kashi 80 cikin 100 na su sun bukaci yin amfani da iska mai guba, wanda ya fi na COVID-19 yawa, kuma ya yi daidai da yawan mutuwar MERS fiye da COVID-19.
A cikin marasa lafiya da ke fama da cutar MERS an kuma lura da zawo (26%) da ciwon makogwaro (21%).
Babban alamun marasa lafiya da ke dauke da cutar SARS sune zazzabi (99100 %), tari mai bushe (2975 %), rashin numfashi (4042 %), zawo (2025 %) da ciwon makogwaro (1325 %), kuma ana bukatar yin amfani da iska ta wucin gadi a cikin 1420 % na marasa lafiya.
A ranar 14 ga Fabrairu, mutuwar COVID-19 ya kai kashi 2%, kuma jimillar adadin waɗanda aka tabbatar da su a duniya ya kai 66,576.
Idan aka kwatanta da wannan, mutuwar SARS a watan Nuwamba na shekara ta 2002 ya kai kashi 10 cikin 100 na mutane 8,096 da aka tabbatar da cutar.
A cikin yanayin cutar MERS, binciken alƙaluma da aka gudanar a watan Yunin 2012 ya nuna cewa mutuwar mutane 37% ne daga cikin 2,494 da aka tabbatar da su.
A cikin binciken da aka yi a baya, an gano ma'aunin haifuwa (R0) na SARS-CoV-2 a matakin 6.47 a cikin kashi 95 cikin dari na lokacin amincewa (CI) a cikin kewayon 5.717.23, yayin da R0 na SARS-CoV ya kasance a cikin kewayon 2 zuwa 4.
Kwatanta SARS-CoV-2 da MERS-CoV da SARA-CoV bisa ga bayyanar cututtuka, matakin mutuwa da kuma R0 an nuna su a cikin tebur Table 1.1.
Abubuwan da aka ambata a sama sun nuna cewa SARS-CoV-2 na da karfin yaduwa fiye da MERS-CoV da SARS-CoV, amma yawan mutuwar da ake samu daga sabon kwayar cutar ya fi na na biyun.
Saboda haka, ya fi wahalar hana barkewar cutar SARS-CoV-2 fiye da yadda ya faru da cutar MERS-CoV da SARS-CoV.
Cluster sau da yawa yakan faru ne a cikin iyali ɗaya ko kuma a cikin mutane da suka taru don wani dalili ko kuma suka shiga jirgin ruwa, kamar jirgin ruwa mai tafiya.
Marasa lafiya sun yi tafiya zuwa birnin Wuhan ko wasu yankuna da cutar ta shafa, sun zauna a wurin ko kuma sun yi hulɗa da waɗanda suka kamu da cutar ko kuma waɗanda suka kamu da cutar a cikin makonni biyu da suka gabata kafin cutar ta fara.
Amma rahotanni sun nuna cewa mutane na iya kamuwa da cutar ba tare da wata alama ba har tsawon makonni biyu, kuma masu lafiya da aka sallame daga asibiti na iya sake kamuwa da cutar, kuma wannan alama ce mai ban tsoro ga tsawaita lokacin keɓewa.
A farkon lokaci, marasa lafiya suna da ƙarancin ƙwayoyin jini (musamman lymphocytes) a cikin jini.
Alal misali, an gano ƙwayoyin cuta masu ƙarancin jini < 4×109/L a cikin marasa lafiya 1,099 da ke da cutar COVID-19, ciki har da ƙwayoyin cuta masu ƙarancin jini < 1×109/L, da kuma ƙaruwa a cikin asparagin-aminotransferase da kuma cutar virusemia.
An gano yawan ƙwayoyin hanta, ƙwayoyin tsoka, da kuma ƙwayar myoglobin a cikin jinin wasu marasa lafiya, kuma yawancin marasa lafiya suna da ƙwayoyin C-reactive da kuma ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin cuta.
A cikin marasa lafiya masu ciwon, yawan D-dimer, wanda shi ne kayan da ke sa fibrin ya rushe a cikin jini, ya ƙaru kuma yawan ƙwayoyin lymphocytes sun ragu.
Yawancin marasa lafiya da ke da COVID-19 sun sami cututtuka a cikin ƙirjin su ta hanyar yin amfani da radiyo wanda ke nuna rashin daidaito a bangarorin biyu ko kuma a cikin huhu.
Sau da yawa marasa lafiya suna samun ciwon huhu, ciwon huhu mai tsanani da kuma cututtukan numfashi mai tsanani.
Idan mutum yana da ciwon ciwon zuciya, sai ya yi kumburi da yawa, ya yi ruwa da yawa, kuma ya ci gaba da shan ciwon, sai ya yi rashin iskar gas.
Rashin aiki na nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'
Saboda haka, sakamakon da ba shi da kyau a gwajin da ake yi wa mutane sau da yawa yana nuna cewa suna da ciwo mai tsanani.
A ranar 18 ga Fabrairu, 2020, gwajin farko na COVID-19 ya nuna ɓarkewar ƙwayoyin huhu, samar da membrane na hyaline da kuma shiga cikin ƙwayoyin lymphocyte, kuma ƙwayoyin syncytial na ƙwayoyin cuta da yawa a cikin huhu na marasa lafiya da suka mutu daga cutar sun dace da cutar kwayar cuta da kuma ARV kuma sun yi kama da waɗanda aka samu a cikin marasa lafiya tare da SARS da MERS.
A matsayin babban ma'auni yayin gano COVID-19, an yi amfani da hanyar gano SARS-CoV-2 RNA ta hanyar polymerase chain reaction tare da juyawa (PCR tare da juyawa).
Amma, saboda yawan sakamakon da ba daidai ba da ke iya hanzarta yaduwar annobar, daga ranar 13 ga Fabrairu, 2020, an fara tantance cutar a kasar Sin bisa alamun asibiti (ba tare da dogaro da PCR ba tare da sake fassarar bayanan).
Haka ma yanayin yake da cutar SARS.
Saboda haka, don a iya gane cutar da kyau, yana da muhimmanci a haɗa bayanan da ke cikin tarihin cutar, da na asibiti, da na gwaji, da kuma na radiyo.
A ranar 14 ga Fabrairu, 2020, wata ƙungiyar masana karkashin jagorancin Mr. Feng Zhang sun bayyana yarjejeniyar amfani da hanyar SHERLOCK, bisa maimaita CRISPR, don gano SARS-CoV-2; wannan hanyar tana ba da damar gano ɓangarorin SARS-CoV-2 RNA na roba a cikin ƙarancin 20 × 1018 mol / l zuwa 200 × 1018 mol / l (10100 kwafi a kowace microliter na samfurin asali) ta amfani da siginan sigina a cikin ƙasa da awa ɗaya ba tare da amfani da kayan aiki mai rikitarwa ba.
Wannan sabuwar hanyar, idan ta yi nasara a gwajin magani, za ta iya inganta ƙwarewar gwaji da kuma sauƙin gudanar da su.
Saboda rashin ƙwarewa wajen magance cutar coronavirus da ba a sani ba, likitoci na iya ba marasa lafiya da ke da COVID-19 magani na tallafi kawai, yayin da suke ƙoƙarin yin amfani da wasu hanyoyin warkarwa da aka yi amfani da su ko aka ba da shawarar su wajen magance wasu cututtukan coronavirus, kamar SARS-CoV da MERS-CoV, da sauran cututtukan ƙwayoyin cuta (tebur (tebur 2).2).
Waɗannan hanyoyin warkewa sun haɗa da shan magungunan rigakafin ƙwayoyin cuta, masu hana rigakafi, steroids, plasma na marasa lafiya da suka warke, maganin gargajiya na kasar Sin, da kuma taimakon tunani.
An ce ana iya yin amfani da jini daga marasa lafiya da suka warke.
Kamfanonin harhada magunguna suna gaggauta samar da rigakafi da kuma allurar rigakafi don yaki da cutar.
A farkon, SARS-CoV-2 ya fi kaiwa ga huhu, kuma yana iya kaiwa ga wasu gabobin da ke bayyana ACE2, kamar hanji da kuma koda.
Duk da haka, rashin aiki da kuma rashin aiki na jikin numfashi ne ke da muhimmanci a rayuwar marasa lafiya.
Saboda haka, don sauƙaƙa bayyanar cututtuka da ceton rayuka, yana da mahimmanci a tallafawa aikin numfashi, gami da maganin oxygen na gaba ɗaya, samar da iskar oxygen mai ƙarfi, iska mai iska mai ƙarfi da iska mai ƙarfi, wanda aka tsara dangane da tsananin yanayin cutar.
Marasa lafiya da ke da alamun numfashi masu tsanani suna bukatar tallafi ta hanyar yin amfani da iskar oxygen ta waje da jiki (ECMO), wata hanyar da aka gyara don yin amfani da jini a waje da jijiyoyin jini, wadda ake amfani da ita wajen magance cututtukan zuciya da na numfashi.
Bugu da ƙari, kiyaye daidaiton ruwa da gishiri, hanawa da kuma kula da cututtuka na biyu da kuma girgizar sararin samaniya, da kuma kare ayyukan gabobin jiki na da muhimmanci ga marasa lafiya da ke dauke da SARS-CoV-2.
An san cewa, wannan hadarin na cytokine sakamakon hawan karfin jikin marasa lafiya ne da ke dauke da cutar SARS da MERS.
Cutar Cytokine wani nau'i ne na tsarin kumburi wanda ke tasowa a cikin martani ga sakin jerin cytokines, ciki har da TNFα, IL-1β, IL-2, IL-6, IFNα, IFNβ, IFNγ da MCP-1.
Waɗannan sunadarai suna sa ƙwayoyin cuta su fitar da ƙwayoyin cuta masu yawa da suke sa mutane su kamu da cututtukan zuciya da kuma rashin isasshen kwayoyin halitta.
A lokacin da ake warkar da cutar cytokine, musamman ma a cikin marasa lafiya masu tsanani, hana rigakafi yana da muhimmanci.
Don maganin guguwar cytokine, an yi amfani da maganin corticosteroids da tocilizumab, ƙwayoyin cuta masu ƙwayoyin cuta masu aiki a matsayin mai hana interleukin-6.
Sauran hanyoyin maganin cytocin storm, waɗanda suka dogara da hana rigakafi, sun haɗa da daidaitawar amsawar rigakafi, wanda aka nufa don sarrafa ƙwayoyin T; toshewar fitowar cytocin IFN-γ, IL-1, da TNF; hana janus-kinase; amfani da blinatumomab, suppressors na siginar cytocin 4 da masu hana histoneacetalase.
Ana amfani da kwayoyin steroid a matsayin masu hana rigakafi don rage tsananin sakamakon cutar SARS.
Amma, steroids masu yawa ba su da amfani wajen kula da mummunar lalacewar huhu a cikin marasa lafiya da ke da SARS da COVID-19.
Maimakon haka, suna iya haifar da mummunar illa, musamman cutar osteonecrosis, wadda ke sa yanayin rashin lafiyar ya yi muni sosai.
Duk da haka, ana ba da shawarar a yi amfani da gajeren maganin corticosteroid a ƙananan da matsakaitan allurai a hankali wajen kula da marasa lafiya masu cutar COVID-19 a cikin mawuyacin yanayi.
A lokacin da ake rubuta wannan, babu wani magani da aka tabbatar yana da tasiri.
Amma, maganin remdesivir, wanda yake da kwayar nucleotide, ya yi tasiri wajen kula da wani mai cutar COVID-19 a Amurka.
Remdecivir wani sabon magani ne na rigakafin cutar da kamfanin Gilead ya fara samarwa don magance cututtukan da ƙwayoyin cutar Ebola da Marburg ke haifarwa.
Daga baya, remdesivir ya nuna cewa yana iya kawar da wasu ƙwayoyin cuta masu RNA guda ɗaya, ciki har da ƙwayoyin cuta na MERS da SARS.
Bisa ga wannan bayanin, Gilead ta ba da wannan maganin ga China don yin gwaji na biyu a kan marasa lafiya da ke dauke da cutar SARS-CoV-2, kuma ana jiran sakamakon binciken.
Bugu da ƙari, baricitinib, α-interferon, lopinavir/ ritonavir, da ribavirin an ba da shawarar a matsayin zaɓuɓɓukan magani ga marasa lafiya da ke da alamun cututtukan numfashi.
Maganin haɗin da aka yi da lopinavir/ritonavir zai iya haifar da zawo, rashin jin daɗi, amai, raunin hanta, da sauran sakamako masu illa.
Ya kamata a lura da yadda waɗannan magungunan suke shafan wasu magunguna da aka ba marasa lafiya.
Plasma na marasa lafiya da suka warke da kuma samar da kwayoyin cutar
An daɗe ana yin amfani da jini daga marasa lafiya da suka warke daga wata cuta mai saurin yaɗuwa don a yi wa wasu marasa lafiya da suke da wannan cuta magani ko kuma a kāre mutane masu lafiya.
A gaskiya ma, jinin marasa lafiya da suka warke yana ɗauke da ƙwayoyin cuta masu yawa da suke yaƙi da wannan cuta.
Antibodies suna cikin immunoglobulin da B-lymphocytes ke samarwa don yaƙar ƙwayoyin cuta da sauran abubuwa na waje; suna gane wasu kwayoyin ƙwayoyin cuta kuma suna kawar da su.
Bisa ga wannan zato, an cire jini daga samfurin jini na rukunin marasa lafiya da suka warke daga COVID-19, sannan aka saka wa marasa lafiya 10 masu fama da cutar.
A cikin sa'o'i 24 suka sami ci gaba a cikin bayyanar cututtuka, rage ƙarancin kumburi da ƙwayar cutar, da kuma ƙaruwa a cikin jini na oxygen.
Amma, don a ce za a yi amfani da wannan hanyar a kan mutane da yawa kafin a yi amfani da wani magani, ana bukatar a yi bincike a kan wannan hanyar kuma a yi bayani a kan wannan batun.
Bugu da ƙari, ya kamata a bincika wasu ƙalubalen da ake fuskanta sa'ad da ake amfani da jini domin a san yadda zai iya taimaka wa mutum.
Alal misali, ƙwayoyin cuta suna iya sa jikin mutum ya yi tsayayya da cuta kuma hakan zai iya sa mutum ya yi ciwon cytokine, wanda hakan zai iya kashe mutum.
Yawan kwayoyin cutar a cikin jini ba shi da yawa, kuma ana bukatar jini mai yawa don kula da marasa lafiya masu tsanani.
Ba shi da sauƙi a ƙera kuma a samar da takamaiman ƙwayoyin cuta da sauri don magance annobar duniya.
Saboda haka, yana da muhimmanci kuma ya fi dacewa a ware ƙwayoyin B daga marasa lafiya da suka warke kuma a gano lambar kwayoyin da ke da tasiri ko kuma a yi bincike don gano ƙwayoyin cuta masu tasiri a kan wasu sunadarai masu muhimmanci na kwayar cutar.
Wannan zai sa mu iya yin amfani da maganin nan take.
A cikin shekaru dubbai, mutanen China sun yi amfani da maganin gargajiya don magance cututtuka daban-daban.
Amma, ingancinsa ya dogara ne da haɗuwa da abubuwa da yawa na ƙira, wanda abun da ke ciki ya bambanta dangane da ganewar asali na cutar, bisa ka'idodin maganin gargajiya na kasar Sin.
Yawancin abubuwan da ke da tasiri har yanzu ba a san su ba ko kuma suna da aiki mara tabbas, saboda ganowa da gwada waɗannan abubuwan ko haɗuwa da su mafi kyau yana da wahala.
A halin yanzu, saboda rashin ingantaccen maganin COVID-19, maganin gargajiya na kasar Sin ya zama daya daga cikin manyan hanyoyin magance marasa lafiya masu saurin rashin lafiya ko kuma marasa lafiya da ke murmurewa daga mawuyacin yanayi.
Alal misali, Shu Feng Jie Du da Lian Hua Qing Wen sun tabbatar da inganci wajen maganin COVID-19.
An samu mafi yawan masu warkewa daga COVID-19 a lardunan Sin da suka yi amfani da maganin gargajiya na kasar Sin wajen kula da kashi 87 cikin dari na marasa lafiya, ciki har da Gansu (63.7%), Ningxi (50%) da Hunan (50%), yayin da a lardin Hubei, inda aka yi amfani da maganin gargajiya na kasar Sin wajen kula da kusan kashi 30 cikin 100 na marasa lafiya da ke fama da COVID-19, an samu mafi karancin masu warkewa (13%) a lardin.
Amma wannan kwatancen bai dace ba domin ana bukatar a yi la'akari da wasu abubuwa da yawa, kamar yawan marasa lafiya da kuma yadda suke da ciwo.
A ranar 18 ga Fabrairu, 2020, Mr. Boli Zhang da abokan aikinsa sun wallafa wani bincike da ya kwatanta hanyoyin magani na yammaci da hanyoyin magani na yammaci da na gargajiya na kasar Sin.
Sun gano cewa, masu shan magani da suka yi amfani da hanyoyin gargajiya na yamma da na kasar Sin sun fi waɗanda suka yi amfani da hanyoyin gargajiya na yamma jinkirin samun zafin jiki, warkewa, da kuma samun kulawar likita.
Abin mamaki shi ne, yawan marasa lafiya da suka fara samun munanan cututtuka (daga mai sauƙi zuwa mai tsanani) sun fi ƙasa a cikin rukunin da aka bi da hanyoyin gargajiya na Yammacin Turai da na kasar Sin fiye da waɗanda aka bi da su ta hanyar Yammacin Turai (7.4% da 46.2%) kuma yawan mutuwar marasa lafiya a cikin rukunin farko ya fi ƙasa da na biyun (8.8% da 39%).
Duk da haka, inganci da amincin maganin gargajiya na kasar Sin har yanzu yana buƙatar ƙarin bincike mai kulawa, wanda aka gudanar a mafi girma kuma a cikin yankuna da yawa.
Wani sha'awa kuma shine samun yiwuwar bayanin aikin aiki da kuma bayanin bangarorin ingancin abubuwan da ake amfani da su a cikin hanyoyin maganin gargajiya na kasar Sin, ko kuma haɗuwa da su.
Marasa lafiya da ke da ko kuma ke da COVID-19 suna yawan jin tsoron kamuwa da cutar, har ma da mutuwa, kuma mutanen da ke keɓewa suna jin bacin rai, kaɗaici da kuma fushi sosai.
Ƙari ga haka, alamun kamuwa da cuta kamar zazzabi, rashin ƙarfi, da kuma tari, da kuma sakamako na magani kamar rashin bacci da ake samu daga maganin corticosteroids, suna iya ƙara yawan damuwa da kuma damuwa.
A farkon barkewar cutar SARS, an bayar da rahoton bayyanar cututtukan kwakwalwa da dama, ciki har da ciwon zuciya, tashin hankali, tashin hankali, tashin hankali, bayyanar cututtukan zuciya, ɓacin rai, da kuma halin kashe kansa.
Kulawa da keɓewa da ake bukata a matsayin wani ɓangare na matakan da hukumomin kiwon lafiya ke ɗauka don hana yaduwar COVID-19, na iya ƙara damuwa da alhakin mutane game da yaduwar kamuwa da cuta, keɓewa da kuma nuna rashin jin daɗi ga danginsu da abokai.
Saboda haka, ya kamata a ba da taimako na tunani da na tunani ga waɗanda ke da cutar COVID-19, waɗanda ake zargi da kuma waɗanda suka taɓa yin hulɗa da su, da kuma duk wasu da suke bukatar taimako.
A cikin tsarin tallafi na tunani, ya kamata a kafa ƙungiyoyin kula da lafiyar kwakwalwa da yawa, a kafa ingantaccen bayani tare da sabunta bayanai a kai a kai da kuma daidai game da annobar SARS-CoV-2 da tsare-tsaren magani, da kuma amfani da na'urorin lantarki da aikace-aikacen sana'a don kaucewa kusanci na sirri.
Magungunan rigakafi masu tasiri suna taka muhimmiyar rawa wajen katse hanyar watsa cutar daga dabbobi masu dauke da cutar da kuma mutane masu kamuwa da cutar zuwa ga masu karɓa, kuma ana amfani da su ne a matsayin kari ga maganin rigakafin cutar da ake amfani da shi wajen dakile barkewar cutar da sabbin ƙwayoyin cuta ke haifarwa.
An yi aiki kan samar da alluran rigakafi bisa S-protein, wanda burin su shine samar da tsayi da kuma tsananin aiki na kawar da kwayoyin cutar SARS-CoV da (ko) kariya ta rigakafi.
A cikin binciken da aka yi a kan dabbobi, an samar da rigakafin cutar SARS mai rai.
Amma kafin a fara gwajin asibiti, ana bukatar a gano yadda za a yi amfani da waɗannan alluran rigakafi a yanayi na halitta a cikin tsofaffi, da kuma yadda za a yi amfani da su wajen kashe mutane, da kuma yadda za a iya kāre su daga kamuwa da ƙwayoyin cuta.
Wataƙila saboda SARS ya ɓace shekaru 17 da suka shige, kuma babu wani sabon hali da aka ba da rahoto tun daga lokacin.
A lokaci guda, ana ci gaba da samun wasu cututtuka da kuma tarin cututtuka da cutar MERS ke haifarwa, wanda ke samo asali a Gabas ta Tsakiya kuma yana yaduwa zuwa wasu yankuna saboda adana tushen dabbobi a wuraren da masu cutar ke zaune.
An tsara dabarun allurar rigakafi don magance MERS ta amfani da kwayar cutar da aka kashe, DNA plasmid, masu ɗaukar kwayar cutar, nanoparticles, ƙwayoyin cuta masu kama da kwayar cuta da kuma abubuwan da ke cikin sunadaran sake haɗawa, kuma an gwada wasu daga cikin waɗannan dabarun a cikin dabbobi.
Samar da maganin rigakafin SARS-CoV-2 mai lafiya da inganci ga mutanen da ba su da rigakafi gaggawa ne kuma yana bukatar mafita don hana annobar ta taɓarɓare.
Amma akwai matsaloli masu tsanani saboda tsawon lokaci (a matsakaici watanni 18) da ake bukata don samar da allurar rigakafi da kuma sauyin halittar kwayar cutar korona.
A matsayin cutar da ba a sani ba a baya, COVID-19 yana fara nuna cikakken yanayin cutar a asibiti, tare da dubban marasa lafiya.
A yawancin lokaci, marasa lafiya suna samun sauƙi a hankali ba tare da matsaloli ba.
Amma COVID-19, kamar SARS da MERS, an kuma danganta shi da yawan rikitarwa da mutuwa a tsakanin marasa lafiya masu ciwon mai tsanani.
Saboda haka, yana da muhimmanci ga ma'aikatan kiwon lafiya su tsara tsarin da zai iya nuna yadda za su yi maganin cutar, musamman ma a yankunan da ba su da isassun kayan aiki.
Bisa ga bayanan binciken asibiti da aka gabatar a yanzu, waɗannan abubuwan na iya shafar ko kuma danganta yanayin cutar a cikin marasa lafiya da ke da COVID-19 (tebur (tebur 33)):
Shekaru: Shekaru ya kasance mafi mahimmancin abin da ke haifar da cutar SARS, wanda hakan ma ya dace da COVID-19.
COVID-19 ya fi shafar marasa lafiya masu shekaru 30 zuwa 65, 47.7% daga cikinsu sun fi shekaru 50, bisa ga binciken da aka ambata na 8,866.
Marasa lafiya da suka bukaci kulawa mai zurfi sun fi samun cututtuka da rikitarwa na asali kuma sun fi tsofaffin marasa lafiya da ba su buƙatar kulawa (a matsakaita shekaru 66 da 51), wanda ke nuna cewa shekaru na iya zama sanadin cutar COVID-19.
Jima'i: kamuwa da SARS-CoV-2 ya fi na maza fiye da na mata (0.31/100,000 vs. 0.27/100,000), kamar yadda aka ambata a sama.
Rashin lafiya da rikitarwa: marasa lafiya da ke da COVID-19 da suke bukatar kulawa mai tsanani suna da damar samun raunin zuciya mai saurin tashi da kuma rashin isasshen jini.
Abubuwan da ke faruwa a zuciya su ne kuma suka fi kashe marasa lafiya da cutar SARS.
An bayar da rahoton cewa SARS-CoV-2 na iya haɗuwa da kwayar cutar ACE2 mai kyau, wanda zai iya haifar da cutar hanta a cikin marasa lafiya da COVID-19.
Ya kamata a lura cewa shekaru da kuma ciwon da ke sa mutum ya kamu da cutar suna da nasaba sosai kuma suna iya gurbata sakamakon binciken.
Rashin daidaituwa da aka gano a binciken dakin gwaje-gwaje: Matsakaicin furotin mai amsawa na C a cikin jini yana nuna irin tsananin kumburi ko lalacewar nama, kuma an ba da shawarar yin la'akari da shi azaman mai yuwuwar yanayin cutar, amsawa ga magani da warkewa ta ƙarshe.
An kuma ba da shawarar yin la'akari da alaƙar da ke tsakanin matakin furotin mai amsawa na C, da kuma tsananin cutar da kuma hasashen cutar COVID-19.
Bugu da ƙari, ƙaruwa na lactate dehydrogenase, asparagin-aminotransferase, alanine-aminotransferase da creatine kinases na iya hango sakamakon.
Ana fitar da waɗannan sinadarai a yawancin gaɓoɓin jiki, musamman zuciya da hanta, kuma ana fitar da su sa'ad da nama ya lalace.
Saboda haka, sun kasance alamun rashin aiki na zuciya ko hanta.
Alamomin asibiti: Ana bukatar a yi la'akari da bayanan da ke cikin ƙwayar kirji da kuma ci gaban alamun asibiti a tsawon lokaci don a yi hasashen sakamakon da kuma rikitarwa na maganin COVID-19, tare da wasu dalilai.
Amfani da steroids: kamar yadda aka riga aka bayyana a sama, steroids  sune masu hana rigakafi, waɗanda aka yi amfani da su sosai a cikin cututtukan cututtuka a matsayin ƙarin magani don rage girman yanayin kumburi.
Tun da yake ana amfani da maganin corticosteroid wajen kula da marasa lafiya da ke fama da SARS, mutane da yawa da suka tsira daga cutar sun kamu da cutar avascular osteonecrosis, wanda ya haifar da nakasa da kuma rashin ingancin rayuwa.
Saboda haka, idan ana bukatar amfani da maganin steroid don maganin marasa lafiya da ke da COVID-19, ya kamata a ba da waɗannan magungunan a ƙananan allurai da kuma gajere.
Damuwa ta tunani: Kamar yadda aka bayyana a sama, a cikin annobar COVID-19, marasa lafiya da yawa suna fama da matsanancin damuwa da ba a zata ba, saboda yawanci suna jure wa dogon lokaci na keɓewa, suna fuskantar rashin tabbas da kuma ganin mutuwar danginsu da sauran marasa lafiya.
Don a sauƙaƙa yanayin da suke ciki kuma a taimaka musu su koma ga rayuwarsu, ya kamata a yi musu shawarwari na tsawon lokaci.
Bisa ga binciken alƙaluma da aka yi a yanzu, annobar COVID-19 ta bambanta da annobar SARS.
Baya ga yin kwafi a cikin ƙananan hanyoyin numfashi, cutar SARS-CoV-2, kamar sauran ƙwayoyin cuta masu saurin kamuwa da mura, na iya yin kwafi a cikin ƙananan hanyoyin numfashi kuma ya haifar da ƙananan alamomi ko kuma ba ya haifar da alamomi a farkon kamuwa da cuta.
Saboda haka, marasa lafiya da ke da cutar a farkon lokaci ko kuma waɗanda ba su gama lokacin da ake cutar ba, za su iya yada kwayar cutar a manyan wurare a rayuwarsu, kuma hakan zai sa ya zama da wuya a gudanar da bincike.
Amma an yi tunanin cewa ana samun SARS-CoV lokacin da marasa lafiya suka yi rashin lafiya, yayin da yawancin marasa lafiya ba su kamu ba da wuri.
Saboda haka, annobar COVID-19 ta yau ta fi ta SARS tsanani, kuma ta fi wahalar sarrafawa.
A halin yanzu, ana gudanar da aiki mai yawa a kasar Sin, wanda ya hada da sanya dokar killace kowa a birnin Wuhan da kuma biranen da ke kewaye da shi, da kuma tsawaita dokar killace kusan dukkan jama'a, da aka kafa domin katse jerin yaduwar cutar SARS-CoV-2.
Duk da cewa wadannan matakan na kawo babbar illa ga tattalin arzikin kasar da sauran bangarorin rayuwarta, adadin sabbin masu kamuwa da cutar na raguwa, wanda ke nuna jinkirin yaduwar cutar.
A cewar masu ra'ayin kirki, cutar za ta kare a watan Maris, kuma za ta yi tsawon watanni uku zuwa huɗu.
Amma wasu masana ba su da ra'ayin da ya dace.
Mista Paul Hunter da abokan aikinsa sun kimanta cewa annobar COVID-19, wadda ta fi SARS yaduwa, ba za ta ƙare ba a shekarar 2020.
Masu bincike daga ƙungiyar da Ira Longini ke jagoranta sun kafa samfurin da zai iya hango ƙarshen annobar kuma sun yi hasashen cewa cutar SARS-CoV-2 na iya shafar kashi biyu bisa uku na yawan mutanen duniya.
Wata ƙungiyar masana na Kanada ta ba da rahoton cewa an gano cutar SARS-CoV-2 a cikin ƙwayar hanci da makogwaro da aka ɗauka daga marasa lafiya da suka warke kuma aka sallame su daga asibitoci makonni biyu da suka gabata, wanda ke nuna cewa sabon kwayar cutar na iya zama cutar da ke juyawa kamar mura.
Amma, raguwar yawan sabbin kamuwa da cutar a China na da ban ƙarfafa, yana nuna cewa dabarun da ake amfani da su a yanzu na iya samun sakamako.
A farko, an yi hasashen cewa za a iya samun mutane miliyan ɗaya da cutar Ebola kuma za a kashe mutane miliyan ɗari.
Amma ta hanyar tsauraran matakan killacewa da kuma keɓewa, an sami nasarar shawo kan cutar.
Akwai yiwuwar cewa kamar SARS-CoV, ƙwayar cutar SARS-CoV-2 za ta iya raunana kuma ta ɓace ko kuma ta zama ƙarancin ƙwayar cuta da ke rayuwa tare da mutane.
A ƙasa akwai kwatancen annobar COVID-19 da annobar SARS da MERS (hoto (Hoto 55).
Kwayar cutar SARS-CoV-2 tana da saurin yaduwa ta hanyar tari ko hancin, kuma mai yiwuwa ta hanyar hulɗa kai tsaye da kayan da ke da cutar.
An kuma gano cutar a cikin kwari, wanda ke nuna cewa ana iya watsa ta ta bakin jini.
Wani bincike na baya-bayan nan ya nuna cewa kashi 41 cikin ɗari na mutane 138 da aka bincika sun kamu da cutar a asibiti, har da marasa lafiya 17 da suka kamu da wasu cututtuka da aka riga aka gano da kuma ma'aikatan kiwon lafiya 40.
Saboda haka, ya kamata a ɗauki matakan tsaro don kare jama'a, musamman ma ma'aikatan kiwon lafiya, ma'aikatan zamantakewa, danginsu, abokan aiki, har ma da waɗanda ba su san su ba da ke hulɗa da marasa lafiya ko waɗanda ke da cutar.
Layin farko na kariya wajen rage haɗarin kamuwa da cutar  shi ne sanya abin rufe fuska; kuma abin rufe fuska na tiyata da na numfashi na aji N95 (tsarin 1860s) suna taimakawa wajen sarrafa yaduwar ƙwayoyin cuta.
Takunkumin tiyata na hana 'yan jarirai masu cutar daga tashi a iska su zauna a kan wasu wurare da za su iya kaiwa ga wasu.
Amma, abin rufe fuska na aji N95 (seri na 1860s) ne kawai zai iya kare numfashin kwayar cutar daga 10 zuwa 80 nm, suna wucewa kashi 5 cikin 100 na kwayar cutar; cutar SARS-CoV-2 daidai take da SARS-CoV, kuma duka suna da girman kusan 85 nm.
Tun da ƙwayoyin cuta na iya shiga ko da ta hanyar abin rufe fuska biyar da aka saka tare, ma'aikatan kiwon lafiya da ke hulɗa kai tsaye da marasa lafiya dole ne su sa abin rufe fuska na aji N95 (jerin 1860s), ba abin rufe fuska ba.
Ban da abin rufe fuska, ya kamata ma'aikatan kiwon lafiya su sa rigar kariya da ta dace da siffarsu domin rage yiwuwar kamuwa da ƙwayoyin cuta.
Ƙari ga haka, ƙwayoyin cuta suna iya shiga jikin mutum ta idanu.
A ranar 22 ga Janairu, 2020, likita ya kamu da cutar SARS-CoV-2 duk da cewa yana sanye da abin rufe fuska na aji N95; mai yiwuwa cutar ta shiga jikinsa ta hanyar idanunsa da suka kumbura.
Saboda haka, ya kamata ma'aikatan kiwon lafiya su saka abin kariya na fuska ko kuma tabarau na kariya na rufe fuska.
Ana ƙarfafa dukan mutane a yankunan da cutar ta shafa ko kuma waɗanda za su iya kamuwa da cutar su wanke hannayensu da kayan wankewa da ke kashe ƙwayoyin cuta, su yi ƙoƙari su zauna a gidajensu, su keɓe kansu, kuma su rage hulɗa da waɗanda za su iya kamuwa da cutar.
Ana iya yarda da nisan kusan mita ɗaya daga wurin mai haƙuri.
Waɗannan matakan suna rage haɗarin kamuwa da cutar kuma suna hana yaduwar cutar.
Duk da cewa cutar SARS-CoV-2 ba a san ta da farko ba, babban kamanninta da SARS-CoV, kamar yadda aka ruwaito a ranar 7 ga Janairu, 2020, ya kamata ya zama abin firgita ga China, la'akari da kwarewar da ta samu yayin barkewar cutar SARS a 2003.
Amma bayan 19 ga Janairu, 2020, ne kawai daraktan Cibiyar Kula da Cututtuka a Wuhan ya kwantar da hankalin jama'a, yana mai cewa sabon kwayar cutar tana da ƙarancin kamuwa da cuta da iyakantaccen haifuwa a lokacin da ake watsawa daga mutum zuwa mutum kuma cewa hana yaduwar cutar da sarrafa ta ba zai zama matsala ba.
Wannan sanarwa ta rage tashin hankali sosai, musamman a lokacin da kasar ke shirin bikin sabuwar shekara ta kasar Sin, kuma an rasa lokacin da za a iya shawo kan cutar a Wuhan tare da karancin asarar rayuka.
Hukumomin kiwon lafiya na kasar Sin na iya koyon darasi daga wannan mummunan darasi kuma su inganta a nan gaba.
Misali, hukumomin kiwon lafiya ya kamata su: (1) yi karin kauri a cikin kalaman jama'a, saboda kowane kalma ana la'akari da shi ta hanyar 'yan kasa kuma yana iya tasiri ga halayensu da shawarwarinsu; (2) sanya ido sosai da kuma amsawa ga bayanai masu ban mamaki da ke fitowa daga asibitoci maimakon jiran rahotanni na hukuma daga likitoci da jami'ai; (3) dauki matakai masu karfi don hana yiwuwar barkewar cutar a farkon matakan ci gabanta, maimakon kwantar da hankalin jama'a; da (4) gudanar da atisaye masu ma'ana da tasiri don kara wayar da kan jama'a game da cututtukan annoba da kuma duba akai-akai da kuma inganta tsarin mayar da martani ga al'umma.
Cutar COVID-19, wadda cutar coronavirus mai tsanani mai saurin numfashi ta nau'i na biyu (SARS-CoV-2) ta haifar, ta fara ne a ƙarshen Disamba na 2019.
A cikin kasa da watanni biyu, cutar ta yaɗu a duk ƙasar Sin, kuma a lokacin da nake rubuta wannan labarin, ta yaɗu a ƙasashe 50 na duniya.
Saboda kwayar cutar ta yi kama da kwayar cutar coronavirus mai saurin kamuwa da cutar numfashi (SARS-CoV) kuma alamun COVID-19 sun yi kama da alamun cutar SARS, cutar ta COVID-19 ta haifar da sake dawowar cutar SARS.
Duk da haka, akwai wasu bambance-bambance masu muhimmanci tsakanin COVID-19 da SARS, waɗanda suke da muhimmanci a batun hana annobar da kuma kula da marasa lafiya.
COVID-19 na shafar tsofaffi fiye da matasa, maza fiye da mata; yawan manyan cututtuka da yawan mutuwa a cikin tsofaffi ma sun fi na matasa.
Yawan mutuwar SARS ya fi na COVID-19 (10,91% idan aka kwatanta da 1,44%).
Marasa lafiya da COVID-19 suna yada kwayar cutar ko da ba su da alamun cutar, yayin da marasa lafiya da SARS yawanci suna yada cutar ne kawai a lokuta masu tsanani, saboda haka ya fi wahalar hana yaduwar COVID-19 fiye da SARS.
Wannan ya bayyana dalilin da yasa SARS-CoV-2 ke yaduwa da sauri da kuma a kan sikelin SARS-CoV.
Wasu marasa lafiya da ke da COVID-19 na iya samun sakamako mara kyau na gwajin SARS-CoV-2 RNA.
A wani bangare kuma, marasa lafiya da aka warkar suna iya sake nuna tabbatacciyar cutar.
Duk wannan yana ƙara yawan haɗarin yaduwar cutar.
A cikin irin wannan saurin ci gaba na binciken COVID-19, wasu muhimman tambayoyi sun kasance ba a warware su ba, wato:
Menene asalin cutar SARS-CoV-2?
Duk da cewa an gano kashi 96 cikin 100 na SARS-CoV-2 da kuma wasu nau'in SARS-like coronavirus guda biyu, har yanzu ba za mu iya tabbatar da cewa SARS-CoV-2 ya samo asali ne daga bat.
Wane dabba ne ya zama irin da ya canja kwayar cutar daga mahaifarta na farko, kamar bat?
Idan ba mu san amsoshin tambaya ta farko da ta biyu ba, ba za mu iya dakatar da yaduwar cutar ba, kuma yanayin annobar na iya ƙaruwa a kowane lokaci.
Tsarin kwayoyin halitta da kuma gwajin kwayoyin sun nuna cewa SARS-CoV-2 yana da alaƙa da ACE2, amma ta yaya ainihin cutar take shiga cikin ƙwayoyin numfashi kuma ta haifar da canje-canje na rashin lafiya?
Shin kwayar cutar tana da alaƙa da ƙwayoyin ACE2 a wasu gabobin jiki?
Idan ba mu da amsoshi na gaskiya ga waɗannan tambayoyin ba, ba za mu iya ba da tabbacin ganewar asali da kuma magani mai inganci ba.
Har yaushe cutar za ta ci gaba?
Ta yaya ne kwayar cutar take samun ci gaba a tsarin halittar mutum zuwa mutum?
Zai zama annoba ta duniya, zai ɓace kamar SARS, ko kuma zai sake dawowa kamar mura?
Waɗannan abubuwa suna da muhimmanci sosai, amma za a ɗauki lokaci kafin a sami amsoshin waɗannan tambayoyin da kuma wasu da yawa.
Amma ba mu da wani zaɓi sai dai mu dakatar da annobar da wuri-wuri kuma mu koma ga rayuwarmu ta yau da kullun, ko da menene sakamakon.
Tushen kwayar cutar korona ta mutum
Juyin halitta da daidaitawa sun ƙarfafa coevolution na coronavirus (CoVs) da masu ɗaukar su, ciki har da mutane, tsawon dubban shekaru.
Kafin shekara ta 2003, an san cewa kwayar cutar korona guda biyu (HCoVs) na haifar da rashin lafiya mai sauƙi kamar sanyi.
Barkewar cutar SARS da MERS sun sauya tunaninmu game da yadda cutar korona ta mutum take da hatsari da kuma yadda take da hadari ga rai.
Bayyanar cutar coronavirus mai tsanani na nau'i na biyu (SARS-CoV-2) a tsakiyar kasar Sin a karshen shekarar 2019 ya sake jan hankalin jama'a game da cutar korona, kuma ya ba mu mamaki da yadda cutar ke da yaduwa sosai amma ba ta da cutarwa sosai idan aka kwatanta da cutar SARS-CoV.
Cutar korona ta mutum cuta ce ta dabbobi, kuma fahimtar asalinta zai taimaka sosai.
Yawancin kwayar cutar korona ta mutum ta samo asali ne daga batsa, wanda ba ta cutar da su.
An kuma san wasu masu dauke da kwayar cutar korona na ɗan adam.
Ƙayyade masu watsa dabbobi yana da tasiri kai tsaye a kan hana yaduwar cututtukan mutane.
Binciken yadda dabbobi suke hulɗa da juna da ke dauke da kwayar cutar korona na iya ba da haske kan yadda kwayar cutar korona ke haifar da mutane.
A cikin wannan bita mun kawo bayanan da muke da su a kan kwayar cutar korona guda bakwai da ke kamuwa da mutane, muna mai da hankali kan tarihin gano su, da kuma asalin su na dabbobi da kuma hanyoyin watsa su tsakanin jinsuna.
Yana da muhimmanci a lura cewa muna gwadawa da kuma kwatanta nau'o'in kwayar cutar korona ta mutum daban-daban dangane da juyin halitta na kwayar cutar da kuma sake hada kwayoyin halitta.
A wannan mahallin ana kuma duba annobar cutar korona da aka gano a shekarar 2019 (COVID-19).
Bugu da ƙari, an lura da yanayin da ake buƙata don nasarar sauya masu ɗaukar hoto, da kuma tasirin juyin halitta na kwayar cutar akan tsananin yanayin cutar.
Kwayar cutar korona ta shafi dangin Coronaviridae, wanda rukuni ne na kwayar cutar fata mai madaidaicin zaren RNA guda.
Waɗannan ƙwayoyin cuta da suke da jini mafi girma a cikin ƙwayoyin cuta masu ɗauke da RNA, suna ɗauke da ƙwayoyin nucleotide dubu 26 zuwa 32, sun sami sunansu ne domin siffarsu da take kama da rawani idan aka duba ta hanyar duba ƙirar lantarki.
A bangaren tsari, kwayar cutar korona tana dauke da kwayoyin halittar da ba a rarraba su ba, wadanda suke da tsari iri daya.
Kimanin kashi biyu bisa uku na kwayoyin halitta suna dauke da manyan manyan sassan karatu guda biyu (ORF1a da ORF1b) wadanda suke watsawa zuwa polyprotein pp1a da pp1ab.
Wadannan polyprotein suna sake sarrafawa don samar da sunadarai 16 da ba a tsara su ba, wanda ake kira nsp1~16.
Sauran ɓangaren kwayoyin sun ƙunshi buɗe ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙ
A wasu layin kwayar cutar korona kuma an yi amfani da wasu layin da ke da takamaiman bayani.
Bisa bambance-bambance a jerin sunayen sunadarai, an raba kwayar cutar corona zuwa nau'i hudu (alpha-, beta-, gamma- da delta-coronavirus), yayin da nau'in beta-coronavirus ya hada da yawancin kwayar cutar ta mutum kuma an raba shi zuwa layi hudu (A, B, C da D).
Akwai shaidar ilimin halittar halittu da ke nuna cewa mafi yawan alpha da beta coronavirus sun fito ne daga bat da kuma masu ciwon daji, yayin da tsuntsaye  su ne babban wurin ajiye gama da delta coronaviruses.
A cikin dubun dubatan shekaru, ƙwayoyin cuta na corona sun ci gaba da ƙetare iyakokin tsakanin jinsuna, kuma wasu daga cikinsu sun samo asali zuwa cututtukan cututtukan da ke da haɗari ga mutane.
A yau an san mutane bakwai da suka kamu da cutar korona.
Waɗannan sun haɗa da kwayar cutar HCoV-229E da HCoV-NL63 na ɗan adam.
Sauran beta-coronavirus guda biyar sun hada da HCoV-OC43, HCoV-HKU1, coronavirus mai saurin numfashi mai tsanani (SARS-CoV), coronavirus mai saurin numfashi na Gabas ta Tsakiya (MERS-CoV) da kuma SARS-CoV-2 mai saurin numfashi mai tsanani na nau'i na biyu.
Kwayar cutar korona ta mutum HCoV-229E, HCoV-OC43, HCoV-HKU1 da HCoV-NL63 yawanci suna haifar da alamun rashin lafiya, kamar sanyi da (ko) zawo.
Akasin haka, ƙwayoyin cuta na SARS-CoV, MERS-CoV da kuma SARS-CoV-2 da aka gano kwanan nan suna da cututtuka sosai, suna haifar da cututtuka masu saurin kamuwa da ƙananan hanyoyin numfashi a cikin ƙididdigar yawan marasa lafiya tare da yiwuwar ci gaba da cututtukan numfashi mai tsanani (ARS) da bayyanar cututtuka na waje da huhu.
An samo zaren farko na kwayar cutar HCoV-229E, B814, daga samfurin da aka cire daga hanci da hanci na marasa lafiya masu sanyi a cikin shekarun 1960.
Tun daga wannan lokacin, bincike mai zurfi ya kawo ƙarin bayani game da ƙwayoyin cuta HCoV-229E da HCoV-OC43 waɗanda ke haifar da alamun kamuwa da cuta a cikin gida.
Hakika, kafin barkewar cutar SARS, an yi imani cewa kamuwa da cutar korona ba ta da lahani.
Barkewar cutar SARS a 2003 na ɗaya daga cikin munanan annobar cutar a tarihin yanzu; sama da mutane 8,000 suka kamu da cutar, kuma yawan mutuwar kusan kashi 10 ne.
Shekaru goma bayan haka, cutar MERS ta haifar da annoba mai tsawo a yankin Larabawa, kuma ta bazu zuwa wasu ƙasashe na duniya.
Sabon kwayar cutar coronavirus ta mutum (2019-nCoV) da aka gano a shekarar 2019, wanda daga baya aka sake masa suna SARS-CoV-2, shine wanda ke haifar da annobar cutar coronavirus ta 2019 (COVID-19), wacce a ranar 3 ga Maris, 2020 ta kashe mutane sama da 3,120, kuma adadin wadanda suka kamu da cutar ya wuce mutane 91,000.
An ba da sanarwar gaggawa, kuma duniya ta shirya don annobar SARS-CoV-2 mai zuwa.
Dukkanin kwayar cutar korona guda bakwai na mutum sun samo asali ne daga dabbobi, ko dai daga batsa, ko kuma daga beraye ko kuma daga dabbobi.
Bayanai da yawa sun nuna cewa kwayar cutar korona ta mutum ta samo asali ne daga batsa, wadda kwayoyin cutar suka dace da ita kuma ba su da cutar, amma suna nuna bambancin kwayoyin halitta.
Cutar COVID-19 ta jefa kalubale ga kasar Sin da kuma duniya baki daya ta fuskar kiwon lafiya, kimiyya, zamantakewa da kuma ɗabi'a.
Binciken tsarin kwayar cutar korona ta mutum zai taimaka wajen fahimtar tarihin halitta, abubuwan da ke motsa juyin halitta da kuma abubuwan da ke hana yaduwar cutar tsakanin jinsuna.
Zai iya kuma ba da shawara ko kuma hanzarta gano maɓuɓɓugar SARS-CoV-2 da ke tsakanin da kuma mai yaduwa, wanda ke da muhimmanci wajen hana sake yaduwar cutar a nan gaba.
Wannan bita ya ƙunshi bayanai na gaba ɗaya game da asalin dabbobi, watsawa tsakanin jinsuna da kuma cutar coronavirus na ɗan adam.
Musamman, mun gano kuma mun bincika wannan fasalin na kowa: ƙwayoyin cuta na asali waɗanda suka haifar da kwayar cutar coronavirus na ɗan adam ba su da cutar ga masu ɗaukar su, amma suna da cutar bayan watsawa tsakanin nau'ikan zuwa sabon mai ɗaukar hoto.
Muna kuma nazarin yanayin juyin halittar kwayar cutar korona ta mutum, wanda ke nuna cewa yawanci yawan kamuwa da cuta yana tare da raguwar cutar.
A cikin wannan mahallin ana kuma duba sakamakon barkewar cutar SARS-CoV-2 da ke faruwa a yanzu.
An san cutar korona ta dabbobi tun daga ƙarshen shekarun 1930.
Kafin a fara gano kwayar cutar B814 na kwayar cutar HCoV-229E daga samfurin da aka cire daga hanci da hanci na marasa lafiya masu sanyi, an sami nau'ikan kwayar cutar korona a cikin dabbobi daban-daban da suka kamu da cutar, ciki har da turke, mice, shanu, aladu, kuliyoyi da karnuka.
An gano kwayar cutar korona guda bakwai a cikin shekaru goma da suka gabata.
A cikin tebur 1 an nuna taƙaitaccen tarihin gano kwayar cutar korona ta mutum cikin tsari na lokaci.
An samo kwayar cutar HCoV-229E ta farko daga samfurin da aka ɗauka daga hanyoyin numfashi na marasa lafiya tare da lalacewar kamuwa da cutar ta sama a cikin 1966; daga baya wannan kwayar cutar ta daidaita don haɓaka a cikin layukan ƙwayoyin huhu na WI-38.
Marasa lafiya da ke dauke da kwayar HCoV-229E sun nuna alamun sanyi, ciki har da ciwon kai, hancin, rashin jin daɗi da ciwon makogwaro, yayin da zazzabi da tari suka bayyana a kashi 1020 cikin dari.
Daga baya, a shekara ta 1967, an gano kwayar cutar HCoV-OC43 daga al'adun jiki kuma an yi amfani da ita a cikin kwakwalwar linzamin kwamfuta.
Alamomin asibiti na kamuwa da kwayar cutar HCoV-OC43 suna kama da bayyanar kamuwa da kwayar cutar HCoV-229E, alamun da ba su bambanta da lalacewa ta wasu cututtukan cututtukan numfashi, kamar su ƙwayoyin cuta na mura na nau'in A da rhinoviruses.
Dukansu kwayar HCoV-229E da kwayar HCoV-OC43 suna da yaduwa a ko'ina a duniya kuma yawanci ana watsa su a lokacin hunturu a matsakaitan wurare.
Yawancin lokaci, lokacin da wannan ƙwayoyin cuta biyu suke kwance ba ya kai mako guda, sai kuma bayan haka sai a yi rashin lafiya na kusan makonni biyu.
Binciken da aka yi a kan masu sa kai ya nuna cewa mutanen da ke da lafiya da ke dauke da kwayar cutar HCoV-229E suna da sanyi mai sauƙi.
Wasu marasa lafiya da suke da ƙarancin garkuwar jiki ne kawai suke da ciwon numfashi mai tsanani.
Cutar SARS, wanda kuma aka sani da  annobar cutar huhu ta atypical, ita ce ta farko a tarihin ɗan adam da aka rubuta ta da kyau ta hanyar cutar coronavirus ta ɗan adam, kuma cutar ta haifar da cutar SARS-CoV, ta uku daga cikin ƙwayoyin cuta na ɗan adam da aka gano.
An gano farkon cutar SARS a ƙarshen 2002 a lardin Guangdong na kasar Sin.
A lokacin annobar SARS an samu mutum 8,096 da suka kamu da cutar kuma mutum 774 suka mutu, kuma cutar ta bazu zuwa kasashe da nahiyoyi da dama.
Ba tare da la'akari da masu yaduwa ba, an kiyasta cewa kowane mutum da ya kamu da cutar zai iya kamuwa da wasu mutane biyu; lokacin incubation ya kasance daga kwanaki 4 zuwa 7, kuma mafi girman nauyin kwayar cutar ya kasance a ranar 10 na cutar.
Marasa lafiya da ke dauke da cutar SARS-CoV sun fara da ciwon tsoka, ciwon kai, zazzabi, rashin jin daɗi da kuma sanyi, kuma daga baya sun sami rashin numfashi, tari da kuma rashin numfashi.
Abubuwan da suka fi faruwa a cikin SARS su ne lymphopenia, rashin daidaito a gwajin hanta da kuma yawan creatine kinase.
A cikin marasa lafiya da ke da cutar SARS, an kuma ga lalacewar alveolar diffuse, ƙaruwar ƙwayoyin epithelial da kuma ƙaruwar macrophage.
Kusan kashi 2030 na marasa lafiya suna bukatar kulawa mai tsanani da kuma yin amfani da iska mai guba.
A irin wannan mawuyacin hali, ban da ƙananan hanyoyin numfashi, wasu gabobin jiki na iya kamuwa da cutar, ciki har da gabobin ciki, hanta da koda, wanda yawanci yakan haifar da guguwar cytokine, wanda zai iya zama mai kisa, musamman ga marasa lafiya da ke da rauni.
An fara gano kwayar cutar ne daga kwayar cutar da aka yi a bude a cikin huhu na wani dangin wanda ya zo Hong Kong daga Guangzhou.
Tun daga lokacin an yi gagarumar kokarin bincike kan kwayar cutar korona ta mutum.
A ƙarshen 2004, an gano HCoV-NL63 a cikin jariri mai wata bakwai a Netherlands.
Da farko an gano cewa ya fi shafar yara ƙanana, tsofaffi, da marasa lafiya da ke da rashin garkuwar jiki da kuma cututtukan numfashi.
Cutar da HCoV-NL63 ke haifarwa ta ƙunshi bayyanar cututtuka kamar su kumburi, cutar hawan jiki, zazzabi da kuma cutar sankarar bargo.
Wani bincike na 'yanci ya nuna cewa an gano wannan kwayar cutar ne daga hanci da aka samo daga wani yaro ɗan wata takwas da ke Netherlands da ke fama da ciwon huhu.
An gano wannan cuta ne a Netherlands, amma a gaskiya ta yaɗu ko'ina.
An kiyasta cewa HCoV-NL63 na haifar da kusan kashi 4.7% na cututtukan numfashi da suka fi yawa, kuma yawan cututtukan da ke haifar da shi yana zuwa a farkon bazara, bazara da kuma hunturu.
HCoV-NL63 yana da alaƙa da cutar laringitis ta ƙuntatawa, wanda kuma ake kira croup.
An gano HCoV-HKU1 a Hong Kong a wannan shekarar daga wani mutum mai shekara 71 da aka kwantar da shi a asibiti da ciwon huhu da kuma ciwon kumburin huhu.
Baya ga ciwon huhu da kuma cutar sankarar bargo, ana danganta HCoV-HKU1 da cutar asma.
Kamar HCoV-NL63, HCoV-229E da HCoV-OC43, an gano kwayar cutar HCoV-HKU1, wadda ke haifar da rashin lafiya mai sauƙi na numfashi a duk duniya.
Duk waɗannan ƙwayoyin cuta guda huɗu na mutum waɗanda ke haifar da kamuwa da cuta a waje da asibiti sun dace da mutane sosai, kuma sauyin da ke haifar da cututtuka masu saurin kamuwa da cuta ba shi da tabbas, kodayake akwai abubuwan da suka faru kuma ba a san dalilin su ba, kamar yadda yake a cikin wani misali mai wuya tare da ƙaramin nau'in HCoV-NL63 wanda aka ba da rahoton kwanan nan cewa ya haifar da kamuwa da cuta mai tsanani a cikin ƙananan hanyoyin numfashi a China.
A al'ada, ta hanyar samun damar watsawa da kuma adanawa cikin jikin mutum, wadannan kwayar cutar korona ta mutum ba ta da kwayar cuta ko kuma cutar.
An fara gano cutar coronavirus na Gabas ta Tsakiya (MERS-CoV) a shekarar 2012 a Saudi Arabiya daga huhu na wani mutum mai shekaru 60 da ke fama da ciwon huhu mai tsanani da kuma rashin aikin koda.
Yawancin lab da aka tabbatar da su sun faru ne a Gabas ta Tsakiya, amma an samu wasu cututtuka a kasashen Turai da Tunisia da suka kai ga yaduwar cutar ta hanyar kamuwa da ita ta hanyar kusanci.
Wani kuma annobar ta biyu da ta tabbatar da mutane 186 ta faru ne a Koriya ta Kudu a shekarar 2015.
Alamar asibiti na ciwon numfashi na Gabas ta Tsakiya (MERS) yana kama da alamun cutar numfashi mai tsanani (SARS)  duka cututtuka biyu suna da ciwon huhu mai tsanani.
Ba kamar SARS ba, mutane da yawa da ke fama da cutar MERS sun kuma samu rashin aikin koda, wanda har yanzu ya bambanta MERS da sauran cututtukan da ke haifar da kwayar cutar korona da ke yaduwa zuwa ga mutane.
Fiye da kashi 30 cikin dari na marasa lafiya suna da alamun ciwon ciki, kamar zawo da kuma amai.
Ya zuwa ranar 14 ga Fabrairu, 2020, an sami fiye da mutane 2,500 da aka tabbatar da su a cikin dakin gwaje-gwaje na ciwon numfashi na Gabas ta Tsakiya tare da yawan mutuwar (34.4%), saboda haka ana daukar MERS-CoV daya daga cikin cututtukan da suka fi kashe mutane.
A tsakiyar zuwa ƙarshen Disamba na 2019, an gano tarin marasa lafiya da ke fama da cutar huhu a birnin Wuhan na lardin Hubei na kasar Sin, wanda yanzu idan aka duba baya, ana danganta shi da kamuwa da cutar coronavirus mai saurin numfashi mai tsanani nau'i na 2 (SARS-CoV-2).
Hukumar Lafiya ta Duniya ta sanar da cewa barkewar cutar ta SARS-CoV-2 ta hanyar numfashi ta duniya ta zama gaggawa a fannin kiwon lafiyar jama'a, kuma cutar kanta ta sami sunan coronavirus infection 19 (COVID-19).
A ranar 3 ga Maris, 2020, an samu mutane 90 053 da suka kamu da cutar a duniya, inda yawan mutuwar mutane ya kai kusan kashi 3.4 cikin dari.
Ya kamata a lura cewa yawan mutuwar mutane a lardin Hubei na kasar Sin ya kai kashi 4.2 bisa dari, kuma a kasashen waje ya kai kashi 1.2 bisa dari.
SARS-CoV-2, kamar SARS da MERS, yana haifar da mummunar kamuwa da cuta ta hanyar numfashi, wanda ke nuna zazzabi, tari da kuma rashin numfashi.
Wasu marasa lafiya ma suna da zawo.
Ciwon huhu yana ɗaya daga cikin alamun da ke da tsanani kuma yana iya saurin zama ciwon numfashi mai tsanani.
Duk da kamanceceniya tsakanin SARS-CoV da SARS-CoV-2, saboda yawan daidaiton jerin nucleotides (82%), waɗannan ƙwayoyin cuta, duk da haka, suna samar da rassan bishiyar phylogenetic daban-daban.
SARS-CoV-2 a bayyane yake ba shi da cutar amma yana da damar watsawa fiye da SARS-CoV da MERS-CoV.
An samu wasu cututtuka na SARS-CoV-2 da ba su da alamun cutar, wanda ke nuna cewa cutar tana iya yaduwa cikin sauri a duniya.
Kwatanta SARS-CoV-2 da sauran kwayar cutar korona guda shida na mutum ya nuna muhimman kamance da bambance-bambance.
Na farko, kwayar cutar korona da ke yaduwa ga mutane tana da irin wannan lokacin da take kwance da kuma tsawon lokacin da take kwance.
A wannan yanayin, SARS-CoV-2 yana nuna irin wannan yanayin kamar sauran kwayar cutar korona guda shida na ɗan adam.
Na biyu, a cikin yanayin bayyanar cututtuka, COVID-19 yana tsakanin SARS-CoV da kuma kwayar cutar coronavirus guda huɗu na mutum da ke haifar da kamuwa da cutar daga asibiti (watau HCoV-229E, HCoV-OC43, HCoV-HKU1, da HCoV-NL63).
A gefe guda, bayyanar cutar SARS-CoV-2 ta yi kama da wanda ake samu a cikin kwayar cutar coronavirus ta mutum, wadda ke haifar da kamuwa da cuta a waje da asibiti, ciki har da bayyanar da ba ta da takamaiman yanayi, bayyanar cututtuka masu sauƙi ko ma rashin bayyanar cututtuka.
A gefe guda, kamar yadda yake a SARS-CoV, za a iya gano ƙaramin rukunin manyan shari'o'in COVID-19, ko da yake rabo a nan ya ɗan ƙasa.
Na uku, ana kuma lura da wasu abubuwa masu ban sha'awa a cikin hanyar watsa SARS-CoV-2 da ke da alaƙa da kwayar cutar korona ta mutum da ke haifar da kamuwa da cutar a waje da asibiti, da kuma SARS-CoV.
A gefe guda, SARS-CoV-2 yana da yaduwar cutar kamar yadda kwayar cutar korona ta mutum take da yaduwar cutar a waje da asibiti.
A gefe guda, har yanzu ana bukatar a bincika ko SARS-CoV-2 yana raguwa da kowane sauyin kwayar cutar (watau kamuwa da kowane mutum na gaba), kamar yadda yake a SARS-CoV da MERS-CoV.
A ƙarshe, kamar sauran ƙwayoyin cuta na mutum da ke haifar da kamuwa da cuta a waje da asibiti, ana iya gano SARS-CoV-2 a cikin ƙwayoyin ƙwayoyin ƙwayoyin cuta.
Har yanzu ba mu amsa tambayar ko hanyar watsa SARS-CoV-2 ta bakin jini tana da muhimmanci (aƙalla a wasu yanayi) kamar yadda take a SARS-CoV.
Tambayar yiwuwar yanayi na SARS-CoV-2 da ke da alaƙa da kwayar cutar korona ta mutum da ke haifar da kamuwa da cuta a waje da asibiti, na da ban sha'awa.
Koyaya, ci gaban gaba na barkewar COVID-19 zai dogara ne akan fasalin SARS-CoV-2, gami da yaduwa, cutar, da kuma ci gaba da yaduwa bayan ya wuce ta hanyar mutane.
Dukkanin kwayar cutar korona guda huɗu da ke haifar da kamuwa da cuta a waje da asibiti da kuma bayyanar cututtuka masu sauƙi sun daidaita da mutane sosai.
A wani bangare kuma, wataƙila mutane ne suka daidaita da waɗannan ƙwayoyin cuta guda huɗu na ɗan adam.
A wasu kalmomi, dukansu za a iya cewa su ne kawai suka tsira daga annobar korona a baya.
Kwayar cutar korona ta mutum da ke haifar da mummunar cuta a cikin mutane, da kuma mutanen da kwayar cutar korona ta mutum ke haifar da mummunar cuta, ba su tsira ba.
Don hakan ya faru, dole ne kwayar cutar korona ta ɗan adam ta ninka a jikin ɗan adam yadda ya kamata don samun tarin ƙwayoyin halittar da ke adawa da abubuwan da ke hana mai ɗaukar hoto.
A wannan ma'anar, yayin da annobar SARS-CoV-2 ke ci gaba da ƙaruwa kuma mutane da yawa suna kamuwa da ita, za a sami damar cewa cutar za ta iya daidaita kanta ga mutane.
Idan ya dace, zai yi wuya a hana shi ya yaɗu tsakanin mutane ta hanyar keɓewa ko kuma wasu hanyoyin sarrafa cututtuka.
An yi shekaru ana yaduwar wasu nau'o'in cutar korona guda hudu a cikin jama'a, wadanda ke haifar da sanyi a cikin mutanen da suke da garkuwar jiki.
Waɗannan ƙwayoyin cuta ba sa bukatar dabba mai riƙe da ruwa.
Kwayar cutar SARS-CoV da MERS-CoV ba su daidaita da mutane yadda ya kamata ba, kuma ba za a iya ci gaba da watsa su tsakanin mutane ba.
Suna bukatar su ci gaba da haifuwa a cikin tasoshin dabbobin da kuma neman damar shiga cikin mutane masu karɓa, watakila ta hanyar daya ko fiye na matsakaici ko masu haɓaka.
SARS-CoV-2 yana da halaye masu kama da SARS-CoV/MERS-CoV, da kuma ƙwayoyin cuta huɗu na HCoV.
Yana da sauƙin yaduwa kamar HCoVs na waje, aƙalla a yanzu.
Amma ya fi cutar HCoVs da ake samu a waje da asibiti, kuma ba shi da cutar SARS-CoV ko MERS-CoV.
Abin da ya rage shi ne ganin ko ya dace da 'yan Adam kuma ko zai iya zama a cikin yanayin 'yan Adam ba tare da tanki ba ko kuma tare da dabba mai ɗaukar hoto.
Kafin mu tattauna asalin dabbobi na kwayar cutar HCoVs, zai taimaka mana mu tattauna ma'anar da kuma halayen masu ɗaukar kwayar cutar HCoVs na juyin halitta, na halitta, na tsaka-tsaki, mai haɓaka, da na tanadi.
Dabba na iya zama mai ɗaukar kwayar cutar HCoV idan ta ɗauki wani magaji mai dangantaka da juna wanda yake da irin wannan daidaito a matakin jerin nucleotides.
Kwayar cutar ta asali tana da sauyi sosai kuma ba ta haifar da cuta a cikin wannan mai ɗaukar hoto.
Hakazalika, mai ɗaukar kwayar cutar HCoV yana ɗaukar kwayar cutar a kai a kai na dogon lokaci.
A duka biyun, masu dauke da cutar sun kamu da cutar ta halitta kuma su ne masu dauke da HCoV ko kuma kwayar cutar da ta haife su.
Akasin haka, idan HCoV ya shiga cikin mai ɗaukar hoto na tsakanin nan da nan kafin ko kusa da lokacin da aka kai shi ga ɗan adam, ba a daidaita shi da kyau ga sabon mai ɗaukar hoto ba kuma sau da yawa yana haifar da cuta.
Wannan mai watsawa na iya zama tushen cutar ta ɗan adam kuma ya zama mai ɗaukar hoto, yana ba da damar kwayar cutar ta ninka da sauri, sannan ta watsa shi ga mutane, yana ƙara yawan kamuwa da mutane.
HCoV zai iya ɗaukar kamuwa da cuta ta hanyar toshe idan ba zai iya jure watsawa a cikin mai ɗaukar hoto ba.
Akasin haka, ƙwayoyin cuta na HCoVs na iya daidaitawa ga mai ɗaukar hoto na tsakiya har ma da kafa ƙarancin ƙarancin lokaci.
A wannan yanayin, mai ɗaukar na'urar tsakiya ya zama mai ɗaukar tanki na halitta.
Bayanan cututtuka sun nuna cewa ba a taɓa samun cutar SARS ba, kuma an gano cewa an yi ta da dabbobi masu farauta.
Ƙarin bincike na yawan ƙwayar cutar ya nuna cewa yawan kwayoyin cutar IgG zuwa cutar SARS-CoV a cikin masu sayar da dabbobi ya fi na sauran mutane.
Ciftawar Himalayanci (Paguma larvata) da kare mai kama da naman-dumi a kasuwannin dabbobi masu rai sun zama farkon waɗanda aka gano cewa suna dauke da ƙwayoyin cuta masu kama da SARS-CoV.
An tabbatar da hakan ta hanyar cewa bayan an kawar da duk wani ciwon daji a kasuwanni, ba a sake samun rahoton cutar SARS ba.
A lokaci guda, an bayar da rahoton cewa a cikin ciyawa na Himalayan da ke rayuwa a cikin yanayi ko a gonaki kuma ba a samu a kasuwa ba, ba a gano SARS-CoV a mafi yawan lokuta, wanda ya ba da damar yanke shawarar cewa ciyawa na Himalayan na iya zama kawai a matsayin mai ɗaukar hoto na tsaka-tsaki, ba kamar tanadin SARS-CoV na halitta ba.
Abin lura ne cewa, saboda kashi 80% na dabbobi daban-daban a kasuwannin Guangzhou suna da kwayar cutar SARS-CoV, ba za a iya ware yiwuwar cewa yawancin nau'in ƙananan dabbobi masu shayarwa na iya zama masu ɗaukar kwayar cutar ba.
Dukkanin su sun zama masu dauke da cutar SARS-CoV.
Binciken da aka yi na dabba mai dauke da SARS-CoV ya gano CoV na bat da ke da alaka da cutar huhu ta HKU3 (SARSr-Rh-BatCoV HKU3) kuma yana cikin batunan da ke dauke da cutar.
Waɗannan berayen sun sami kwayar cutar SARS-CoV da kuma SARSr-Rh-BatCoV HKU3 mai kyau.
Wannan da sauran kwayar cutar bat coronavirus suna da kashi 8892% na daidaiton jerin nucleotides kamar SARS-CoV.
Wannan bincike ya kafa tushen sabon ra'ayi cewa batutuwan sun zama masu kawo sabbin cututtukan mutum.
An kuma gano wasu nau'o'in cutar korona irin ta SARS (SL-CoV) a cikin batsa, amma babu wani daga cikinsu sai dai wanda ake kira WIV1 da za a iya ware shi a matsayin kwayar cutar mai rai.
An san cewa mai karɓar SARS-CoV shine enzyme mai canza angiotensin na mutum 2 (ACE2).
An nuna cewa WIV1, wanda aka samo daga samfurin ƙwayoyin bat, yana amfani da ACE2 na bat, ciwon daji da mutum a matsayin mai karɓa don shiga cikin kwayar.
Abin sha'awa, ruwan da aka yi wa marasa lafiya da ke da cutar SARS da suka warke ya iya kawar da cutar WIV1.
WIV1 ya kasance mafi kusa da kakannin SARS-CoV a cikin bat, yana raba kashi 95% na daidaiton jerin nucleotides.
Duk da yawan kamance tsakanin kwayar cutar biyu, ana ganin cewa WIV1 ba kwayar cutar SARS-CoV ce ta kai tsaye ba, kuma bat ba mai ɗaukar SARS-CoV ba ne kai tsaye.
Binciken ilimin halittu ya nuna cewa MERS-CoV yana cikin rukuni ɗaya da CoV-HKU4 na batsa da CoV-HKU5 na batsa.
CoV-HKU4 na bat da MERS-CoV suna amfani da mai karɓar mai ɗaukar hoto iri ɗaya, dipeptildipeptidase-4 (DPP4), don shiga cikin ƙwayoyin cuta.
Tsarin RNA-da ke dogara da RNA-polymerase na kwayar cutar MERS-CoV ya fi kusa da jerin beta-coronavirus na bat da aka gano a Turai da Afirka.
Har zuwa yanzu, ba a gano kwayar cutar MERS-CoV mai rai a cikin namomin kaza ba.
Halin da ke tsakanin MERS-CoV da CoV-HKU25 na ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙ
Wannan yana nufin cewa bat ba zai iya zama mai ɗaukar kwayar cutar MERS-CoV kai tsaye ba.
A gefe guda, binciken da aka yi a Gabas ta Tsakiya ya nuna cewa raƙuman raƙuman sun nuna cewa sun kamu da kwayar cutar MERS-CoV, kamar yadda raƙuman da ke Gabas ta Tsakiya suka kamu da cutar a ƙasashen Afirka da dama.
An gano MERS-CoV mai rai, wanda yake kama da wanda aka gano a cikin mutane, daga hanci na raƙuman raƙuman, wanda ya ƙara tabbatar da matsayin raƙuman a matsayin masu ɗaukar MERS-CoV na gaskiya.
Ya kamata a lura cewa raƙuman da ke dauke da cutar MERS-CoV a gwaji ba su da alamun cutar, amma sun samu cutar sosai.
Abin lura ne cewa raƙuman da suka kamu da cutar ba su fitar da kwayar cutar ta hanyar numfashi kawai ba, har ma ta hanyar ƙwayoyin cuta, wanda kuma shine babban hanyar fitar da kwayar cutar a cikin bat.
Duk da haka, akwai tambayoyi da yawa, tun da yawancin mutanen da aka tabbatar da cutar ta MERS ba su da tarihin haɗuwa da raƙuma kafin bayyanar cututtuka, kuma ana iya danganta su da mutum-zuwa-mutum ko kuma hanyar da ba a sani ba, wanda ya haɗa da nau'in dabbobi da ba a gano ba waɗanda ke dauke da MERS-CoV.
Kwayar cutar SARS-CoV-2 ta yi daidai da kashi 96.2% na CoV RaTG13 na batsa, wanda aka gano a cikin Rhinolophus affinis na Asiya.
Kamar yadda yake a cikin SARS-CoV da MERS-CoV, bambancin jerin tsakanin SARS-CoV-2 da RaTG13 ya yi yawa don a danganta su da alaƙar iyaye.
Wannan yana nufin cewa batsa ba za ta iya zama mai ɗaukar SARS-CoV-2 kai tsaye ba, sai dai idan a nan gaba an sami kusan iri ɗaya da batsa coronavirus.
Ana ganin cewa dabbobi masu dauke da cutar SARS-CoV-2 na iya kasancewa a cikin dabbobin da ake sayar da su a kasuwar sayar da abincin teku ta Wuhan, inda aka samu mutane da yawa da suka kamu da cutar COVID-19, wanda ke nuna yiwuwar kamuwa da cutar daga dabbobi zuwa mutane.
Wasu bincike na kwanan nan da aka yi ta hanyar jerin nau'in metagenome sun gano cewa wasu ƙananan dabbobi masu shayarwa da ke fuskantar hallaka da ake kira pangolins (Manis javanica) na iya ɗaukar kwayar cutar beta-coronavirus ta iyaye, wanda ke da alaƙa da nau'in SARS-CoV-2.
Tsarin kwayar cutar ta coronavirus na sabon kwayar cutar ta pangolin ya yi daidai da SARS-CoV-2 da kashi 8592%.
Amma suna da dangantaka sosai da RaTG13, kuma suna da daidaito na kashi 90 cikin ɗari.
An rarraba su a cikin layin bambancin ƙwayoyin cuta guda biyu kamar SARS-CoV-2, a cikin itacen phylogenetic, wanda ɗayan yana da yankin haɗuwa da mai karɓa (RSD) wanda ya fi kusa da SARS-CoV-2 tare da daidaiton jerin amino acid a matakin 97.4%.
Akasin haka, SARS-CoV-2 da RaTG13 sun fi bambanta, duk da cewa suna da daidaito a cikin kwayoyin halitta.
A cikin binciken farko na pangolin marasa lafiya, an kuma bayar da rahoton gano ƙwayoyin cuta a cikin samfurori na huhu, wanda ya zama kama da SARS-CoV-2.
A wannan binciken, an yi amfani da wasu hanyoyin hadawa da kuma sarrafawa ta hannu don samun jerin kwayoyin halitta, wanda ya hada da kusan kashi 86.3 cikin dari na cikakken kwayar cutar.
Ba za a iya ware yiwuwar pangolin ya zama daya daga cikin dabbobi masu kawo SARS-CoV-2 ba.
Koyaya, saboda bambancin jerin tsakanin SARS-CoV-2 da beta-coronavirus na pangolin, dangin SARS-CoV-2, a halin yanzu babu wata hujja da za ta goyi bayan asalin kai tsaye na SARS-CoV-2 daga pangolin.
Bugu da ƙari, tazarar tsakanin SARS-CoV-2 da RaTG13 ta fi tazarar tsakanin SARS-CoV-2 da beta-coronavirus na pangolin da ke da alaƙa da SARS-CoV-2.
Ba a riga an gano hanyar juyin halitta na SARS-CoV-2 a cikin batsa, pangolin da sauran dabbobi masu shayarwa ba.
Yayin da aka sami mafi girman daidaiton jerin abubuwa a cikin RSD tsakanin SARS-CoV-2 da beta-coronavirus pangolins, dangin SARS-CoV-2, SARS-CoV-2 da RaTG13 suna da mafi girman daidaiton jerin abubuwa a cikin dukkanin kwayoyin halitta.
A ka'ida, babban kamani tsakanin beta-coronavirus na pangolin, dangi na SARS-CoV-2, da SARS-CoV-2 ya danganta ne da juyin halitta na layi daya ta hanyar zaɓaɓɓu.
Ainihin ra'ayi na gaba shine sake haɗawa tsakanin beta-coronavirus na pangolin, dangin SARS-CoV-2, da RaTG13 a cikin nau'in dabbobi na uku.
A matsayin abin motsa juyin halitta, sake haɗuwa ya zama ruwan dare gama gari a tsakanin ƙwayoyin cuta masu cutar beta.
Har yanzu babu wani bayani na ƙarshe game da asalin SARS-CoV-2 na dabbobi.
Baya ga ƙwayoyin cuta masu yawa na HCoV, ana kuma nazarin asalin ƙwayoyin cuta na HCoV-229E, HCoV-OC43, HCoV-NL63 da HCoV-HKU1.
Shaidar ilimin halittu ta nuna cewa duka HCoV-NL63 da HCoV-229E na iya samo asali daga kwayar cutar batsa, yayin da aka gano kwayar cutar HCoV-OC43 da HCoV-HKU1 a cikin masu ciwon daji.
An bayar da rahoton cewa cutar coronavirus ta bat, da ake kira ARCoV.2 (Appalachian Ridge CoV) da aka gano a cikin wani ɗan ƙaramin ɗan ƙaramin ɗan ƙaramin ɗan ƙaramin ɗan ƙaramin ɗan ƙaramin ɗan ƙaramin ɗan ƙaramin ɗan ƙaramin ɗan ƙaramin ɗan ƙaramin ɗan ƙaramin ɗan ƙaramin ɗan ƙaramin ɗan ƙaramin ɗan ƙaramin ɗan ƙaramin ɗan ƙaramin ɗan ƙaramin ɗan ƙaramin ɗan ƙaramin ɗan ƙaramin ɗan ƙaramin ɗan ƙaramin ɗan ƙaramin ɗan ƙaramin ɗan ƙaramin ɗan ƙaramin ɗan ƙaramin ɗan ƙaramin ɗan ƙaramin ɗan ƙaramin ɗan ƙaramin ɗan ƙaramin ɗan ƙaramin ɗan ƙaramin ɗan ƙaramin ɗan ƙaramin ɗan ƙaramin ɗan ƙaramin ɗan ƙaramin ɗan ƙaramin ɗan ƙaramin ɗan ƙaramin ɗan ƙaramin ɗan ƙaramin ɗan ƙaramin ɗan ƙaramin ɗan ƙaramin ɗan ƙaramin ɗan ƙaramin ɗan ƙaramin ɗan ƙaramin ɗan ƙaramin ɗan ƙaramin ɗan ƙaramin ɗan ƙaramin ɗan ƙaramin ɗan ƙaramin ɗan ƙaramin ɗan ƙaramin ɗan ƙaramin ɗan ƙaramin ɗan ƙaramin ɗan ƙaramin ɗan ƙaramin ɗan ƙaramin ɗan ƙaramin ɗan ƙaramin ɗan ƙaramin ɗan ƙaramin ɗan ƙaramin ɗan ƙaramin ɗan ƙaramin ɗan ƙaramin ɗan ƙaramin ɗan ƙaramin ɗan ƙaramin ɗan ƙaramin ɗan ƙaramin ɗan ƙaramin ɗan ƙaramin ɗan ƙaramin ɗan ƙaramin ɗan ƙaramin.
A gefe guda, HCoV-229E yana da alaƙa da kwayar cutar bat da ake kira Hipposideros/GhanaKwam/19/2008, wanda aka gano a Ghana, kodayake akwai zargin cewa raƙuma na iya zama mai watsawa.
Don a bayyana a fili, an taƙaita ilimin da ake da shi a yanzu game da asalin dabbobi na ƙwayoyin cuta na corona da aka sani a hoto na 1 da kuma tebur na 2.
Binciken ilimin halittu ya ba da tabbacin abubuwan da suka faru na watsa HCoV tsakanin jinsuna a cikin tarihin.
Lokacin da aka samu yaduwar kwayar cutar HCoV-OC43 tsakanin jinsuna a wajen 1890, kuma mutane suka kamu da ita daga dabbobin gida, an sami annobar cutar numfashi.
Tarihin watsawa tsakanin nau'in HCoV-229E bai bayyana sarai ba.
An gano alphacoronavirus na bera, wanda ke da dangantaka da HCoV-229E.
A tsakanin su akwai cutar alpaca coronavirus.
Akwai wasu bayanai da suka nuna cewa ana iya watsa kwayar cutar kai tsaye daga bat zuwa mutum.
Na farko, mutane ne, ba alpacas ba, suka iya yin hulɗa da batsa a cikin yanayin da ke cikin yanayi.
A lokaci guda kuma, mutane suna da dangantaka ta kusa da alpacas.
Na biyu, kwayar cutar ta HCoV-229E, wadda ta shafi batutuwan, ta bambanta a cikin batutuwan kuma ba ta haifar da cuta ba, yayin da kwayar cutar ta alpaca ta haifar da ciwon numfashi a cikin dabbobi masu kamuwa da cutar.
A ƙarshe, ba a gano cutar alpaca a cikin namun daji ba.
Saboda haka, ba za a iya ware yiwuwar cewa alpacas sun sami cutar alfa-coronavirus, dangi na HCoV-229E, daga mutane ba.
A gaskiya, bat ne tushen cututtukan da ke cutar mutane, har da cutar zazzabin cizon sauro, cutar Ebola, cutar Nipah, da kuma cutar Hendra.
Saboda haka ba abin mamaki ba ne cewa batutuwan sun iya kaiwa mutane HCoV-229E kai tsaye.
A gefe guda, yayin da alphacoronavirus na bat zai iya zama tushen kwayar cutar HCoV-229E, alpacas da raƙuma guda ɗaya na iya zama masu watsawa na tsakiya waɗanda ke watsa ƙwayoyin cuta ga mutane, kamar yadda yake a cikin cutar MERS-CoV.
MERS-CoV misali ne mai kyau na yaduwar nau'i-nau'i daga batutuwan zuwa raƙuman raƙuma da kuma daga raƙuman raƙuma zuwa ga mutane.
An san asalin juyin halittar MERS-CoV daga batsa a farkon gano shi kuma an tabbatar da shi ta hanyar binciken da aka yi.
A bayyane yake cewa batutuwan suna ba da tarin nau'ikan ƙwayoyin cuta don musayar ƙwayoyin cuta tsakanin jinsuna da kuma watsawa tsakanin jinsuna.
Rayuwa mai tsawo, da yawaita a cikin mazauna, da kuma dangantaka mai kyau da kuma iyawar tashi, ya sa batutuwan su zama "masu rarrabawa".
A gefe guda, an gabatar da kwayar cutar MERS-CoV a cikin raƙuman raƙumi shekaru da yawa da suka gabata.
Ya daidaita da kyau ga waɗannan raƙuman, waɗanda suka zama mai riƙe da ruwa mai ɗorewa da ɗorewa.
A cikin waɗannan dabbobi, kwayar cutar MERS-CoV tana haifar da rashin lafiya mai sauƙi kuma ana nuna ta da ƙarancin sauyin halittar.
Canza shi zuwa ga mutane ba zato ba tsammani ne, kuma mutum ya kasance mai ɗaukar MERS-CoV a matsayin mai ɗaukar hoto, saboda ba a tallafawa watsa shi.
Ba kamar yadda raƙuma ke da muhimmanci wajen watsa MERS-CoV ba, haka ma pangolin, idan akwai, suna da muhimmanci wajen watsa cutar SARS-CoV-2.
Musamman, betacoronavirus na pangolin yana da cututtuka masu yawa a cikin pangolins.
Suna iya zama masu ɗaukar kwayar cutar beta-coronavirus, masu dangantaka da SARS-CoV-2, kamar yadda ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon.
Binciken da za a yi nan gaba zai tabbatar ko kuma kawar da yiwuwar kamuwa da cutar SARS-CoV-2 daga dabbobi zuwa ga mutane.
Na farko, batutuwan na iya zama masu ɗaukar kwayar cutar da ke da alaƙa da SARS-CoV-2, wanda kusan iri ɗaya ne da SARS-CoV-2.
Mutane suna iya raba wurin da suke da shi da batsa ta wajen hakar ma'adinai ko kuma cin naman waɗannan dabbobi.
Na biyu, pangolins na iya zama ɗaya daga cikin masu ɗaukar hoto na tsakiya wanda kwayar cutar SARS-CoV-2 ta shiga kwanan nan.
Mutane suna kamuwa da cutar ta hanyar cin naman daji da kuma cin naman dabbobi.
Wataƙila dabbobin gida da yawa suna iya kamuwa da cutar SARS-CoV-2.
Ana iya gwada dabbobi da kuma dabbobin daji don gano kwayoyin cutar.
Na uku, kamar yadda aka ambata a sama, sake haɗuwa da daidaitawa na SARS-CoV-2 na iya faruwa a cikin nau'in nau'i na uku wanda ya yi hulɗa da duka bat da pangolin.
Ana ci gaba da neman asalin SARS-CoV-2 daga dabbobi.
Baya ga nau'ikan dabbobi masu rarrafe, akwai abubuwa uku da suka sa ƙwayoyin cuta suka ƙetare iyakar jinsin.
Na farko, suna da saurin canji a kwafin RNA.
Idan aka kwatanta da sauran ƙwayoyin cuta masu RNA guda ɗaya, ana iya ɗaukar ƙimar juyin halittar ƙwayoyin cuta na coronavirus  Matsakaici-mai girma tare da matsakaicin sauyawar sauye-sauye kusan sau 104 a shekara a yanki ɗaya 2 dangane da matakin daidaitawar coronavirus zuwa sababbin masu masaukin baki.
Kwayar cutar korona tana da ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar
Abin sha'awa, kwayar cutar ta Remdesivir tana hana kwayar cutar ta corona ta hanyar hana wannan exoribonuclease da RNA-dependent RNA polymerase.
Remdecivir  yana ɗaya daga cikin magungunan da ke da tabbaci a kan SARS-CoV-2 da ake bukatar a gwada a gwajin asibiti.
Duk da haka, yawan kwayar cutar korona ya ninka na masu dauke da ita sau miliyan.
Bugu da ƙari, yawan canjin kwayar cuta na iya ƙaruwa idan ba a daidaita kwayar cutar ta coronavirus da kyau ga mai ɗaukar ta ba.
Idan aka kwatanta da SARS-CoV mai yawan sauyin halittar, ana iya ganin sauyin halittar SARS-CoV-2 ya yi ƙasa, wanda ke nuna cewa yana da sauyin halittar mutum.
An yi hasashen cewa wannan kwayar ta riga ta daidaita zuwa wani mai watsawa da ya yi kama da mutum.
Baya ga SARS-CoV-2, wannan kuma ya shafi MERS-CoV, wanda ya dace da raƙuman raƙuma.
A ka'ida, ba zai yiwu ba cewa alluran rigakafin SARS-CoV-2 da magungunan rigakafin cutar za su yi gaggawa su rasa inganci saboda ɓoyewar kwayoyin halitta.
Na biyu, babban kwayar RNA a cikin kwayar cutar korona na haifar da karko a cikin gyaran kwayar halitta game da sauye-sauye da kuma sake haɗuwa, don haka yana ƙara yiwuwar coevolution tsakanin nau'ikan, wanda ke da kyau don haifar da sabbin kwayar cutar korona idan akwai yanayi.
Wannan yana faruwa ne saboda yawancin ƙididdigar buɗewa da kuma ayyukan sunadarai da aka tsara a cikin hanyar 3′-karshen kwayoyin halitta.
Na uku, saboda tsarin zaɓin matrix na musamman, coronaviruses suna canza matrix a bazuwar kuma sau da yawa yayin yin kwafin RNA.
A lokacin da ake rubuta DNA na kwayar cutar korona a cikin kwayar da take aiki a matsayin tasoshin hadawa, sau da yawa ana sauya zaren.
RNA mai girma da kuma na gaba-gaba na iya sake haɗuwa da kuma samar da sabbin ƙwayoyin cuta.
An gano shaidar phylogenetic na sake haɗuwa ta halitta a cikin HCoV-HKU1 da HCoV-OC43, da kuma a cikin kwayar cutar coronavirus ta dabbobi kamar SL-CoV da batCoV-HKU9 na bat.
Hadin kan mai dauke da kwayar cutar dangane da watsa
Baya ga abubuwan da aka ambata a sama guda uku na kwayar cutar, wani muhimmin abu da ke da muhimmanci ga watsawar kwayar cutar tsakanin jinsuna shi ne yadda kwayar cutar take hulɗa da mai karɓa.
A cikin wannan labarin, ana kawo sake haɗuwa da SARS-CoV a matsayin misali na yau da kullun wanda kuma ke nuna hujjojin zaɓi mai kyau a cikin abubuwan watsawa tsakanin nau'ikan.
Bisa ga kwatancen da aka yi tsakanin nau'in SARS-CoV na mutum da na ciyawa, an yi imanin cewa SARS-CoV yana saurin daidaitawa a cikin masu watsawa daban-daban, musamman dangane da sauye-sauye a kan S protein RSD.
Gabaɗaya, kwayar cutar coronavirus S tana hulɗa da mai karɓar kwayar halitta, kuma maganin rigakafin mai ɗaukar hoto yana ɗaukar shi sosai.
RSD a cikin SARS-CoV  amino acid ne, daga 318 zuwa 510-th, a kan sashin S1, wanda don shigar da kwayar cutar cikin kwayar halitta yana haɗuwa da enzyme mai canza angiotensin 2 (APF2) na mutum, da kuma masu karɓar sa.
SARS-CoV RSD na iya gane masu karɓar APF2 na dabbobi daban-daban, ciki har da bat, civet, linzamin kwamfuta da kare mai kama da naman daji, wanda ke ba da damar watsa kwayar cutar tsakanin jinsuna.
A gaskiya, an gano amino acid guda 6 ne kawai a cikin RSD wanda ya bambanta da kwayar cutar mutum da kwayar cutar ciwon daji, kuma 4 daga cikinsu suna cikin hanyar haɗawa da mai karɓa don hulɗa tare da mai karɓar APF2.
SARS-CoV yana da sauye-sauyen K479N da S487T a cikin RSD, wanda zai iya ƙara ƙwarewar hulɗar ƙwayoyin cuta na ƙwayoyin cuta tare da mai karɓar APF2 na ɗan adam.
A wasu kalmomi, waɗannan amino acid guda biyu na iya zama da muhimmanci musamman wajen daidaita kwayar cutar ga mutane.
Ya kamata a lura cewa SARS-CoV-2 yana da irin kwayar cutar da SARS-CoV ke da ita.
Bambanci na 30% tsakanin SARS-CoV-2 da SARS-CoV a cikin sashin S1 na furotin S yana nuna cewa ƙawancen haɗin S na furotin S zuwa APF2 na ɗan adam na iya canzawa.
A gaskiya, binciken da aka yi ta amfani da cryophosphate microscope ya nuna cewa, wannan alaƙar ta ninka ta mutum APF2 sau 10 zuwa 20 fiye da wadda ke tsakanin kwayar S na cutar SARS-CoV.
Zai kuma zama da ban sha'awa a gano ko akwai wasu masu karɓar maganin da ake bukata don watsa SARS-CoV-2.
Abin mamaki shine HCoV-NL63 yana da alaƙa da APF2 amma tare da wani ɓangaren furotin S.
Akwai sauran masu karɓar HCoV da yawa, kamar su aminopeptidase N don HCoV-229E da 9-O-acetylsilic acid don HCoV-OC43.
Suna iya zama masu alhakin nasarar daidaita waɗannan ƙwayoyin cuta a cikin mutane bayan watsawa tsakanin jinsuna daga dabbobi masu ɗaukar hoto.
Baya ga masu karɓar ƙwayoyin halitta, sakamakon watsa HCoV tsakanin jinsuna kuma ana sarrafa shi ta wasu abubuwan dogara da ƙuntatawa na mai ɗaukar hoto.
Bambancin waɗannan sunadarai masu ɗaukar hoto tsakanin mutane da masu ɗaukar HCoVs na halitta, kamar su batsa, raƙuma mai ido ɗaya, da masu ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon
Don samun nasarar watsawa tsakanin jinsuna, kwayar cutar HCoVs tana buƙatar kwace abubuwan dogara da kuma sarrafa abubuwan da ke hana masu ɗaukar hoto.
A wannan yanayin, abubuwan da ke sa a samu kwayoyin halittar da ke cikin wannan muhimmin yanki na hulɗa tsakanin kwayar cutar da mai ɗaukar hoto har yanzu suna bukatar a bayyana su kuma a rarraba su.
Za a iya samun sakamako mai kyau ta hanyar yin cikakken bincike na SARS-CoV-2 da ke nuna cewa cutar ta kamu da cutar ta hanyar amfani da sabuwar fasahar CRISPR.
Sabbin HCoVs: koma baya zuwa alamar sifili
Bambancin kwayar cutar bat coronavirus na haifar da sabbin hanyoyin samar da HCoVs.
A wannan ma'anar, kwayar cutar bat korona tana aiki a matsayin wurin ajiyar kwayoyin HCoV.
Bugu da ƙari, saurin canzawa da sake haɗuwa na kwayoyin halitta su ma sune ke motsa juyin HCoV kuma suna aiki a matsayin matakai biyu masu mahimmanci a cikin wannan tsari.
Alal misali, samun ko rasa sababbin kwayoyin halittar da ke tsara sunadarai na iya kawo sauyi mai yawa a cikin fasalin ƙwayoyin cuta.
ORF8 yana cikin sunadarai masu amfani da SARS-CoV da ke da muhimmanci wajen daidaitawa ga mutane, tun da an ware ƙwayoyin cutar bat da ke da alaƙa da SARS-CoV, amma an gano cewa suna yin kwafin sunadarai masu bambancin ORF8.
An gano kwayar cutar da ke dauke da kwayar cutar SARS-CoV-29, a cikin kwayar cutar da aka ware a farkon annobar cutar.
Wannan raunin ya karya ORF8 zuwa ORF8a da ORF8b, kuma ana daukarsa canji mai dacewa wanda ke hanzarta sauya masu watsa labarai.
Bugu da ƙari, SARS-CoV yana da tarihin yiwuwar sake haɗuwa tare da layin alpha da gamma coronaviruses, inda aka gano ƙananan ƙananan yankuna masu haɗuwa a cikin RNA-dangane da RNA-polymerase.
An kuma gano wuraren sake haɗawa a cikin sunadarai marasa tsari na nsp9, yawancin nsp10 da ɓangarorin nsp14.
Haka kuma, an nuna cewa cutar MERS-CoV ta sake haɗuwa tsakanin layin da aka yi a kan raƙuman raƙuma a Saudiyya.
Baya ga SARS-CoV da MERS-CoV, an kuma lura da abubuwan da suka sake haɗuwa a cikin wasu HCoVs, waɗanda HCoVs suka sake haɗuwa da wasu ƙwayoyin cuta na dabbobi a cikin ƙwayoyin halittar su.
Ya kamata a kuma yi gargadin cewa zaɓin ƙwayoyin cuta na iya haifar da canje-canje a cikin kwayoyin halitta na ƙwayoyin cuta, wanda ya fi yiwuwa ya faru ne ta hanyar kawar da ƙwayoyin cuta daga matsin lamba na zaɓin, misali, daga tsarin garkuwar jiki na mai ɗaukar hoto.
Misali na irin wannan tasirin shine asarar cikakken girman ORF4 a cikin kwayar HCoV-229E ta hanyar kwayar cutar nucleotide biyu.
Yayin da za a iya ganin sararin buɗewar ORF4 a cikin ƙwayoyin cuta na bat da raƙumi, da ke da alaƙa da HCoV-229E, alphacoronavirus na alpaca yana nuna shigarwar nucleotide guda ɗaya, wanda ke haifar da sauya sararin.
A ƙarshe, canjin sabon HCoVs kuma ya dogara ne da matsin lamba na zaɓin a kan masu ɗaukar su.
A lokacin da batutuwan suka kamu da cutar coronavirus, an samu alamun cutar ko kuma babu alamun cutar, wanda ke nuna cewa akwai daidaituwa tsakanin kwayar cutar coronavirus da batutuwan.
Ya nuna cewa batutuwan sun dace da kwayar cutar korona sosai.
Alal misali, rashin aiki na amsawar kumburi a cikin batsa yana rage cutar da coronavirus ke haifarwa.
Bugu da ƙari, aikin halitta na ƙwayoyin kisa a cikin batsa an hana ta ta hanyar apregulation na mai hana ƙwayoyin halitta na kisa na halitta NKG2/CD94 da kuma ƙananan ƙwayoyin halitta na babban tsari na haɗin gwiwar I.
Bugu da ƙari, yawan iskar oxygen da ake samu ta hanyar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar cuta, zai iya hana kwayar cutar ta coronavirus, kuma hakan zai iya shafar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar cuta, ta haka ne za a iya samar da nau'in ƙwayar cuta da ke da illa sosai idan aka shiga cikin sabon ƙwayar cuta.
Ƙarin nau'in cutar korona na iya juyawa ta hanyar sake haɗuwa, wanda ke haifar da samun sabbin sunadarai ko kuma halayen sunadarai don daidaitawa ga mai ɗaukar hoto.
Saboda haka ba abin mamaki ba ne cewa a cikin shekaru ashirin da suka gabata, an samu sababbin ƙwayoyin cuta guda uku na mutum.
Kwayar cutar korona ba ta haifar da cuta ko kuma tana haifar da wasu alamun rashin lafiya a cikin masu dauke da ita, kamar su batsa ko raƙuma.
Suna yin kwafi da tabbaci ba tare da sa rigakafin jikin mutum ya yi tsayayya ba.
Wannan shi ne asirin da ya sa muke ganin masu dauke da cutar ba tare da alamun cutar ba, kuma abin da ke haifar da mummunan kamuwa da cutar a cikin mutane.
Ainihin alamun cutar suna da nasaba da yawan halayen garkuwar jiki da kuma tsananin cutar cytokine, wanda idan garkuwar jikin mutum ta yi ƙarfi, sai a yi rauni sosai a cikin huhu.
Akasin haka, a cikin masu dauke da cutar da ba su da alamun cutar, ba a haɗa amsawar garkuwar jiki da kwayar cutar coronavirus.
Wannan dabarar na hana rigakafin cutar shiga zai iya samun sakamako mai kyau a maganin SARS-CoV-2.
Bat da ke da ƙwayar interferon tana da ƙarfi sosai.
Saboda haka, shan maganin Interferon Type I, aƙalla a farkon kamuwa da cutar SARS-CoV-2 a cikin mutane, ya kamata ya kasance da tasiri mai kyau.
Bugu da ƙari, batutuwan sun yi rashin aikin NLRP3 inflammasome.
Bisa ga wannan, hana NLRP3-inflammasome ta hanyar MCC950 na iya zama da amfani wajen maganin COVID-19.
Tushen SARS-CoV-2 ya bi tsarin SARS-CoV da MERS-CoV.
Yayin da aka gano betacoronavirus na bat da ke da kashi 95% na daidaiton nucleotide da SARS-CoV, akwai kuma coronavirus na bat da ke da kashi 96% na daidaiton nucleotide da SARS-CoV-2.
Ko da yake an gano cewa ciwayen da sauran dabbobi a kasuwa suna dauke da kwayar cutar da ta yi kama da SARS-CoV, ba a gano masu watsawa na kai tsaye ba don SARS-CoV-2.
An gano beta-coronavirus na pangolin da ke da daidaituwa da SARS-CoV-2, wanda ke nuna cewa pangolin na iya zama ɗaya daga cikin masu watsawa na tsaka-tsaki ko kuma cewa ɓangarorin ƙwayoyin halittar beta-coronavirus na pangolin na iya shiga cikin sigar ƙarshe ta SARS-CoV-2.
Duk da sauran tambayoyi, babu wata shaida da ke nuna cewa SARS-CoV-2 an yi shi da gangan ko kuma ba zato ba tsammani.
Cutar korona ta jawo hankalin jama'a saboda barkewar cutar SARS-CoV-2 da ta auku kwanan nan.
Binciken kwayar cutar korona a cikin bat da sauran dabbobi ya sauya ra'ayinmu game da muhimmancin asalin dabbobi da kuma ma'ajiyar HCoVs a watsawa zuwa ga mutane.
Tabbacin da ya tabbata ya nuna cewa SARS-CoV, MERS-CoV da SARS-CoV-2 sun samo asali ne daga batsa kuma an watsa su ga mutane ta hanyar masu watsawa.
Idan cutar SARS-CoV ta samo asali ne daga hulɗa tsakanin mutane da dabbobi a cikin kasuwanni, rufe kasuwanni na namun daji da kuma kawar da dabbobi a cikinsu na iya kawo ƙarshen annobar SARS.
Saboda wannan dalili, saboda gano bambancin kwayar cutar beta-coronavirus, wanda ke da alaƙa da SARS-CoV-2, don hana yaduwar cutar daga kasuwannin abinci, ya kamata a cire kwayar cutar.
Ko SARS-CoV-2 zai iya yaduwa ga mutane ta hanyar pangolins da sauran dabbobi masu shayarwa, da kuma yadda hakan zai iya faruwa, abin tambaya ne ga bincike na gaba.
A gefe guda, kwayar cutar MERS-CoV ta daɗe tana wanzuwa a cikin raƙuman raƙuma.
Waɗannan raƙuma suna da muhimmanci a sufuri, kuma su ne tushen nama, madara, fata, da kuma kayayyakin ulu ga mazauna yankin.
An yi amfani da su sosai a Gabas ta Tsakiya da Afirka.
Saboda haka ba zai yiwu a ba da dukkan raƙuma don a sarrafa MERS ba kamar yadda aka yi a kasuwannin namun daji na kasar Sin don hana yaduwar SARS-CoV da SARS-CoV-2.
Don dakatar da barkewar cutar MERS, ana bukatar a yi amfani da tsarin da ya dace wajen samar da maganin rigakafin MERS-CoV ga raƙuma tare da sauran matakan sarrafa cutar.
Tun da ba za mu iya kawar da waɗannan ƙwayoyin cuta ba, za a iya samun sababbin nau'o'in kwayoyin halittar da ke haifar da ɓarkewar cuta.
Akwai nau'o'in kwayar cutar korona da ke yaduwa a duniya.
Musamman, akwai nau'ikan nau'ikan kwayar cutar coronavirus na bat da ke da damar cutar dabbobi.
Akwai damar da yawa na juyin halitta da kuma sake haɗuwa da waɗannan ƙwayoyin cuta na dabbobi, wanda zai haifar da sababbin ƙwayoyin cuta a nan gaba waɗanda suke da sauƙin yaduwa da kuma (ko) kisa ga mutane.
Don rage yawan hulɗa tsakanin mutane da dabbobi, ya kamata a daina al'adun cin dabbobi a wasu yankunan kasar Sin.
Bayan irin wannan gwaji na SARS, MERS da COVID-19, ana bukatar shiri da kuma shirin da ya fi dacewa don magance irin wannan yanayi.
A gaskiya, ƙwayoyin cuta da yawa sun wanzu a duniya na dogon lokaci.
Suna zama a cikin ɗakunan ajiyarsu na halitta har sai an sami damar mamaye wasu yankuna.
Ko da yake abubuwa da yawa da suke da wutsiyoyi suna sa mutane su yaɗa ƙwayoyin cuta, idan aka koya wa mutane su guje musu, za a iya rage haɗuwa da wutsiyoyi da kuma sauran dabbobin daji.
Don fahimtar yanayin halittu na kwayar cutar korona da masu dauke da ita ta halitta, ana bukatar ci gaba da kula da masu shayarwa, wanda zai taimaka wajen hana kwayar cutar korona daga dabbobi zuwa mutane da kuma barkewar cutar nan gaba.
A ƙarshe, hanya mafi inganci don hana cutar ta dabbobi  ita ce a nisanta mutane daga wuraren da ke tattare da ƙwayoyin cuta.
Har yanzu akwai wasu abubuwa da ba a gano ba game da asalin SARS-CoV-2 daga dabbobi.
Na farko, idan dabbobin sun watsa kwayar cutar SARS-CoV-2 zuwa pangolins, yana da ban sha'awa ganin yanayin da ke raba bat da pangolins a cikin yanayin muhalli.
Na biyu, idan batutuwan suna taka rawa sosai wajen kaiwa ga mutane, to, ya kamata mu gano yadda mutane suka samu damar zuwa batutuwan.
Na uku, idan har dabba mai shayarwa ta uku ce take da matsayin mai kawowa, to, ya kamata mu fahimci yadda take hulɗa da wasu nau'o'i, har da mutane, da batsa, da kuma pangolin.
A ƙarshe, saboda dabbobi masu shayarwa da yawa, ciki har da dabbobin gida, na iya kamuwa da SARS-CoV-2, ya kamata a gudanar da sa ido kan annobar da kuma kamuwa da ita ta hanyar gwaji.
Ko da shi farar hula ne, ko kuma wani dabba mai shayarwa, ana sa ran cewa a nan gaba za a gano SARS-CoV-2 ko kuma ƙwayoyin cutar da suka riga sun kamu da cutar a cikin mahaifansu.
Ƙarin bincike a wannan fannin zai ba da haske kan hanyar juyin halitta na SARS-CoV-2 a cikin dabbobi, wanda zai kasance da muhimman tasiri ga rigakafi da kuma kula da COVID-19 a cikin mutane.
Ana bukatar sabunta ka 'idojin ganewar asali don kasashe da ake zargi da cutar da kasashe da aka tabbatar da su  COVID-19
A ranar 6 ga Fabrairu, 2020, ƙungiyarmu ta wallafa taƙaitaccen jagorar bincike da magani na sabon kamuwa da cutar korona (2019-nCoV) na 2019, wanda ke ba da cikakkun bayanai game da kwarewarmu da kuma shawarwari masu kyau don magance wannan annobar a duk duniya.
Koyaya, cutar coronavirus ta 2019 (COVID-19) sabuwar cuta ce, saboda haka fahimtarmu da iliminmu sun ƙaru a hankali bisa ga sakamakon bincike na yanzu da ƙwarewar asibiti; don haka dabarun ganewar asali da aikin jiyya suma suna ci gaba da sabuntawa.
A cikin wannan wasikar mun amsa ga wani bayani game da shawarwarinmu kuma mun kawo sabbin ka'idojin ganewar asali don kasashe da ake zargi da cutar da kasashe da aka tabbatar da su bisa ga takardar Shawarwarin Ganowa da Kula da COVID-19 (na bakwai) da Kwamitin Lafiya na kasa na kasar Sin ya fitar.
A watan Disambar 2019 ne aka samu barkewar sabon kwayar cutar korona 2019 (2019-nCoV), wanda yanzu aka ba da sunan hukuma na cutar korona 2019 (COVID-19), kuma cutar ta kamu da cutar ne da ake kira mafi munin cutar numfashi ta 2 (SARS-CoV-2).
A ranar 11 ga Maris, 2020, WHO ta bayyana COVID-19 a matsayin annoba.
Don magance cutar SARS-CoV-2, ƙungiyarmu ta tsara taƙaitaccen jagora kuma ta buga shi a Intanet a shafin yanar gizon mujallar Military Medical Research a ranar 6 ga Fabrairu, 2020.
Wannan littafin ya jawo hankalin mutane da yawa.
Ya kamata a lura cewa COVID-19 sabon cuta ne, saboda haka fahimtarmu da iliminmu sun ƙaru a hankali bisa ga sakamakon bincike na yanzu da kuma kwarewar asibiti; saboda haka dabarun ganewar asali da kuma hanyoyin warkarwa sun ci gaba da sabuntawa.
Alal misali, daga ranar 16 ga Janairu zuwa 3 ga Maris, 2020, an fitar da takarda guda bakwai na Shawarwarin Ganowa da Kulawa don COVID-19 da Kwamitin Lafiya na PRC ya wallafa (http://www.nhc.gov.cn/), tare da wasu canje-canje masu muhimmanci a cikin wasu sassansa.
Wani bincike da Zhou da abokan aikinsa suka yi kwanan nan ya ba da bayani game da shawararmu, kuma sun ba da shawarwari masu sauƙi game da ganewar asali bisa ga gwajin da aka riga aka yi.
Wannan aikin ya kara mana wasu sabbin bayanai na aiki da kuma bayanai masu amfani game da wannan annobar da ta shafi duniya.
Muna mai da hankali ga aikin da suke yi kuma muna godiya.
Amma bisa ga sabon fitowar Shawarwari kan ganewar asali da maganin COVID-19 (na bakwai na gwaji) da kuma sakamakon binciken da ake yi yanzu, aikin na bukatar sabuntawa.
Dangane da fitowar ta bakwai na wannan takaddar (daga 3 ga Maris, 2020), don yin cikakken bincike yayin tabbatar da yanayin zargin cutar dole ne a haɗa wani abu ɗaya daga cikin halayen tarihin annobar tare da bayyanar cututtukan asibiti guda biyu:
Tarihin cutar: (1) Tarihin tafiya ko zama a Wuhan da ke kewaye da ita ko kuma wasu wuraren zama inda aka samu mutanen da suka kamu da cutar COVID-19 cikin kwanaki 14 kafin bayyanar cututtuka; (2) Tarihin hulɗa da marasa lafiya da ke dauke da cutar SARS-CoV-2 (tare da gwajin nucleic acid mai kyau); (3) Tarihin hulɗa da marasa lafiya masu zazzabi ko cututtukan numfashi daga Wuhan da ke kewaye da ita ko kuma wasu wuraren zama inda aka samu mutanen da suka kamu da cutar COVID-19 cikin kwanaki 14 kafin bayyanar cututtuka; (4) Tarihin hulɗa da gungun mutane da suka kamu da cutar (≥ 2 na masu fama da zazzabi ko cututtukan numfashi, an samu a cikin makonni 2 a cikin gidaje, makarantu, ofisoshin aji ko gidajen aji).
Bayyanar asibiti: (1) zazzabi da/ko alamun numfashi; (2) bayyanar bayyanar cutar COVID-19; (3) yawan ƙwayoyin jini na ƙwayoyin jini na al'ada ne ko kuma ya ragu tare da ƙarancin ƙwayoyin jini a farkon bayyanar alamun.
Ganowar cutar da aka tabbatar da cutar ya kamata ya dogara ne akan zargin cutar tare da ɗayan waɗannan abubuwan da ke gaba na kwayar halitta ko hujjojin kwayar halitta, wato: (1) gwajin PCR na ainihi yana da kyau ga SARS-CoV-2; (2) cikakken tsarin kwayar cutar yana nuna babban daidaituwa dangane da sabbin ƙwayoyin cuta; (3) sakamako mai kyau na gwajin kwayar cutar don takamaiman SARS-CoV-2 IgM da IgG; ko canza sakamakon gwajin daga mara kyau zuwa tabbatacce don takamaiman SARS-CoV-2 IgG, ko ƙaruwa aƙalla sau 4 a cikin fasorawa dangane da mai dacewa a cikin matsanancin yanayi.
Hakanan za a iya lura cewa a cikin na biyu (Janairu 18, 2020) da na uku (Janairu 22, 2020) na wannan takaddar an kara gwajin PCR a ainihin lokacin don acid na nucleic a cikin hanyoyin numfashi ko gwajin jini.
An ƙara ganewar asali na gwajin jini a fitowar ta huɗu (27 Janairu 2020) da ta biyar (8 Fabrairu 2020); sannan a fitowar ta bakwai an ƙara buƙatar hujja ta serological.
Waɗannan canje-canjen sun samo asali ne daga ci gaba da bincike na bincike na gano mafi kyawun saiti don gano nucleic acid don saurin ganewar asali, da kuma nazarin samfuran da aka ɗauka daga hanyoyin numfashi, gami da ɗaukar samfuran jini, wanda ke haɓaka wadatar samfuran daban-daban da kuma ba da damar haɗa sakamako mai kyau na gwaje-gwaje don takamaiman ƙwayoyin cuta a cikin ka'idodin tabbatar da cutar.
Duk da haka, akwai ƙarin tabbaci game da bukatar a mai da hankali wajen kula da marasa lafiya da ba su da alamun cutar da kuma marasa lafiya da ba su da alamun cutar.
Saboda haka, taswirar hanyar da aka gabatar a cikin aikin Zhou da sauransu, ya kamata a sabunta, saboda a cikinta, mutane ba tare da alamun asibiti ba, an rarraba su a matsayin rukunin "ƙarancin haɗari".
Tsarin kimantawa yana bukatar a yi masa gyara a ci gaba da yin gwaji da bincike.
A ƙarshe, muna fatan samun ƙarin hujjoji kai tsaye kuma muna ƙarfafa masu karatu su bar maganganun su.
Game da gano "masu zargi" da "masu tabbatar da cutar", muna ƙarfafa masu karatu su bi kuma su bi shawarwari na yanzu da aka bayar a ƙasashen da suke zaune.
Ƙungiyarmu za ta kuma ci gaba da sabunta shawarwarin da ta bayar don a taimaka wa mutane yadda ya kamata.
Bangladesh ta ba da rahoton sabbin mutane biyar da suka mutu sakamakon COVID-19  Matsakaicin Rana
A jiya, Bangladesh ta tabbatar da sabbin mutane biyar da suka mutu sakamakon COVID-19 a rana guda.
Wannan shi ne adadin mutane da suka mutu a rana guda saboda cutar.
Kamar yadda ya kasance a jiya, Cibiyar Kula da Cututtuka da Kula da Cututtuka ta Bangladesh (IEDCR) ta ba da rahoton cewa adadin masu kamuwa da cutar da aka samu sun hada da mutum 114 da ke fama da cutar a halin yanzu, da kuma mutum 33 da suka warke da ke gida.
An samu mutuwar mutane 17 a duka.
A wani jawabi na kan layi, Daraktan IEDCR Dr. Mirjabi Sabrina Flora ta bayyana cewa, mutane hudu maza da mace daya ne suka mutu.
A cewar Dr. Mirjabi, mutane biyu da suka mutu sun haura shekaru 60, biyu daga shekaru 51 zuwa 60, kuma daya daga shekaru 41 zuwa 50.
Ta kuma ce, wadanda suka mutu biyu daga Dhaka ne.
A ranar 11 ga watan Maris ne Hukumar Lafiya ta Duniya (WHO) ta ayyana annobar COVID-19.
Wani ma'aikacin asibitin ya shaida wa kamfanin dillancin labarai na Anadolu cewa daya daga cikin wadanda suka mutu shi ne Jalal Saifur Rahman, daraktan hukumar yaki da cin hanci da rashawa ta Bengal, wanda ke jinya a asibitin na Meitri a Kuwait.
A cikin wani jawabi na bidiyo na ranar Asabar, Ministan Sufurin Motoci da Gidajen Ruwa na Bangladesh, Obaydul Quader ya ce za a dakatar da zirga-zirgar jama'a na tsawon lokaci fiye da yadda aka tsara, har zuwa Asabar mai zuwa.
An dakatar da zirga-zirgar jama'a tun daga ranar 26 ga watan Maris kuma ya kamata a dawo ranar Asabar, 4 ga watan Afrilu.
Har yanzu an ba da izinin jigilar kayayyakin rayuwa  magunguna, man fetur da abinci .
An fara samun mutane biyu da suka dawo daga Italiya da matar daya daga cikinsu a ranar 8 ga watan Maris a Bangladesh.
A ranar 19 ga watan Maris, mutanen uku sun warke.
SARS-CoV-2 ya wuce miliyan na kamuwa da cutar a duniya
A ranar Alhamis, adadin mutanen da suka kamu da cutar SARS-CoV-2 a duniya ya zarce miliyan daya, a cewar Jami'ar Johns Hopkins.
Aƙalla mutane dubu 52 sun mutu sakamakon cutar COVID-19.
Wannan lokaci na musamman ya zo ne a ranar da aka tabbatar da kamuwa da cutar ta farko a Malawi, kuma aka samu mutuwar ta farko daga cutar ta korona a Zambia.
Koriya ta Arewa ta ce a ranar Alhamis ita ce daya daga cikin kasashen da ba a samu mutum daya da cutar coronavirus ba.
A jiya, Hukumar Lafiya ta Duniya ta bayar da rahoton mutane 1,051,635 da aka tabbatar da kamuwa da cutar, ciki har da mutane 79,332 a cikin sa'o'i ashirin da huɗu da suka gabata, kafin karfe 10:00 na tsakiyar Turai (0800 UTC) ranar 4 ga Afrilu.
A Amurka an samu fiye da mutane 244,000 da suka kamu da cutar, kuma akalla mutane 5,900 sun mutu.
CBS News ta ruwaito cewa, a ranar Laraba, an samu mutuwar mutane fiye da 1,000 a Amurka sakamakon cutar coronavirus.
Kasashe a duniya sun sanar da tsaurara matakan hana yaduwar cutar.
A ranar Alhamis, magajin garin Moscow, Sergey Sobyanin, ya tsawaita dokar keɓe kai na 'yan birnin har zuwa ranar 1 ga watan Mayu.
A baya dai, shugaba Vladimir Putin ya bayyana cewa duk 'yan kasar Rasha, duk da cewa an killace su, za su samu albashi har zuwa ranar 30 ga watan Afrilu.
Majalisar Portugal ta kada kuri'ar tsawaita dokar ta baci na tsawon kwanaki 15; sakamakon kuri'ar: 215 a kan, goma a baya da kuma murya daya a kan.
Saudiyya ta tsawaita dokar hana fita a biranen Makka da Madina na tsawon yini guda, inda a baya dokar hana fita ta kasance daga karfe 3 na rana zuwa karfe 6 na safe.
Thailand ta shirya ta kafa dokar hana fita daga karfe 10 na dare zuwa 4 na safe.
Gwamnan jihar Ohio, Mike DeWine, ya sanar da cewa an tsawaita dokar keɓe kai a gida a jihar har zuwa ranar 1 ga watan Mayu.
Shaguna a Ostiraliya sun ƙayyade adadin takardar bayan gida da za a iya saya a lokaci guda
A ranar Lahadi da Asabar da yamma, manyan kantunan Woolworths da Coles na Australia sun rage adadin takardar wanka da za a iya saya a duk kantunan da ke kasar zuwa biyu da daya.
A ranar Litinin kuma, ALDI ta kafa iyaka ta fakiti guda.
An sanar da wannan takunkumi a tallace-tallace da aka yi a kantuna da kuma shafin Facebook.
An ruwaito cewa, 'yan ƙasa sun fara yin ajiyar gaggawa saboda tsoron cewa COVID-19 na iya haifar da shigar da keɓewar kai.
A ranar Laraba, kamfanin Woolworths ya kuma rage adadin takardar wanka da ake sayarwa zuwa fakiti daya.
A ranar 4 da 5 ga watan Maris, Woolworths da Coles sun riga sun ƙuntata wannan adadin zuwa fakiti 4.
Kamfanin Coles a cikin sanarwar sa ta 8 ga watan Maris ya ce, tare da iyakance takardun wanka guda hudu a kantuna da dama, har yanzu ana sayar da takarda bayan gida cikin sauri, inda ya kira bukatar da ake samu da cewa, "ba a taba ganin irinta ba", yayin da ALDI a cikin wani sakon Facebook da ta wallafa a ranar Talata ta kira wannan yanayin da cewa, "ba zato ba tsammani".
Wani wakilin kamfanin Woolworths ya ce, an samu karuwar tallace-tallace a makon da ya gabata.
Costco a Canberra a makon da ya gabata ma sun rage adadin zuwa biyu.
Don cike rashi, Coles ya fara yin odar manyan kaya daga masu samarwa kuma ya kara yawan isar da kayayyaki, Woolworths ya yi odar ƙarin kaya, yayin da ALDI ya yi tanadi don kamfen na musamman na farkon sayarwa a ranar Laraba.
Russell Zimmerman, babban daraktan kungiyar 'yan kasuwar sayar da kayayyaki ta Australiya, ya ce 'yan kasuwar suna kokarin kara kayayyaki amma hakan na da wuya saboda takunkumin da hukumomin yankin suka yi kan jadawalin tafiye-tafiyen motocin.
Yana tsammanin farashin kayayyaki zai yi girma yayin da masu samarwa ke ƙoƙarin biyan buƙata, amma ba a samun wadatattun kayayyaki.
A ranar Talata, ALDI ta sanar da cewa saboda rashin wadata wasu shagunan ba za su iya gudanar da tallace-tallace a ranar Laraba ba.
A wani rahoto da aka wallafa a shafin News.com.au, Dr. Gary Mortimer, wani masani a fannin sayar da kayayyaki a jami'ar fasaha ta Queensland, ya ce, kantuna suna cika kayayyaki a kowane dare.
Ya ce takardar wanka kaya ne mai girma, saboda haka adadin kayayyakin ajiya ba su da yawa, kuma bayan an sayar da dukkan kayayyakin, dogon layuka na shelves suna zama fanko, yana kara jin cewa babu wadata.
Coles da Woolworths sun yi imanin cewa idan za a iya cika shelves, kuma idan za a iya sanya kayayyaki kamar takardar bayan gida da kayan tsabtace hannu a kan waɗannan shelves a cikin adadi mai yawa, masu sayen ba za su yi fargaba ba, "in ji Russell Zimmerman.
A ranar Laraba da ta gabata, mai yin takardar wanka mai sake amfani da ita mai suna Who Gives a Crap ya ce ba shi da kayayyaki.
A cewar News.com.au, Kimberly-Clark, kamfanin kera takardar wanka na Kleenex da Solaris Paper, wanda ke kera kayayyakin Sorbent, sun ce suna aiki a ko'ina don samar da isassun kayayyaki.
Domain.com, wani shafin sayar da gidaje, ya ruwaito cewa lokacin da adadin kantunan sayar da kayayyaki a Melbourne ya ragu saboda rashin masu saye a makon ranar hutu ta ranar aiki, wasu dillalai sun fara ba da takardar wanka kyauta ga masu fara siyarwa.
Mujallar NT News ta Darwin ta ranar Alhamis ta ƙunshi shafuffuka takwas da za a iya yankewa da kuma amfani da su a matsayin takardar wanka.
A cewar rahoton ABC Australia na ranar 3 ga watan Maris, a farko, shagunan sun yi jinkirin sanya iyaka kan adadin kayayyakin da ake saya, suna mai cewa ba su da shirin yin hakan.
Russell Zimmerman ya kara da cewa wasu kayayyaki ma suna da bukatar gaske, ciki har da abin rufe fuska na likita, kayan kashe kumburi na hannu, kayan wanki, kayan wanke hannu da kuma gari.
Hakazalika, ban da abin da ya faru a Ostiraliya, an lura a daren Lahadi cewa kantin sayar da kayayyaki na Ocado na Burtaniya ya iyakance sayar da takardar bayan gida ta Andres zuwa fakiti biyu na 12 a kowane guda.
Hukumar Lafiya ta Duniya ta ayyana annobar COVID-19
A ranar Laraba ne Hukumar Lafiya ta Duniya (WHO) ta sanar da annobar cutar COVID-19, wadda cutar korona SARS-CoV-2 ke haifarwa.
Duk da cewa kalmar " annobar" ta nuna girman cutar ne kawai, ba haɗarin takamaiman yanayin ba, WHO ta lura cewa gwamnatocin ƙasashe suna buƙatar ɗaukar matakai:
Duk ƙasashe suna da ikon yin tasiri a kan yadda cutar ke gudana
Wannan zai yiwu ne idan kasashe suka yi aiki wajen ganowa, gwaji, magani, warewa, lura da cutar, da kuma tura 'yan kasarsu, "in ji Darakta Janar na WHO, Mr. Tedros Adnan Gebeirisus.
"Muna matukar damuwa da yadda cutar ke yaduwa da kuma yadda take da tsanani, da kuma yadda ba a yi wani abu ba".
A cewar Dokta Tom Frieden, tsohon daraktan Cibiyoyin Kula da Cututtuka da Rigakafin Amurka, wannan annoba ce da ba a taba ganin irinta ba.
Ya ce a cikin hirarsa da CNN ta watsa a watan Fabrairu, cewa "babu wani kwayar cutar numfashi banda mura da aka gano tun lokacin da ta fara zuwa ga yaduwar duniya".
Mista Gebreyesus ya bayyana irin wannan ra'ayi, yana mai cewa ba mu taɓa ganin annobar da coronavirus ta haifar ba.
Ba mu taɓa ganin annobar da za a iya sarrafawa ba.
Da farko, a watan Janairu, WHO ta ayyana barkewar cutar a matsayin gaggawa ta kiwon lafiya ta duniya, sannan ta sake sanya ta a matsayin annoba.
Darakta Anthony Fauci, darektan Cibiyar Kula da Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar
A cewar Associated Press, a ranar Alhamis an samu mutane 126,000 da suka kamu da cutar COVID-19 a duniya, kuma sama da mutane 4,600 sun mutu.
Cutar cutar korona 20192020  cutar korona 2019 (COVID-19), wadda cutar coronavirus mai saurin numfashi mai tsanani-2 (SARS-CoV-2) ke haifarwa.
An gano annobar a Wuhan, China, a watan Disamba na 2019, kuma an ayyana gaggawa ta duniya ta lafiyar jama'a a ranar 30 ga Janairu, 2020, wanda daga bisani, a ranar 11 ga Maris, 2020, aka ayyana ta a matsayin annoba.
A ranar 10 ga Afrilu, 2020, an samu kimanin mutane miliyan 1.61 da suka kamu da cutar COVID-19 a kasashe da yankuna 210 kuma kusan mutane 97,000 sun mutu.
Mutane kusan 364,000 sun warke.
Yawan mutuwar mutane a China ya kai kashi 4 cikin dari, yayin da a duniya ya kebanta daga kashi 13.04 cikin dari a Aljeriya zuwa kashi 0.08 cikin dari a New Zealand.
Alamun da suka fi yawa sun haɗa da zazzabi, tari, da wahalar numfashi.
Ƙila kuma za a iya samun ciwon huhu da kuma ciwon numfashi mai tsanani.
Lokaci daga bayyanar cututtuka zuwa lokacin da cutar ta fi tsanani yawanci kwanaki biyar ne, amma kuma zai iya bambanta daga kwana biyu zuwa goma sha huɗu.
A halin yanzu, ba a samu maganin rigakafi ko magani na musamman ba.
Maganin farko na cutar yana da alamun cutar kuma yana da taimako. Matakan rigakafi da aka ba da shawarar sun haɗa da wanke hannu, rufe baki lokacin da kake tari, nisantar mutane, ganowa da kuma ware mutanen da suke ganin suna da cutar.
Hukumomi a duk duniya sun amsa wannan matsalar ta hanyar sanya takunkumin tafiye-tafiye, keɓewa, dokar hana fita, kula da haɗarin aiki, da rufe wurare.
Cutar ta haifar da mummunan tasirin tattalin arziki da zamantakewar duniya, da jinkirta ko soke wasanni, addini, siyasa da al'adu, da kuma karancin kayayyaki da aka yi ta hanyar sayayya.
An rufe makarantu da jami'o'i a kasa ko yanki a kasashe 193, wanda ya shafi kimanin kashi 99.4 cikin 100 na daliban duniya.
Rashin gaskiya game da cutar ya fara yaduwa a Intanet, akwai kuma wasu lokuta na kyamar baki da nuna wariya ga 'yan kasar Sin, wasu 'yan kasar Gabas da Kudu maso gabashin Asiya, ko kuma mutanen da suke kama da su, da kuma sauran kungiyoyin mutane da ke zaune a yankunan da ake samun karuwar cutar.
Saurin rage tafiye-tafiye da rufe masana'antu masu nauyi sun rage gurɓataccen iska da kuma fitar da iskar carbon.
A ranar 31 ga watan Disamba na shekarar 2019, hukumomin kiwon lafiya na birnin Wuhan (babban birnin lardin Hubei), kasar Sin, sun ba da rahoton cewa an samu kamuwa da cutar huhu da ba a san dalilin ba, kuma a farkon watan Janairun 2020 ne aka fara binciken lamarin.
Yawancin cututtukan sun kasance daga kasuwar sayar da abincin teku ta Huanan, saboda haka ana ganin cutar ta samo asali ne daga dabbobi.
Kwayar cutar da ta haifar da barkewar cutar ana kiranta SARS-CoV-2. Kwayar cutar da aka gano kwanan nan, tana da kamanceceniya da kwayar cutar bat, kwayar cutar pangolin da SARS-CoV. Daga baya an gano cewa farkon cutar ta faru ne a ranar 1 ga Disamba, 2019, kuma wanda ya kamu da cutar bai ziyarci kasuwa ba bayan wannan kwanan wata.
Kashi biyu bisa uku na masu kamuwa da cutar da aka samu a watan Disambar 2019 sun shafi wannan kasuwa.
A ranar 13 ga Maris, 2020, wani labarin da aka buga a ofishin jaridar Morning Post na Kudancin China, wanda ba a tabbatar da bayanansa ba, ya nuna cewa an fara samun cutar ne a wani mutum mai shekaru 55 da ke lardin Hubei a ranar 17 ga Nuwamba, 2019. A ranar 26 ga Fabrairu, 2020, WHO ta ba da rahoton cewa, yawan sabbin kamuwa da cutar a China ya ragu, amma ba zato ba tsammani ya fara ƙaruwa a Italiya, Iran da Koriya ta Kudu, kuma sabon kamuwa da cutar a waje da China ya wuce sabon kamuwa da cutar a China a karon farko.
Ana iya rage yawan cutar, musamman saboda yawan mutane da ba su da alamun cutar.
A ranar 26 ga watan Fabrairu, an samu karancin masu kamuwa da cutar a tsakanin matasa, tare da marasa lafiya masu shekaru 19 da ƙasa da haka, wanda ya kai kasa da kashi 2.4% na masu kamuwa da cutar a duniya. Babban mai ba da shawara kan kimiyya na Burtaniya Patrick Wallans ya kiyasta cewa kashi 60% na yawan mutanen Burtaniya za su kamu da cutar kafin a samu ingantaccen garkuwar garkuwar cutar a cikin al'ummar kasar.
Wannan ƙididdigar ta haɗa da mutanen da suka kamu da cutar COVID-19 kuma suka tabbatar da tabbatacciyar cutar bisa ga ƙa'idodin hukuma.
Ya zuwa ranar 23 ga watan Maris, babu wata ƙasa da ta iya gwada fiye da kashi 3 cikin dari na yawan jama'arta, kuma a ƙasashe da dama kamar Italiya, Netherlands, Spain da Switzerland, an kafa manufofin da suka hana yin gwaji idan akwai ƙananan alamun cutar.
Binciken da aka fitar a ranar 16 ga watan Maris ya nuna cewa a China, kashi 86% na masu kamuwa da COVID-19 ba a gano su ba har zuwa ranar 23 ga watan Janairu, kuma cewa irin waɗannan marasa lafiya da ba a yi rajista ba sun zama tushen kamuwa da cutar a kashi 79% na waɗanda aka yi rajista.
Wani bincike na kididdiga da aka buga a ranar 30 ga watan Maris ya nuna cewa adadin mutanen da suka kamu da cutar a Italiya ya fi adadin mutanen da aka samu.
Ƙididdigar farko na asalin yawan haifuwa (R0) na kamuwa da cutar COVID-19 ya kasance daga 1.4 zuwa 2.4.
Wani bincike da aka yi da kuma cibiyar kula da cututtuka ta Amirka ya ce wannan adadin zai iya kaiwa 5.7.
Yawancin marasa lafiya da ke da COVID-19 suna samun sauƙi.
A wasu lokuta masu wuya, lokaci daga bayyanar cututtuka zuwa lokacin mutuwa ya kasance daga kwanaki 6 zuwa 41, mafi yawan lokuta kwanaki 14.
A ranar 10 ga Afrilu, 2020, kusan mutane 97,000 sun mutu sakamakon COVID-19.
A China, kusan kashi 80% na mutuwar sun kasance sama da shekaru 60, kuma kashi 75% na waɗanda suka mutu suna da cututtukan da suka haɗa da cututtukan zuciya da ciwon sukari. Bayanai na hukuma game da mutuwar cutar COVID-19 yawanci sun haɗa da mutuwar marasa lafiya waɗanda suka sami sakamako mai kyau na gwajin COVID bisa ga ƙa'idodin hukuma.
Adadin mutuwar COVID-19 na iya zama mafi girma, saboda ƙididdigar hukuma na iya ƙin ƙididdigar mutanen da suka mutu ba tare da an gwada su ba  misali, idan suka mutu a gida, a gidajen tsofaffi, da sauransu.
Bayanai marasa cikakke na Italiya sun nuna cewa ainihin adadin mutuwar a lokacin annobar ya ninka na COVID sau 45.
Wani mai magana da yawun Cibiyoyin Kula da Cututtuka da Rigakafin Cutar Amurka (CDC) ya yarda: Mun san cewa [adadin mutuwar da aka ruwaito] ya fi na ainihi. An tabbatar da maganarsa ta hanyar rahoton wasu shari'o'i na musamman a Amurka. Irin wannan lissafin da ba cikakke ba ne sau da yawa a cikin annoba kamar annobar cutar sankarar naman alade ta H1N1 na 2009. An tabbatar da mutuwar farko a Wuhan a ranar 9 ga Janairu, 2020.
An fara samun mutuwar mutum daya a waje da kasar Sin a ranar 1 ga watan Fabrairu a Philippines, sannan a ranar 14 ga watan Fabrairu a Faransa a wajen Asiya.
A ranar 28 ga watan Fabrairu, an samu mutuwar mutane fiye da goma a kasashen waje, wato Iran, Koriya ta Kudu da Italiya.
A ranar 13 ga watan Maris, sama da kasashe 40 da yankuna a duk nahiyoyi, sai dai Antarctica, sun ba da rahoton mutuwar.
Dukkanin alamomin sun bambanta dangane da yankin da lokacin yaduwar cutar; kuma suna da tasiri kan yawan gwajin, ingancin tsarin kiwon lafiya, tsarin maganin da aka yi amfani da shi, lokacin da cutar ta fara, da kuma sigogin jama'a kamar shekaru, jinsi da yanayin lafiyar gaba ɗaya.
A cewar bayanan da Jami'ar Johns Hopkins ta bayar, a ranar 10 ga Afrilu, 2020, adadin mutuwar duniya da kuma masu kamuwa da cutar ya kai kashi 6.0% (97 039/1 617 204).
Bayanai sun bambanta a yankuna dabam dabam.
A kasar Sin, yawan mutuwar da cutar ta yi ya ragu daga kashi 17.3% (ga wadanda suka fara nuna alamun cutar a ranar 1/10 ga watan Janairun 2020) zuwa kashi 0.7% (ga wadanda suka fara nuna alamun cutar bayan ranar 1 ga watan Fabrairun 2020). Sauran hanyoyin sun hada da sanin yawan mutuwar cutar (CFR)  yawan mutanen da aka gano cewa sun mutu daga cutar, da kuma yawan mutanen da suka mutu daga kamuwa da cuta (IFR), wanda ke nuna yawan mutanen da suka kamu da cutar (da wadanda aka gano da wadanda ba a gano ba) wadanda suka mutu daga cutar.
Waɗannan ƙididdigar ba su da wani lokaci, kuma suna nuna yadda mutane suke a lokacin kamuwa da cutar har zuwa lokacin da ta ƙare.
Wasu masana sun yi ƙoƙari su ƙididdige waɗannan ƙididdigar a kan takamaiman rukunin mutane.
Cibiyar Nazarin Magunguna ta Jami'ar Oxford ta kiyasta cewa yawan mutuwar wannan annoba ya kai daga kashi 0.1 zuwa 0.39 cikin dari.
Matsakaicin wannan zangon ya yi daidai da sakamakon gwajin COVID-19 na farko da aka yi a Jamus, da kuma binciken kididdiga da ke nazarin tasirin gwajin akan ƙimar CFR.
WHO ta ce za a iya sarrafa annobar.
Ba za a iya sanin lokacin da za a yi wannan fashewar ba kuma zai iya bambanta dangane da wurin da aka yi.
Macey Bonney, a Jami'ar Jihar Pennsylvania, ya ce, yawanci, cututtukan da ba a iya sarrafawa ba, sukan tashi a kan tudu, sa'an nan kuma idan suka ƙare, sai su fara raguwa.
Amma a halin da muke ciki, ba shi yiwuwa a yi wani kyakkyawan hasashen lokacin da hakan zai faru.
Babban mai ba da shawara kan harkokin kiwon lafiya na gwamnatin China, Jung Nansheng ya ce, "dukkanin abubuwan na iya karewa nan da watan Yuni" idan dukkan kasashe suka hada kai su bi shawarar WHO kan matakan dakile yaduwar cutar.
A ranar 17 ga watan Maris Adam Kucharsky daga Makarantar Lafiya da Magunguna ta London ya ce SARS-CoV-2 zai kasance yana yawo, mai yiwuwa a cikin shekara ɗaya ko biyu.
Wani bincike da kwalejin Imperial ta gudanar karkashin jagorancin Neil Ferguson ya nuna cewa,  har sai an samar da allurar rigakafi (watakila watanni 18 ko fiye)  za a bukaci kiyaye nisantar jiki da sauran matakan.
William Schaffner na Jami'ar Vanderbilt ya ce: "Ba na tsammanin wannan cutar za ta kare gaba daya, saboda tana da saurin yaduwa, kuma tana iya zama wata cuta ta yanayi, tana barkewa a kowace shekara".
Rashin lafiyar mutane da kuma yadda suka kamu da cutar zai iya shafan yadda cutar take yaduwa.
Alamun COVID-19 na iya zama marasa ma'ana, kuma wasu mutane da suka kamu da cutar na iya ɗaukar cutar ba tare da wata alama ba.
Alamun biyu da suka fi yawa sune yawan zafin jiki (88%) da kuma tari mai bushe (68%).
Alamomin da ba su da yawa sun hada da gajiya, kumburi a cikin numfashi (hawaye), rashin jin ƙanshi, rashin numfashi, ciwon tsoka da haɗin gwiwa, ciwon makogwaro, ciwon kai, sanyi, amai, zubar da jini, zawo ko cyanosis. WHO ta ce kusan kowane mutum shida yana da mummunan cuta tare da ci gaban matsalolin numfashi.
Cibiyoyin Kula da Cututtuka na Amurka (CDC) sun lissafa alamun gaggawa kamar wahalar numfashi, ciwo na kullum ko jin matsi a cikin kirji, jin rikicewar hankali kwatsam, wahalar farkawa da launin ruwan kasa na fuska ko lebe. Idan akwai waɗannan alamun, ya kamata a nemi taimakon likita nan da nan. Ci gaban cutar na iya haifar da mummunar cutar huhu, cututtukan numfashi mai tsanani, sepsis, tashin hankali, da mutuwa.
Wasu mutane da suka kamu da cutar ba su da alamun cutar, amma sakamakon gwajin ya tabbatar da cewa sun kamu da ita, saboda haka likitoci sun ba da shawarar a sanya mutanen da ke da kusanci da marasa lafiya da aka tabbatar da cutar a ƙarƙashin kulawa mai tsanani kuma a gwada su don kamuwa da cutar.
Masana kimiyya na kasar Sin sun kiyasta cewa yawan wadanda ba su da wata alama na cutar ya kai kashi 44 cikin dari na wadanda suka kamu da cutar.
Lokacin da aka saba da shi (lokacin tsakanin kamuwa da cutar da bayyanar cututtuka) ya kasance daga kwana daya zuwa 14, yawanci kwana biyar.
Har yanzu ba a san wasu bayanai game da yadda cutar take yaduwa ba.
Ana ganin cewa cutar tana yaduwa ne a lokacin kusanci, da kuma ta kananan raƙuman da ke fita cikin iska tare da tari, hancin ko kuma lokacin magana; a cikin kusanci ana nufin tuntuɓar a cikin radius daga mita 1 zuwa 2 (daga 3 zuwa 6 feet).
Wasu bincike sun nuna cewa idan mutum ya yi tari a fili, za a iya samun sauro mai nisa daga mita 4.5 zuwa mita 8.2.
Akwai hasashe cewa cutar na iya yaduwa ta hanyar ƙananan ɗigon da ake fitarwa cikin iska yayin magana, waɗanda ke iya kasancewa cikin iska na dogon lokaci. Rashin numfashi na iya haifar da numfashi, gami da lokacin magana, kodayake ba a yawanci ana yaduwar cutar ta iska.
Za a iya samun ruwan da ke saukowa daga cikin hanci zuwa cikin baki ko kuma cikin hanci, da kuma cikin huhu.
Wasu hanyoyin kiwon lafiya kamar su intubation da kuma aikin numfashi na zuciya da huhu (CPR) na iya haifar da yayyafa abubuwan numfashi kuma, saboda haka, ya iya sa cutar ta yaɗu a cikin iska.
Hakanan za a iya shiga jikin mutum idan mutum ya taɓa wani gurɓataccen wuri, ciki har da fata, sannan ya taɓa idanunsa, hanci, ko bakinsa.
Akwai kuma fargabar cewa za a iya yada cutar ta hanyar kwari, amma an yi la'akari da cewa wannan hanyar ba ta da hadari.
Gwamnatin China ta musanta yiwuwar watsa SARS-CoV-2 ta hanyar magungunan jini. Kwayar cutar tana da yaduwar yaduwa a cikin kwanaki uku na farko bayan bayyanar cututtuka, kodayake za ta iya yaduwa kafin bayyanar cututtuka da kuma a cikin matakan cutar.
Akwai wasu lokuta da aka samu sakamakon gwajin da ya nuna cewa cutar ta kamu da cutar kwanaki uku kafin bayyanar cututtuka, kuma hakan na nuna cewa cutar ta iya yaduwa kafin bayyanar cututtuka.
Akwai rahotanni kaɗan na lab da aka tabbatar da cutar ba tare da bayyanar cututtuka ba, amma binciken da aka yi a wasu ƙasashe ya gano cewa akwai wasu cututtuka daga masu dauke da cutar ba tare da bayyanar cututtuka ba.
Ma'aikatan Cibiyar Kula da Cututtuka ta Turai (ECDC) sun ce ba a san yadda cutar ke yaduwa ba, amma an san cewa mutum ɗaya da ke da cutar yakan kamu da mutane 23 da suka kamu da ita.
Musamman, an gano cewa a kan filastik (polypropylene) da kuma bakin karfe (304) cutar na iya rayuwa har zuwa kwana uku, a kan takarda  har tsawon rana guda, kuma a kan tagulla  har zuwa awanni 4.
Amma, wannan ya bambanta dangane da zafi da zafin jiki, kuma dabbobi da sauran dabbobi sun nuna cewa suna da cutar COVID-19.
Babu wata hujja da ta nuna cewa dabbobi na iya yada cutar zuwa ga mutane, duk da cewa hukumomin Birtaniya sun bada shawara a wanke hannu bayan an yi hulɗa da dabbobi, kamar yadda ake yi bayan an yi hulɗa da wasu wurare da mutane masu cutar suka taɓa.
Cutar coronavirus mai saurin numfashi mai tsanani 2 (SARS-CoV-2)  sabuwar cuta ce da aka fara ganowa a cikin mutane uku da ke da ciwon huhu daga rukunin masu cutar numfashi mai saurin kamuwa da cuta da aka samu a Wuhan.
Dukkanin alamun sabon kwayar cutar SARS-CoV-2 ana samunsu ne a cikin yanayi a cikin kwayar cutar coronavirus. A wajen jikin mutum za a iya kashe kwayar cutar ta hanyar sabulu na gida wanda ke narkar da murfin kariya. SARS-CoV-2 yana da kamanceceniya da kwayar cutar SARS-CoV ta asali.
An yi imanin cewa ya samo asali ne daga dabbobi.
Binciken kwayoyin cutar coronavirus ya nuna cewa yana da alaƙa da Betacoronavirus, wani nau'in Sarbecovirus (sashin kwayar B) tare da wasu nau'ikan ƙwayoyin cuta biyu na bat.
A matakin kwayoyin halitta, ya yi kama da sauran kwayoyin cutar baturi (BatCov RaTG13) da kashi 96 cikin dari.
A watan Fabrairun 2020, masu bincike na kasar Sin sun gano cewa akwai bambanci guda daya ne kawai a cikin amino acid na wasu sassan jerin kwayoyin halittar kwayoyin halittar mutane da kuma na mutane.
Kwatantawar kwayoyin halitta ya zuwa yanzu ya nuna cewa mafi yawan kashi (92%) na kamance tsakanin kwayar cutar ta pangolin da SARS-CoV-2, amma wannan bai isa ya tabbatar da cewa pangolins sune masu watsa kwayar cutar ba.
Ana iya gane kamuwa da kwayar cutar a kan alamun cutar, amma a ƙarshe za a tabbatar da hakan ta hanyar nazarin polymerase chain reaction tare da sake rubutawa (RT-PCR) na ɓacin rai ko kuma ta hanyar daukar hoto.
Sakamakon binciken da ya kwatanta hanyoyin PCR da CT da aka yi amfani da su a Wuhan, ya nuna cewa CT ya fi PCR jin dadi sosai, kodayake ba shi da takamaiman bayani, saboda yawancin ayyukan gani da ke ciki sun yi daidai da sauran cututtukan huhu da kuma hanyoyin cutar.
Tun daga watan Maris na shekarar 2020, Kwalejin Radiology ta Amurka ta wallafa shawarar  kada a yi amfani da CT don yin bincike ko kuma a matsayin hanyar gwajin farko a cikin gano COVID-19 .
WHO ta wallafa wasu takardun gwaji na RNA don SARS-CoV-2, kuma na farko daga cikinsu an buga shi a ranar 17 ga Janairu.
Ana yin gwaji don polymerase sarkar amsawa a cikin ainihin lokacin (RT-PCR).
Ana iya yinsa ta wurin yin gwajin numfashi da kuma gwajin jini.
Sakamakon zai kasance a shirye cikin sa'o'i da yawa zuwa kwanaki da yawa.
Ana amfani da maganin hanci da hanci, ko da yake ana iya amfani da maganin zuma. Wasu dakunan gwaje-gwaje da kamfanoni suna yin gwajin maganin da zai iya gano kwayoyin cutar.
Ya zuwa ranar 6 ga Afrilu, 2020, babu ko ɗaya daga cikinsu da ya isa ya sami amincewa don amfani a ko'ina.
A Amurka, gwajin ƙwayar cuta da Cellex ya tsara, an amince da shi ne kawai don amfani da shi a cikin gaggawa ta hanyar ingantattun dakunan gwaje-gwaje.
Abubuwan da ke nuna alamun bayyanar cututtuka a kan x-ray da kuma kwamfuta (CT) sun haɗa da asymmetrical na waje na gilashin gilashi da rashin zubar da jini.
Ƙungiyar Radiology ta Italiya ce ke tattara hotuna na mutanen da suka kamu da cutar a ƙasashen duniya.
Saboda kamannin da ke tsakanin wasu cututtuka kamar su adenovirus, a gano COVID-19, hotunan da ba a tabbatar da su ta gwajin PCR ba suna da iyakantaccen takamaiman asibiti.
An yi wani babban bincike a China inda aka gwada CT na kirji da gwajin PCR, kuma an gano cewa ko da yake hotuna ba su da takamaiman bayani game da kamuwa da cuta, amma za a iya gane su da sauri; kuma suna da saukin ganewa, saboda haka za a iya yin amfani da wannan hanyar bincike a matsayin kayan aikin gano cutar a yankunan da ke da cutar.
Don gano cutar ta hanyar yin amfani da radiyo da kuma daukar hoto ta kwamfuta, an kirkiro hanyoyin sadarwa na jijiyoyin jiki masu amfani da fasaha.
Dabaru na hana yaduwar cutar sun haɗa da kiyaye tsabtace jiki, wanke hannu, guje wa taɓa idanu, hanci, ko baki da hannaye masu datti, da kuma amfani da tawul da za a zubar da su nan da nan bayan an yi amfani da su.
Waɗanda suka riga sun kamu da cutar ya kamata su sanya abin rufe fuska a wuraren jama'a.
Don hana yaduwar cutar, an kuma bada shawarar a nisanta jiki daga mutane. Gwamnatoci da dama sun bada shawarar a guji duk wata tafiya da ba ta dace ba zuwa kasashen da ke fama da annobar, kuma sun takaita zirga-zirgar jama'a.
Duk da haka, cutar ta iya yaduwa a yawancin yankuna na duniya.
Wannan yana nufin cewa kwayar cutar tana yaduwa a cikin jama'a, wasu daga cikin su ba su san inda ko yadda suka kamu da cutar ba. Ana ba da shawarar ma'aikatan kiwon lafiya da ke kula da marasa lafiya waɗanda za su iya kamuwa da cutar su yi amfani da matakan tsaro na yau da kullun, da kuma matakan kariya yayin hulɗa da wasu mutane da kayan kariya na ido. Binciken hulɗa kuma hanya ce mai mahimmanci da hukumomin kiwon lafiya ke amfani da ita don gano tushen kamuwa da cuta da hana ci gaba da yaduwar ta.
Amfani da gwamnatoci ke yi da bayanan wurin da 'yan kasa suke ta wayar salula domin wannan manufar ya haifar da damuwa game da tsare sirri, kuma kungiyoyi kamar Amnesty International da kuma kungiyoyi sama da 100 sun fito da sanarwa suna neman a rage irin wannan sa ido.
An tsara kuma an gabatar da aikace-aikacen wayar hannu daban-daban don amfani da son rai; har zuwa 7 ga Afrilu, 2020, sama da gungun masana goma suna aiki kan haɓaka mafita don tabbatar da sirrin bayanan sirri  misali, yin rajistar kusanci mai amfani da wasu wayoyin hannu ta hanyar fasahar Bluetooth.
Idan mai amfani da wayar salula ya kasance tare da wanda ya sami tabbacin cutar COVID-19, za a sanar da shi. Akwai kuma wasu ra'ayoyi marasa inganci game da yadda za a hana kamuwa da cutar  kamar wanke hanci da baki, wanda a zahiri ba shi da tasiri.
A yanzu haka babu allurar rigakafin COVID-19, duk da cewa kungiyoyi da dama na aiki a kan samar da ita.
Ana ba da shawarar wanke hannu don hana yaduwar cutar.
CDC (Cibiyar Kula da Cututtuka da Rigakafin Cutar) ta kuma ba da shawarar wanke hannaye da sabulu da ruwa aƙalla na dakika 20, musamman bayan zuwa bayan gida ko kuma idan hannayenka sun yi datti sosai, da kuma kafin cin abinci, bayan yin hancinka, tari, ko hancinka.
Wannan ya zama dole domin idan ta fito daga jikin mutum, za a kashe ta da sabulu da ke kashe garkuwar jikinta.
Bugu da ƙari, idan sabulu da ruwa ba su da sauƙi, CDC ta ba da shawarar yin amfani da maganin kashe ƙwayoyin cuta na hannu da ke da kashi 60 cikin ɗari na barasa.
WHO ta ba da shawarar kada mutane su taɓa idanunsu, hanci, ko kuma bakinsu da hannayensu masu datti.
Za a iya kawar da surface da wasu magunguna (a kan farfajiyar bakin karfe mai lalata yana aiki a minti daya bayan an yi amfani da shi) tare da 6271% ethanol, 50100% isopropanol, 0,1% sodium hypochlorite, 0,5% hydrogen peroxide da 0,27,5% povidone-iodine.
Sauran abubuwan kamar benzalkonium chloride da chlorhexidine gluconate ba su da tasiri sosai.
CDC ta ba da shawarar cewa idan ana zargin ko an tabbatar da COVID a cikin wani wuri kamar ofishi ko asibiti, duk wuraren da ake ciki, ciki har da ɗakunan aiki, wuraren wanka, wuraren da ake amfani da su, kayan aikin lantarki kamar su allunan, allon taɓawa, mabuɗan rubutu, kwamfutar tafi-da-gidanka, da na'urorin ATM da masu cutar ke amfani da su, a yi musu maganin kashe ƙwayoyin cuta.
Ƙungiyoyin kiwon lafiya sun ba da shawarar cewa idan kana yin tari ko kuma hancinka, ka rufe bakinka da hancinka da takunkumi ko kuma takunkumi kuma ka zubar da kayan tsabta da ka yi amfani da su nan da nan.
Ana ba da shawarar cewa waɗanda za su iya kamuwa da cutar su sanya abin rufe fuska, domin yin amfani da abin rufe fuska zai iya rage yawan da kuma yawan abubuwan numfashi da ke fitowa daga iska yayin magana, hancin da kuma tari.
Hukumar lafiya ta duniya ta fitar da umarni kan lokacin da kuma yadda za a yi amfani da abin rufe fuska.
A cewar Stephen Griffin, masanin ilmin cututtuka a jami'ar Leeds, "Yin amfani da abin rufe fuska na iya rage sha'awar mutane su taba fuskokinsu, kuma taɓa fuska da ƙazamar hannu" ita ce babbar hanyar kamuwa da cutar.
WHO ta ba da shawarar cewa mutane masu lafiya su sanya abin rufe fuska na likita ne kawai idan suna cikin haɗari, kamar waɗanda ke kula da mutumin da ke da COVID-19, ko da yake ta kuma yarda cewa amfani da abin rufe fuska yana rage yawan taɓa fuska.
Kasashe da dama sun fara kira ga amfani da abin rufe fuska a wuraren jama'a.
CDC na Amurka ta ba da shawarar sanya abin rufe fuska na masana'anta don dalilai marasa lafiya. China ta ba da shawarar yin amfani da abin rufe fuska na likita na lokaci guda ga mutanen da ke da lafiya, musamman idan suna kusa da mutane (mita 1 (ƙafa 3) ko ƙasa da haka).
A Hong Kong, ana ba da shawarar a sa abin rufe fuska a cikin sufuri na jama'a ko kuma a wuraren da mutane suke.
Jami'an kiwon lafiya na Thailand sun bukaci mutane su yi takunkumin fuska a gida kuma su wanke shi kullum.
A Jamhuriyar Czech da Slovakia, an hana mutane fita waje ba tare da rufe hanci da baki ba.
A ranar 16 ga watan Maris, gwamnatin Vietnam ta nemi dukkan 'yan kasar su sanya abin rufe fuska a wuraren jama'a domin kare kansu da sauran mutane.
Gwamnatin Austria ta tilasta wa duk masu zuwa kantin sayar da kayayyaki su sanya abin rufe fuska.
Gwamnatin Isra'ila ta kuma nemi 'yan kasar su sanya abin rufe fuska a wuraren jama'a.
A ranar 1 ga Afrilu, an umurci Taiwan, inda ake samar da abin rufe fuska miliyan goma a kowace rana tun tsakiyar watan Maris, ta yi amfani da abin rufe fuska ga dukan fasinjojin jiragen kasa da na bas.
A Panama, an tilasta wa mazauna garin su sanya abin rufe fuska yayin da suke fita waje, kuma an shawarci waɗanda ba su da kuɗin sayan abin rufe fuska su yi ɗamara a gida.
Mazauna Japan, Koriya ta Kudu, Malaysia da Singapore ma suna amfani da abin rufe fuska na likita sosai.
Nisa nesa (wanda kuma ake kira nesa na jiki)  wani mataki ne na yaki da kamuwa da cuta da ake nufi da rage yaduwar cutar ta hanyar rage kusanci tsakanin mutane.
Matakan kariya sun haɗa da keɓewa, ƙuntatawa kan tafiye-tafiye, rufe makarantu, wuraren aiki, filayen wasa, gidajen wasan kwaikwayo da cibiyoyin kasuwanci.
Mutane na iya amfani da matakan nisantar jama'a ta hanyar zama a gida, rage tafiye-tafiye, guje wa wuraren jama'a, amfani da gaisuwa ba tare da tuntuɓar mutum ba, da nisantar mutane.
Gwamnatoci da yawa na yankuna, musamman waɗanda cutar ta shafa, a yanzu suna ba da umarni ko kuma ba da shawarar nisantar jama'a.
An rage yawan mutane da za su iya taruwa a wuri guda bisa ga shawarar hukumomin gwamnati na Amurka da kungiyoyin kiwon lafiya daga mutane 250 (a yankunan da ba a samu bayanan yaduwar COVID-19 ba), zuwa mutane 50, daga baya kuma zuwa mutane 10.
A ranar 22 ga Maris, 2020, Jamus ta hana taron jama'a sama da mutane biyu. Tsofaffi da waɗanda ke fama da cututtuka kamar su ciwon sukari, cututtukan zuciya, cututtukan numfashi, hawan jini, da kuma raunin tsarin garkuwar jiki suna fuskantar haɗarin kamuwa da cutar da gaske. CDC ta ba da shawarar su zauna a gida har tsawon lokacin da zai yiwu idan akwai barkewar cutar a yankin. A ƙarshen Maris, 2020, WHO da sauran hukumomin kiwon lafiya sun fara maye gurbin amfani da kalmar  nisantar zamantakewa da  nisantar jiki, don haka ya bayyana manufar wannan matakin  don rage hulɗa ta jiki a cikin alaƙar zamantakewa, ko ta hanyar sadarwa ta yanar gizo ko ta hanyar kiyaye ta ta jiki.
Amfani da kalmar "yanke nesa" an fahimta ne ta hanyar cewa mutane su sanya kansu cikin keɓewar jama'a gaba ɗaya, maimakon ci gaba da hulɗa da wasu ta wasu hanyoyi. Wasu hukumomi sun buga jagororin kiwon lafiya na jima'i da ya kamata a yi amfani da su yayin annobar.
A cikin wasu, an ba da shawarar a yi jima'i da abokan zamanka kawai, waɗanda kake zama tare da su, waɗanda ka tabbata ba su da cutar da kuma alamunta.
An shawarci waɗanda aka gano suna da cutar COVID-19 da waɗanda suke tsammanin suna da cutar su keɓe kansu a gida.
Cibiyoyin kiwon lafiya sun wallafa cikakkun bayanai kan yadda za a kebe kai, gwamnatocin kasashe da dama sun kuma tilasta ko kuma sun bada shawarar cewa duk mazauna yankunan da cutar ta shafa su kebe kansu.
An ba da umarnin a yi wa mutanen da ke cikin rukunin da ke da haɗari sosai, tsauraran matakan keɓewa.
An shawarci mutanen da suka iya kasancewa cikin hulɗa da waɗanda ke da cutar COVID-19, ko kuma waɗanda suka ziyarci ƙasa ko yanki kwanan nan da cutar ta yi tasiri sosai, su keɓe kansu na tsawon kwanaki 14 daga lokacin da suka kasance cikin hulɗa da su.
Dabaru na yaki da barkewar cutar sun hada da hana yaduwar cutar, hana ta ko kuma rage ta.
Ana hana yaduwar cutar a farkon lokaci kuma ana yin hakan ne don a lura da kuma ware waɗanda suka kamu da cutar, kuma yana nufin wasu matakan kula da kamuwa da cuta da kuma allurar rigakafi don dakatar da yaduwar cutar a cikin sauran jama'a.
A lokacin da ba za a iya hana yaduwar cutar ba, ana kokarin rage tasirin cutar ta hanyar daukar matakan rage yaduwar cutar da kuma rage tasirinta a kan tsarin kiwon lafiya da al'umma.
Ana iya yin matakan hana cutar da kuma rage ta a lokaci guda.
Dakatar da kamuwa da cuta na bukatar karin matakan gaggawa don mayar da annobar ta baya ta hanyar rage yawan kamuwa da cuta zuwa kasa da 1. Wani bangare na kokarin da ake yi na sarrafa barkewar cutar mai yaduwa shine rage girman cutar, wanda aka sani da daidaita yanayin annobar.
Irin waɗannan ƙoƙarin suna rage haɗarin ɗimbin ayyuka a fannin kiwon lafiya kuma suna ba da ƙarin lokaci don samar da allurar rigakafi da hanyoyin magani.
Sauran hanyoyin da ba na magani ba da za su iya taimakawa wajen magance annobar sun hada da matakan rigakafin mutum kamar tsaftace hannu, amfani da abin rufe fuska da keɓe kai; matakan zamantakewa da ke nufin nisantar jiki kamar rufe makarantu da soke taron jama'a; shigar da al'umma don taimakawa da shiga cikin waɗannan matakan; da kuma matakan kiyaye muhalli kamar tsabtace farfajiyoyi. Bayan da annobar ta zama mai tsanani a China, an ɗauki matakai masu ƙarfi don hana annobar kamar keɓe birane baki ɗaya da kuma sanya takunkumin tafiye-tafiye.
Sauran ƙasashe ma sun ɗauki wasu matakai da suka shafi hana yaduwar cutar.
A Koriya ta Kudu an fara yin gwajin cutar a ko'ina kuma an kafa wasu wuraren da ake keɓe mutane, da kuma tsarin sanar da mutane game da inda suka ke tafiya.
A Singapore, an ba da tallafi na kuɗi ga waɗanda ke da cutar da ke keɓe kansu kuma an sanya manyan tarar waɗanda ba su yi hakan ba.
A Taiwan, an kara samar da takunkumin rufe fuska da kuma tarawa kan yawan magunguna. Tsarin kirkirar da aka yi a Birtaniya da Amurka ya nuna cewa akwai matsaloli masu tsanani game da rage (ragewa, amma ba dakatar da yaduwar cutar) da kuma hana (dakatar da ci gaban cutar).
Ka'idoji masu kyau na rage yaduwar cutar na iya rage yawan aikin kiwon lafiya da kashi biyu bisa uku, da kuma mutuwar mutane da rabi, amma har yanzu yana haifar da dubban dubban mutuwar mutane da kuma rushewar tsarin kiwon lafiya.
Rashin rigakafi na iya zama hanya mafi kyau, amma ya kamata a yi amfani da shi har sai cutar ta kewaya a cikin jama'a (ko kuma har sai an samar da allurar rigakafi, idan hakan ta faru da wuri), in ba haka ba yaduwar cutar za ta sake faruwa da sauri idan an sassauta matakan.
Saurin hana annobar ya jawo tsadar tattalin arziki da zamantakewa.
Babu maganin rigakafin cutar da aka amince da shi don maganin COVID-19, amma ana ƙoƙari a ci gaba da samar da su, ciki har da gwajin magungunan da ake da su.
Shan magungunan sanyi da ba a ba da takardar magani, shan ruwa mai yawa, da kuma hutawa na iya taimakawa wajen rage alamun.
Dangane da yadda cutar take, mai haƙuri zai bukaci maganin oxygen, da kuma taimakon numfashi.
Yin amfani da kwayoyin steroid zai iya cutar da mutum.
An kuma duba wasu abubuwa da aka amince da su a baya don magance wasu cututtukan ƙwayoyin cuta don maganin COVID-19.
WHO ta kuma ce wasu magunguna na gargajiya da na gida na iya sauƙaƙa alamun cutar SARS-CoV-19.
WHO ta ɗauki inganta lafiyar jama'a da kuma daidaitawa ga bukatun marasa lafiya da ke fama da COVID-19 a matsayin babban matakin magance cutar.
Cibiyar Kula da Cututtuka ta Turai (ECDC) da Ofishin Yankin WHO na Turai sun fitar da jagororin ga asibitoci da kuma ayyukan kiwon lafiya na farko don taimakawa wajen sake rarraba albarkatu a matakai da dama, gami da mai da hankali kan ayyukan gwaji na COVID-19, kawar da hanyoyin gaggawa idan ya yiwu, gano kwayar cutar da ke ware marasa lafiya da aka tabbatar da cutar ta COVID-19, da kuma fadada damar kulawa mai tsanani ta hanyar horar da ma'aikata da kuma kara yawan na'urorin IVL da gadaje.
Akwai ra'ayoyi da dama game da inda cutar ta fara, wanda ake kira "marasa lafiya".
An yi zaton cewa an samu mutum na farko da ya kamu da cutar coronavirus a ranar 1 ga watan Disamba, 2019 a birnin Wuhan na lardin Hubei, China.
A cikin wata guda, adadin masu kamuwa da cutar coronavirus a lardin Hubei ya ci gaba da ƙaruwa.
An yi la'akari da cewa cutar ta shiga jikin mutum ne daga daya daga cikin wadannan dabbobin, wato, cutar ta samo asali ne daga dabbobi. A ranar 26 ga watan Disamba, an samu kamuwa da cutar huhu da ba a san asalin ta ba a asibitin lardin Hubei, inda likita Zhang Tianjin ta yi aiki, kuma a ranar 27 ga watan Disamba, ta kai rahoton cutar ga Cibiyar Kula da Cutar da Cutar da ke birnin Wuhan.
A ranar 30 ga watan Disamba, wasu likitoci a asibitin Wuhan sun gargadi abokan aikinsu game da cutar korona, wadda take kama da SARS.
Likitoci takwas daga cikin wadannan likitoci, ciki har da Li Wenlian, 'yan sanda sun gargadi su da alhakin yada jita-jita, kuma likita, Ai Feng, ta sami horo daga shugabanninta saboda ta firgita.
Daga baya, a ranar 31 ga watan Disamba, Hukumar Kiwon Lafiya ta Wuhan ta fitar da sanarwar jama'a kuma ta sanar da WHO game da halin da ake ciki.
Hukumomin kiwon lafiya na Wuhan sun ba da rahoton adadin mutanen da suka kamu da cutar huhu da ba a san ko su waye ba, wanda ya isa a fara bincike a farkon watan Janairu.
A farkon da tsakiyar watan Janairun 2020, cutar ta kuma bazu zuwa wasu lardunan kasar Sin, saboda bukukuwan Sabuwar Shekarar kasar Sin da kuma gaskiyar cewa Wuhan ita ce babbar hanyar sufuri da kuma hanyar jirgin kasa.
A ranar 20 ga watan Janairu, kasar Sin ta bayar da rahoton sabbin mutane 140 da suka kamu da cutar a rana daya, ciki har da mutum biyu da suka kamu da cutar a birnin Beijing da kuma mutum daya a birnin Shenzhen.
A cewar bayanan hukuma na baya-bayan nan, a ranar 20 ga Janairu, 2020, alamun cutar sun bayyana a cikin mutane 6,174. A ranar 26 ga Maris, Amurka ta zarce China da Italiya a cikin mafi yawan adadin wadanda aka tabbatar da kamuwa da cutar a duniya. A ranar 9 ga Afrilu, 2020, an sami sama da mutane miliyan 1.61 da suka kamu da cutar a duniya, sama da mutane 97,000 sun mutu, kuma sama da 364,000 sun warke.
Kimanin kasashe da yankuna 200 sun samu aƙalla mutum ɗaya da ya kamu da cutar.
Saboda annobar, ƙasashen Turai da dama na yankin Schengen sun takaita motsi da kuma kafa iko a kan iyakoki.
Matakan amsawa na ƙasa sun haɗa da matakan hana yaduwar cutar kamar keɓewa (wanda aka sani da zama a gida, rufe gida ko keɓewa), da kuma dokar hana fita. A ranar 2 ga Afrilu, kusan mutane miliyan 300, ko kusan kashi 90% na yawan jama'ar Amurka, suna cikin wani nau'in keɓewa, sama da mutane miliyan 50 suna cikin keɓewa a Philippines, kusan mutane miliyan 59 suna cikin keɓewa a Afirka ta Kudu, da mutane biliyan 1.3  a Indiya.
A ranar 26 ga watan Maris, mutane biliyan 1.7 a duniya suna cikin wani nau'i na keɓewa, kuma bayan kwana biyu, wannan adadi ya ƙaru zuwa biliyan 2.6  kusan kashi ɗaya bisa uku na yawan mutanen duniya.
An samu tabbacin kamuwa da cutar COVID-19 a Wuhan a ranar 1 ga Disamba, 2019; a cewar wani rahoto, wanda ba a tabbatar da gaskiyar bayanin ba, wannan kwanan wata shine  17 ga Nuwamba.
A ranar 26 ga watan Disamba, likita Zhang Jissian ta yi aiki da wani babban ciwon huhu da ba a san ko wane irin ciwo ne ba, kuma a ranar 27 ga watan Disamba, asibitinta ta sanar da Cibiyar Kula da Cututtuka da Rigakafin cutar ta Jianghan a birnin Wuhan.
Gwajin farko na kwayoyin halittar marasa lafiya, wanda ya faru a ranar 27 ga Disamba, 2019, ya nuna cewa akwai cutar coronavirus mai kama da SARS.
A ranar 31 ga watan Disamba, hukumar kiwon lafiya ta Wuhan ta wallafa sanarwar da ta shafi jama'a.
An sanar da WHO a ranar.
A sakamakon irin wannan sanarwar, 'yan sanda sun gargadi likitoci a Wuhan game da alhakin "yadda ake yada jita-jita" game da barkewar cutar.
A farko hukumar kiwon lafiya ta kasar Sin ta ce babu wata hujja da ta nuna cewa cutar za ta iya yaduwa daga mutum zuwa mutum.
A karshen watan Janairu, gwamnatin kasar Sin ta kaddamar da wani yunkuri na dakile yaduwar cutar, wanda daga baya babban sakataren jam'iyyar kwaminis ta kasar Sin, Xi Jinping ya kira "yaƙin jama'a".
An fara abubuwan da suka faru na "mafi girman keɓewa a tarihin ɗan adam", a ranar 23 ga Janairu an sanar da layin tsabtace jiki da hana shiga Wuhan da dawowa, daga baya wannan matakin ya bazu gaba ɗaya zuwa birane 15 na lardin Hubei kuma ya shafi mutane kusan miliyan 57.
An hana amfani da motocin mutane a birnin.
An soke bukukuwan Sabuwar Shekara ta kasar Sin a wurare da yawa (ranar 25 ga Janairu).
Hukumomi sun kuma sanar da gina asibitin wucin gadi na Huoshenshang, wanda aka kammala cikin kwanaki 10.
Daga baya aka gina wani asibiti, Leishenshan, wanda ya karbi sauran marasa lafiya.
A ranar 26 ga watan Janairu, gwamnatin ta dauki karin matakai don dakile barkewar COVID-19, gami da bayar da takardun shaida na lafiya ga matafiya da kuma tsawaita lokacin bikin Sabuwar Shekarar Sin.
An rufe jami'o'i da makarantu a dukan ƙasar.
Yankunan Hong Kong da Macau sun kafa wasu matakan musamman game da makarantu da jami'o'i.
A wasu yankuna na kasar Sin, hukumomi sun kafa tsarin aiki daga nesa.
An kafa takunkumin hana tafiye-tafiye a lardin Hubei da kuma wajensa.
An sauya jadawalin zirga-zirgar jama'a, kuma an rufe gidajen tarihi na ɗan lokaci a duk ƙasar Sin.
An kafa tsarin kula da zirga-zirgar jama'a a birane da yawa, kuma an kiyasta cewa mutane miliyan 760 (fiye da rabin yawan jama'a) sun fuskanci wasu nau'ikan takunkumin zirga-zirga a waje. Bayan barkewar cutar ta shiga duniya a watan Maris, hukumomin kasar Sin sun dauki tsauraran matakai don hana shigo da cutar daga wasu ƙasashe.
Misali, Beijing ta kafa dokar killacewa na kwanaki 14 ga duk matafiya na duniya da ke shigowa birnin. A ranar 23 ga watan Maris, an samu mutum daya ne kawai da ya kamu da cutar a kasar Sin, wanda ya kamu da cutar kwanaki biyar da suka gabata, wanda ya kamu da cutar ne daga wani mutum da ya dawo Guangzhou daga Istanbul.
A ranar 24 ga Maris, 2020, Firayim Ministan kasar Sin Li Keqiang ya sanar da cewa an dakatar da yaduwar cututtukan da ake yadawa a cikin kasar, kuma an sami nasarar sarrafa barkewar cutar a kasar Sin.
A wannan ranar ne aka dage takunkumin tafiye-tafiye zuwa Hubei, sai dai Wuhan, bayan watanni biyu da rufe lardin don keɓewa. A ranar 26 ga Maris, 2020, Ma'aikatar Harkokin Wajen Sin ta sanar da cewa daga ranar 28 ga Maris, za a dakatar da shigar da mutanen da ke da biza ko izinin zama. Ba a bayyana takamaiman lokacin da za a soke wannan umarnin ba.
Waɗanda suke son zuwa ƙasar Sin za su nemi biza a ofishin jakadancin ƙasar Sin ko kuma ofishin jakadancin ƙasar.
A ranar 30 ga watan Maris, gwamnatin kasar Sin ta bukaci kamfanoni da masana'antu da su ci gaba da aiki tare da samar wa kamfanoni da wasu matakan karfafa kudi. A ranar 4 ga watan Afrilu da karfe 10:00 na safe, an yi zaman minti uku na shiru, wanda ya bude ranar makoki ga wadanda cutar coronavirus ta shafa, wanda majalisar jihar ta ayyana, wanda ya yi daidai da bikin Qinmin, amma gwamnatin tsakiya ta nemi 'yan kasa su girmama wadanda suka mutu ta hanyar yanar gizo, tare da kiyaye nesa ta jiki don kaucewa sake barkewar COVID-19.
An tabbatar da cewa COVID-19 ya bazu zuwa yankin Koriya ta Kudu a ranar 20 ga Janairu, 2020 daga China.
A ranar 20 ga watan Fabrairu, Ma'aikatar Lafiya ta kasa ta bayar da rahoton karuwar adadin wadanda suka kamu da cutar, wanda ya faru ne saboda yawan mabiyan wani sabon addini da aka sani da Shinchongji Church of Jesus da ke Tagu.
Mabiyan Shinchongji sun zo garin Taghu daga Wuhan, wanda ake ganin shine tushen annobar.
A ranar 22 ga watan Fabrairu, daga cikin masu bin coci 9,336, 1,261 (kusan 13%) sun ba da rahoton cewa suna da alamun cutar.
A ranar 28 ga watan Fabrairu, an samu fiye da mutane 2,000 da suka kamu da cutar a Koriya, kuma a ranar 29 ga watan Fabrairu, adadin ya kai 3,150.
An sanya dukkan sansanonin sojin Koriya ta Kudu a cikin keɓewa bayan da aka tabbatar da cewa sojoji uku suna da kwayar cutar.
Yaduwar cutar ta shafi yawan tafiye-tafiye, saboda haka an canza jadawalin jirgin sama na kamfanonin jiragen sama. Koriya ta Kudu ta ƙaddamar da shirin yin gwajin cutar, bin diddigin lambobin sadarwa da kuma tsara matakan keɓewa ga mutanen da suka sadu da ita. Wannan shirin ana ɗaukarsa mafi girma kuma mafi kyau dangane da tsarinsa a duniya.
Hanyoyin tantancewa sun hada da tilastawa ga duk wanda ya zo daga kasashen waje ya sanar da alamomin cutar ta wayar salula, gwajin kwayar cutar a rana daya, da kuma fadada damar gwajin wanda ya ba da damar gwajin mutane 20,000 a kowace rana.
An yi la'akari da shirin Koriya ta Kudu a matsayin nasara wajen magance barkewar cutar, duk da cewa ba a kebe birane ba. Da farko al'ummar Koriya ta Kudu ta rabu saboda yadda Shugaba Moon Jae-in ya amsa matsalar.
Yawancin 'yan Koriya sun sanya hannu kan takardun neman izini, ko dai suna yaba wa shugaban kasar ko kuma suna kira ga tsige Mista Muno saboda rashin dacewar yadda gwamnati ta magance annobar.
A ranar 23 ga watan Maris, an bayar da rahoton cewa Koriya ta Kudu ta samu mafi ƙarancin adadin masu kamuwa da cutar a rana guda a cikin makonni huɗu.
A ranar 29 ga watan Maris aka samu sanarwar cewa daga ranar 1 ga watan Afrilu duk wanda ya dawo daga kasashen waje za a sanya shi a cikin keɓewar mako biyu.
A cewar kafofin watsa labarai, a ranar 1 ga Afrilu, kasashe 121 sun nemi taimakon Koriya ta Kudu wajen gwajin cutar.
A ranar 19 ga watan Fabrairu, Iran ta bayar da rahoton farkon tabbatar da kamuwa da cutar SARS-CoV-2 a Kum, inda, a cewar Ma'aikatar Lafiya da Ilimi na Kiwon Lafiya, mutane biyu suka mutu daga baya a wannan rana.
Matakan farko da gwamnati ta dauka sun hada da soke kide kide da wake-wake da sauran al'adu da wasanni, sallar Juma'a, da kuma rufe jami'o'i, manyan makarantu da makarantu.
Iran ta ba da tiriliyan biyar na Riyal don yaki da cutar.
Shugaba Hassan Rouhani ya bayyana a ranar 26 ga Fabrairu, 2020 cewa gwamnati ba ta da shirin sanya dukkan yankunan da cutar ta shafa cikin keɓewa, amma za a sanya wasu mutane ne kawai a keɓewa.
A watan Maris aka sanar da tsare-tsaren da za a takaita tafiye-tafiye tsakanin birane, amma ana ci gaba da yin zirga-zirga tsakanin birane kafin Sabuwar Shekarar Farisa.
Wuraren ibada na Shi'a a Kum sun kasance a bude ga masu ziyara har zuwa 16 ga Maris, 2020, inda Iran ta zama cibiyar yaduwar cutar bayan China a watan Fabrairu.
A yayin da ake ikirarin cewa kasar Iran ta boye cutar, fiye da kasashe goma sun danganta cutar da Iran a ranar 28 ga watan Fabrairu, wanda ke nuna cewa cutar ta fi tsanani fiye da 388 da gwamnatin Iran ta samu a wannan ranar.
An rufe majalisar dokokin Iran, kuma 23 daga cikin mambobinta 290 sun tabbatar da cutar a ranar 3 ga watan Maris.
A ranar 12 ga watan Maris, Human Rights Watch (A kan Tsaron 'Yancin Dan Adam) ta yi kira ga hukumomin gidan yarin Iran da su saki masu kare hakkin dan adam da aka tsare saboda rashin amincewarsu da zaman lafiya, tare da sakin duk fursunonin da suka dace da wannan rukuni na fursunoni na wucin gadi.
Kungiyar ta ce akwai hadarin yaduwar cutar a wuraren da aka rufe kamar gidajen yari inda ake rashin isassun hanyoyin kiwon lafiya.
A ranar 15 ga watan Maris ne gwamnatin Iran ta bayar da rahoton mutuwar mutane 100 a cikin kwana daya  wanda shi ne mafi yawan mutuwar da aka samu a kasar tun bayan barkewar cutar.
A ranar 17 ga watan Maris, aƙalla 'yan siyasa da jami'an gwamnati 12 na yanzu ko na baya sun mutu daga wannan cuta.
A ranar 23 ga watan Maris, ana samun sabbin mutane 50 da suka kamu da cutar a kowace awa a Iran, kuma ana samun sabon mutum daya da ya mutu saboda cutar a kowane minti goma.
Wani jami'in WHO ya ce, cutar ta iya kaiwa sau biyar a Iran fiye da yadda aka bayyana a hukumance.
An kuma ce takunkumin Amurka kan Iran na iya shafar ikon kasar wajen kare kanta daga yaduwar cutar.
Babban Kwamishinan Majalisar Dinkin Duniya kan 'yancin dan adam ya bukaci a sassauta takunkumin tattalin arziki kan kasashen da suka fi fama da annobar, ciki har da Iran.
A ranar 31 ga Janairu, an tabbatar da cewa cutar ta shiga ƙasar Italiya, lokacin da gwajin SARS-CoV-2 da aka yi a Roma ya nuna cewa ba su da cutar.
Yawan masu kamuwa da cutar ya fara ƙaruwa sosai, wanda ya sa gwamnatin Italiya ta dakatar da duk jirage zuwa da daga China kuma ta ayyana dokar ta baci.
An gano wani rukunin mutane 16 da suka kamu da cutar COVID-19 a ranar 21 ga watan Fabrairu, inda aka samu mutane 16 da suka kamu da cutar a Lombardy. A ranar 22 ga watan Fabrairu, Majalisar Ministoci ta ba da sabuwar dokar hana yaduwar cutar, inda aka sanya mutane sama da 50,000 a cikin unguwannin 11 na arewacin Italiya a cikin keɓewa.
Firayim Minista Giuseppe Conte ya ce: "Za a rufe kofa a duk inda cutar ta bulla.
A ranar 4 ga watan Maris gwamnatin Italiya ta ba da umarnin rufe dukkan makarantu da jami'o'i a duk faɗin ƙasar, saboda a lokacin an riga an sami mutuwar mutane 100 a Italiya.
Duk manyan wasannin wasanni, gami da wasannin kwallon kafa na Serie A, ya kamata a gudanar da su a rufe har zuwa watan Afrilu, amma a ranar 9 ga Maris an dage dukkan wasannin wasanni na akalla wata daya.
A ranar 11 ga Maris, Firayim Minista Conte ya ba da umarnin dakatar da kusan duk ayyukan kasuwanci da rufe kamfanoni ban da manyan kantuna da kantunan magani. A ranar 6 ga Maris, Kwalejin Kula da Magunguna, Magunguna, Gyaran Jiki da Magunguna (SIAARTI) ta Italiya ta buga shawarwari kan ɗabi'ar likita game da ladabi na tsarawa don ba da kulawa ga marasa lafiya, wanda wataƙila za a buƙaci a yi amfani da shi.
A ranar 19 ga watan Maris, Italiya ta zarce China a yawan mutuwar mutane da suka kamu da cutar korona, inda ta zama ta farko a duniya, bayan da ta sanar da mutuwar mutane 3,405.
A ranar 22 ga watan Maris aka sani cewa Rasha ta tura jiragen yaki tara da kayan aikin kiwon lafiya zuwa Italiya.
A ranar 5 ga Afrilu, an tabbatar da kamuwa da cutar korona a Italiya da mutum 128,948, an samu mutuwar mutum 15,887 da kuma warkewar mutum 21,815, kuma mafi yawan wadanda suka kamu da cutar sun kasance a yankin Lombardy.
Wani rahoto na CNN ya nuna cewa yawan mutanen da ke mutuwa a Italiya na iya kasancewa sakamakon abubuwa biyu  yawan tsofaffi a ƙasar da kuma rashin samun damar yin gwajin cutar coronavirus ga duk wanda ke da cutar a yau.
Ƙasar Ingila ta fi sauran ƙasashe da cutar ta shafa a hankali, kuma har zuwa ranar 18 ga Maris, 2020, gwamnatin Burtaniya ba ta tilasta wa 'yan ƙasa su bi kowane irin nisantar zamantakewa ko kuma keɓewa ba.
A sakamakon haka, an soki gwamnati saboda rashin saurin amsawa da kuma gaggawa ga haɗarin da ke cikin ƙasar. A ranar 16 ga Maris, Firayim Minista Boris Johnson ya ba da sanarwar da ke ba da shawarar kaucewa duk tafiye-tafiye da hulɗar zamantakewar da ba ta da mahimmanci, yana ba mutane damar yin aiki daga gida kuma su guji wuraren jama'a kamar mashaya, gidajen cin abinci da gidajen wasan kwaikwayo.
A ranar 20 ga Maris, gwamnati ta sanar da cewa duk wuraren nishaɗi kamar mashaya da kungiyoyin wasanni dole ne su rufe da wuri-wuri, kuma ta yi alkawarin biyan ma'aikata har zuwa kashi 80 cikin dari na albashi, amma ba fiye da fam 2,500 a wata ba a matsayin wani matakin tallafi ga jama'a yayin rikicin. A ranar 23 ga Maris, firaministan ya sanar da tsauraran matakai kan nisantar zamantakewar jama'a, yana hana taruwa sama da mutane biyu, kuma yana iyakance tafiye-tafiye da hutu a waje kawai ga abubuwan da suka fi muhimmanci.
Ba kamar matakan da suka gabata ba, an gabatar da wannan takunkumin ne tare da shigar da 'yan sanda, da sanya tarar da kuma tarwatsa taron jama'a.
An umarci a rufe yawancin kamfanoni, sai dai kamfanonin da ke samar da "rayuwar jama'a", ciki har da manyan kantuna, kantunan magani, bankuna, shagunan kasuwanci, tashoshin mai da motoci da kuma gidajen ajiye motoci.
A ranar 20 ga watan Janairu, an tabbatar da mutum na farko da ya kamu da cutar COVID-19 a jihar Washington da ke arewa maso yammacin tekun Pacific, wanda ya dawo daga birnin Wuhan a ranar 15 ga watan Janairu.
A ranar 29 ga watan Janairu ne aka kafa wata kungiya mai aiki da nufin yaki da cutar korona a fadar White House.
A ranar 31 ga watan Janairu, gwamnatin Trump ta ayyana dokar ta baci a bangaren kiwon lafiyar jama'a kuma ta sanya takunkumin shiga kasashen waje ga mutanen da suka zo daga China.
A ranar 28 ga Janairu, 2020, Cibiyar Kula da Cututtuka da Rigakafin Cutar, babbar hukumar kula da lafiyar jama'a ta gwamnatin Amurka, ta sanar da cewa ta kirkiro kayan gwajin nata.
Duk da haka, ba a fara gwajin cutar ba a Amurka nan da nan, kuma sakamakon haka, ba a san ainihin yadda cutar ta bulla a wannan lokacin ba.
Gwajin ya kasance da wahala saboda rashin kayan gwajin da gwamnatin tarayya ta fitar a watan Fabrairu, rashin izinin gwamnatin tarayya har zuwa ƙarshen Fabrairu don amfani da kayan gwajin da ba na gwamnati ba, waɗanda ƙungiyoyin kimiyya, kamfanoni da asibitoci daban-daban ke haɓaka, da kuma ƙuntatawa har zuwa farkon Maris, wanda zai ba da damar 'yan ƙasa su gwada (ana iya yin hakan ne kawai bisa ga umarnin likita mai kulawa).
Jaridar The Washington Post ta ruwaito cewa a ranar 27 ga watan Fabrairu, an yi gwaje-gwaje kasa da 4,000 a Amurka.
The Atlantic ta ruwaito cewa an yi gwaje-gwaje kasa da 14,000 a ranar 13 ga Maris.
A ranar 22 ga Maris, kamfanin dillancin labarai na Associated Press ya ruwaito cewa: Masu yawa daga cikin marasa lafiya, ko da suna da alamun cutar da kuma umarnin likita, sun jira sa'o'i ko kwanaki don yin gwajin. Bayan da aka samu rahoton mutuwar farko ta coronavirus a Amurka a ranar 29 ga Fabrairu daga jihar Washington, Gwamna Jay Insley ya ayyana dokar ta baci, wanda wasu jihohi suka yi nan da nan.
A ranar 3 ga watan Maris, an soke makarantun Seattle, kuma a tsakiyar watan Maris, an rufe makarantu a duk faɗin ƙasar. A ranar 6 ga watan Maris, 2020, ƙungiyar masu ilimin cututtuka na Kwalejin Imperial, London, ta sanar da Amurka game da hasashen tasirin sabon coronavirus a ƙasar.
A wannan ranar ne Shugaba Trump ya sanya hannu kan dokar karin kudade don shirye-shirye da kuma daukar matakan magance cutar coronavirus, wanda ya ba da tallafin gaggawa na dala biliyan 8.3 ga hukumomin tarayya don magance barkewar cutar.
Kamfanoni sun kafa takunkumin hana ma'aikata tafiya, sun soke taro, kuma sun bukaci ma'aikata su yi aiki daga gida.
An soke wasanni da kuma lokutan wasanni. A ranar 11 ga watan Maris, Trump ya sanar da hana tafiye-tafiye zuwa mafi yawan kasashen Turai, sai dai Birtaniya, na tsawon kwanaki 30, daga ranar 13 ga watan Maris.
Washegari, ya ƙara ƙuntatawa zuwa ƙasar Ingila da kuma Ireland.
A ranar 13 ga watan Maris, shugaban ya ayyana dokar ta baci a kasar, wanda ya ba da damar amfani da kudaden tarayya don magance rikicin.
Tun daga ranar 15 ga watan Maris, kamfanoni da dama sun fara rufe ko rage sa'o'in aiki a duk fadin Amurka, don taimakawa wajen yaki da yaduwar cutar.
A ranar 17 ga watan Maris, an tabbatar da annobar a jihohi 50 da kuma D.C. A ranar 23 ga watan Maris, an bayar da rahoton cewa New York ta samu mutum 10,700 da suka kamu da cutar a cikin kwana daya, wanda ya fi adadin mutanen da suka kamu da cutar a Koriya ta Kudu.
A ranar 25 ga watan Maris, gwamnan ya ce nisantar mutane daga wajen jama'a wataƙila mataki ne mai tasiri, saboda kimar ninka yawan masu kamuwa da cutar ya ragu daga rana ta biyu zuwa 4.7.
A ranar 28 ga watan Maris, an samu mutum 32,308 da suka kamu da cutar a birnin New York, kuma mutane 672 ne suka mutu. An ruwaito cewa a ranar 26 ga watan Maris, Amurka ta samu mutane da yawa da suka kamu da cutar fiye da kowace kasa a duniya, ciki har da China da Italiya. A ranar 8 ga watan Afrilu, Amurka ta samu mutane 400,335 da suka kamu da cutar, kuma mutane 12,841 ne suka mutu.
A cewar rahotannin kafofin watsa labarai na ranar 30 ga watan Maris, Shugaba Trump ya yanke shawarar tsawaita dokar nisantar mutane har zuwa ranar 30 ga watan Afrilu.
A wannan ranar ne jirgin asibiti mai dauke da gadaje 1,000 mai suna USNS Comfort ya sauka a tashar jiragen ruwa ta New York.
A ranar 3 ga watan Afrilu, an samu mutuwar mutane 884 a Amurka sakamakon cutar korona a cikin sa'o'i 24.
A jihar New York, adadin masu kamuwa da cutar ya zarce 100,000 a ranar 3 ga Afrilu. An soki fadar White House saboda rashin kimanta barazanar da kuma sanya takunkumin shiga bayanan da aka samu a fili, ta hanyar amfani da ofishin Mataimakin Shugaban Kasa Mike Pence wajen sa ido kan maganganun jama'a da kuma wallafe-wallafen jami'an kiwon lafiya da masana kimiyya da suka shafi cutar.
A gaba ɗaya, ra'ayoyin magoya bayan Shugaba Trump game da yadda ya yi nasarar magance matsalar sun rabu.
Wasu jami'ai da masu sharhi sun soki dogaro da Amurka kan shigo da kayan masarufi, ciki har da kayan masarufi, daga China.
A tsakiyar watan Janairun 2020, an buga wani bincike a cikin mujallar Travel Medicine game da tsarin tafiye-tafiyen jiragen sama, wanda aka yi amfani da shi wajen yin taswira da kuma hasashen yadda cutar za ta yadu.
Dangane da bayanan kungiyar sufuri ta sama ta duniya na 2018, Bangkok, Hong Kong, Tokyo da Taipei sun karbi mafi yawan matafiya daga Wuhan.
Dubai, Sydney da Melbourne ma sun kasance sanannun wuraren da waɗannan masu yawon bude ido ke zuwa.
Daga cikin shahararrun wurare 20 na yawon bude ido, Bali an kira shi mafi ƙarancin shiri don barkewar cutar, yayin da biranen Ostiraliya ana ganin sun fi shirya.
An ce akwai abubuwa da yawa da za a gano game da COVID-19, kuma Australia za ta mai da hankali sosai kan kula da kan iyakoki da sadarwa a lokacin da aka sami barazana.
A ranar 21 ga watan Maris ne aka ayyana dokar ta baci a kasar Australia domin kare lafiyar dan adam.
Sakamakon ingantattun matakan keɓewa da aka yi a bangaren sufuri na jama'a a Wuhan da Hubei, wasu ƙasashe sun shirya su kwashe 'yan ƙasa da ma'aikatan diflomasiyya daga yankin, galibi ta hanyar jiragen haya na ƙasashensu, wanda hukumomin China suka ba da izinin.
Kanada, Amurka, Japan, Indiya, Sri Lanka, Australia, Faransa, Argentina, Jamus da Thailand na cikin na farko da suka fara shirin kwashe 'yan kasarsu.
Pakistan ta ce ba za ta kwashe 'yan kasar Sin ba.
A ranar 7 ga watan Fabrairu, Brazil ta kwashe 'yan Brazil 34 da dangin 'yan Brazil, da kuma wasu 'yan Poland hudu, da wani dan kasar Sin da kuma wani dan kasar Indiya.
'Yan kasar Poland, China da Indiya sun sauka a Poland, inda jirgin Brazil ya tsaya kafin ya tashi zuwa Brazil bisa ga hanyar da ya kamata.
An sanya 'yan Brazil da suka ziyarci birnin Wuhan a cikin keɓewa a wani sansanin soja da ke kusa da birnin Brasilia.
A wannan ranar ne aka kwashe 'yan Kanada 215 (mutane 176 daga jirgin farko da 39  daga na biyu, da gwamnatin Amurka ta yi haya) daga Wuhan, aka kai su sansanin sojin Kanada na Trenton kuma aka sanya su a cikin keɓewa na tsawon makonni biyu.
A ranar 11 ga watan Fabrairu, wani jirgin sama da ke dauke da 'yan kasar Canada 185 da aka kwashe daga birnin Wuhan ya sauka a sansanin jiragen sama na CFB Trenton.
A ranar 3 da 4 ga watan Fabrairu, hukumomin Australia sun kwashe 'yan kasar su 277 suka sanya su a wani wurin zama na wucin gadi a tsibirin Kirsimeti, wanda aka mayar da shi cibiyar killacewa, inda suka zauna na tsawon kwanaki 14.
A ranar 5 ga Fabrairu, jirgin saukar jiragen sama na New Zealand ya isa Auckland; fasinjojinsa (ciki har da wasu daga Ostiraliya da yankin Asiya da Pacific) an sanya su a cikin keɓewa a sansanin sojan ruwa na Vangaparoa, arewacin Auckland.
A ranar 15 ga watan Fabrairu, Amurka ta sanar da cewa za ta kwashe 'yan kasar da ke cikin jirgin ruwan Diamond Princess.
A ranar 21 ga watan Fabrairu, jirgin sama mai dauke da fasinjoji 129 na Kanada da aka kwashe daga Diamond Princess ya sauka a Trenton, Ontario.
A farkon watan Maris, gwamnatin Indiya ta fara kwashe 'yan kasarta daga Iran. A ranar 14 ga watan Maris, jirgin saman kamfanin jiragen sama na South African Airways, wanda gwamnatin Afirka ta Kudu ta yi haya, ya tashi tare da 'yan Afirka ta Kudu 112 a cikin jirgin.
An yi wa fasinjoji gwajin lafiya kafin tashi, kuma an bar 'yan Afirka ta Kudu huɗu da suka nuna alamun cutar coronavirus a China don rage haɗarin.
Sai dai 'yan Afirka ta Kudu da suka nuna cewa ba su da cutar coronavirus ne kawai aka kwashe.
An yi gwajin dukkan 'yan kasar Afirka ta Kudu, ciki har da ma'aikatan jirgin, matukan jirgi, ma'aikatan otal, 'yan sanda da sojoji da ke cikin aikin agaji, kuma a matsayin kariya, an sanya su a cikin keɓewa na kwanaki 14 a The Ranch Resort.
A ranar 20 ga watan Maris, Amurka ta fara janye dakarunta daga Iraki saboda annobar.
A ranar 5 ga watan Fabrairu, Ma'aikatar Harkokin Wajen Sin ta sanar da cewa kasashe 21 (ciki har da Belarus, Pakistan, Trinidad da Tobago, Masar da Iran) sun tura taimakon su zuwa kasar Sin.
Wasu daliban kasar Sin da ke karatu a jami'o'in Amurka sun hada kai don tarawa da kuma tura kayan agaji zuwa yankunan kasar Sin da cutar ta shafa, tare da wani rukuni daga Chicago da aka ruwaito cewa sun aika da na'urori masu numfashi 50,000 na N95 zuwa asibitocin lardin Hubei a ranar 30 ga Janairu.
A ranar 5 ga watan Fabrairu, Bill da Melinda Gates sun sanar da bayar da gudummawar dala miliyan 100 ga WHO don tallafawa samar da maganin rigakafi da maganin cutar coronavirus, da kuma kare mutanen da ke fuskantar hadarin cutar a Afirka da Kudancin Asiya daga barazanar cutar.
Interaksyon ta ruwaito cewa a ranar 6 ga watan Fabrairu, gwamnatin China ta ba da gudummawar abin rufe fuska na likita 200,000 ga Philippines bayan Sanata Richard Gordon ya aika da abin rufe fuska miliyan 3.16 zuwa birnin Wuhan.
A ranar 19 ga watan Fabrairu, kungiyar agaji ta Singapore ta sanar da cewa za ta tura dala miliyan 2.26 zuwa kasar Sin.
Japan ta kuma ba da gudummawar abin rufe fuska na likita miliyan daya zuwa Wuhan, Turkiyya ta aika kayan aikin likita zuwa can, Rasha  sama da tan 13 na magunguna, Malaysia ta sanar da bayar da gudummawar safofin hannu na likita miliyan 18, Jamus ta aika da kayan aikin likita daban-daban ciki har da kayan kariya 10,000, Amurka ta ba da gudummawar tan 17.8 na magunguna, sannan ta yi alkawarin bayar da dala miliyan 100 a matsayin tallafin kuɗi ga ƙasashen da abin ya shafa. Bayan da yanayin ya daidaita a China, kasar ta kuma aika da taimako ga sauran ƙasashen da cutar ta shafa.
A watan Maris, Sin, Cuba da Rasha sun aika da magunguna da masana zuwa Italiya don taimakawa al'ummar kasar wajen shawo kan barkewar cutar coronavirus.
Wani dan kasuwa mai suna Jack Ma ya aika wa kungiyar tarayyar Afirka, Addis Ababa, Habasha, da kayan gwaji miliyan 1.1, da abin rufe fuska miliyan shida da kuma rigunan kariya dubu 60 domin kungiyar ta rarraba su a cikin kasashe mambobinta.
Daga baya kuma ya aika da kayan gwaji 5,000, da abin rufe fuska 100,000 da na'urorin IVL guda biyar zuwa Panama.
Ma ya kuma ba da gudummawar magunguna ga Kanada. Netherlands, Spain, Turkey, Georgia da Czech Republic sun nuna damuwa game da abin rufe fuska da kayan gwajin da aka yi a kasar Sin.
Misali, Spain ta janye kayan gwajin cutar korona na kasar Sin 58,000 da ke da kashi 30 cikin 100 na daidaito, yayin da Netherlands ta janye kayan rufe fuska na kasar Sin 600,000 da suka lalace.
Belgium ta kuma janye abin rufe fuska na kiwon lafiya 100,000 da ba su dace da amfani ba: an yi zaton cewa an yi su ne a China, amma daga baya aka gano cewa sun fito ne daga Colombia.
A wani bangaren kuma, an yi maraba da taimakon kasar Sin a wasu sassan Latin Amurka da Afirka. A ranar 2 ga watan Afrilu, Bankin Duniya ya fara gudanar da ayyukan agaji na gaggawa ga kasashe masu tasowa.
Hukumar lafiya ta duniya WHO ta yaba wa kokarin da hukumomin kasar Sin ke yi wajen yaki da annobar da kuma dakile yaduwar cutar.
WHO ta lura da bambance-bambance tsakanin yanayin annobar cutar huhu ta 2002-2004, inda aka zargi hukumomin kasar Sin da ɓoye bayanai, wanda ke hana cutar da kuma hana yaduwar ta, da kuma rikicin yanzu, inda gwamnatin tsakiya ke ba da sabunta bayanai akai-akai don kauce wa fargaba a ranar Sabuwar Shekarar kasar Sin.
A ranar 23 ga watan Janairu, a mayar da martani ga shawarar da gwamnatin tsakiya ta yanke na hana zirga-zirgar ababen hawa a birnin Wuhan, kakakin WHO Gauden Galea ya ce, ko da yake wannan matakin ba shawarar WHO ba ne, amma kuma  muhimmin tabbaci ne na cika alkawuran da aka dauka na dakile annobar a inda ta fi yaduwa, kuma ya kira ta marar da aka taba gani a tarihin kiwon lafiyar jama'a.  A ranar 30 ga watan Janairu, bayan tabbatar da iyawar kamuwa da cutar daga mutum zuwa mutum a wajen kasar Sin da kuma karuwar wadanda suka kamu da cutar a wasu kasashe, WHO ta ayyana gaggawa a tsarin kiwon lafiyar jama'a mai muhimmanci a duniya (PICHE); wannan shine karo na shida tun daga shekarar 2009 da aka fara amfani da irin wannan matakin a lokacin annobar cutar.
Darakta Janar na WHO, Mr. Tedros Adhanom ya ce sanarwar PHEIC na da hadarin yaduwa a duniya, musamman a ƙasashe masu ƙarancin kuɗi da matsakaitan kuɗi waɗanda ba su da ingantaccen tsarin kiwon lafiya.
Da yake tsokaci kan takunkumin tafiye-tafiye, Mista Tedros ya ce "babu wani dalili na matakan da ke hana zirga-zirgar kasa da kasa da kasuwanci" kuma "WHO ba ta ba da shawarar a takaita kasuwanci da zirga-zirga ba".
A ranar 5 ga watan Fabrairu, WHO ta nemi al'ummar duniya su ba da dala miliyan 675 domin samar da shirye-shiryen farfadowa a kasashe masu karancin kudin shiga, inda ta yi kira ga kasashen da basu da tsarin gano mutanen da suka kamu da cutar, duk da cewa cutar ba ta kai kasashen ba.
Mista Tedros ya kuma bayyana cewa "ma'aunin shirye-shiryenmu" shine yadda muke shirye don cutar ta mafi rauni", kuma ya yi kira ga al'ummar duniya "suyi zabi: su saka hannun jari a yau ko su biya nan gaba". A taron manema labarai da aka gudanar a ranar 11 ga Fabrairu, WHO ta sanya sunan cutar a hukumance  COVID-19.
A wannan ranar Tedros ya bayyana cewa Sakatare Janar na Majalisar Dinkin Duniya, António Guterres ya amince ya ba da "ikon iya aiki na dukan tsarin Majalisar Dinkin Duniya" a matsayin amsar matsalar.
Sakamakon haka, an kafa rukunin kula da rikice-rikicen Majalisar Dinkin Duniya don daidaita duk matakan da Majalisar Dinkin Duniya ta ɗauka; WHO ta ce waɗannan matakan za su "mai da hankali kan maganin kiwon lafiya, yayin da sauran hukumomi za su iya amfani da ƙwarewarsu don magance barkewar cutar a cikin mafi girman zamantakewa da tattalin arziki. "
A ranar 14 ga Fabrairu, WHO da China sun fara kafa wata kungiya ta musamman ta hadin gwiwa wacce ta samar da kwararru na kasa da kasa da ma'aikatan WHO a cikin kasar Sin don taimakawa wajen daidaita yanayin cikin gida da kuma kimanta tsananin cutar da yaduwar ta, ta shirya tarurruka da tarurruka tare da manyan cibiyoyin kasa, da kuma tafiye-tafiye zuwa wuraren don kimanta inganta matakan amsawa a matakin lardi da gundumomi, gami da birane da yankunan karkara. A ranar 25 ga Fabrairu, WHO ta ce duniya tana bukatar yin karin shiri don yiwuwar cutar ta coronavirus, tana mai lura cewa lokaci bai yi ba tukuna da za a kira cutar a matsayin annoba, amma duk da haka, ya kamata kasashe su kasance a shirye.
Lokacin da annobar ta bulla a Iran, WHO ta tura wata ƙungiya mai haɗin gwiwa don kimanta yanayin. A ranar 28 ga Fabrairu, jami'an WHO sun ce za a ƙara yawan yiwuwar yaduwar cutar ta coronavirus a duniya daga "babba" zuwa "mai matukar girma" a matsayin mafi girman matakin shiri da haɗari.
Mike Ryan, babban daraktan shirin gaggawa na kiwon lafiya na WHO, ya yi gargadin a cikin wata sanarwa: "Wannan gwaji ne ga kowace gwamnati a duniya kan shirye-shiryen da take da shi don ganin abin da ke faruwa: lokaci ya yi da za a yi aiki.
Ya kuma jaddada cewa, amsa mai kyau zai iya taimakawa duniya wajen kauce wa mafi munin yanayin da zai iya faruwa.
Ryan ya kuma ce bayanan na yanzu ba su da wani dalili da zai sa jami'an kiwon lafiya su ayyana annobar a duniya, ya kuma kara da cewa, sanar da annobar zai nuna cewa "a zahiri mun yarda da gaskiyar cewa kowane mutum a duniya zai kasance cikin hadarin kamuwa da wannan kwayar cutar".
A ranar 11 ga watan Maris ne WHO ta ayyana annobar coronavirus a matsayin annoba.
Darakta Janar na WHO ya bayyana cewa WHO  tana da matukar damuwa game da yawan yaduwar cutar da kuma tsananin cutar, da kuma rashin yin komai game da matsalar. WHO tana fuskantar mummunan suka saboda yadda ake ganin rashin dacewar batun cutar, gami da sanar da gaggawa na kiwon lafiyar jama'a da kuma rarraba cutar a matsayin annoba.
A matsayin martani ga halin da ake ciki, an gabatar da takarda neman murabus ga Darakta Janar na WHO, Mr. Tedros Adanom, wanda mutane 733,000 suka sanya hannu a ranar 6 ga Afrilu.
A ranar 26 ga Maris, 2020, masana na Majalisar Dinkin Duniya kan hakkin dan adam sun jaddada muhimmancin kiyaye hakkin kowane mutum a lokacin annobar COVID-19.
Kungiyar ta ce kowa na da hakkin daukar matakan ceton rai, kuma gwamnati ce ke da alhakin gudanar da irin wannan matakin.
Kungiyar ta jaddada cewa rashin albarkatu ko rashin inshorar lafiya ba zai zama hujja ba don nuna bambanci ga kowane rukuni na mutane.
Masana sun jaddada cewa kowa yana da hakkin samun kulawar lafiya, gami da nakasassu, 'yan tsirarun al'umma, tsofaffi, wadanda suka rasa gidajensu, marasa gida, 'yan kasa da ke cikin mawuyacin yanayi, fursunoni, da kuma 'yan gudun hijira da sauran kungiyoyi da ba a bayyana su ba da suke bukatar tallafin gwamnati.
Ƙungiyoyin gwamnati na duniya suna duba tasirin tattalin arziki da zamantakewa na rikicin COVID-19.
Kungiyar hadin gwiwar tattalin arziki da ci gaba ta kirkiro wani dandamali da aka tsara don samar da cikakken bayani kan matakan siyasa a kasashen duniya, da kuma samun ra'ayoyi da shawarwari.
Cibiyar ta na ba da bayanai game da manufofin da kasashe daban-daban (Country Policy Tracker) ke bi wajen karfafa tsarin kiwon lafiya da tattalin arzikin duniya, kawar da tasirin keɓewa da takunkumin tafiye-tafiye, don taimakawa ƙasashe su koyi darussa daga juna da kuma inganta daidaitaccen martani na duniya kan cutar korona.
Gwamnatin China ta fuskanci suka daga Amurka, Ministan Ministan Burtaniya Michael Gow da Eduardo Bolsonaro, dan shugaban Brazil Jair Bolsonaro, saboda ayyukan da suka yi na magance annobar da ta fara daga lardin Hubei na kasar Sin.
An kori wasu shugabannin jam'iyyar kwaminis ta kasar Sin (CCP) a matakin lardi saboda takunkumin da suka dauka a tsakiyar kasar Sin, kuma wannan sallamar ta nuna rashin jin dadin yadda hukumomin siyasa ke mayar da martani ga barkewar cutar a wadannan yankuna.
Wasu masu sharhi sun yi imanin cewa an yi wannan matakin ne don kare babban sakataren jam'iyyar kwaminis ta kasar Sin, Xi Jinping daga fushin jama'a game da barkewar cutar coronavirus.
Wasu jami'an kasar Sin, kamar Zhao Lijian, sun nuna rashin amincewa da da'awar da aka yi a baya cewa barkewar cutar coronavirus ta fara ne a Wuhan, amma sun goyi bayan ka'idar makirci cewa COVID-19 ta samo asali ne a Amurka ko Italiya.
Gwamnatin shugaban Amurka Donald Trump ta kira coronavirus  cutar Sin ko  cutar Wuhan, inda ta ce  tacewar da ake yi a China na kara tsananta yanayin cutar da ta zama annoba ta duniya, kuma wannan furucin ya sha suka daga wasu masu sharhi, wadanda suka ce wannan tsarin na nuna wariyar launin fata ne kuma  yana jan hankali daga rashin iyawar gwamnatin shugaban Amurka wajen dakile yaduwar cutar .
The Daily Beast ta samu damar samun sakon gwamnatin Amurka wanda ke dauke da wata dabarar sadarwa da ake ganin ta fito ne daga kwamitin tsaron kasa, inda aka ambaci dabarar: Dukkanin China.
An nemi mu yada wannan bayanin ta kowace hanya da za mu iya, ciki har da taron manema labarai da kuma yin jawabai a talabijin. Kungiyoyi kamar Politico, Foreign Policy da Bloomberg sun ce kokarin da China ke yi na taimakawa kasashen da cutar ta addabi wani bangare ne na "ta'addanci" da ke neman samun tasiri a duniya.
Shugaban hukumar kula da harkokin wajen EU, Josep Borrell ya yi gargadin cewa akwai wani bangare na "yanayin siyasa da ya hada da fafutukar samun rinjaye ta hanyar talla da kuma abin da ake kira siyasar karimci".
Borrell ya kuma ce, "China tana ta yin taƙama wajen gabatar da ra'ayin cewa ita ce mai alhakin da kuma amintaccen abokin tarayya, ba kamar Amurka ba".
China ta kuma bukaci Amurka da ta soke takunkumin da ta kafa kan Syria da Venezuela da kuma Iran, tare da aika da tallafi ga kasashen biyu na karshe, kamar yadda aka ruwaito.
An hana Jack Ma bayar da kayan rufe fuska 100,000 ga Cuba saboda takunkumin Amurka da aka kafa a ranar 3 ga watan Afrilu.
An kuma zargi hukumomin Amurka da tura taimakon da aka yi niyya ga wasu ƙasashe zuwa ƙasarsu.
An kuma yi jayayya game da abin rufe fuska tsakanin wasu ƙasashe kamar Jamus, Austria da Switzerland, Czech da Italiya.
Bugu da ƙari, Turkiyya ta mallaki ɗaruruwan na'urorin IWL da aka yi niyya ga Spain.
A farkon watan Maris gwamnatin Italiya ta soki rashin goyon bayan da Tarayyar Turai ke bayarwa ga kasar Italiya da ke fama da cutar korona.
Maurizio Massari, jakadan Italiya a EU, ya ce China ce kawai ta mayar da martani a bangarorin biyu.
Wannan ba ya nuna haɗin kan Turai.
A ranar 22 ga watan Maris, bayan tattaunawar wayar tarho da firaministan Italiya Giuseppe Conte, shugaban Rasha Vladimir Putin ya shirya tura sojojin Rasha masu kula da lafiya, da motocin kashe cututtuka na musamman da sauran kayan aikin kiwon lafiya zuwa Italiya.
Jaridar La Stampa ta Italiya ta nakalto wani babban jami'in siyasa mai suna Anonymous, wanda ya ce kashi 80 cikin 100 na taimakon Rasha ba shi da amfani ko kuma bai taimaka wa Italiya sosai ba.
Majiyar ta zargi Rasha da cewa tana neman ta yi wa duniya kyau a fannin siyasa da diflomasiyya.
Shugaban Lombardy Attilio Fontana da Ministan Harkokin Wajen Italiya Luigi Di Maio sun yi watsi da hare-haren da kafofin watsa labarai suka kai kuma sun nuna godiya ga taimakon da aka bayar.
Rasha ta kuma aika da jirgin saman kaya da taimakon lafiya zuwa Amurka.
Sakataren yada labarai na Kremlin Dmitry Peskov ya ce, "ta hanyar bayar da taimako ga takwarorinsu na Amurka, [Putin] yana nuna cewa yayin da masana'antun kayan aikin likitanci da kayan aikin Amurka suka kara karfin samarwa, su ma za su iya bayar da taimako idan an bukaci hakan".
Nazarin sojin NATO Mafiki-2020 da aka shirya a Jamus, Poland da kasashen Baltic  babban atisayen sojin NATO tun bayan karshen yakin sanyi  za a gudanar da su a takaitaccen tsari.
Babban Sakatare na Kamfen na Kare Nukiliya Kate Hudson ta soki atisayen Defender 2020 (Mai Kare 2020): A cikin rikicin da ya faru a fannin kiwon lafiyar jama'a a yau, gudanar da waɗannan atisayen yana sanya rayuwar ba kawai sojojin Amurka da na yawancin ƙasashen Turai da ke cikin ƙungiyar ba, har ma da mazaunan ƙasashen da ya kamata a gudanar da irin waɗannan ayyukan. Gwamnatin Iran ta sha wahala sosai daga kwayar cutar. Kimanin 'yan majalisa ashirin da biyar da suka kamu da cutar, da kuma wasu manyan jami'an siyasa goma sha biyar.
A ranar 14 ga Maris, 2020, Shugaba Hassan Rouhani ya yi kira ga shugabannin duniya da su taimaka masa, yana mai cewa kasarsa na fuskantar matsaloli wajen magance annobar saboda rashin samun damar shiga kasuwannin duniya saboda takunkumin da Amurka ta sanya wa Iran. Annobar ta haifar da kira ga Amurka da ta aiwatar da manufofin zamantakewa da suka mamaye sauran kasashe masu arziki, gami da gabatar da tsarin kiwon lafiya guda daya da kula da yara, hutun da ake biya na iyalai da kuma kara kudaden kiwon lafiya na jama'a.
Masana siyasa sun yi tsammanin hakan na iya shafar damar Donald Trump na sake zabarsa a zaben shugaban kasa na 2020.
Koriya ta Kudu ta soki "talakawar da ba ta dace ba" ta Japan bayan da Japan ta sanar da cewa duk wani dan kasa da ya zo daga Koriya ta Kudu za a sanya shi a keɓe na makonni biyu a wuraren da gwamnati ta keɓe.
Jama'ar Koriya ta Kudu sun fara rarrabuwa ne saboda yadda Shugaba Moon Jae-in ya mayar da martani ga rikicin.
Yawancin 'yan Koriya sun sanya hannu kan takardun neman izini, ko dai suna yaba wa matakin shugaban kasa ko kuma suna kira ga tsige Mista Muno saboda rashin dacewar yadda gwamnati ta amsa annobar. Cutar ta tilasta wa kasar ta kafa dokokin gaggawa a matsayin martani.
Wasu masu sharhi sun nuna damuwa cewa wannan matakin zai ba gwamnatoci damar karfafa ikonsu.
A Hungary, majalisar dokokin kasar ta kada kuri'ar bai wa firaminista Viktor Orban ikon yin mulki ba tare da wani lokaci ba, ta hanyar zartar da umarni, dakatar da aikin majalisar, da gudanar da zabe da kuma hukunta duk wanda aka zarga da yada labaran karya game da cutar da kuma matakan gwamnati na magance matsalar.
An kira barkewar cutar coronavirus dalilin da ya sa aka samu karancin kayayyaki da dama saboda karuwar yawan kayan aiki a duniya don yaƙar cutar, sayen kayayyaki a cikin fargaba da katsewar ayyukan samarwa da kayan aiki.
Hukumar kula da ingancin abinci da magunguna ta Amurka ta ba da gargadi game da karancin magunguna da kayan aikin kiwon lafiya, wanda ya samo asali ne daga karuwar bukatar masu amfani da kayayyaki da kuma rashin aiki a wajen masu samar da kayayyaki.
A wasu garuruwa ma, an yi ta yin sayayya cikin fargaba, wanda ya haifar da rashin kayayyakin da ake bukata kamar abinci, takardar wanka da ruwan kwalba daga kantunan kantuna, wanda hakan ya haifar da karancin kayayyaki.
Musamman ma masana'antar fasaha na gargadin jinkirin isar da kayayyakin lantarki.
Darakta Janar na WHO, Mr. Tedros Adanom ya ce bukatar kare kai ta ninka sau 100.
Wannan tsalle ya haifar da hauhawar farashin sau ashirin fiye da yadda aka saba, da kuma jinkirin isar da kayayyakin kiwon lafiya na watanni hudu zuwa shida.
Ya kuma haifar da karancin kayan kariya na mutum a duniya, kuma WHO ta yi gargadin cewa ma'aikatan kiwon lafiya za su fuskanci matsala saboda wannan.
A Ostiraliya, saboda annobar, masu sayen daigoo sun sami sabon damar sayar da kayayyakin Australiya zuwa China.
Wannan aikin ya haifar da karancin abincin yara a wasu manyan kantuna kuma daga bisani gwamnatin Ostiraliya ta hana shi. Duk da yawan adadin COVID-19 a Arewacin Italiya da yankin Wuhan, da kuma babban bukatar abinci, an iya kauce wa matsanancin karancin abinci a yankuna biyun.
Matakan da China da Italiya suka dauka kan tara kayayyaki da kuma cinikin kayayyakin da ake bukata da suka yi nasara sun hana gagarumar karancin abinci da ake tsammani a Turai da kuma Arewacin Amurka.
Arewacin Italiya, wanda ke da ƙananan masana'antun noma, ba su sami raguwa sosai ba, amma, a cewar wakilan masana'antu, farashin kayayyakin gona na iya tashi.
Shagunan kantin sayar da abinci sun kasance a banza na ɗan lokaci, har ma a birnin Wuhan, yayin da jami'an gwamnatin kasar Sin suka ba da damar samun abincin alade don samar da abinci mai gina jiki ga jama'a.
Haka kuma akwai irin wannan doka a Italiya da ta bukaci masu samar da abinci su adana kayan abinci domin a yi amfani da su a lokacin gaggawa.
Sakamakon lalacewar tattalin arzikin duniya ya shafi China: a cewar kafofin watsa labarai na ranar 16 ga Maris, tattalin arzikin China ya yi matukar rauni a farkon watanni biyu na shekarar 2020 saboda matakan da gwamnati ta dauka na magance yaduwar cutar, wanda ya haifar da raguwar tallace-tallace na 20.5%.
Kasar Sin babban cibiyar tattalin arziki da masana'antu ce; saboda haka ana ganin annobar ta haifar da mummunar barazana ga tattalin arzikin duniya.
Agate Demarai, a cikin Economist Intelligence Unit, ya yi hasashen cewa, za a ci gaba da samun tashin hankali a kasuwannin har sai an sami cikakken bayani game da sakamakon da zai iya zuwa.
A watan Janairun 2020, wasu manazarta sun kiyasta cewa tasirin tattalin arzikin annobar a halin yanzu a cikin ci gaban duniya na iya wuce tasirin annobar cutar huhu ta 2002-2004.
Wani masani daga Jami'ar Washington a St. Louis ya ce, hasarar da za ta iya kaiwa sarkar samar da kayayyaki a dukan duniya ya kai dala biliyan 300, kuma hakan zai iya ci gaba har tsawon shekara biyu.
An ruwaito cewa Kungiyar Kasashen Da Ke Fitar Da Man Fetur (OPEC) ta fara daukar matakan gaggawa bayan faduwar farashin man fetur sakamakon faduwar bukatar da kasar Sin ke yi.
A ranar 24 ga watan Fabrairu, kasuwannin hannayen jari na duniya sun yi ta faduwa saboda karuwar adadin mutanen da suka kamu da cutar COVID-19 a wajen kasar Sin.
A ranar 27 ga watan Fabrairu, saboda karuwar fargabar barkewar cutar korona, wasu alamomin hannun jari na Amurka, ciki har da NASDAQ-100, da S&P 500 da Dow Jones na hannun jari na masana'antu, sun nuna raguwa mafi girma tun shekara ta 2008, yayin da Dow ya fadi da maki 1191  mafi girma a rana guda bayan rikicin kuɗi na 2007 2008.
A karshen makon, duk sunayen sun ragu da fiye da kashi 10.
A ranar 28 ga watan Fabrairu, kamfanin Scope Ratings GmbH ya tabbatar da darajar cinikin kasar Sin, amma ya ci gaba da hasashen rashin riba.
Hannun jari sun sake faduwa saboda fargabar yaduwar cutar coronavirus, kuma mafi girma ya fadi ne a ranar 16 ga watan Maris.
Mutane da yawa suna ganin cewa akwai yiwuwar koma bayan tattalin arziki.
Masanin tattalin arziki Mohammed El-Erian ya yaba da matakan gaggawa da aka dauka a kan lokaci da bankunan tsakiya da kuma jihohi suka dauka.
Bankunan tsakiya sun fi saurin amsawa fiye da lokacin matsalar kuɗi ta 2008.
Yawon shakatawa  na ɗaya daga cikin ɓangarorin da suka fi fuskantar ƙuntatawa saboda ƙuntatawa, rufe wuraren jama'a, ciki har da wuraren yawon buɗe ido, da shawarwarin gwamnatoci na kada a yi tafiya.
Sakamakon duk waɗannan matakan, kamfanonin jiragen sama da yawa sun soke jirage saboda raguwar buƙatun tikiti, gami da British Airways, China Eastern Airlines da Qantas, kuma kamfanin jirgin sama na yankin na Burtaniya Flybe ya daina wanzuwa.
Sakamakon da ya samu ya fi ƙarfin da ya taɓa samu a masana'antar jirgin ruwa.
An kuma rufe tashoshin jirgin kasa da tashoshin jiragen ruwa da yawa.
Cutar ta zo daidai da Chung-yun, babban lokacin yawon shakatawa na bikin Sabuwar Shekarar China.
Gwamnatocin kasa da na yankuna sun soke wasu ayyuka da ke tattare da yawan jama'a, ciki har da bukukuwan Sabuwar Shekara na shekara-shekara; kamfanoni masu zaman kansu sun rufe shagunan su da wuraren shakatawa kamar su Hong Kong da Shanghai Disneyland.
An soke bukukuwan Sabuwar Shekara da yawa, kuma an rufe wuraren yawon shakatawa don hana taron jama'a; misali, an rufe Forbidden City a Beijing kuma an soke bukukuwan gargajiya na haikalin.
A larduna 24 daga cikin 31 da ke kasar Sin, hukumomi sun tsawaita hutun sabuwar shekara zuwa ranar 10 ga watan Fabrairu, inda suka umurci yawancin kamfanoni da su daina bude kafin wannan rana.
Wadannan yankuna sun kai kashi 80% na GDP na kasar da 90% na fitarwa.
Hukumomin Hong Kong sun kara yawan maganin cututtukan da ke yaduwa zuwa mafi girma kuma sun ayyana dokar ta baci, tare da rufe makarantu har zuwa Maris da soke bikin Sabuwar Shekara.
Ziyartar kantin sayar da kayayyaki a Turai da Latin Amurka ya ragu da kashi 40 cikin dari.
Kamfanonin sayar da kayayyaki a Arewacin Amirka da Gabas ta Tsakiya sun rage yawan tallace-tallace da kashi 50 zuwa 60 cikin dari.
Sakamakon haka, a watan Maris, yawan masu zuwa cibiyoyin kasuwanci ya ragu da kashi 3343 cikin dari idan aka kwatanta da na watan Fabrairu.
Masu gudanar da cibiyoyin kasuwanci a duk duniya sun aiwatar da ƙarin matakan kamar inganta yanayin tsabtace jiki, shigar da kayan aikin duba zafin jiki na baƙi, da soke abubuwan da ake yi. A cewar Hukumar Tattalin Arzikin Majalisar Dinkin Duniya kan Latin Amurka, koma bayan tattalin arziki a Latin Amurka da cutar ta haifar na iya barin mutane miliyan 14.22 a kan iyakar talauci fiye da yadda zai kasance a irin wannan yanayin amma ba tare da cutar ba.
A watan Janairu da Fabrairu na shekarar 2020, a lokacin da annobar ta yi tsanani a birnin Wuhan, mutane kusan miliyan biyar ne suka rasa ayyukansu a kasar Sin.
Da yawa daga cikin ma'aikatan karkara masu ƙaura miliyan 300 na kasar Sin sun sami kansu a gidajensu a lardunan ƙasarsu ko kuma a tsare a lardin Hubei. A watan Maris na shekarar 2020, sama da Amurkawa miliyan 10 sun rasa ayyukansu kuma sun nemi taimakon gwamnati.
A cewar kimantawar Bankin Tsaro na St. Louis, barkewar cutar coronavirus na iya rasa ayyuka ga mutane miliyan 47 a Amurka, kuma yawan rashin aikin yi na iya kaiwa 32%. matakan keɓewa da aka gabatar a Indiya zai bar dubun miliyoyin ma'aikatan Indiya masu ƙaura da ke karɓar albashi na yau da kullun ba tare da aiki ba. Binciken da Cibiyar Angus Reid ta gudanar ya nuna cewa kashi 44% na iyalai na Kanada sun fuskanci rashin aikin yi ta wata hanya. Kusan ma'aikatan Spain 900,000 sun rasa ayyukansu tun lokacin da aka gabatar da tsauraran keɓewa a Spain a tsakiyar Maris 2020.
A cikin rabin watan Maris, ma'aikata miliyan 4 na Faransa sun nemi tallafin rashin aikin yi na wucin gadi, kuma ma'aikata miliyan 1 na Burtaniya sun nemi a ba su kudin albashi guda. Kusan kamfanoni miliyan rabin a Jamus sun sauya ma'aikatansu zuwa tsarin aiki na lokaci-lokaci da gwamnati ke tallafawa.
An kuma gabatar da tsarin biyan albashi na Jamus na aiki na ɗan lokaci a Faransa da kuma Birtaniya.
Har ila yau, fannonin fasaha da al'adun gargajiya sun sha wahala sosai sakamakon annobar, wanda ya shafi ayyukan ƙungiyoyi da kuma mutane, ko suna aiki bisa hukuma ko masu zaman kansu, a duk faɗin duniya.
Kungiyoyin al'adu da fasaha sun yi ƙoƙari su tallafa wa aikin su (galibi ana tallafawa da gwamnati) don samar da damar samun al'adun al'adu ga jama'a, ta hanyar tabbatar da amincin ma'aikatansu da jama'a, da kuma, idan ya yiwu, tallafa wa mutane masu fasaha.
A watan Maris na shekarar 2020, gidajen tarihi, dakunan karatu, dakunan kide kide da wake-wake da sauran cibiyoyin al'adu a duk duniya an rufe su har abada, ko kuma an hana su shiga ko dai a wasu hanyoyi, an kuma soke ko kuma an dage nune-nunen, abubuwan da ake yi da kuma nuna su.
A maimakon haka, an yi ƙoƙari sosai don samar da wasu ayyuka ta hanyar dandamali na dijital. Wani sakamako na kwanan nan da ke karuwa na yaduwar cutar shine soke ayyukan addini, manyan wasanni da sauran abubuwan jama'a kamar bukukuwan kiɗa da kide-kide, taron fasaha da nunin kayan kwalliya.
A cikin masana'antar fina-finai ma akwai rashin ƙarfi. Vatican ta sanar da soke taron Makon Passion a Roma, wanda ake gudanarwa a makon ƙarshe na lokacin tuba na Kirista  Babban Lent.
Da yawa daga cikin majami'u suna ba da shawara cewa tsofaffi Kiristoci su zauna a gida kuma kada su halarci ayyuka a ranar Lahadi; a wasu majami'u, an soma watsa ayyukan coci a rediyo, a kai tsaye, ko kuma a talabijin, yayin da wasu shugabannin majami'u suke ba da shawarar yin hidima a waje.
Cocin Roman Katolika na Roma ya rufe majami'unsu, majami'u da filin St. Peter don baƙi ba su sake zuwa ba, kuma daga baya wasu kungiyoyin addini sun soke bautar su kuma sun iyakance damar yin bautar jama'a a majami'u, masallatai, majami'u, temples da gurduwar.
Ma'aikatar Lafiya ta Iran ta sanar da soke sallar Juma'a a yankunan da cutar coronavirus ta shafa, kuma daga baya an rufe wuraren ibada; Saudi Arabiya ta hana baƙi da mazauna cikin gida zuwa wuraren ibada na Makka da Madina.
Cutar ta haifar da sauye-sauye mafi girma a kalandar wasannin duniya tun bayan yakin duniya na biyu.
Yawancin manyan wasannin motsa jiki an soke su ko kuma an jinkirta su, gami da gasar cin kofin zakarun Turai ta 2019 20, Premier League 2019 20, UEFA Euro 2020, kakar NBA ta 2019 20 da kuma kakar NHL ta 2019 20.
Cutar coronavirus ta kuma lalata shirin gudanar da wasannin Olympics na bazara na 2020, wanda aka shirya fara a ƙarshen Yuli; a ranar 24 ga Maris, kwamitin wasannin Olympics na duniya ya sanar da cewa za a "dakatar da taron zuwa bayan shekarar 2020, amma ba daga lokacin bazara na 2021 ba". An rufe gidajen caca da sauran wuraren caca a duk duniya, kuma an sake dawo da wasannin karta, waɗanda galibi ana watsa su kai tsaye.
Wannan ya haifar da yawancin 'yan wasa sun koma kan layi, kuma yawancin shafukan yanar gizo na caca suna ba da rahoton ƙaruwa mai yawa na sabbin masu biyan kuɗi. Har ila yau, masana'antar nishaɗi ta sha wahala yayin da ƙungiyoyin kiɗa daban-daban suka dakatar ko soke rangadin wasan kwaikwayo.
Yawancin manyan gidajen wasan kwaikwayo, kamar su Broadway, su ma sun soke duk wasanninsu.
A matsayin madadin ayyukan da ba na layi ba, wasu masu zane-zane da mawaƙa sun fara nazarin hanyoyin ci gaba da ayyukansu da kuma raba sakamakon su ta hanyar Intanet, shirya watsa shirye-shiryen raye-raye na kan layi ko bukukuwan yanar gizo; wannan yana taimaka wa masu sana'a su ci gaba da yin wasa, samarwa ko buga ayyukansu.
An samu labaran yanar gizo masu yawa game da cutar korona, da dama daga cikinsu suna da ban dariya da kuma sauƙaƙa yanayin damuwa da ke faruwa a lokutan rashin tabbas.
Tun lokacin da COVID-19 ya bayyana, an lura da ƙiyayya, ƙiyayya da wariyar launin fata da ke ƙaruwa ga 'yan ƙasar Sin da mutanen asalin Gabashin Asiya, da kuma ga mutanen da ke cikin wuraren zafi na Turai, Amurka da sauran ƙasashe.
An lura da tsoro, shakku, da kuma ƙiyayya a ƙasashe da yawa, musamman a Turai, Gabashin Asiya, Arewacin Amurka da yankin Asiya da Pacific.
Rahotanni na watan Fabrairu (lokacin da yawancin masu kamuwa da cutar har yanzu suna cikin China) sun nuna wariyar launin fata da aka nuna a kungiyoyi daban-daban a duniya game da 'yan kasar Sin da ake zargin sun cancanci cutar ko kuma sun sami lada mai kyau.
A wasu ƙasashen Afirka ma, an ga ƙaruwar halin ƙin yarda da ƙasar Sin.
Mutane da yawa a Wuhan da Hubei sun ba da rahoton nuna wariya saboda asalin yankin.
An ba da tallafi ga 'yan kasar Sin da kuma mazauna yankunan da cutar ta addabi a layi da kuma layi.
A cikin sabon yanayi, Italiya  ita ce kasa ta farko a Turai da ta fuskanci mummunan barkewar COVID-19; saboda haka, 'yan ƙasa na waɗannan yankuna na iya fara jin tasirin shakku da ƙiyayya. 'Yan ƙasa na ƙasashe kamar Malaysia, New Zealand, Singapore da Koriya ta Kudu sun sanya hannu kan takarda neman hana 'yan ƙasar Sin shiga ƙasashensu don hana annobar.
A Japan, hashtag #ChineseDontComeToJapan ya kasance a kan Twitter.
'Yan kasar Sin da kuma wasu mutanen Asiya da ke zaune a Birtaniya da kuma Amurka suna ba da rahoton karuwar nuna wariyar launin fata da har ma da kai hare-hare.
Shugaban Amurka Donald Trump ya fuskanci suka saboda kiran cutar korona "kwayar cutar Sin"; masu sukar sun dauki wannan ra'ayi na wariyar launin fata da kuma adawa da kasar Sin.
A Ukraine, masu zanga-zanga sun kai hari kan motocin bas da ke dauke da 'yan kasar Ukraine da na kasashen waje da aka kwashe daga Wuhan zuwa New Sanjar.
Dalibai da ke zuwa daga arewa maso gabashin Indiya da ke iyaka da China da ke karatu a manyan biranen Indiya sun ba da rahoton cewa ana tsananta musu saboda barkewar cutar coronavirus.
Dilip Ghosh, shugaban jam'iyyar Bharatiya Janata ta jihar Bengal ta Yamma, ya ce Sinawa sun lalata yanayi kuma "don haka Allah ya rama musu".
Daga baya, ofishin jakadancin kasar Sin a Calcutta ya yi tir da wannan furucin, inda ya ce "ta'addanci ne". A kasar Sin, annobar ta sake haifar da nuna kyamar kasashen waje da wariyar launin fata ga mutanen da ba 'yan kasar Sin ba: an fara kiran' yan kasashen waje "tarkace na kasashen waje" da kuma abubuwan da za a iya amfani da su.
Yawancin jaridu masu biyan kuɗi sun kawar da waɗannan ƙuntatawa ga wasu ko kuma duk yankunan da cutar ta shafa.
Yawancin masu wallafa littattafan kimiyya sun wallafa takardunsu na kimiyya game da barkewar cutar coronavirus.
Wasu masana kimiyya sun yanke shawarar ba da damar samun damar bincike na ɗan gajeren lokaci a kan sabobin buga takardu kamar bioRxiv.
Cutar da ke yaduwa  Cutar da ke yaduwa daga wata cuta mai dawowa, wanda ba a san yawan yaduwarta ko hanyar watsa ta ba
Duniya da cutar  Binciken duniya da yaduwar cutar
Jerin annoba da annobar cutar  Jerin wadanda suka mutu sakamakon kamuwa da cuta
Cinikin dabbobi da kuma cututtuka da ake yadawa daga dabbobi zuwa ga mutane  Rashin lafiyar da ke tattare da cinikin dabbobi masu ban mamaki.
Gwajin dakin gwaje-gwaje na kwayar cutar coronavirus na numfashi ta 2019 (COVID-19) da kwayar cutar SARS-CoV-2 da ke da nasaba da ita ya hada da hanyoyin gano cutar da kuma hanyoyin gano kwayoyin cutar da ake samarwa a lokacin da ake amsa kamuwa da cutar.
An tabbatar da cewa akwai ƙwayoyin cuta a cikin samfurori ta hanyar OT-PCR, wadda ke gane RNA na coronavirus.
Wannan gwajin na musamman ne kuma an yi shi ne don gano RNA na cutar SARS-CoV-2.
Ana amfani da shi don tabbatar da cewa akwai wani cuta da ya riga ya kamu da ita.
Ana iya amfani da gano kwayoyin cuta (serology) don ganewar asali da kuma don kula da yawan jama'a.
Ana yin gwajin kwayar cutar ta gano adadin mutanen da suka kamu da cutar, har da waɗanda ba su da alamun cutar ko kuma ba su da alamun cutar da za a kai su asibiti.
Za a iya sanin ainihin yawan mutuwar da kuma yawan garkuwar jiki ta wurin gwajin.
Ya zuwa Maris 2020, babu wata ƙasa da ke da tabbataccen bayanai game da yaduwar cutar a cikin al'umma saboda iyakancewar damar gwajin.
Ba wata kasa da ta gwada fiye da kashi uku cikin dari na yawan jama'arta ba a ranar 23 ga watan Maris, kuma bayanai game da yawan gwaje-gwajen da aka yi a kasashe daban-daban sun bambanta.
Wataƙila irin wannan bambancin ya shafi yawan mutuwar da ake samu, wanda a wasu ƙasashe ana iya ƙara yawan abin da ake faɗa.
Ta hanyar yin amfani da polymerase chain reaction real-time reverse transcription (rRT-PCR), ana iya yin gwajin a kan samfurin daga hanyoyin numfashi da aka samu ta hanyoyi daban-daban, ciki har da ƙwanƙwasa daga hanci ko samfurin sputum.
Sakamakon yana zuwa cikin sa'o'i kadan zuwa kwana biyu.
Binciken CT-PCR da aka yi a kan ƙwayar da aka ɗauka daga cikin makogwaro yana da inganci ne kawai a cikin mako na farko na ciwon.
Daga baya, kwayar cutar za ta iya ɓacewa daga cikin makogwaro, amma ta ci gaba da yaduwa a cikin huhu.
A cikin marasa lafiya masu kamuwa da cutar, waɗanda ake gwadawa a mako na biyu na cutar, a matsayin madadin za a iya ɗaukar abu daga ƙananan hanyoyin numfashi ta hanyar catheter mai tsotsa, ko kuma za a iya amfani da kayan ɓoyewa (ƙwaƙwalwa).
An tsara gwajin PCR na farko a asibitin Sharite, Berlin, a watan Janairun 2020 ta amfani da amsawar sarkar polymerase tare da sake rubutawa a ainihin lokacin (rRT-PCR) kuma ya zama tushen saiti 250,000, wanda daga baya Hukumar Lafiya ta Duniya (WHO) ta rarraba.
A ranar 23 ga Janairu, 2020, Burtaniya ta kuma samar da gwajin kanta. A ranar 28 ga Janairu, 2020, kamfanin Kogenebiotech na Koriya ta Kudu ya samar da kayan bincike don gano SARS-CoV-2 bisa matakin asibiti na PCR (PowerChek Coronavirus).
Yana gano kwayar E, wanda ya zama ruwan dare ga dukkan kwayar cutar beta-coronavirus, da kuma kwayar RdRp, wacce ta zama ruwan dare ga SARS-CoV-2. Kamfanin BGI Group na kasar Sin na ɗaya daga cikin kamfanoni na farko da suka sami izinin Hukumar Kula da Magunguna ta Kasa ta China don yin amfani da kayan aikin gano SARS-CoV-2 na gaggawa bisa PCR. A Amurka, Cibiyoyin Kula da Cututtuka da Rigakafi (CDC) suna rarraba ta hanyar International Reagent Resource, allon ganewar asali na RT-PCR na ainihin lokacin (2019-Novel Coronavirus (2019-nCoV) Real-Time RT-PCR Diagnostic Panel) a cikin dakunan gwaje-gwajen kiwon lafiyar jama'a.
Daya daga cikin gwaje-gwaje uku na kwayoyin halitta daga tsofaffin sigar gwajin sun ba da sakamako mara kyau saboda rashin isassun abubuwa da ƙarancin yankin gwajin da CDC ke gudanarwa a Atlanta; sakamakon haka a cikin watan Fabrairun 2020 gaba ɗaya, an sami nasarar sarrafa samfura ƙasa da 100 a rana.
Ba a yi la'akari da gwajin da ke amfani da bangarori biyu da tabbaci ba har zuwa 28 ga Fabrairu, 2020, kuma bayan wannan kwanan wata ne aka ba da izinin fara gwajin ga dakunan gwaje-gwaje na jihar da na gida.
An amince da gwajin ne ta Hukumar Kula da Ingancin Abinci da Magunguna a matsayin wani bangare na izinin gaggawa.
A ranar 5 ga Maris, 2020, LabCorp ta sanar da yiwuwar gwajin kamuwa da COVID-19 bisa tsarin RT-PCR a duk fadin kasar.
Quest Diagnostics ta fara gwajin COVID-19 a duk faɗin ƙasar daga 9 ga Maris, 2020.
Babu wani iyaka na adadi da aka bayyana; dole ne a yi tattara da kuma sarrafa gwaje-gwaje bisa ga bukatun CDC.
A Rasha, Cibiyar Nazarin Kimiyya da Cibiyar Nazarin Kwayoyin cuta da Fasaha ta VEKTOR ce ta tsara kuma ta samar da gwajin COVID-19.
A ranar 11 ga Fabrairu, 2020, an yi rajistar gwajin ne ta Hukumar Kula da Kiwon Lafiya ta Tarayya. An ruwaito cewa a ranar 12 ga Maris, 2020, asibitin Mayo ya kirkiro gwajin don gano cutar COVID-19. A ranar 13 ga Maris, 2020, Roche Diagnostics ta sami amincewar FDA don amfani da gwajin wanda za a iya gudanar da shi cikin awanni 3.5 a kan manyan samfura, wanda ke ba da damar injin guda ɗaya ya aiwatar da kimanin gwaje-gwaje 4,128 a cikin awanni 24.
A ranar 19 ga Maris, 2020, FDA ta ba da izinin gaggawa na amfani (EUA) ga Abbott Labs don gudanar da gwajin Abbott m2000; a baya FDA ta ba da izini irin wannan ga Hologic, LabCorp da Thermo Fisher Scientific.
A ranar 21 ga Maris, 2020, Cepheid kuma ta sami EUA daga FDA don gwajin tsawon minti 45.
Hukumar ta FDA ta kuma amince da gwajin da ke amfani da fasahar isothermic nucleic acid amplification maimakon PCR.
Tun da ba a buƙatar jerin zagayen zafin jiki don yin wannan gwajin, wannan hanyar na iya gano sakamako mai kyau a cikin minti biyar kawai kuma mummunan  a cikin minti 13.
A yanzu haka akwai kimanin na'urori 18,000 na irin wannan a Amurka, kuma Abbott na shirin kara samar da su zuwa gwaje-gwaje 50,000 a rana. A yanzu haka, ana yin gwajin amfani da kwayar cutar ta monoclonal a Taiwan, wadda ke da alaƙa ta musamman da furotin nucleocapsid (N-furotin) na sabon kwayar cutar korona, kuma ana fatan samun sakamako cikin mintuna 15-20, kamar yadda ake yi da gwajin hanzari na mura.
Wani bita na wallafe-wallafen da aka yi a watan Maris na shekarar 2020 ya ce, hotunan kirji ba su da amfani sosai a farkon lokacin da ake yin cutar, yayin da CT scan zai iya amfani sosai kafin a fara nuna alamun cutar.
Alamomin da aka gano a yayin CT sun haɗa da ƙuƙwalwar ƙuƙwalwar ƙuƙwalwa ta biyu ta hanyar nau'in matte glass tare da rarrabawar gefe, asymmetric da aposterior.
Ƙarfin subpleural, alamar ganuwar ganuwar da kuma ƙarfafawa suna tasowa yayin da cutar ta ci gaba.
Sakamakon binciken da ya kwatanta hanyoyin PCR da CT da aka yi amfani da su a Wuhan a lokacin barkewar annobar, ya nuna cewa CT ya fi PCR jin dadi, duk da cewa ba shi da takamaiman bayani, saboda yawancin ayyukanta na gani sun yi daidai da sauran hanyoyin cutar huhu da sauran cututtuka.
Tun daga watan Maris na shekarar 2020, Kwalejin Radiology ta Amurka ta wallafa shawarar  kada a yi amfani da CT don yin bincike ko kuma a matsayin hanyar gwajin farko a cikin gano COVID-19.
An nuna wani ɓangare na amsawar garkuwar jiki ga kamuwa da cuta ta hanyar samar da ƙwayoyin cuta, ciki har da IgM da IgG.
Ana iya amfani da waɗannan ƙwayoyin cuta don gano kamuwa da cuta a cikin mutane bayan kwana bakwai na bayyanar cututtuka, don ƙayyade rigakafi da kuma don gudanar da kulawar al'umma. Ana iya yin bincike a cikin ɗakunan gwaje-gwaje na tsakiya (CLT) ko ta hanyar ganewar asali (PoCT)
A yawancin dakunan gwaje-gwaje, za a iya yin waɗannan gwaje-gwajen ta hanyar tsarin sarrafa kansa mai aiki sosai, amma samunsu zai dangana ne a kan saurin da ake samar da kowane irin tsarin.
A CLT, ana amfani da samfurin jini guda ɗaya, ko da yake ana iya amfani da samfuran jerin don lura da amsawar rigakafi.
A PoCT, ana samun jini guda ta hanyar huda fata.
Ba kamar hanyoyin PCR ba, ba a buƙatar matakin tattara jini don ɗaukar gwajin gwaji. A ranar 26 ga Maris, 2020, FDA ta ambaci ƙungiyoyi 29 waɗanda suka bi duk hanyoyin rajista da suka dace kuma yanzu suna iya yada gwajin su zuwa ƙwayoyin cuta.
A karshen watan Maris na shekarar 2020, Euroimmun Medical Laboratory Diagnostics da Epitope Diagnostics sun sami izinin Turai don amfani da kayan gwajin su wanda zai iya gano IgG da IgA a cikin jinin da ke da ikon yaƙar kwayar cutar.
Ana iya yin gwajin da yawa a cikin sa'o'i kaɗan, kuma hakan ya fi saurin yin PCR na RNA na ƙwayoyin cuta.
Ana iya gano kwayoyin cutar bayan kwanaki 14 da kamuwa da cutar. A farkon watan Afrilu, Birtaniya ta gano cewa babu wani daga cikin kayan gwajin kwayoyin cutar da ta saya da ke ba da sakamako mai gamsarwa.
A Hong Kong an tsara wani tsari wanda zai ba marasa lafiya da ake zargi da cutar damar zama a gida: Ma'aikatan sashen gaggawa suna ba wa mai haƙuri kwayar samfurin, mai haƙuri ya yi ta tsotsa a ciki, ya ba da baya, kuma bayan ɗan lokaci ya sami sakamakon gwajin. NHS na Burtaniya ta sanar da ƙaddamar da tsarin gwajin gwajin gwajinsa na gida wanda ke kawar da haɗarin kamuwa da sauran baƙi na asibiti, ko buƙatar kashe motar gaggawa idan an yi amfani da ita don jigilar mai haƙuri. A lokacin gwajin gaggawa don COVID-19, lokacin da ake zargi da cutar, ma'aikacin kiwon lafiya zai yi nazari, ta amfani da duk matakan tsaro da suka dace.
Cibiyoyin gwajin gaggawa sun taimaka wa Koriya ta Kudu wajen gudanar da wasu daga cikin gaggawa da kuma manyan hanyoyin gwajin da aka yi a kowace kasa. A Jamus, a ranar 2 ga watan Maris, Ƙungiyar Likitocin Kula da Kiwon Lafiya ta Kasa ta ce za ta iya yin gwajin kusan 12,000 a rana a cikin ɗakunan asibiti, inda a makon da ya gabata za su iya yin gwajin 10,700 a mako.
Idan likita ne ya ba da umurnin yin gwajin, asusun inshorar lafiya ne ke biyan kuɗin.
A cewar shugaban Cibiyar Robert Koch, jimillar gwajin da Jamus ke yi a mako guda ya kai 160,000.
A ranar 19 ga watan Maris, an ba da shawarar gudanar da gwajin gaggawa a manyan birane da dama.
Har zuwa 26 ga Maris, 2020, ba a san adadin gwajin da aka yi a Jamus ba, saboda sakamakon da aka samu na tabbatacce ne kawai.
Binciken farko na dakin gwaje-gwaje ya nuna cewa a makon kalanda na 12/2020 an yi gwajin SARS-CoV-2 aƙalla 483,295 har zuwa mako na 12/2020, kuma an sami sakamako mai kyau a cikin samfurin 33,491 (6.9%). Masu bincike daga asibitocin Technion da Rambam Hospital na Isra'ila sun tsara kuma sun gwada hanyar gwajin lokaci guda da aka ɗauka daga marasa lafiya 64, haɗa samfuran kuma suna yin ƙarin bincike kawai idan samfurin hade ya nuna sakamako mai kyau. A Wuhan a ranar 5 ga Fabrairu, 2020, kamfanin BGI ya buɗe dakin gwaje-gwaje na ɗan lokaci mai girman mita 2,000 don gano yanayin gaggawa a ƙarƙashin Hoo-po (Yun-O) ko Thai Eye, wanda zai iya sarrafa samfuran sama da 10,000 a rana.
An shirya gina wannan dakin gwaje-gwaje ne da Wang Jian wanda ya kafa BGI ya tsara kuma an kammala shi cikin kwanaki biyar; samfurin ya nuna cewa idan ba a fara aiki da wannan saurin ba, za a sami kamuwa da cutar a Hubei da kashi 47% kuma a daidai wannan lokacin, farashin keɓewa zai ninka.
Bayan bude dakin gwaje-gwaje a Wuhan, nan da nan an bude dakunan gwaje-gwaje na Huo-Yang a Shenzhen, Tianjin, Beijing da Shanghai  a cikin birane 12 na kasar Sin.
A ranar 4 ga Maris, 2020, yawan gwajin yau da kullun ya kai gwaje-gwaje 50,000 a rana. An fitar da tsarin buɗewa na Origami Assays wanda zai iya gwada gwaje-gwaje 1,122 na marasa lafiya don COVID19 ta amfani da ƙwayoyin cuta 93 kawai. Irin waɗannan daidaitattun ƙirar na iya aiki a ƙananan dakunan gwaje-gwaje, ba tare da buƙatar amfani da masu sarrafa ruwa na mutum-mutumi ba.
A watan Maris, saboda karancin kayan aiki, an sami matsala wajen gudanar da gwajin a EU, Birtaniya da Amurka.
Sakamakon haka, wasu marubuta sun koma ga yarjejeniyar sarrafa samfurin gwaji wanda ke ba da shawarar dumama samfuran a 98 ° C (208 ° F) na tsawon mintuna 5 don sakin kwayoyin RNA don ƙarin gwaji. A ranar 31 ga Maris, an sanar da cewa yawan gwajin coronavirus da Hadaddiyar Daular Larabawa ke gudanarwa a halin yanzu ya fi na kowace ƙasa, kuma ba da daɗewa ba za a gwada yawancin jama'a.
Wannan ya faru ne saboda damar yin gwajin gaggawa, tare da sayen Laboratory na gwajin taro daga Group 42 da BGI (wanda aka kirkira bisa ga dakunan gwaje-gwajen su don gano yanayin gaggawa na Huo-Yang a China).
Wannan dakin gwaje-gwaje, wanda aka kafa cikin kwanaki 14, zai iya yin dubun dubatan gwaje-gwaje na CT-PCR a rana, kuma shi ne na farko a duniya da ya fara aiki a waje da kasar Sin.
An tsara bambance-bambancen gwaji da ke mai da hankali kan sassa daban-daban na tsarin kwayar cutar coronavirus a China, Faransa, Jamus, Hong Kong, Japan da Amurka.
Hukumar Lafiya ta Duniya ta amince da amfani da samfurin gwajin gwajin Jamus wanda ake turawa zuwa ƙasashe masu ƙarancin kuɗi waɗanda ba su da albarkatun da za su samar da nasu kayan gwajin.
An buga sigar Jamusanci a ranar 17 ga Janairu, 2020; yarjejeniyar da cibiyoyin kula da lafiya da cututtuka na Amurka suka tsara ba ta samuwa har zuwa ranar 28 ga Janairu, wanda ya haifar da rashin kayan gwajin a Amurka. A farkon barkewar cutar, China da Amurka suna da matsalolin amincin kayan gwajin, kuma waɗannan ƙasashe, da Ostiraliya, ba su iya samar da isassun kayan aikin da masana kiwon lafiya suka ba da shawarar ba.
A Koriya ta Kudu, masana sun ce samun gwajin ya taimaka wajen rage yaduwar sabon kwayar cutar.
A cikin 'yan shekarun nan gwamnatin Koriya ta Kudu ta yi aiki wajen samar da hanyoyin yin gwaji, musamman a dakunan gwaje-gwaje na masu zaman kansu.
A ranar 16 ga watan Maris, Hukumar Lafiya ta Duniya ta bukaci a kara inganta shirye-shiryen gwaji a matsayin hanya mafi kyau ta rage yaduwar cutar COVID-19. Sakamakon karuwar bukatar gwajin da ya taso sakamakon saurin yaduwar cutar, dakunan gwaje-gwaje masu zaman kansu da dama na Amurka, waɗanda ke karɓar ɗaruruwan dubban samfuran bincike, sun cika da kaya, kuma kayan samar da kayan aikin da ake amfani da su don yin samfur da kuma kayan aikin sunadarai suna ƙarewa da sauri.
A watan Maris na shekarar 2020, kasar Sin ta bayar da rahoton cewa tana da matsala game da daidaito na kayan gwajin ta.
Kayan gwajin Amurka da CDC ta tsara suna da 'yan nakasa, kuma saboda wannan dalili gwamnati ta kawar da shingen da ke hana masu zaman kansu yin gwajin. Spain ta sayi kayan gwajin daga kamfanin Shenzhen Bioeasy Biotechnology Co Ltd na kasar Sin, amma ta gano cewa sakamakon amfani da waɗannan kayan ba daidai bane.
Kamfanin ya bayyana cewa sakamakon rashin daidaito na iya zama sakamakon rashin nasarar samfurin ko amfani da saiti ba daidai ba.
Ma'aikatar Spain ta ce za ta janye kayan gwajin da ke ba da sakamako mara kyau kuma za ta maye gurbin su da wasu kayan gwajin  na kamfanin Shenzhen Bioeasy. 80% na kayan gwajin da Czech Republic ta saya a China sun ba da sakamako mara kyau. 1.2 miliyan na kayan gwajin da Slovakia ta saya a China suma ba su da kyau.
Firayim Minista Matović ya ba da shawarar a jefa su a cikin Danube. Atesh Kara, wani ma'aikacin Ma'aikatar Lafiya ta Turkiyya, ya yi ikirarin cewa kayan gwajin da aka saya daga China suna da "babban kuskure" kuma Ma'aikatar "ta daina amfani da su". Burtaniya ta sayi kayan gwajin miliyan 3.5 daga China, amma a farkon Afrilu 2020 an sanar da cewa waɗannan kayan gwajin ba su dace da amfani ba.
Ka'idojin keɓewa ga mutanen da suka gwada tabbatacce ga SARS-CoV-2, da kuma lura da mutanen da suka yi hulɗa da irin waɗannan marasa lafiya, sun sami sakamako mai kyau.
Masu bincike a garin Wau na Italiya, inda mutum na farko ya mutu daga COVID-19 a Italiya, sun gudanar da gwaje-gwaje biyu na gwajin yawan jama'a kusan 3400 a tsakanin kwanaki goma.
Kusan rabin mutanen da suka kamu da cutar ba su da alamun cutar, kuma an sanya dukkan marasa lafiya da aka tabbatar da cutar a keɓe.
An rufe hanyar shiga yankin, kuma wannan matakin ya dakatar da yaduwar cutar gaba daya.
A cikin yanayin sa ido sosai kan hulɗa, ƙuntatawa kan shiga, gwaji da matakan keɓewa, annobar cutar coronavirus ta 2020 a Singapore ta kasance mai sauƙi fiye da sauran ƙasashe masu tasowa, kuma ba a buƙatar sanya takunkumi masu tsananin gaske kamar rufe gidajen cin abinci da shagunan.
An soke ayyuka da yawa a can, kuma a ranar 28 ga Maris, Singapore ta fara ba da shawarar cewa mazauna su zauna a gida, amma makarantu, waɗanda hutunsu ya ƙare a ranar 23 ga Maris, sun buɗe bisa jadawalin.
Wasu ƙasashe kamar Iceland da Koriya ta Kudu sun kuma shawo kan annobar ta hanyar saka idanu mai zurfi, ƙuntatawa kan shiga, gwaji da kuma keɓewa, amma ƙuntatawa a can ba ta da ƙarfi.
Binciken ya nuna cewa a ƙasashen da aka yi gwaje-gwaje da yawa fiye da yadda ake kashe mutane, yawan mutuwar mutane ya ragu sosai, mai yiwuwa saboda waɗannan ƙasashe sun sami damar gano marasa lafiya da yawa da ke da ƙananan alamun cutar ko kuma marasa alamun cutar.
WHO ta ba da shawarar ƙasashe da ba su da albarkatun yin gwaji da yawa, da kuma dakunan gwaje-gwaje na ƙasa waɗanda ba su da ƙarancin ƙwarewa a kan COVID-19, su aika da sakamakon gwajin COVID-19 na farko guda biyar da suka nuna cewa sun sami sakamako mai kyau da na farko goma marasa kyau zuwa ɗaya daga cikin dakunan gwaje-gwaje na WHO guda 16 don tabbatar da gwajin.
7 daga cikin wadannan dakunan gwaje-gwaje 16 suna Asiya, 5  a Turai, 2  a Afirka, 1  a Arewacin Amurka da 1  a Australia.
A cikin wannan jadawalin, adadin % na sakamako mai kyau ya dogara da manufofin gwaji da aka yi a wata ƙasa.
Kasar da ake gwada marasa lafiya a asibiti ne kawai za ta sami kashi mafi girma na tabbatacce idan aka kwatanta da ƙasar da ake gwada dukan 'yan ƙasa, ko da kuwa suna da alamun cutar, a duk sauran yanayi.
Wanke hannu, wanda kuma aka sani da "tsabtace hannu" shine aikin wanke hannu don kawar da gurbatawa, kitse, microorganisms ko wasu abubuwa masu cutarwa.
Wanke hannuwanka da sabulu a lokutan da suka dace a rana yana hana kamuwa da cututtuka da dama, kamar su zawo da kuma cutar kwalara, da ake yadawa ta hanyar bakin jini.
Mutum zai iya kamuwa da cututtukan numfashi kamar mura ko sanyi, alal misali, idan ya taɓa idanunsa, hanci, ko bakinsa (watau mucous membranes) da hannunsa da ba a wanke ba.
Akwai muhimman lokuta biyar na rana da ya kamata a wanke hannaye da sabulu: kafin da kuma bayan yin fitsari, bayan wankewa da jariri ko canza mata, kafin ciyar da jariri, kafin cin abinci, da kuma kafin da kuma bayan dafa abinci ko sarrafa naman alade, kifi da tsuntsaye.
Idan ba a samu sabulu da ruwa ba, za a iya wanke hannayenka da toka.
Kafin, lokacin da ake dafa abinci, da kuma bayan haka.
Kafin da kuma bayan kula da mai ciwo.
Bayan an canja mata wanka ko kuma bayan an wanke jariri bayan ya je gidan wanka.
Bayan ka yi hancinka, ka yi tari ko kuma ka yi hancinka.
Bayan ka taɓa dabbobi, abinci, ko kuma ɓarnar dabbobi.
Tsabtace hannu na likita yana nufin ayyukan tsabtace jiki da ke da alaƙa da hanyoyin kiwon lafiya.
Wanke hannu kafin shan magani ko yin aikin likita zai iya hana ko rage yaduwar cutar.
Babban manufar wanke hannu a fannin kiwon lafiya shi ne tsabtace hannu daga kwayoyin cuta (kwayoyin cuta, ƙwayoyin cuta ko wasu ƙwayoyin cuta da ke iya haifar da cuta), da kuma daga sinadarai da ke iya zama masu cutarwa ko kuma su haifar da wasu cututtuka.
Wannan hanya tana da muhimmanci musamman ga mutanen da suke dafa abinci ko kuma waɗanda suke aikin kiwon lafiya, amma yana da muhimmanci ga dukan mutane.
Wanke hannu yana da amfani sosai ga lafiyar mutum, kamar rage yaduwar mura, coronavirus da sauran cututtuka, hana kamuwa da cututtukan ciki, rage yaduwar cututtukan numfashi.
kuma yana rage yawan mutuwar jarirai a gida.
Wani bincike na 2013 ya nuna cewa wanke hannu mai inganci zai iya haifar da ɗan saurin girma a cikin yara 'yan ƙasa da shekara biyar.
A ƙasashe masu tasowa, ana iya rage mutuwar yara da ke tattare da cututtukan numfashi da na zawo ta wajen yin wasu abubuwa kamar wanke hannu da sabulu.
Wannan tsari na farko zai iya rage yawan mutuwar mutane daga waɗannan cututtuka da kusan kashi hamsin.
Tunatarwa akai-akai game da amfanin wanke hannu zai iya rage yawan cututtukan zawo da kashi uku, kuma hakan ya yi daidai da amfanin samar da ruwa mai tsafta a yankunan da ke da karancin ruwa.
Kashe yawan cututtukan zawo da kashi 48% na iya danganta ga wanke hannu da sabulu. Wanke hannu da sabulu shine hanya daya da ta fi inganci da kuma tsada don hana zawo da cututtukan numfashi masu tsanani (ACD) idan aka samar da halaye masu dacewa a cikin kowane gida, a makarantu da sauran wuraren jama'a a duniya.
Ciwon huhu, ɗaya daga cikin manyan matsalolin cutar ta RIS, shine babban dalilin mutuwar yara 'yan ƙasa da shekara biyar, yana kashe kusan yara miliyan 1.8 a kowace shekara.
Cutar amai da kuma ciwon huhu suna kashe kusan yara miliyan 3.5 kowace shekara.
Asusun kula da yara na Majalisar Dinkin Duniya ya ruwaito cewa wanke hannu da sabulu kafin cin abinci da bayan wanka, wanda ya zama al'ada, na iya ceton rayuka fiye da duk wani allurar rigakafi ko kuma aikin likita, kuma ya rage mutuwar zawo da kusan kashi biyu, da kuma mutuwar cututtukan numfashi masu tsanani da kashi ɗaya cikin huɗu.
Ana wanke hannuwanka tare da sauran ayyukan tsabtace jiki da ake yi a cikin shirin samar da ruwa, tsabtace jiki da kuma tsabtace jiki (WASH).
Wanke hannu yana kuma hana kamuwa da cutar impetigo, wadda ake yadawa ta wurin saduwa da mutum.
Wani mummunan sakamako na yawan wanke hannu shi ne, zai iya sa fata ta bushe, kuma ta lalace.
Wani bincike na Danish na shekarar 2012 ya nuna cewa yawan wanke hannu yana iya haifar da itching da dandano da kuma cututtukan da ake kira eczema ko dermatitis na hannu, wanda yafi yawa a tsakanin ma'aikatan kiwon lafiya.
Wanke hannu sau da yawa yana iya zama ɗaya daga cikin alamun rashin lafiyar da ke sa mutum ya damu sosai.
Akwai abubuwa biyar da ake kira "mafi muhimmanci" a rana, lokacin da wanke hannu da sabulu yake da muhimmanci don rage haɗarin kamuwa da cutar ta bakin jini: bayan ka zubar da ciki (shigarwa, zubar da ciki), bayan wankewa da jariri (canjin kayan wanka), kafin ka ciyar da jariri, kafin ka ci abinci, da kuma kafin/bayan ka dafa abinci ko ka sarrafa naman kaza, kifi ko tsuntsaye.
Wasu lokatai da ya kamata a wanke hannu domin hana yaduwar cutar su ne: kafin ko bayan a yi wa mutum yanka ko rauni, bayan a yi tari, tari ko kuma yin hancin, bayan a taɓa ƙazamar dabba ko dabba, bayan a taɓa shara.
A ƙasashe da yawa, ba a wanke hannu da sabulu sosai ba.
Wani bincike na wanke hannu da aka gudanar a shekarar 2015 a kasashe 54 ya nuna cewa, a matsakaita, kashi 38.7% na iyalai suna wanke hannu da sabulu  a matsayin al'ada. Binciken na shekarar 2014 ya nuna cewa mafi girma, kashi 97%, an samu a Saudi Arabiya; Amurka tana kusa da tsakiyar wannan jerin, da kashi  77%; mafi ƙasƙanci an samu a China  23%. A halin yanzu, akwai wasu hanyoyin da za a yi don sauya halayyar wanke hannu da sabulu a lokuta masu mahimmanci. A cikin ƙasashe masu tasowa, wanke hannu a cikin rukuni a cikin ɗalibai a lokacin da aka tsara  yana ɗaya daga cikin hanyoyin da ke taimakawa wajen koya wa yara wannan hanya.
 Shirin kula da lafiyar gaggawa na Ma'aikatar Ilimi ta Philippines,  misali ne na manyan ayyuka na inganta lafiyar yara da kuma inganta ilimin yara.
Wannan shirin na kasa ya dogara ne akan cire gashin gashi sau biyu a shekara, da kuma wanke hannu da sabulu kullum da kuma wanke haƙora da fluorine kullum.
An yi wannan shirin da kyau a ƙasar Indonesia.
Idan ana amfani da sabulu ko kuma kayan wanki a wankewa, za a iya kawar da ƙwayoyin cuta daga fata.
Babban aikin sabulu da kayan wanki shine kawar da shingen narkewa da kuma kara yawan narkewa.
Ba a yi la'akari da ruwa da kansa a matsayin ingantaccen kayan tsabtace fata, saboda kitse da furotin, waɗanda sune abubuwan gurɓataccen ƙwayoyin cuta, ba su narkewa cikin ruwa.
Amma, samun isashen ruwa yana taimaka wajen tsabtace jikinmu.
Sabulu mai wuya, saboda amfani da shi sau da yawa, yana iya ƙunsar ƙwayoyin cuta da za su iya shiga cikin sabulu a lokacin amfani da shi.
Ƙananan bincike da aka yi a kan yadda ƙwayoyin cuta suke shiga cikin fata daga takardar sabulu mai ƙarfi da ke da ƙazanta, ya nuna cewa ba za a iya samun irin wannan cuta ba domin ƙwayoyin cuta suna wankewa tare da kumfa.
Hukumar Tsaro ta Tsakiya ta ci gaba da cewa sabulu mai ruwa da aka yi amfani da shi a hannu shi ne mafi kyau wajen wanke hannu.
Ana tallata sabulu mai hana ƙwayoyin cuta a cikin al'ummomin da suke kula da lafiyarsu.
A yau babu wata hujja da ta nuna cewa amfani da maganin kashe cututtukan da ake bada shawara ko kuma maganin kashe cututtukan yana da tasiri mai kyau a kan kwayoyin da suke da juriya ga maganin rigakafi.
Amma sabulu mai hana ƙwayoyin cuta yana ɗauke da abubuwa da ake yawan amfani da su wajen hana ƙwayoyin cuta kamar su triclosan, wanda yawancin nau'in kwayoyin da ba su da ƙwayoyin cuta suke da shi.
Saboda haka, ko da yake nau'in maganin da ya fi ƙarfin maganin ƙwayoyin cuta ba shi da zaɓi a kan sabulu mai ƙwayoyin cuta, amma ƙila ba zai yi tasiri kamar yadda ake talla ba.
Baya ga kayan aiki da kayan kariya na fata, mahaɗan hadaddun na iya ƙunsar acid (mai kaifi, ascorbic, madara) a matsayin mai daidaita pH, da kuma antibacterial mai aiki benzoic acid da sauran abubuwan da aka hura (aloe vera, bitamin, menthol, tsire-tsire na tsire-tsire). Wani bincike mai zurfi da Makarantar Kiwon Lafiyar Jama'a ta Jami'ar Oregon ta gudanar ya nuna cewa a cikin rigakafin cututtuka da kawar da ƙwayoyin cuta daga fata, nau'ikan sabulu masu sauƙi suna da tasiri kamar sabulu na yau da kullun wanda ke dauke da triclosan.
Duk da haka, ruwan zafi da ke da zafin jiki ga fatar mutum bai isa ya kashe ƙwayoyin cuta ba.
Kwayoyin cuta suna ƙaruwa da sauri a zafin jiki na 37°C.
Amma, ruwan dumi da sabulu ya fi ruwan sanyi tasiri wajen kawar da kitse na zahiri da ke riƙe gurɓataccen abu da ƙwayoyin cuta.
Akasin abin da mutane suke tunani, bincike ya nuna cewa yin amfani da ruwan dumi ba ya rage yawan ƙwayoyin cuta a hannayenmu.
Maganin wanke hannu (sanitizer) ko maganin kashe kumburi na hannu  magani ne na tsabtace hannu wanda ba ya dauke da ruwa.
A ƙarshen shekarun 1990 da farkon ƙarni na 21, kayan tsabtace hannu na giya da ba su da ruwa (wanda aka fi sani da kayan tsabtace hannu na giya, kayan kashe kumburi don kashe kumburi ko sanitizer) sun zama sananne.
Yawancin waɗannan kayan an yi su ne bisa isopropyl spirits ko ethanol tare da ƙara masu karfafawa kamar su carbomer (polymer na acrylic acid) a cikin nau'in gel, ko kuma masu danshi kamar su glycerin a cikin ruwa ko kumfa, suna ba da sauƙi don amfani da waɗannan kayan kuma suna rage tasirin bushewar fata da barasa.
Ƙara ruwan hydrogen mai narkewa yana ƙara ƙwayoyin cuta. Maganin kashe ƙwayoyin cuta da ke da kashi 60 zuwa 95 cikin ɗari na giya suna kashe ƙwayoyin cuta sosai.
Magungunan kashe ƙwayoyin cuta na barasa suna kashe ƙwayoyin cuta, ciki har da ƙwayoyin cuta masu tsayayya da magunguna da yawa (MRSA da VRE), da ƙwayar cutar sankara, da kuma wasu ƙwayoyin cuta (ciki har da HIV, herpes, RSV, rhinovirus, vaccina, mura da hepatitis) da fungi.
Abubuwan da ke kashe ƙwayoyin cuta da ke dauke da 70% na barasa suna kashe kashi 99.97% na kwayoyin cuta (ƙididdigar raguwa 3.5 daidai yake da raguwa zuwa decibel 35) a hannaye bayan dakika 30 bayan amfani da kuma kashi 99.99%  99.999% na kwayoyin cuta (ƙididdigar raguwa 45) a hannaye bayan minti 1 bayan amfani. Abubuwan da ke kashe ƙwayoyin cuta don hannu sun fi tasiri akan ƙwayoyin cuta kuma sun fi tasiri akan wasu ƙwayoyin cuta.
Magungunan kashe ƙwayoyin cuta na barasa ba su da tasiri sosai a kan ƙwayoyin cuta na Norovirus (ko Norwalk), wanda shine sanadin cututtukan gastroenteritis. Dole ne a yi amfani da isasshen maganin kashe ƙwayoyin cuta ko abin da ke dauke da barasa don a kula da fata da kyau kuma a sanya shi a bangarorin biyu.
Ana shafa fuska da bayan hannu biyu da kuma tsakanin yatsunsu tsawon kusan dakika 30 har sai ruwan, kumfa ko gel sun sha.
Ƙungiyar Kula da Cututtuka ta Amirka ta ba da shawarar a yi amfani da wanke hannu maimakon yin amfani da kayan tsabtace jiki, musamman idan hannuwanka suna da ƙazanta sosai.
Ana amfani da irin waɗannan kayan aikin kashe ƙwayoyin cuta domin suna da sauƙin amfani kuma suna kashe ƙwayoyin cuta da sauri, amma bai kamata su zama madadin wanke hannu sosai ba idan akwai ruwan sha da sabulu.
Yin amfani da kayan kashe kumburi na hannu da ke da turare sau da yawa zai iya sa fata ta bushe idan ba su da kayan da za su sauƙaƙa da kuma (ko) masu shayar da fata.
Ana iya rage ko kawar da tasirin bushewar fata ta hanyar ƙara glycerin da (ko) wasu abubuwa masu sauƙaƙa zuwa cikin kayan.
A gwajin asibiti, maganin kashe kumburi na hannu mai dauke da barasa, wanda ke dauke da kayan taushi, ya rage yawan tashin hankali da bushewar fata fiye da sabulu ko kayan wanke-wanke.
Ba a yawan samun cututtukan fata da ke sa mutum ya yi ciwon ciwon hauka ko kuma ya yi rashin lafiyar giya ko kuma wasu abubuwa da ake amfani da su wajen kashe ƙwayoyin cuta.
Ƙarancin yiwuwar cutar ta farfaɗowa ta hanyar tuntuɓe ya zama abin da ya sa aka fi amfani da sabulu da ruwa wajen kashe cututtuka.
Ko da yake suna da amfani, amma ba sa wanke hannayenka daga abubuwa masu guba.
Wannan shi ne dalilin da ya sa kayan wanke hannu ba su da tasiri wajen hana yaduwar kwayoyin cuta kamar sabulu da ruwa, domin idan aka yi amfani da su, kwayoyin cuta suna ci gaba da kasancewa a hannunka.
Amfanin maganin kashe cutar hannu wanda ba shi da barasa ya dogara da abubuwan da ke ciki da kuma abun da ke ciki, kuma a tarihi ya kasance ƙasa da na barasa ko abubuwan da ke dauke da barasa.
Kwanan nan, an nuna cewa maganin da ke amfani da benzalkonium chloride yana da tasiri mai ƙarfi da kuma ƙwayar cuta, ba kamar barasa ba, wanda aka nuna cewa yana raguwa bayan amfani da shi sau da yawa, mai yiwuwa saboda ci gaban cututtukan fata.
Mutane da yawa a cikin ƙananan al'ummomi ba su iya sayen sabulu ba, sai suka maye gurbinsa da zinariya ko kuma yumɓu.
Ƙura ko yumɓu zai iya zama mafi tasiri fiye da ruwa kawai, amma koyaushe zai zama ƙasa da sabulu.
Wata matsala da wannan hanyar ita ce idan laka ko toka ta gurɓata da ƙwayoyin cuta, hakan zai iya ƙara yaduwar cuta.
Kamar sabulu, ash yana da amfani wajen kashe ƙwayoyin cuta, domin yana samar da ruwan da ke da ƙanshi mai ƙanshi.
Idan ba a iya samun sabulu ba, WHO ta ba da shawarar yin amfani da toka ko yashi a matsayin madadin.
Don hana kamuwa da cuta, Cibiyar Kula da Cututtuka ta Amirka ta ba da shawarar yin amfani da wannan hanyar wanke hannu, wadda ta ƙunshi waɗannan matakai:
Ka wanke hannunka da ruwan dumi ko ruwan sanyi.
Ana ba da shawarar ruwa mai gudana, domin ruwan da ke tsaye zai iya zama mai ƙazanta, amma yawan zafin ruwan ba shi da muhimmanci.
Ka wanke hannayenka da sabulu mai yawa, har da bayan hannu, da kuma tsakanin yatsun hannu da kuma ƙarƙashin ƙusa.
Sabulu yana kawar da ƙwayoyin cuta daga fata, kuma bincike ya nuna cewa idan mutum yana amfani da sabulu (maimakon ruwa ɗaya) zai iya wanke hannunsa sosai.
Ka shafe hannunka na akalla dakika 20.
Yin wanka yana kawar da ƙwayoyin cuta daga fata, kuma idan ka daɗe kana wanke hannunka, za ka kawar da ƙwayoyin cuta da yawa.
Ka wanke hannunka sosai a ƙarƙashin ruwan da ke gudana.
Wanke hannu a cikin ruwa mai tsayawa zai iya haifar da sake kamuwa da cutar.
Ka goge hannunka da tawul mai tsabta ko kuma ka bar su su bushe da kansu.
Hannun da suke da danshi da kuma danshi suna da saukin kamuwa da cutar, kuma mutane sun fi yin watsi da wuraren da suke da su kamar su babban yatsunsu, wuyan hannu, tsakanin yatsunsu da kuma ƙarƙashin ƙusa.
Ƙugiya na wucin gadi da kuma ƙwanƙwasa ƙusa na iya ƙunsar ƙwayoyin cuta masu yawa.
Ana yawan yin amfani da man shafawa don hana bushewar fata, wanda zai iya sa a yi rauni kuma ya ƙara haɗarin kamuwa da cuta.
Idan ruwa mai gudana da sabulu ba su samuwa, akwai hanyoyi da yawa na wanke hannu: zuba ruwa daga kwanon rufi ko kwalban kwalba tare da ramuka da aka yi, da kuma (ko) amfani da toka idan ya zama dole, kamar yadda ake yi a ƙasashe masu tasowa. A wuraren da ba a samar da ruwa sosai (misali, makarantu ko yankunan karkara a ƙasashen da ke tasowa) akwai hanyoyin da za a iya amfani da su wajen rage ruwa kamar su famfo da ƙafafun kafa da sauran hanyoyin da ba su da tsada.
Kiran da ke da ƙafa  tsari ne mai sauƙi wanda ya ƙunshi akwati da aka rataye a kan igiya da kuma ƙafar ƙafa wanda ya kamata a danna don ruwa ya zuba a hannunka; a wannan yanayin ya kamata a yi amfani da sabulu.
Yin bushe hannu yadda ya kamata yana da muhimmanci a tsarin tsabtace hannu, amma akwai wasu muhawara game da yadda za a bushe hannu a cikin gidajen wanka na jama'a.
Bincike da yawa da ake yi ya nuna cewa tawul ɗin takarda sun fi na lantarki tsabtace hannu da aka saka a gidajen wanka da yawa.
A shekara ta 2008, Jami'ar Westminster a London ta gudanar da wani bincike, wanda aka tallafawa da taron karawa juna sani na Turai kan samar da takarda da tawul; batun wannan binciken shine kwatanta matakin tsabtace takarda, bushewar hannu tare da iska mai dumi da kuma bushewar hannu na zamani.
An gano cewa bayan wanke hannu da bushewa a cikin na'urar bushewa tare da iska mai dumi, adadin kwayoyin cuta a kan yatsunsu ya karu da kashi 194 cikin dari, kuma a kan hannayen hannu  254 cikin dari.
An kuma gano cewa bayan wanke hannu da bushewa a cikin na'urar bushewa, adadin kwayoyin cuta a kan yatsunsu ya karu da kashi 42 cikin dari, kuma a kan hannu  kashi 15 cikin dari.
Bayan wanke hannu da bushewa da tawul ɗin takarda, adadin ƙwayoyin cuta a kan yatsunsu ya ragu zuwa kashi 76%, kuma a kan hannayen hannu  zuwa kashi 77%.
Mai bushewa da iska mai iska, wanda ke fitar da iska da saurin 180 m / s (650 km / h, 400 mph), yana iya busa kwayoyin cuta daga hannayensu da kuma daga bangon kansa kuma yana iya cutar da sauran masu amfani da ɗakin wanka da kuma wanka a cikin mita 2.
Yin amfani da busassun hannu da iska mai dumi yana yada ƙwayoyin cuta a cikin radius na mita 0.25 daga busassun hannu.
A shekara ta 2005, kamfanin TÜV Produkt und Umwelt ya gudanar da bincike kan yadda ake bushe hannu.
Ana lura da canje-canje masu zuwa a yawan kwayoyin cuta dangane da hanyar bushewa hannu:
Akwai masana'antun bushe-bushe hannu da yawa, kuma ana kwatanta bushe-bushe hannu da takarda mai bushewa.
Wanke hannu ta hanyar amfani da tawul na kashe ƙwayoyin cuta zai iya zama madadin lokacin tafiya idan sabulu da ruwa sun gaza.
Abin sha na hannu da ke da barasa ya kamata ya ƙunshi aƙalla kashi 60 cikin ɗari na barasa.
Hanyar wanke hannu ta zama wajibi tun da daɗewa bayan da likitan Hungary Ignaz Zemmelweiss ya gano cewa yana da tasiri sosai (a shekara ta 1846) wajen hana cututtuka a cikin gidajen asibiti.
Akwai na'urorin lantarki da ke tunatar da ma'aikatan asibiti cewa su wanke hannayensu idan sun manta.
Wani bincike ya nuna cewa yin amfani da irin waɗannan na'urori yana rage yawan kamuwa da cuta.
Wanke hannu na likita yana ɗaukar aƙalla sakan 15, inda ake amfani da sabulu mai yawa, ruwa ko gel don wankewa da goge kowane ɓangare na hannu.
Ya kamata a shafa hannayenka sosai, a haɗa yatsunsu.
Idan akwai datti a ƙarƙashin ƙusoshi, za ka iya amfani da goga don cire shi.
Tun da yake ƙwayoyin cuta suna iya zama a cikin ruwan da ke hannayenka, yana da muhimmanci ka wanke hannayenka sosai kuma ka goge su da tawul mai tsabta.
Bayan an bushe hannu, a rufe famfo, kuma idan ya cancanta, a rufe ko a buɗe kofa, a yi amfani da tawul ɗin takarda.
Wannan zai hana a sake gurɓata hannayenka da waɗannan abubuwa.
Manufar wanke hannu a cibiyoyin kiwon lafiya shine kawar da kwayoyin cuta (microbes) da kuma hana su yaduwa.
Jaridar New England Journal of Medicine ta ba da rahoto cewa wanke hannu ya zama abin da ba a yarda da shi ba a yawancin wuraren kiwon lafiya: Likitoci da ma'aikatan jinya da yawa suna mantawa da wanke hannu a kai a kai kafin su taɓa marasa lafiya, kuma hakan yana yaɗa ƙwayoyin cuta.
Wani bincike ya nuna cewa wanke hannu da kuma wasu ayyuka na yau da kullum na iya rage kamuwa da cututtukan jini da ke tattare da yin amfani da catheter da kashi 66%. Hukumar Lafiya ta Duniya ta fitar da wata takarda da ke nuna yadda ake wanke hannu da kuma kula da shi a fannin kiwon lafiya.
Ana kuma samun takardar umarnin WHO game da tsaftace hannu a shafin yanar gizon ta kuma a bude take don tattaunawa.
Whitby ne ya rubuta wannan bita.
Idan ana bukatar tabbacin bin ƙa'idodi, ana iya amfani da na'urorin kasuwanci don auna ma'auni da kuma bincika tsabtace hannu.
Hukumar Lafiya ta Duniya ta bayyana lokutan da ya kamata a wanke hannu.
bayan sun yi hulɗa da jini ko ruwa mai rai,
kafin amfani da maganin kashe kumburi, da kuma
Bayan kulawar mai haƙuri, ƙara sinadarai masu hana ƙwayoyin cuta a cikin sabulu na wanke hannu ( magani ko  antimicrobial sabulu) yana taimakawa wajen kashe ƙwayoyin cuta.
Ana buƙatar irin waɗannan kaddarorin antibacterial kafin yin tiyata ko a cikin yanayi mai yawan kwayoyin da ke da juriya ga maganin rigakafi. Don tsabtace hannayenka kafin tiyata ana buƙatar famfo wanda za'a iya kunnawa da kashewa ba tare da taɓa hannayenka ba; Hakanan ya kamata a yi amfani da ɗan chlorhexidine ko ruwan iodine don wanke hannayenka, tawul ɗin da aka bushe don bushe hannayenka bayan wanka, goga mai tsabta don yin tir da sauran kayan aikin tsabta don tsabtace ƙusa.
Dole ne a cire duk kayan ado.
Wannan aikin yana buƙatar wanke hannu da kuma forearms zuwa cinya yawanci na mintuna 26.
Ba lallai ba ne a shafe hannayenka na tsawon lokaci, kamar minti 10.
Sa'ad da ake wanka, kada ruwa ya koma hannayenka.
Bayan an gama wanka, sai a bushe hannayen da kayan shafawa kuma a saka rigar tiyata.
Don rage yaduwar ƙwayoyin cuta, yana da kyau a wanke hannu ko kuma a yi amfani da maganin kashe ƙwayoyin cuta kafin a yi wa mutum jinya da kuma bayan an gama.
A asibitoci, an gano cewa mafi yawan amfanin wanke hannu shine kashi 20 cikin 100 na wanke hannu, kuma an sami fa'ida kaɗan idan aka ƙara yawan wanke hannu sama da kashi 35 cikin 100.
Idan aka kwatanta da wanke hannu da sabulu mai dauke da barasa, da wanke hannu da sabulu mai dauke da kwayoyin cuta, a matsakaita na dakika 30 a kowane hanya, an gano cewa wanke hannu da sabulu mai dauke da barasa ya rage gurbatawar kwayoyin cuta da kashi 26 cikin dari idan aka kwatanta da sabulu mai dauke da kwayoyin cuta.
Duk da haka, sabulu da ruwa sun fi ruwan giya tasiri wajen rage yawan kwayar cutar mura A H1N1 da Clostriidium difficile a hannu. Ayyukan inganta tsabtace hannu a wuraren kiwon lafiya na iya hada da koyar da ma'aikata game da wanke hannu, kara samun ruwan giya a hannu, da kuma rubuta da kuma tunatar da ma'aikata game da bukatar wanke hannu.
Ana bukatar ƙarin bincike game da hanyoyin da suka fi dacewa a ma'aikatun kiwon lafiya.
A ƙasashe masu tasowa, wanke hannu da sabulu ya zama abin da ake kira da amfani mai kyau da kuma inganta lafiyar jiki da kuma narkewa.
Amma rashin ruwa mai kyau, sabulu, da kuma kayan wanke hannu a gida, makaranta, da kuma wurin aiki suna sa wanke hannu a kai a kai ya zama da wuya.
Alal misali, a yawancin yankunan karkara na Afirka, ba duk gidajen wanka na jama'a ko na masu zaman kansu da ke da famfo na wanke hannu ba, ko da yake akwai hanyoyin da za a iya wanke hannu a wurare masu arha.
Amma rashin tsaftace hannu na iya zama sanadin halaye na yau da kullum, ba rashin sabulu ko ruwa ba.
Tallafawa da kuma ƙarfafa wanke hannu da sabulu na iya tasiri kan manufofin siyasa, ya kara wayar da kan jama'a game da amfanin wanke hannu, kuma ya haifar da sauye-sauye na dogon lokaci a halayyar jama'a.
Don tabbatar da ingancin irin waɗannan matakan, dole ne a gudanar da sa ido da kuma kimanta sakamakon.
Wani bincike na tsarin bincike na bincike 70 ya gano cewa, kula da tsabtace hannu a ƙasashe masu samun kudin shiga na ƙasa da matsakaici yana da tasiri sosai, yayin da kamfen ɗin tallatawa na jama'a ba shi da tasiri sosai. Ɗaya daga cikin misalai na talla game da wanke hannu a makarantu shine tsarin Ƙungiyar Ƙungiyar Yara ta Majalisar Dinkin Duniya  Three Star Approach: yana tallata aiwatar da matakan tattalin arziki mai sauƙi a makarantu, yana ƙarfafa ɗalibai su wanke hannu da sabulu, da kuma bin wasu buƙatun tsabta.
Ta wajen tabbatar da cewa an bi ƙa'idodi mafi ƙanƙanta, makarantu za su iya ɗaukaka darajarsu daga tauraro ɗaya zuwa uku.
Sauya wanki  wani mataki ne da ake iya ɗauka a cikin kamfen na wayar da kan jama'a game da tsabtar hannu domin rage yawan yara da ke kamuwa da cutar da kuma mutuwa.
Ranar wanke hannu ta duniya (Global Hand Washing Day)  wani misali ne na kamfen na bayanai da ke da nufin canza halayyar. A sakamakon annobar cutar coronavirus ta 2019-20, Asusun Kula da Yara na Majalisar Dinkin Duniya yana inganta amfani da emojis wanda ke nuna wanke hannu.
A wasu bincike an duba yadda wanke hannu yake da tasiri a kasashe masu tasowa idan aka kwatanta da DALYs (shekaru na rayuwa da aka ajiye ba tare da nakasa ba).
Amma, wani bincike ya nuna cewa, yin amfani da sabulu wajen wanke hannu ya fi yin amfani da sauran hanyoyin tsabtace jiki.
Muhimmancin wanke hannu ga lafiyar mutum  musamman ga marasa karfi kamar matasa uwaye ko sojoji da suka ji rauni a asibitoci  an fara ganewa ne a tsakiyar karni na 19 ta hanyar sababbin sababbin abubuwa a fannin tsaftace hannu: likitan Hungary Ignaz Semmelweis, wanda ke aiki a Vienna (Austria), da Florence Nightingale, ma'aikaciyar jinya ta Ingila kuma  wanda ya kafa kulawar marasa lafiya ta zamani .
A lokacin, yawancin mutane sun gaskata cewa ana samun cututtuka ne daga wari mai guba da ake kira miasma.
A shekarun 1980, sakamakon barkewar cututtukan da ke yaduwa ta hanyar narkewar abinci da kuma kamuwa da cuta da ke tattare da kulawar lafiya, Cibiyoyin Kula da Cututtuka da Rigakafin Cutar a Amurka sun fara inganta tsabtace hannu sosai a matsayin muhimmin mataki na hana yaduwar cuta.
Sakamakon barkewar annobar mura ta alade a shekara ta 2009 da kuma annobar COVID-19 a shekarar 2020, mutane a kasashe da dama sun fahimci muhimmancin wanke hannu da sabulu wajen kare jiki daga irin wannan cuta.
Alal misali, a Jamus, an saka allon da ke nuna "daidaitaccen wanke hannu" a bayan gidajen wanka na jama'a da kuma na ofisoshin gwamnati da kuma na filayen jirgin sama.
Wannan furcin "wanke hannuwanku" yana nufin rashin son ɗaukar alhakin wani abu ko kuma kasancewa cikin wani abu.
Ya fito ne daga Littafi Mai Tsarki, Linjilar Matiyu: Pontius Bilatus ya "wanke hannunsa" lokacin da ya yanke shawarar gicciye Yesu Kristi; daga baya wannan magana ta sami ƙarin amfani a wasu al'ummomin Ingilishi.
A wasan Shakespeare na Macbeth, Lady Macbeth ta fara wanke hannayenta ba da son ranta ba, a ƙoƙarin tsarkake kanta daga wani tabo da ake tsammani yana nuna rashin lamiri, saboda laifuffukan da ta aikata da kuma sa mijinta ya aikata.
An kuma gano cewa mutanen da suka tuna ko suka ga wani abu da bai dace ba sun fi sauran mutane wanke hannayensu, kuma wanke hannu ya fi muhimmanci a gare su.
Haka kuma, mutanen da suka iya wanke hannayensu bayan sun ga abin da suka gani ba za su iya shiga cikin wani aikin "tsabtacewa" na gyara ba, kamar aikin sa kai.
A cikin addinai wanke hannu yana da ma'ana ta tsabtace jiki da kuma alama. Wanke hannu da ruwa amma ba tare da sabulu ba,  wani ɓangare ne na al'ada da aka tsara a addinai da yawa, ciki har da Baha'i, Hindu, tevilah da netilat yadayim a addinin Yahudanci, Lavabo a Kristanci da Wudhu a Musulunci. Addinai kuma sun ba da umarnin wanke hannu na tsabta, musamman bayan wasu ayyuka.
Addinin Hindu, Yahudanci da Musulunci sun bada umurni a wanke hannu bayan an je gidan wanka.
A addinin Hindu, Buddha, Sikhism da Musulunci, ana ganin wanke hannu kafin da kuma bayan kowane abinci wajibi ne.
Kula da abubuwan samarwa dangane da COVID-19
Kula da abubuwan samar da kayayyaki dangane da COVID-19 na nufin amfani da hanyoyin samar da tsaro da kiyaye lafiya don kula da hadarin da kuma yaki da cutar coronavirus ta 2019 (COVID-19).
Kula da haɗarin aiki da kyau ya dogara da wuri da aikin, ya dogara da kimanta haɗarin, tsananin cutar a cikin al'umma da kuma abubuwan haɗarin ma'aikata na musamman waɗanda za su iya zama masu rauni saboda COVID-19.
Hukumar Kula da Lafiya da Aikin Aiki ta Amurka (OSHA) ta ce ayyuka masu ƙarancin haɗari suna da ƙarancin hulɗa da jama'a da abokan aiki, kuma a irin waɗannan lokuta ana buƙatar matakan rigakafin kamuwa da cuta, gami da wanke hannu, ƙarfafa ma'aikata su zauna a gida idan akwai alamun rashin lafiya, kiyaye ƙa'idodin numfashi, da tsaftacewa da kuma kashe ƙwayoyin cuta na yau da kullun.
Matsakaicin aiki na bukatar yawan ko kusanci da mutanen da ba su da tabbacin ko kuma ana zargin cewa suna da cutar COVID-19, amma suna iya kamuwa da cutar saboda yaduwar cutar a cikin al'umma ko kuma a tafiye-tafiye na ƙasashen waje.
Wannan rukunin zai iya haɗa da ma'aikata da suke hulɗa da jama'a, kamar su a makarantu, wuraren aiki da ke da yawan jama'a, da kuma wasu manyan kantunan sayar da kaya.
Matakan sarrafa haɗari ga irin wannan rukuni, ban da matakan rigakafin kamuwa da cuta sun haɗa da samun iska mai iska mai inganci, amfani da allon kariya da kuma kayan kariya na mutum da ke da sauƙi idan aka haɗu da mutumin da ke da cutar COVID-19.
OSHA ta yi imanin cewa ma'aikatan kiwon lafiya da na gawawwaki da suka yi hulɗa da wanda aka tabbatar da cutar ko ake zargin yana da cutar COVID-19 suna cikin manyan haɗarin; kuma haɗarin ya ƙaru sosai idan ma'aikatan suka yi aikin da ke tattare da samar da aerosol ko tattara/sarrafa samfur daga mutumin da aka tabbatar da cutar ko ake zargin yana da cutar COVID-19.
Matakan sarrafa haɗari da suka dace da irin waɗannan ma'aikata sun haɗa da amfani da kayan aikin injiniya da na fasaha, kamar su ɗakunan da ke da iska mai guba, da kuma kayan kariya na mutum wanda ya dace da aikin.
Cutar COVID-19 na iya haifar da tasiri iri-iri a wurin aiki.
Ma'aikata na iya yin rashin aiki saboda rashin lafiyarsu, ko kuma domin suna bukatar su kula da wasu, ko kuma don suna tsoron cewa za su iya kamuwa da cutar.
Yanayin kasuwanci na iya canzawa dangane da nau'ikan kayayyakin da ake buƙata da kuma hanyoyin sayan waɗannan kayayyaki (misali yin sayayya a lokutan da ba su da yawa tare da isarwa ko sabis ba tare da fita daga motar ba).
A ƙarshe, ana iya samun katsewar isar da kayayyaki daga yankunan da cutar COVID-19 ta shafa.
Shirye-shiryen sun tattauna batutuwan haɗari da suka shafi wurare da ayyuka dabam dabam, haɗe da tushen kamuwa da cuta, abubuwan da ke haddasa haɗari a gida da kuma cikin al'umma, da kuma abubuwan da ke haddasa haɗari ga ma'aikata, kamar tsufa ko kuma ciwon kullum.
Shirye-shiryen suna kuma nuna hanyoyin da ake bukata don magance matsalolin da ke tattare da wannan hatsarin, da kuma shirin gaggawa don yanayin da zai iya tasowa sakamakon annobar.
Shirye-shiryen annobar da kuma shirin mayar da martani na iya bin shawarar matakin ƙasa ko na jiha.
Wasu daga cikin manufofin da ake da su na samar da maganin cutar sun hada da rage yaduwar cutar a tsakanin ma'aikata, kare mutanen da ke fuskantar hadarin kamuwa da cuta mai tsanani, kiyaye ayyukan kasuwanci da rage tasirin da zai shafi sauran kungiyoyi a sarkar samar da kayayyaki.
Matsayin da ake bi na shafar yadda cutar take da tsanani a cikin al'ummar da kasuwancin yake.
Tsarin tsarin kula da hadari  tsari ne da aka yi amfani da shi sosai wajen samar da lafiya da kiwon lafiya a wurin aiki, don rarraba irin wadannan hanyoyin bisa ga inganci.
Idan ba za a iya kawar da haɗarin kamuwa da cutar COVID-19 ba, hanyoyin tsaro na injiniya ne suka fi tasiri, sannan  matakan gudanarwa, kuma a ƙarshe  hanyoyin kare kai.
Tsaro na injiniya yana nufin ware ma'aikata daga wuraren da ke da haɗari a wurin aiki, kuma ba ya dogara da halayen ma'aikaci, wanda zai iya zama mafi kyawun zaɓi na tattalin arziki.
Matakan gwamnati suna nufin canje-canje a cikin manufofin aiki ko hanyoyin da suke bukatar aiki daga ma'aikaci ko ma'aikaci.
Ana ganin cewa kayan kariya na mutum (PPE) ba su da tasiri sosai idan aka kwatanta da na injiniya ko na gwamnati, amma suna iya taimakawa wajen kawar da wasu haɗari.
Ya kamata a zaɓi kowane irin kayan kariya na mutum bisa ga haɗarin da ke tattare da ma'aikaci, a daidaita girmansa (misali, na'urar numfashi), a yi amfani da shi a kai a kai kuma yadda ya kamata, a duba shi a kai a kai, a kula da shi yadda ya kamata, kuma a sauya shi yadda ya kamata, kuma a cire shi, a tsabtace shi, a adana shi ko kuma a zubar da shi yadda ya kamata don kauce wa kamuwa da cuta.
Hukumar Kula da Lafiya da Kiwon Lafiya ta Aikin Aiki ta Amurka (OSHA) ta ce ayyukan da ke da ƙarancin haɗari suna da ƙarancin hulɗa da jama'a da kuma abokan aikinsu.
Matakan rigakafin cutar da aka ba da shawarar ga dukkan wuraren aiki sun haɗa da wanke hannu sosai da kuma sau da yawa, shawarwari ga ma'aikata da suka kamu da cutar su zauna a gida, bin ƙa'idodin numfashi, ciki har da rufe bakinsu da hannu lokacin da suke yin tari da fitsari, samar da tawul da kwantena don shara, shirye-shiryen aiki na nesa ko maye, idan ya cancanta, shawarwari ga ma'aikata don kauce wa amfani da wasu kayan aiki da kayan aiki, da kuma tsabtace da kuma kashe gurɓataccen wurin aiki na yau da kullum.
Ganowa da kuma ware mutane da ke da yiwuwar kamuwa da cutar da wuri-wuri  mataki ne mai muhimmanci wajen kare ma'aikata, abokan ciniki, baƙi da sauran mutane a wurin aiki.
Cibiyoyin Kula da Cututtuka da Rigakafin Cututtuka na Amurka (CDC) sun ba da shawarar ma'aikata da ke da alamun cututtukan numfashi na gaggawa su zauna a gida har sai zafin jiki, rashin zafin jiki, da sauran alamun sun daina aƙalla awanni 24 ba tare da amfani da maganin rage zafin jiki ko wasu magungunan da ke rage alamun ba, kuma sun ba da shawarar samar da sassauci a manufofin asibiti, ba da izinin ma'aikata su zauna a gida don kula da wani mai rashin lafiya a cikin iyali, da kuma tabbatar da sanar da ma'aikata game da irin waɗannan manufofin.
Bisa ga OSHA, ayyukan da ke da matsakaicin haɗari suna buƙatar yawan haɗuwa da kusanci na tsawon ƙafa shida (1.8 m) tare da mutanen da ba su da tabbacin ko kuma ana zargin cewa suna da cutar COVID-19, amma akwai yiwuwar kamuwa da SARS-CoV-2 saboda yaduwar cutar a cikin al'umma a yankin da kasuwancin ke, ko kuma saboda irin wannan mutumin ya yi tafiya kwanan nan zuwa wuraren da cutar ta COVID-19 ta yadu.
Irin waɗannan rukuni sun haɗa da ma'aikata waɗanda ke da hulɗa da jama'a, misali a makarantu, wuraren aiki masu haɗari da wasu manyan shagunan sayar da kaya. Tsaro na injiniya don irin waɗannan ƙungiyoyi da ƙungiyoyi masu haɗari sun haɗa da shigar da matattarar iska mai ƙarfi, haɓaka matakan iska, shigar da shinge na zahiri kamar su filastik masu kariya, da kuma kafa tagogin sabis na abokin ciniki ba tare da barin motar ba. Matakan gudanarwa ga irin wannan rukuni da ƙungiyoyi masu haɗari sun haɗa da shawarwarin ma'aikata marasa lafiya su zauna a gida, maye gurbin tarurruka na kai tsaye tare da sadarwa ta hanyar na'urorin na'urar sadarwa, kafa jadawalin sauyawa, dakatar da tafiya ta yau da kullun zuwa wuraren COVID-19, haɓaka matakan iska, shigar da shinge na zahiri kamar su tabarau masu tsabta na filastik, da kuma shigar da windows don sabis na abokin ciniki ba tare da barin motar ba.
A wasu lokatai, ma'aikata da suke cikin wannan rukunin haɗarin suna iya bukatar su saka na'urar numfashi.
Idan mutum ya kamu da cutar a cikin jirgin sama, ana bukatar a yi wasu abubuwa don a tabbatar da lafiyar ma'aikata da sauran fasinjoji, kamar ware mutum mai cutar daga sauran mutane na nisan ƙafa 6, sanya wani ma'aikaci ya kula da mutumin da ke fama da cutar, ba wa mai cutar abin rufe fuska, ko kuma a nemi mutumin ya rufe hanci da baki da tawul idan ya yi tari ko hancinsa.
Ya kamata ma'aikatan jirgin na biyu su sa safofin hannu na magani na lokaci guda sa'ad da suke kusantar matafiyi mai ciwo ko kuma idan suka fuskanci ruwa na jiki ko kuma wuraren da za su iya kamuwa da cutar, kuma wataƙila su yi amfani da ƙarin kayan kariya na mutum idan mai ciwo yana da zazzabi, yana yawan yin tari ko kuma yana da wahalar numfashi.
Ya kamata a saka safofin hannu da sauran kayan da ake amfani da su sau ɗaya a cikin jakar da ba ta da haɗari, kuma a tsabtace wuraren da ke da cutar kuma a kashe su. A cikin yanayin jiragen ruwa na kasuwanci, gami da jiragen ruwa na tafiya da sauran jiragen fasinja, matakan tsaro sun haɗa da jinkirta tafiya idan akwai rashin lafiya, keɓe kai da kuma sanar da cibiyar kiwon lafiya a cikin jirgin nan da nan idan akwai zafi ko wasu alamun cutar a cikin jirgin.
A mafi kyau, ya kamata a yi gwajin a cikin ɗaki mai keɓewa. A game da makarantu da wuraren kula da yara, CDC ta ba da shawarar rufewa na ɗan lokaci don tsabtace ko kuma kashe ƙwayoyin cuta idan mutumin da ke da cutar yana cikin makarantar, ko da kuwa yadda cutar ta yaɗu a cikin al'umma.
Idan akwai ƙarancin ko matsakaicin yaduwar kamuwa da cuta a cikin al'umma, ana iya amfani da dabarun nisantar mutane, kamar su, kawar da tafiye-tafiye na taro, taro da sauran taron jama'a kamar motsa jiki ko waƙar mawaƙa, cin abinci a cikin cafeteria, ƙara tazarar tsakanin wuraren cin abinci, daidaita lokacin isowa da fita, rage ziyarar da ba ta da muhimmanci, amfani da wurin kula da lafiyar yara da ke da alamun mura.
Idan cutar ta yadu sosai a cikin al'umma, za a iya yin la'akari da matakan hana zuwa makaranta na dogon lokaci, ban da dabarun nisantar zamantakewa.
Ana ba ma'aikatan tsaro da ke da alhakin hulɗa da waɗanda aka tabbatar da cutar ko ake zargin suna da cutar COVID-19 shawarar su bi umarnin da aka ba ma'aikatan gaggawa, ciki har da yin amfani da kayan kariya na sirri.
Idan aka kama ma'aikata suna da dangantaka da su, dole ne su tsabtace da kuma kashe ƙwayoyin cuta na belinsu da kayan aiki kafin a sake amfani da su ta hanyar amfani da iskar mai tsabtace gida ko kuma ta hanyar gogewa, su bi ƙa'idodin aiki na yau da kullum don hana yaduwar cuta da kuma kawar da kayan kariya na mutum da aka yi amfani da su, da kuma amfani da tufafi da kuma wanke su.
OSHA ta yi imanin cewa wasu rukunin ma'aikatan kiwon lafiya da na gawawwaki suna da babban hadari ko kuma suna da hadari sosai.
Matsayin da ke da haɗari ya haɗa da ma'aikatan kiwon lafiya, masu ba da taimako, ma'aikatan dakin gwaje-gwaje, da ma'aikatan sufuri na kiwon lafiya da ke hulɗa da marasa lafiya da aka tabbatar da cutar ko kuma ake zaton suna da cutar COVID-19.
Suna da babban haɗarin kamuwa da cutar yayin da suke gudanar da hanyoyin da ke tattare da samar da aerosol ko kuma tattara/sarrafa samfurori daga mutanen da aka tabbatar ko ake zaton suna da cutar COVID-19.
Abubuwan da ake yi don aerosol su ne yin bincike, yin coughing, yin bronchoscopy, wasu hanyoyin haƙori da kuma yin bincike ko kuma yin gwajin da hanyoyin da ake amfani da su wajen yin bincike.
Ma'aikatan gidan gawa da ke da hadari sun hada da ma'aikatan da ke kula da gawawwakin mutanen da aka tabbatar da cutar ko ake zargin suna da cutar COVID-19 a lokacin mutuwarsu; idan irin waɗannan ma'aikatan suna gudanar da binciken gawawwakin, to suna cikin rukunin masu hadari sosai. Ƙarin matakan tsaro na injiniya da fasaha ga irin waɗannan rukunin hadari sun haɗa da amfani da ɗakunan keɓewa don marasa lafiya da aka tabbatar da cutar ko ake zargin suna da cutar COVID-19, ciki har da aiwatar da hanyoyin da ke tattare da samar da iska.
A wasu cibiyoyin kiwon lafiya da kuma a wasu gidajen gawa, ana iya yin amfani da iska mai matsi mai yawa.
Ya kamata a kula da samfurin tare da kiyaye matakan tsaro da aka tsara don matakin tsaro na 3.
Hukumar Lafiya ta Duniya (WHO) ta ba da shawarar a rarraba marasa lafiya masu zuwa zuwa a yankunan jira da aka keɓe dangane da zargin kamuwa da COVID-19. Baya ga sauran matakan kariya na mutum, OSHA ta ba da shawarar yin amfani da na'urorin numfashi ga ma'aikata da ke hulɗa da nesa har zuwa ƙafa 6 tare da marasa lafiya da aka tabbatar da cutar ko ake zargin suna da cutar SARS-CoV-2, da kuma mutanen da ke gudanar da hanyoyin da ke tattare da samar da iska.
A Amurka, ana bukatar amfani da na'urar numfashi ta fuska da ke da N95 ko kuma mafi girma a matsayin wani ɓangare na cikakken shirin kariya na numfashi da aka rubuta, wanda ke nuna bukatun zaɓin kayan aiki da kuma dubawar likita.
Wasu nau'ikan na'urar numfashi na iya samar da kariya da kwanciyar hankali ga ma'aikaci. WHO ba ta ba da shawarar yin amfani da tufafi na musamman ba saboda COVID-19  cuta ce da ake yadawa ta hanyar numfashi, ba ta ruwa ba.
WHO ta ba da shawarar cewa a yi amfani da abin rufe fuska na tiyata ne kawai ga ma'aikatan da ke yin gwajin a wurin da ake karɓar marasa lafiya.
WHO ta ba da shawarar cewa duk wanda ke tattara samfurin numfashi daga marasa lafiya da ke dauke da COVID-19 ko kuma masu dauke da cutar ba tare da yin amfani da hanyoyin da ke haifar da iska ba, su sanya abin rufe fuska, tabarau ko abin rufe fuska, rigar tufafi da safofin hannu.
A lokacin da ake yin aikin da ke tattare da samar da aerosol, a maimakon abin rufe fuska, ya kamata a saka na'urar numfashi ta N95 ko FFP2.
Dangane da karancin kayan kariya na mutum a duniya, WHO ta ba da shawarar rage bukatar kayan kariya ta hanyar amfani da hanyoyin magani na nesa, shinge na jiki, kamar su tagogin da ke nunawa, samar da damar zuwa ga mai cutar COVID-19, kawai ga waɗanda ke ba da kulawa kai tsaye, amfani da kayan kariya na mutum kawai waɗanda ake buƙata don takamaiman aiki, ci gaba da amfani da na'urar numfashi ɗaya ba tare da cirewa ba, yayin aiki tare da marasa lafiya da yawa tare da ganewar asali iri ɗaya, saka idanu da daidaita sarkar samar da kayan kariya na mutum, da ba da shawarar kada a yi amfani da abin rufe fuska ga waɗanda ba su da alamun cutar.
MAFITA: Katherine Maher, babban daraktan zartarwa na Wikimedia Foundation
MUTANE: Dukan ma'aikatan Wikimedia Foundation
JIGOJI: [Covid-19] Sauƙaƙa nauyi da kuma shirya don nan gaba
KYAUTA/Lokacin da aka tabbatar: 14 ga Maris 2020, 00:24 UTC
HUTUMI: CC0: Babu haƙƙoƙin da aka kiyaye
A wannan watan, muna rayuwa ne a yanayi na musamman.
Cutar COVID-19  wani lamari ne da ya haskaka yadda mutane suke da alaka da juna a duniya da kuma yadda muke da hakki ga juna.
Ba mu taɓa fuskantar irin wannan matsalar ba, amma mun san cewa yadda muke yin abubuwa ya dangana ne ga iyawarmu na nuna juyayi, da haɗin kai da kuma bunkasa al'ummomin duniya, wanda ke sa a kafa irin wannan kungiya.
Mun ga yadda abokan aikinmu suke da abokantaka da kuma kula da juna, kuma hakan ya bayyana a cikin imel da kuma kiran waya da kuma hira - wannan tabbaci ne mai kyau cewa muna da mutane masu ban mamaki da muke aiki da su.
Ina alfahari da ku kuma ina godiya sosai don yadda kuke aiki tare.
A makon da ya gabata, an gaya mini cewa an yaba wa aikinmu sosai.
An tunatar da ni cewa yana da muhimmanci a duniya a iya shiga Wikipedia a yanzu, kuma yana da amfani ga kowa ya sami damar shiga wannan muhimmin kayan aiki a kan layi.
Kuma wannan ya yiwu ne saboda aikinku, ko dai don tabbatar da ayyukan yanar gizo, ko biyan abokan aikinmu, ko kuma kare lafiyar al'ummominmu.
Duniya na bukatar bayanin da ke cikin Wikipedia, kuma a yau yana da muhimmanci fiye da kowane lokaci.
A wannan lokaci, don samun sakamako mai ma'ana ga duniya, ba wai kawai abin da muke yi ba ne, amma yadda muke yin hakan.
Saboda muhimmancin wannan aiki da kuma matsayinku a cikin wannan tsari, za mu yi wasu muhimman canje-canje a tsarin aikinmu na yau da kullum, daga mako mai zuwa.
Gyara tsarin aikinmu da jadawalinmu
Kamar yadda Robin ya fada a baya, ƙungiyar c-team ta taru a daren jiya don tattauna tsarinmu da kuma jadawalinmu na kwanaki da watanni masu zuwa.
A cikin tattaunawarmu, mun tattauna ra'ayoyinmu game da yadda za a yi aiki da kyau a halin da ake ciki da kuma yadda za a tabbatar da dorewar kungiyar a irin wannan lokaci.
Yawancinmu muna son mu kwantar da hankalinmu kuma mu ci gaba da aikinmu na dogon lokaci.
Idan kuna son ku yi watsi da shi, to, ku yi watsi da shi.
Ga dukan ma'aikata, 'yan kwangila da kuma ma'aikatan sa kai:
Za mu yi aiki na sa'o'i 4 a rana, ko kuma sa'o'i 20 a mako, kafin a ba da umurni.
Ba ma yin hutun mako, idan za ku iya yin aiki na tsawon sa'o'i, za a iya yin hakan domin manufarmu.
Amma duniya ba ta da tabbas; duk abin da kuke bukata, ko kula da danginku, ko sayen abinci, ko zuwa wurin likita, lafiyarku shine babban abin da muke so.
Ba ma lura da lokacin aikinku.
Idan kana rashin lafiya, kada ka yi aiki.
Babu shakka, amma muna magana game da shi.
Ba a bukatar ka rubuta takardar asibiti ko kuma ka yi hutu: ka gaya wa shugabanka kawai ka taimaki ƙungiyarka ta sake duba kalandarka da kuma tsarin aikinka don tabbatar da cewa an rufe muhimman fannoni.
(Idan an tabbatar maka da cutar COVID-19, ka sanar da Brian daga T&C Ops domin T&C ta iya ba da goyon baya da kulawa daga shugabanci ga yanayinka.)
Za a biya kuɗin awa ɗaya.
Mun riga mun sanar kuma mun tabbatar da aniyarmu na cika alkawuranmu ga 'yan kwangilarmu da ma'aikatanmu da kuma biyan sa'a.
Kowace mutum za a biya shi daidai da kuɗin da ake biya a kowane sa'a a al'amuran yau da kullum.
Wannan ya haɗa da lokutan rashin lafiya da ba za ka iya aiki ba.
Idan kuna son yin aiki, za mu tallafa muku.
Mutane da yawa suna amfani da aiki a matsayin hanyar da za su mai da hankalinsu ga duniya.
Abin da muke yi zai iya kawo sakamako mai ban mamaki, musamman a irin wannan lokaci.
Kuma wannan kuma game da taimakon kai ne.
Muna roƙonku ku tuntuɓi shugabanku domin mu san abin da za mu yi tsammani kuma mu daidaita ayyukanmu yadda ya kamata.
Wasu ayyuka suna da muhimmanci.
Ya kamata mu riƙa tallafa wa irin waɗannan ayyukan.
Ƙungiyoyin SRE, HR Ops, Trust&Safety da kuma Fundraising (da sauransu) suna yin aiki mai muhimmanci da zai iya bukatar ƙarin tallafi.
Muna fara wani tsari a dukan sassanmu don mu bincika abubuwan da muke so mu yi yanzu kuma mu mai da hankali ga tallafa wa mutane, wanda yake da muhimmanci ga aikinmu.
Akwai ayyuka da yawa da za mu yi, kuma muna mai da hankali ga ayyukan da suka fi muhimmanci.
Idan muka jinkirta a yau, ba zai kawo sakamako mai kyau a nan gaba ba.
Ba mu da shirin yin aiki ninki biyu don samun abin da muka rasa bayan annobar ta ƙare.
Ba za ka bukaci ka yi aiki na sa'o'i da yawa ba domin ka cika wasu takunkumi da ba za ka iya ba.
Mun yarda cewa yanayi ya canja, kuma za mu yi aiki a kan kafa sababbin manufofi da kuma lokaci idan ya yiwu.
Menene ke faruwa da APP?
Don daidaitawa da sabon yanayin da ake ciki da kuma tsammanin yawan lokutan aiki na yau da kullum, muna da niyyar daidaita lokacin aiwatar da Shirinmu na Shekara 2020-2021.
Muna son mu ba da shawarar tsawaita tsarinmu na 2019-2020, ta haka za mu ba da karin lokaci don tsara kasafin kuɗi, wanda zai ba ma'aikata damar fifita aiki mai mahimmanci, taimakon kai da kula da ƙaunatattun su, yayin da duk wanda ke buƙatar ko yana son aiki zai sami raguwar jadawalin makonni masu zuwa.
Wannan ya rage yawan aiki da kuma matsi a dukan ƙungiyar.
A mako mai zuwa za mu gabatar da shawararmu ga Kwamitin, kuma za mu sanar da wakilanmu da kuma ƙungiyoyinmu game da matakai na gaba da zarar mun sami tabbacin da ya dace.
Na gode wa tawagar APP don jagorancin wannan aiki.
Yanayin ofishi, haɗari da tsaftacewa
A makon da ya gabata mun samu labarin cewa wani abokin aikinmu a San Francisco yana iya kamuwa da cutar COVID-19.
Amma, ban da yin amfani da matakan tsaro, mun kuma yi amfani da masu tsabtace jiki don su tsabtace dukkan wuraren da ke ofishinmu da ke San Francisco.
Sun yi amfani da maganin rigakafin cutar a matsayin maganin rigakafin cutar a duk faɗin duniya, har ma a cikin ɗakunan shiga da kuma ɗakunan hawa, waɗanda suke kai mu ga bene.
Ana amfani da dokoki na gida a cikin ginin, suna ba da umarni don kiyaye hankali, tare da amfani da kayayyakin da ke tabbatar da lafiyar masu haya.
Muna jin cewa ofishin zai kasance a shirye sosai domin lokacin da za mu koma.
Ofishinmu na D.C. yana cikin hanyar sadarwar WeWork, wanda ya raba mana da ma'aikatansa a D.C. ka'idojinsa na COVID-19.
A makon da ya gabata, ofishinmu da ke D.C. ya koma yin aiki daga nesa bisa ga umurnin da aka ba mu a San Francisco.
Kamar yadda wasu abokan aikinmu a New York suka sani, mun kuma tattauna batun yin hayan wani wuri a Brooklyn.
Za a ci gaba da irin wannan tattaunawar, amma za a iya dakatar da shi.
Wasu abokan aikinmu sun fara aiki daga nesa.
Tsoffin abokan aikinmu da ke aiki daga nesa sun san cewa za a iya gyara wannan yanayin kuma suna so su ba ku wasu shawarwari:
Ana ba da shawarar a rage tsawon tarurruka zuwa awa ɗaya ko biyu.
Idan kuna son ku yi nazari na tsawon lokaci, ku yi la'akari da raba shi zuwa kwana da yawa.
Ka bayyana manufar taron, ka bayyana tsarin ayyukan, kuma ka aika da littattafai na nazari a gaba.
Kafin ka yi amfani da bidiyo, ka yi amfani da kayan aiki kamar Google Docs da Zoom don sauƙaƙa hulɗa da sadarwa.
Don saukakawa, ka sanya mai gudanarwa  mutum wanda zai lura da tambayoyin da ake samu a cikin hira da kuma kula da jerin masu magana, da kuma wanda ke da alhakin yin bayanin kula (ko kuma haɗin kai).
Idan kana bukatar amfani da na'urar sauraro mai sauƙi, ka tuntuɓi masu goyon bayan sana'a ta hanyar imel.
Ka yi amfani da amfanin Wellness Reimbursement sa'ad da kake sayan abincin dare.
Shiga tashar #remoties a Slack don tattaunawa da abokan aiki game da rarraba aiki.
Ƙungiyar HR Operations tana nazarin jagororin ergonomics da ake samu a dandalin yanar gizo domin inganta yadda ake rarraba aiki a duk faɗin ƙungiyar.
A makon da ya gabata mun nemi duk masu karɓar tallafin al'umma su dakatar da manyan abubuwan da Wikimedia ke tallafawa, kamar su editathons, har sai WHO ta sanar da ƙarshen cutar.
Mun fahimci kuma mun sanar da cewa irin wannan bukatar da muka yi na sokewa da sauran takunkumi na iya haifar da rashin iya gudanar da ayyukan tallafin da aka amince da su, kuma ba za a ci tara ga kowa ba saboda jinkiri ko sauya irin wannan manufa.
A mako mai zuwa za mu gudanar da wasu abubuwan da za su biyo baya tare da ƙarin jagorori game da Wikimania da sauran taron yanki da kuma taron al'umma.
Yanayin da ke cikin al'ummar duniya  ba wai kawai baƙin ciki ne game da katsewar aikin ba, amma kuma wani jin dadi ne game da fahimtar juna da kuma damar da za a mayar da hankali kan al'ummomin su, Wikimedia da sauransu.
Game da hangen nesa, CRT tana aiki a kan shafin yanar gizon Meta-Wiki wanda zai samar da sararin samaniya don al'umma don kula da tasiri da sadarwa.
Muna tuntuɓarku game da al'amuran COVID-19
Za mu aika muku da gayyatar taron ma'aikata na musamman da za a yi a ranar Alhamis mai zuwa, karfe 2:00 na yamma UTC zuwa 7:00 na yamma PT.
A wannan karon za mu yi amfani da damar don raba ƙarin bayanai, amsa tambayoyinku, da kuma ciyar da lokaci tare, muna haɗuwa da juna.
Muna cikin wannan halin tare kuma muna shirye mu taimaka da duk abin da za mu iya.
Duk da haka, za ka iya samun bayanai daga wannan imel ɗin, da kuma wasu muhimman bayanai game da COVID-19  daga Office Wiki.
CRT za ta sabunta irin waɗannan shafuka, kuma za a tattara dukan bayanai a wuri guda.
Muna kuma aiki don ci gaba da sadarwa tare da ma'aikatanmu da ke zaune a ƙasashen da yanayin ya shafa.
Idan kana da tambayoyi game da tafiye-tafiye, ayyuka, muhimman ayyuka, matsaloli game da bayanin, ko kuma idan kana bukatar wani taimako, ka tuntuɓi CRT.
Muna shirye mu ba da tallafi da kuma sadarwa idan ya cancanta.
Idan kana da wata damuwa game da sirrinka, ka aika imel zuwa Brian Judan  Daraktan HR International Global Operations.
Kada a ɗauki irin waɗannan canje-canjen a matsayin watsi da aikinmu da kuma wajibai.
Akasin haka, ya nuna cewa akwai bukatar da muke da ita a yanzu don mu daidaita ayyukanmu da kuma ayyukanmu.
Mun yi imanin cewa irin waɗannan matakan suna da mahimmanci don tallafawa juna da kuma tabbatar da damar ci gaba da aiki, don samar da tallafi da ake buƙata ga motsinmu da duniya ta hanyar sabis ɗin da ya dace.
Za mu jira har sai lokacin da ya dace.
Yau ne lokacin da za mu tallafa wa juna da kuma samar da sarari don muhimmin aiki da ke gabanmu a cikin makonni da watakila watanni masu zuwa.
Don hakan ya faru, muna bukatar taimakon kowannenku, kuma muna bukatar ku iya kula da kanku da iyalanku, kuma ku yi aiki da matuƙar ƙarfinku, da zarar bukatar ta taso.
Yanzu, ku wanke hannuwanku kuma kada ku taɓa fuskarku!
Katherine, CRT (Amanda K, Amy V, Bryan J, Doreen D, Gregory V, Jaime V, Joel L, Lynette L, Ryan M, Tony S), da sauran membobin ƙungiyar Leadership Team (Grant I, Heather W, Jaime V, Janeen U, Lisa S, Robyn A, Ryan M, da Toby N).
Enzyme mai canza angiotensin 2 (ACE2) wani enzyme ne wanda yake a jikin kwayoyin halitta a cikin huhu, jijiyoyi, zuciya, koda da hanji.
ACE2 yana hana aikin enzymes na angiotensin-converting enzyme (ACE) ta hanyar rage abun ciki na angiotensin-II da kuma kara Ang (1-7), yana mai da shi mafita mai kyau don magance cututtukan zuciya. AC2 kuma yana aiki a matsayin hanyar shiga cikin ƙwayoyin cuta don wasu ƙwayoyin cuta.
An kira kwayar halitta na ɗan adam hACE2.
Enzyme mai canza angiotensin 2  shine ƙarfe mai ƙunshe da zinc, wanda ke kan farfajiyar endothelial da sauran ƙwayoyin halitta.
Protein ACE2 yana ƙunshe da yankin N-end peptidaz M2 da C-end transport domain na amino acid na ƙwayoyin cuta na ƙwayoyin cuta.
ACE2 shine furotin mai membrane mai nau'in nau'in I, yankin da ke aiki da shi yana shiga cikin kwayoyin huhu da sauran ƙwayoyin.
Ana cire yankin ACE2 na waje da kwayar halitta daga yankin transmembrane ta wani enzyme da ake kira sheddaze, kuma an sami furotin mai narkewa a cikin jini kuma a ƙarshe an fitar da shi tare da fitsari.
ACE2 yana cikin yawancin gabobin jiki: ACE2 yana haɗe da ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin cuta na nau'in II, ƙwayoyin enterocytes na ƙananan hanji, ƙwayoyin endothelial na jijiya da na jijiya da ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayo
Hakanan ana samun kwayar halitta ta ACE2 da RNA a cikin kwakwalwar kwakwalwa, striatum, hypothalamus da kuma kwakwalwar kwakwalwa.
Babban aikin ACE2 shine ya zama mai daidaitawa ga ACE.
ACE tana rarraba kwayar halittar angiotensin I zuwa angiotensin II mai narkewa.
ACE2, a bayansa, yana cire carboxylic amino acid na phenylalanine daga angiotensin II (Asp-Arg-Val-Tyr-Ile-His-Pro-Phe) kuma yana hydrolysing shi zuwa angiotensin mai motsawa (1-7), (H-Asp-Arg Val-Tyr-Ile-His-Pro-OH).
ACE2 kuma na iya raba wasu wasu peptides, gami da [des-Arg9] -bradikinin, orange, neurotensin, dinorphin A, da ghrelin.
ACE2 kuma yana daidaita jigilar membrane na mai ɗaukar amino acid SLC6A19 kuma yana nan a cikin cutar Hartnup.
A matsayinta na furotin mai wucewa, ACE2 tana aiki a matsayin babban wurin shiga cikin ƙwayoyin cuta ga wasu ƙwayoyin cuta na corona, ciki har da HCoV-NL63; SARS-CoV (kwayar cutar da ke haifar da SARS); da SARS-CoV-2 (kwayar cutar da ke haifar da COVID-19).
A takaice, haɗa furotin S1 na SARS-CoV da SARS-CoV2 tare da yankin enzymatic na ACE2 a farfajiyar ƙwayoyin halitta yana haifar da endocytosis da kuma sauyawar cutar da kuma enzyme zuwa endosomes da ke cikin ƙwayoyin.
Wannan tsarin shigarwa kuma yana buƙatar ƙaddamar da furotin S ta hanyar mai ɗaukar hoto na TMPRSS2, wanda hanawa a halin yanzu ana nazarin shi azaman mai yuwuwar magani. Wannan ya haifar da wasu tunanin cewa rage matakan ACE2 a cikin ƙwayoyin zai iya taimakawa wajen yaƙar kamuwa da cuta.
Duk da haka, ƙungiyoyi da yawa na ƙwararru da kuma hukumomi suna ba da shawarar ci gaba da maganin da aka saba da shi na maganin hana A.P.F. da kuma BRA.
Bisa ga bita da kuma nazarin da aka yi a ranar 11 ga Yuli, 2012,  amfani da maganin hana cutar APF ya shafi raguwar cutar huhu da kashi 34% idan aka kwatanta da na masu kula.
Bugu da ƙari, an rage haɗarin kamuwa da ciwon huhu a cikin marasa lafiya da ke shan maganin hana cutar, waɗanda ke da haɗarin kamuwa da ciwon huhu, musamman waɗanda ke fama da bugun jini da kuma rashin ƙarfi na zuciya.
Amfani da masu hana APF ya kuma kasance yana da alaƙa da rage mutuwar cutar huhu, kodayake sakamakon ya kasance mai ƙarancin tabbaci fiye da marasa lafiya tare da haɗarin cutar huhu gaba ɗaya.
Ana tsammanin sake haɗawa na ACE2 na mutum (rhACE2) sabon abu ne a cikin maganin cututtukan huhu kuma yana iya inganta hawan jini da oxygen a cikin aladu tare da cutar rashin ƙarfi na hanta mai saurin lipopolysaccharide.
Lokacin rabin fitarwa na rhACE2 a cikin mutane kusan awanni 10 ne, kuma farkon aiki na mintuna 30, ban da tsawon lokacin tasiri na awanni 24.
Wasu bayanai sun nuna cewa rhACE2 na iya zama mai ban sha'awa ga mutanen da basu yarda da rigakafin tsarin renin-angiotensin (RAS inhibitors) ko kuma a cikin cututtukan da ke da karfin jini na II. An gudanar da nazarin rhACE2 a cikin gwaji na asibiti don magance cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtuk
Aikace-aikacen COVID-19 aikace-aikacen software ne na wayar salula, waɗanda aka tsara don taimakawa a binciken cututtukan cututtuka a cikin yanayin annobar cutar coronavirus ta 2019-20, wato gano mutanen (saduwa) waɗanda zasu iya hulɗa da mutumin da ke da cutar.
A wasu yankuna, an samar da aikace-aikace da yawa da aka amince da su.
An tsara nau'ikan aikace-aikace da yawa don bin diddigin lambobin sadarwa.
Wannan ya haifar da muhawara game da matsalolin sirri, musamman game da tsarin da ke dogara da bin diddigin wurin da masu amfani da aikace-aikacen suke.
Zaɓuɓɓuka masu laushi a wannan batun sun haɗa da amfani da siginar Bluetooth don yin rikodin kusanci da mai amfani da wasu wayoyin hannu.
A ranar 10 ga Afrilu, 2020, Google da Apple sun sanar da cewa za su hada kokarinsu don haɗa ayyukan tallafi na irin waɗannan aikace-aikacen bisa Bluetooth kai tsaye a cikin tsarin aiki na Android da iOS.
A China, gwamnati tare da Alipay sun ƙaddamar da wani manhajar da ke ba wa 'yan ƙasa damar bincika ko sun taɓa yin hulɗa da mutanen da ke da cutar COVID-19.
Ana amfani da shi a birane fiye da 200 a China, kuma a Singapore, akwai wani app da ake kira TraceTogether.
Kamfanonin IT na gida ne suka kirkiro manhajar, kuma an bude ta, kuma za a ba da ita ga gwamnati. Arewacin Macedonia ta kaddamar da manhajar StopKorona!, wadda ke aiki da Bluetooth, wanda ke taimakawa wajen bin diddigin mutanen da ke da cutar da kuma samar da sadarwa da hukumomin kiwon lafiya.
Ma'aikatar Sadarwa da Fasaha da Ma'aikatar Lafiya ne suka hada kai suka tsara wannan manhaja.
Ya zuwa ranar 14 ga Afrilu, 2020, aikace-aikacen yana jiran rajista a cikin Google Play Store da Apple App Store.
A ranar 12 ga Afrilu, gwamnati ta ce aikace-aikacen bin diddigin lamba yana kan matakin karshe na ci gaba kuma za a samu damar turawa cikin makonni. Ana shirin ƙaddamar da irin waɗannan aikace-aikacen a Ireland da Faransa (StopCovid).
Australia da New Zealand suna la'akari da amfani da aikace-aikacen da suka dogara da aikace-aikacen TraceTogether na Singapore da yarjejeniyar BlueTrace. Rasha na son amfani da aikace-aikacen da ke da fasalin yanki wanda burin  shi ne a sa ido don marasa lafiya da aka gano suna da cutar COVID-19 da ke zaune a Moscow su bar gidajensu.
Ross Anderson, Farfesa a fannin tsaro, Jami'ar Cambridge, ya nuna wasu matsaloli na iya aiki da za su iya tasowa tare da tsarin tushen aikace-aikace, gami da karya da kuma rashin inganci idan an yi amfani da aikace-aikacen ne kawai a cikin ƙananan yawan jama'a.
Dangane da damuwar da ake da ita game da yaduwar aikace-aikacen ɓatarwa ko cutar  coronavirus, Apple ya iyakance jerin nau'ikan ƙungiyoyi waɗanda zasu iya ba da aikace-aikacen su masu alaƙa da cutar  a cikin App Store, ta haɗa da  hukuma  ko wasu ƙungiyoyi masu aminci a cikin wannan jerin.
Google da Amazon ma sun kafa irin wannan takunkumi.
Masu shiga cikin kamfen na tsare sirri sun nuna damuwa game da tasirin sa ido kan jama'a ta hanyar aikace-aikacen da suka shafi coronavirus; musamman, an yi tambaya kan ko za a rushe kayan aikin sa ido da aka kirkira don magance cutar ta coronavirus lokacin da barazanar ta ɓace.
Kungiyar Amnesty International da fiye da wasu kungiyoyi 100 sun fitar da wata sanarwa da ke kira da a rage irin wannan sa ido.
Kungiyoyin sun bayyana sharudda takwas da suke gabatar wa ayyukan gwamnati:
sa ido ya zama mutum, wajibi, kuma ya dace;
fadada sa ido da sa ido ya kamata ya kasance tare da ambaton iyakance lokacin aiki;
Ya kamata a ƙuntata amfani da bayanai don magance yaduwar COVID-19.
Tsaro da kuma asirin bayanai dole ne a kiyaye su, kuma dole ne a ba da tabbacin hakan;
sa ido na dijital ya kamata ya kawar da yanayin nuna bambanci da kuma nuna bambanci;
duk wani musayar bayanai da bangarori na uku dole ne a ayyana shi a matakin doka;
ya kamata a tabbatar da kariya daga cin zarafi, da kuma hakkin 'yan ƙasa su amsa cin zarafi;
Dole ne a samu "mahimman shiga" na duk "masu ruwa da tsaki" ciki har da masana kiwon lafiyar jama'a da wakilan kungiyoyin da aka yi wa kauracewa. The German Chaos Computer Club (CCC) da Reporters Without Borders (Reporter ohne Grenzen) (RSF) sun kuma wallafa jerin sharuddan su.
Google da Apple sun gabatar da shirin su na hadin gwiwa don magance matsalar sa ido na dindindin, wanda shine cire tsarin bin diddigin daga tsarin aiki na na'urorin su da zarar babu bukatar hakan.
A wasu ƙasashe, ana amfani da hanyar sa ido ta hanyar sadarwa maimakon aikace-aikace, wanda ke kawar da buƙatar saukar da aikace-aikacen da kuma yiwuwar guje wa sa ido.
An amince da yin amfani da hanyar sa ido a Isra'ila.
Hanyoyin sadarwa da ke da damar samun bayanan wurin da aka samo su ma suna da babbar matsalar tsare sirri.
Koyaya, ba duk tsarin da ke da sabobin tsakiya ya kamata su sami damar zuwa bayanan sirri game da wurin ba; an tsara wasu tsarin tsare sirri waɗanda ke amfani da sabobin tsakiya kawai don sadarwa (duba sashe a ƙasa).
A Koriya ta Kudu, an yi amfani da tsarin bin diddigin lambobin sadarwa wanda ba ya amfani da aikace-aikace a matsayin tushen.
Maimakon amfani da aikace-aikacen musamman, tsarin ya tattara bayanan sa ido daga tushe daban-daban, gami da bayanan sa ido na na'urorin hannu da ma'amaloli na katin, sannan ya haɗa su don ƙirƙirar sanarwar saƙon rubutu da aka aika wa waɗanda ke da yiwuwar kamuwa da cutar.
Gwamnati ba wai kawai ta yi amfani da wannan bayanin ba ne wajen gargadi 'yan kasa game da yiwuwar hulda da mutanen da ke dauke da cutar, amma kuma ta sanya bayanin wurin da suke a fili, saboda canje-canje masu yawa a dokokin kare bayanai da aka yi bayan barkewar cutar MERS a kasar.
Ana iya samun damar wannan bayanin ta hanyar aikace-aikace da shafukan yanar gizo. Kasashe, ciki har da Jamus, suna la'akari da amfani da tsarin da aka daidaita da kuma tsarin tsare sirri.
Har zuwa ranar 6 ga Afrilu, 2020 ba a bayyana cikakken bayani ba.
Binciken tuntuɓar sirri  yana da tsayayyen ra'ayi, tare da babban adadin wallafe-wallafen bincike wanda ya fara aƙalla 2013.
Duk da haka, PEPP-PT samfurin ne na kokarin daidaitawa wanda ya hada da tsarin tsakiya da kuma rarraba, kuma ba yarjejeniya ɗaya ba ce. Yarjejeniyar rarraba sun hada da rarraba bayanan sirri (DP-PPT/DP-3T), lambobin tuntuɓar lokaci (TCN, fka Contact EventNumbers, CEN), ladabi don tabbatar da tsare sirri, hanyoyin da za a bi don wayar salula (PACT) da sauransu.
Waɗannan hanyoyin suna tabbatar da cewa bayanan sirri ba su taɓa barin na'urar ba kuma duk abubuwan da aka yi daidai suna faruwa a kan na'urar.
The Privacy Group, MIT Media Lab suna ci gaba da samar da SafePaths, wani dandamali na tsare sirri da ke tattara da kuma amfani da bayanai game da wurin da kake ko kuma hanyar da kake bi don bin hanyar yaduwar COVID-19.
Aikin wannan dandamali ya dogara ne akan binciken da aka kawo a cikin takaddar Apps Gone Rogue: Maintaining Personal Privacy in an Epidemic (Apps Gone Rogue: Maintaining Personal Privacy in an Epidemic), wanda aka buga a watan Maris na 2020. Wani irin wannan aikin shine dandamali na SafeTrace, wanda Enigma MPC, kamfanin haɓaka fasahar tsare sirri, wanda kuma ya kafa MIT Media Lab.
SafeTrace tana amfani da ingantacciyar fasahar kayan aiki da ke ba masu amfani damar raba bayanan sirri game da wurin zama da kuma lafiyarsu tare da sauran masu amfani da jami'ai ba tare da sanya sirrin waɗannan bayanan cikin haɗari ba.
A ranar 5 ga Afrilu, 2020, ƙungiyoyi masu irin wannan tsarin da kuma amfani da irin wannan yarjejeniya sun kafa TCN Global Coalition, wanda burinsa shine  rage rarrabuwa da kuma tabbatar da daidaiton aikace-aikacen sa ido da faɗakarwa na duniya, wanda shine mabuɗin don yaduwar su.
A ranar 9 ga Afrilu, 2020, gwamnatin Singapore ta sanar da cewa ta buɗe lambar tushe ta BlueTrace da ake amfani da ita don gudanar da aikace-aikacen hukuma.
A ranar 10 ga Afrilu, 2020, Google da Apple, kamfanonin da ke kula da ayyukan dandamali na wayar hannu na Android da iOS, sun sanar da wani shiri na bin diddigin lambobin sadarwa, wanda suka yi ikirarin zai tabbatar da sirrin, kuma wanda ke da alaƙa da haɗin fasahar Bluetooth Low Energy da kuma ɓoye ɓoye don kiyaye sirrin.
Sun kuma wallafa takamaiman fasahohin fasahohin da ake amfani da su wajen aiki da tsarin.
A cewar Apple da Google, tsarin zai kasance a matakai uku:
tura kayan aiki da za su baiwa gwamnatoci damar samar da manhajoji na hukuma don bin diddigin zirga-zirgar mutanen da suka kamu da cutar korona, amma tare da kiyaye bayanan sirri
Ta hanyar haɗa wannan fasalin kai tsaye a cikin iOS da Android, Google da Apple suna shirin magance matsalolin sa ido na yau da kullun ta hanyar fara shigar da tsarin ta hanyar sabunta tsarin aiki, sannan kuma cire shi ta wannan hanyar bayan barazanar ta ɓace.
Sake sanya magani (wanda kuma aka sani da sake tsarawa, sake turawa, sake aiki ko sake tura magunguna)  shine sake tsara maganin da aka amince dashi don magance cutar ko yanayin kiwon lafiya wanda ya bambanta da cutar da aka tsara tun farko.
Wannan wani yanki ne na bincike wanda ake amfani da shi a yanzu don samar da hanyoyin lafiya da kuma ingantaccen maganin COVID-19.
Sauran hanyoyin bincike sun hada da samar da allurar rigakafin COVID-19 da kuma zubar da jini da ke dauke da maganin cutar. SARS-CoV-2 yana dauke da wasu sunadarai 66 da ke iya shafar magunguna, kowannensu yana da yankuna masu ɗaure ligand da yawa.
Binciken waɗannan wuraren haɗin yana aiki a matsayin kyakkyawan tushe don haɓaka ingantaccen maganin rigakafin kwayar cutar COVID-19.
Mafi mahimman sunadarai masu niyya ga SARS-CoV-2  papain-kamar protease, RNA-dangane da RNA-polymerase, helica, S protein da ADF-ribophosphate.
Hussein AA da abokan aikinsa a cikin binciken su na farko sun bincika mahaɗan 'yan takara da yawa, waɗanda aka inganta su, kuma suka bincika kamaninsu na tsari tare da magungunan da aka amince da su don hanzarta haɓaka ingantaccen magani akan SARS-CoV-2 wanda za a ba da shawarar don gwajin asibiti.
Chloroquine magani ne na cutar zazzabin cizon sauro, wanda kuma ake amfani da shi wajen maganin wasu cututtukan da ke saurin kamuwa da cutar.
A ranar 18 ga watan Maris, WHO ta sanar da cewa chlorohine da hydroxychloroquin da ke da nasaba da shi za su kasance cikin magunguna huɗu da ake bincika a cikin gwajin asibiti na  Solidarity .
Gwamnan New York Andrew Cuomo ya sanar da cewa za a fara gwajin chlorohine da hydroxychloroquine a jihar New York a ranar 24 ga Maris. A ranar 28 ga Maris, FDA ta ba da izinin amfani da hydroxychloroquine sulfate da chlorohine phosphate a ƙarƙashin izinin gaggawa na amfani (EUA).
Ba a amince da tsarin maganin ba a cikin tsarin gwajin asibiti na FDA kuma an ba da izini ne kawai a ƙarƙashin EUA a matsayin magani na gwaji don gaggawa a cikin marasa lafiya waɗanda ke asibiti amma ba za su iya samun magani a cikin tsarin gwajin asibiti ba.
CDC ta ce ba a riga an kafa yadda za a yi amfani da, sashi ko tsawon lokacin shan hydroxychloroquine don rigakafi ko maganin cutar SARS-CoV-2 ba.
Likitoci sun ce suna amfani da maganin ne idan ba su da wani zaɓi.
Wata ƙungiyar bincike ta Turkiya a Istanbul tana gudanar da wani karamin bincike game da amfani da chlorohine tare da zinc da bitamin A, C da D.
Ana gudanar da bincike mai yawa a Jami'ar Duke da kuma Jami'ar Oxford.
Makarantar Kiwon Lafiya ta Jami'ar New York a Langone tana nazarin yadda za a iya yin amfani da maganin da ake kira hydroxychloroquine don hana cutar.
Gwaje-gwajen asibiti na kasar Sin a Wuhan da Shenzhen sun nuna cewa favipirovir yana da tasiri sosai.
A Shenzhen, marasa lafiya 35 da suka sha maganin sun sami sakamako mara kyau bayan kwanaki 4 a matsakaici, yayin da marasa lafiya 45 da ba su sha maganin ba suka yi kwanaki 11 da rashin lafiya.
A Wuhan, an gudanar da bincike, inda aka lura da marasa lafiya 240 da ke fama da ciwon huhu, rabin su sun sha maganin favipiravir, sauran rabin kuma sun sha maganin  umfenvir.
Hukumar magunguna ta Italiya ta tunatar da jama'a cewa sakamakon da ke nuna ingancin maganin ba shi da yawa kuma bai kamata a ɗauka cewa ya zama na ƙarshe ba.
A ranar 2 ga Afrilu, Jamus ta sanar da cewa za ta sayi maganin daga Japan don sake cika kayayyakinta, kuma don isar da shi zuwa asibitocin jami'a, inda za a yi amfani da maganin don kula da marasa lafiya da COVID-19, za ta yi amfani da albarkatun soja.
Jaridar South China Morning Post ta ruwaito cewa Shinzo Abe ya sanar da gwamnatin Trump cewa zai iya sayen maganin, wanda zai iya zama mai rauni a cikin cututtukan da suka fara.
Amfani da shi na iya zama da hadari ga mata masu juna biyu ko kuma ga mata masu kokarin yin ciki.
Wani bincike da aka yi a kan maganin rigakafin cutar lopinavir da ritonavir (Kaletra), ya nuna cewa ba a gano amfanin maganin ba.
An tsara maganin don hana kwayar cutar HIV ta hanyar haɗuwa da protease.
Wata ƙungiyar masu bincike daga Jami'ar Colorado suna ƙoƙarin gyara magunguna don gano mahaɗin da zai haɗa da protease na SARS-CoV-2.
Hukumar lafiya ta duniya ta hada maganin lopinavir da ritonavir a gwajin duniya na "Solidarity".
An kirkiro Remdecivir kuma an tsara shi ta Gilead Sciences don maganin cutar Ebola da cututtukan Marburg. Daga baya, ma'aikatan Gilead Sciences sun gano cewa Remdecivir yana da aikin rigakafin kwayar cuta a cikin vitro game da yawancin phyllo, pneumonia, paramyxovirus da coronavirus.
Wata matsala da ke tattare da maganin cutar ita ce, ƙin kamuwa da ƙwayoyin cuta ta hanyar maye gurbi da ke iya haifar da cututtuka masu tsanani da kuma yaduwarsu.
Wasu binciken farko na farko sun nuna cewa remdesivir na iya samun babbar shinge ta kwayoyin halitta don juriya. Ana gudanar da gwaje-gwaje na asibiti da yawa, ciki har da biyu da aka gudanar a asibitocin Jami'ar Cleveland; ana gudanar da daya a kan marasa lafiya tare da yanayin rashin lafiya, kuma wani  a kan marasa lafiya tare da mafi munin nau'in cutar.
A yanzu haka ana gudanar da gwaje-gwaje uku na asibiti na shan bitamin C a cikin jijiya ga mutanen da ke asibiti da cutar COVID-19 mai tsanani: gwaje-gwaje biyu da ake sarrafa su da maganin placebo (China, Kanada) da kuma guda ɗaya da ba a yi amfani da maganin placebo ba (Italiya).
A ranar 24 ga Maris, 2020, an fara gwajin maganin rigakafin azitromycin a jihar New York.
Cibiyar Kula da Lafiya da Magunguna ta Duniya ta Japan (NCGM) na shirin gudanar da gwajin asibiti na Alvesco (cyclesonide) Teijin, maganin cututtukan zuciya na numfashi don maganin asma, don amfani da shi wajen kula da marasa lafiya masu cutar coronavirus.
Ana gudanar da gwajin mataki na II, nau'in angiotensin-converting enzyme 2, tare da halartar marasa lafiya 200 daga Denmark, Jamus da Austria, waɗanda ke asibiti tare da mawuyacin yanayin cutar, don sanin tasirin magani.
Masu bincike daga Cibiyar Kula da Cututtukan Zuciya ta Montreal, Kanada, a yanzu suna nazarin matsayin colchicine wajen rage kumburi da rikitarwa na huhu a cikin marasa lafiya da ke da alamun COVID-19 marasa ƙarfi.
An gayyaci manya 6,000 masu shekaru 40 zuwa sama da aka gano suna da COVID-19 don binciken da ake kira COLCORONA, waɗanda ke da ƙananan alamun da ba sa bukatar a kwantar da su a asibiti.
Mata masu juna biyu, masu shayarwa, da waɗanda ba sa amfani da maganin hana haihuwa mai inganci ba, ba za su iya shiga wannan bincike ba.
A Italiya, an gwada wasu ƙwayoyin cuta da yawa.
Ana amfani da ƙananan ƙwayar heparin don kula da marasa lafiya, wanda ya sa Hukumar Magunguna ta Italiya ta buga shawarwari game da amfani da wannan magani.
A ranar 14 ga Afrilu a Italiya an sanar da wani bincike mai cibiyoyi da yawa tare da halartar marasa lafiya 300, wanda aka keɓe don nazarin amfani da sodium enoxaparin a cikin rigakafi da maganin magani.
Tunda SARS-CoV-2 kwayar cuta ce, an mai da hankali sosai kan sake tsara magungunan rigakafin cutar da aka amince da su, waɗanda aka tsara don annoba ta baya kamar MERS, SARS da cutar West Nile.
Ribavirin: an bada shawarar ribavirin don maganin COVID-19 bisa ga fitowar ta 7 na shawarwarin kasar Sin.
Umfenovir: an bada shawarar umfenovir don maganin COVID-19 bisa ga fitowar ta 7 na shawarwarin kasar Sin
Wasu maganin rigakafi da aka gano suna da yiwuwar amfani da su a matsayin maganin COVID-19:
Tocilizumab (mai karɓar IL-6): an amince da shi a China.
Har ila yau, gwaji a Italiya da China, duba Tocilizumab#COVID-19.
Allurar rigakafin COVID-19  allurar rigakafin cutar korona ta 2019 ce (COVID-19).
Duk da cewa babu wani allurar rigakafin da ya wuce gwajin asibiti, ana ci gaba da yin ƙoƙari da yawa na samar da irin wannan allurar.
A ƙarshen watan Fabrairun 2020, Hukumar Lafiya ta Duniya (WHO) ta ce ba ta tsammanin za a sami allurar rigakafin cutar SARS-CoV-2 ba sai bayan watanni 18.
A watan Afrilu, an yi gwajin lafiya na mataki na I a kan alluran rigakafi biyar.
An gano kwayar cutar COVID-19 a watan Disambar 2019.
A shekarar 2020, babban fashewar cutar ya bazu a duniya, wanda ya haifar da zuba jari mai yawa a cikin samar da allurar rigakafi da ayyukan bincike.
Ƙungiyoyi da yawa suna amfani da kwayoyin halitta da aka buga don samar da allurar rigakafin SARS-CoV-2.
Kamar yadda aka sanar a watan Afrilu, manyan manufofin shirin CEPI na samar da allurar rigakafi  shine samar da saurin da ake bukata, samar da karfin samarwa, turawa da kuma samun damar duniya.
A watan Afrilu, masana kimiyya na CEPI sun ba da rahoton cewa a farkon shekarar 2020, ana gudanar da bincike da kuma ci gaba kan dandamali daban-daban guda 10 na fasaha don samar da ingantaccen allurar rigakafin COVID-19.
Wasu manyan manufofin dandalin da aka haɗa a cikin binciken tsaro na Phase I:
nucleic acid (DNA da RNA) (mai haɓaka mataki na I da kuma samfurin-mai neman allurar rigakafi: Moderna, da kuma RNA-1273)
mai ɗaukar hoto na kwayar cuta (mai samar da mataki na I da kuma wanda zai iya ɗaukar maganin rigakafin: CanSino Biologics, mai ɗaukar hoto na kwayar cuta na nau'in 5)
Kamar yadda masana kimiyya na CEPI suka ruwaito a watan Afrilu, alluran rigakafi 115 suna cikin farkon matakin ci gaba, 78 daga cikinsu ana amfani da su a cikin ayyukan da aka amince da su (79, bisa ga bayanan Cibiyar Milken); ban da haka an bayyana game da ƙarin alluran rigakafi masu neman izini 37, amma akwai ɗan bayani kaɗan game da su (wanda ake tsammani suna cikin tsarin tsarawa ko ci gaba).
A matakai na I-II ana yin gwajin farko don aminci da rigakafi, yawanci bazuwar, ana sarrafa placebo kuma a wurare da yawa tare da ƙayyade lokaci ɗaya mafi daidaito da inganci.
Mataki na III na gwaji yawanci yana ɗaukar mahalarta da yawa, gami da ƙungiyar kulawa; a wannan matakin ana gwada magunguna don inganci a cikin rigakafin cutar kuma a lokaci guda ana lura da tasirin sakamako a mafi kyawun allurai.
Daga cikin alluran rigakafi 79 da ake ci gaba da samarwa (wanda aka tabbatar a farkon watan Afrilun 2020), 74 ba a gwada su a kan mutane ba tukuna (dukansu suna kan matakin binciken rigakafin.
A ranar 24 ga Janairu, 2020, Jami'ar Queensland, Ostiraliya, ta sanar da cewa tana binciken yiwuwar allurar rigakafin da ke da matsi na kwayoyin halitta, wanda ke canza kwayoyin kwayar cutar don motsa amsawar rigakafi.
A ranar 24 ga Janairu, 2020, Cibiyar rigakafin ƙasa da ƙasa (VIDO-InterVac) na Jami'ar Saskatchewan, Kanada, ta sanar da fara aikin yin rigakafin kanta da nufin fara gwajin ɗan adam a 2021.
An kuma sanar da fara ayyukan samar da allurar rigakafi a Cibiyar Kula da Cututtuka da Rigakafin Cutar Sin a ranar 26 ga Janairu, 2020 da kuma Jami'ar Hong Kong  a ranar 28 ga Janairu.
A ranar 29 ga Janairu, 2020, kamfanonin magunguna na Janssen karkashin jagorancin Hanneke Schwitmaker sun sanar da fara aikin samar da allurar rigakafin su.
Janssen tare da Vaxart abokin aikinsa na fasahar kere-kere suna samar da maganin rigakafin da za a iya sha ta baki.
A ranar 18 ga Maris, 2020, Emergent BioSolutions ta sanar da haɗin gwiwar samarwa tare da Vaxart don haɓaka allurar rigakafi.
A ranar 8 ga Fabrairu, 2020, dakin gwaje-gwaje na OncoGen a Romania ya wallafa takarda game da samar da allurar rigakafi bisa fasahar da ta yi kama da wadda ake amfani da ita wajen yin allurar rigakafin cutar kansa.
A ranar 25 ga watan Maris ne shugaban cibiyar binciken kimiyya ya sanar da kammala aikin samar da allurar rigakafin da kuma fara gwajin.
A ranar 27 ga Fabrairu, 2020, wani reshen Generex, NuGenerex Immuno-Oncology, ya sanar da cewa yana fara aikin samar da maganin alurar riga kafi na Ii-Key na COVID-19.
Manufarsu ita ce su samar da maganin da zai iya gwadawa a jikin mutane cikin kwanaki 90.
A ranar 5 ga Maris, 2020, Jami'ar Washington da ke St. Louis ta sanar da shirin samar da maganin rigakafin.
A ranar 5 ga Maris, 2020, Rundunar Sojojin Amurka ta Binciken Kiwon Lafiya da Kayan Aiki, Fort Detroit, da Cibiyar Nazarin Kimiyya ta Sojoji Walter Reed, Silver Spring, da ke yammacin Maryland, sun sanar da cewa suna samar da allurar rigakafin su.
A ranar 10 ga Maris, 2020, Emergent Biosolutions ta sanar da cewa ta shiga cikin kawance tare da Novavax Inc.
don samar da rigakafi.
Abokan hulɗa sun kuma sanar da shirin gudanar da gwajin rigakafin rigakafin da gwajin asibiti na mataki na I a watan Yulin 2020.
A ranar 12 ga Maris, 2020, Ma'aikatar Lafiya ta Indiya ta sanar cewa suna nazarin marasa lafiya 11 da aka ware, kuma cewa ko da a cikin hanzari, zai ɗauki aƙalla shekara ɗaya da rabi zuwa biyu don samar da allurar rigakafi.
A ranar 12 ga Maris, 2020, Medicago, wani kamfanin fasahar kere kere na Quebec, ya ba da rahoton cewa, tare da wani tallafi daga Cibiyar Nazarin Lafiya ta Kanada, sun kirkiro wani kwayar cutar da ta yi kama da cutar korona.
Ana gudanar da gwajin rigakafin a cikin dakin gwaje-gwaje, kuma an shirya yin gwajin a kan mutane a watan Yuli ko Agusta na shekarar 2020.
A farkon wannan makon jaridar The Guardian ta ruwaito cewa shugaban Amurka Donald Trump ya ba CureVac wadata mai yawa don samun damar yin allurar rigakafin Covid-19, abin da gwamnatin Jamus ta nuna adawa da shi.
A ranar 17 ga Maris na shekarar 2020, kamfanin magunguna na Amurka Pfizer ya sanar da cewa ya kulla kawance da kamfanin BioNTech na Jamus don hada kai wajen samar da allurar rigakafi bisa iRNA.
BNT162 ɗan takara ne don allurar rigakafin iRNA; a halin yanzu ana yin gwajin rigakafin rigakafin kafin asibiti, kuma za a fara gwajin asibiti a watan Afrilu na 2020.
A ranar 17 ga Maris, 2020, Kamfanin Takis Biotech na Italiya ya sanar da cewa zai samu sakamakon gwajin rigakafin a watan Afrilu na shekarar 2020, kuma za a iya fara gwajin rigakafin su na ƙarshe a kan mutane a kaka.
A ranar 19 ga Maris, 2020, Coalition for Innovation in the Field of Epidemic Preparedness (CEPI), Faransa, ta sanar da saka hannun jari na dala miliyan 4.9 a cikin ƙungiyar haɗin gwiwar don haɓaka allurar rigakafin COVID-19 tare da haɗin gwiwar Cibiyar Pasteur, Themis Bioscience (Vienna, Austria) da Jami'ar Pittsburgh.
Sauran abokan zuba jari na CEPI a cikin samar da allurar rigakafin COVID-19 su ne Moderna, Curevac, Inovio, Novavax, Jami'o'in Hong Kong, Oxford da Queensland.
A ranar 20 ga Maris, 2020, jami'an kiwon lafiya na Rasha sun sanar da cewa masana kimiyya sun fara gwajin allurar rigakafi daban-daban guda shida a kan dabbobi.
Masu bincike a kwalejin Imperial College, London, sun sanar a ranar 20 ga Maris, 2020, cewa suna samar da rigakafin RNA mai kara girman kanta daga COVID-19.
An samar da maganin rigakafin ne cikin kwanaki 14 bayan an samu jerin kwayoyin daga China.
A ƙarshen Maris, gwamnatin Kanada ta sanar da bayar da dala miliyan 275 na Kanada don tallafawa ayyukan bincike 96 kan magungunan maganin COVID-19, ciki har da haɓaka magungunan rigakafi da yawa a kamfanoni da jami'o'in Kanada, kamar Medicago Initiative da Jami'ar Saskatchewan.
A daidai wannan lokacin ne gwamnatin Kanada ta sanar da ware dala miliyan 192 na Kanada musamman don samar da allurar rigakafin COVID-19, da kuma shirin kafa wani banki na allurar rigakafi na kasa, wanda zai hada da sabbin alluran rigakafi da za a iya amfani da su idan aka sake barkewar cutar coronavirus.
A ranar 2 ga Afrilu, 2020, masu bincike daga Makarantar Likita ta Jami'ar Pittsburgh sun ba da rahoton gwajin PittCoVacc, yiwuwar allurar rigakafin COVID-19 a kan beraye, suna cewa MNA ta gabatar da allurar rigakafin SARS-CoV-2 S1 na ƙananan rukuni, yana haifar da amsawar ƙwayoyin cuta na musamman na antigen [a cikin beraye] waɗanda suka bayyana makonni 2 bayan rigakafin.
A ranar 16 ga Afrilu, 2020, Makarantar Magunguna ta Jami'ar Waterloo ta Kanada ta sanar da cewa tana samar da yiwuwar allurar rigakafin DNA, wanda wataƙila za a samar da shi a cikin nau'in hanci.
DNA za ta iya yin amfani da kwayoyin halittar kwayoyin halittar mutum don yin kwayar cutar da ba ta da lahani, wadda za ta iya motsa tsarin garkuwar jiki don samar da kwayoyin cutar SARS-CoV-2.
A watan Maris na shekarar 2020, gwamnati, masana'antu da jami'o'i uku na Amurka sun hada albarkatun IBM na manyan kwamfutoci tare da albarkatun girgije na Hewlett Packard Enterprise, Amazon, Microsoft da Google.
Wasu alluran rigakafi suna da sakamako na al'ada, wanda ake kira sakamako marar takamaiman abu.
Wannan yana nufin cewa suna iya samun wasu fa'idodi ban da rigakafin cututtuka.
Wani bincike kuma da aka yi a Australia ya shafi ma'aikatan kiwon lafiya 4,170.
Magungunan rigakafin da ake samarwa na iya zama marasa lafiya ko kuma marasa tasiri.
Bincike na farko na kimanta ingancin allurar rigakafi ta amfani da samfurin dabbobi da ke nuna COVID-19, kamar su ACE2-transgenic mice, sauran dabbobi masu gwaji, da ƙananan dabbobi, ya nuna bukatar matakan hana kamuwa da cutar tare da matakin biosafety 3 a lokacin sarrafa ƙwayoyin cuta masu rai, da kuma daidaita matakan tsaro na duniya.
An gwada allurar rigakafin SARS da MERS a kan dabbobi.
Har zuwa shekarar 2020, babu wani magani ko rigakafin da zai iya magance cutar SARS da zai kasance lafiya da kuma tasiri ga mutane.
Bisa ga binciken da aka buga a shekarar 2005 da 2006, ganowa da kuma samar da sabbin alluran rigakafi da magunguna don maganin cutar huhu ta atypical ya kasance babban fifiko ga gwamnatoci da cibiyoyin kiwon lafiya a duk duniya.
Lokacin da cutar MERS ta fara yaduwa, an yi imanin cewa binciken SARS da ake yi a lokacin zai iya zama misali don samar da allurar rigakafi da hanyoyin warkarwa da za a iya yi wa cutar MERS-CoV.
Ya zuwa Maris 2020, akwai rigakafin MERS guda ɗaya (wanda ya dogara da DNA) wanda ya wuce matakin gwaji na farko a kan mutane, da kuma ƙarin rigakafi uku, duk sun kasance allurar rigakafin ƙwayar cuta kuma suna cikin aikin haɓaka, biyu  adenovirus (ChAdOx1-MERS, BVRS-GamVac) da ɗaya  MVA-vector (MVA-MERS-S).
An yada ra'ayin maƙarƙashiya a shafukan sada zumunta cewa cutar COVID-19 ba sabon abu ba ne kuma riga an riga an sami maganin rigakafinta.
Shafukan sada zumunta sun nakalto wasu marasa lafiya da ke ikirarin cewa akwai takardun shaida kan jerin kwayoyin wasu nau'in cutar coronavirus, kamar SARS, da kuma alluran rigakafin wadannan nau'in.
Coronavirus  cuta ce da aka gano a shekarar 2019 (COVID-19), cuta ce mai yaduwa da cutar coronavirus 2 (SARS-CoV-2) ta haifar.
Alamun da suka fi yawa sun haɗa da zazzabi, tari da wahalar numfashi.
Wasu alamun na iya haɗa da gajiya, ciwon tsoka, zawo, ciwon makogwaro, rashin jin ƙanshi, da kuma ciwon ciki.
Lokaci daga bayyanar cututtuka zuwa lokacin da cutar ta fi tsanani yawanci kwanaki biyar ne, amma kuma zai iya bambanta daga kwana biyu zuwa goma sha huɗu.
Yawancin lokuta ana samun saukin bayyanar cututtuka, amma a wasu lokuta cutar tana kaiwa ga cutar huhu da kuma rashin isasshen kwayoyin.
A ranar 17 ga Afrilu, 2020, an samu fiye da mutane miliyan 2.24 da suka kamu da cutar a kasashe da yankuna 210, kuma sama da mutane 153,000 sun mutu sakamakon cutar.
Fiye da mutane 568,000 sun warke. Ana yaduwar cutar ne ta hanyar kusanci da mutane, sau da yawa ta hanyar ƙananan ƙwayoyin da ke fitowa cikin iska lokacin da mutum ya yi tari, ya yi fitsari, ko kuma ya yi magana.
Ko da yake ana samun waɗannan ɗigon sa'ad da mutum ya sha iska, amma yawanci suna iya zama barazana idan suka faɗa ƙasa ko kuma a saman ƙasa, amma ba a isar da su daga iska a nesa mai nisa.
Mutane kuma suna kamuwa da cutar ta wurin taɓa gurɓataccen wuri, sannan su taɓa idanunsu, hanci, ko kuma bakinsu.
Kwayar cutar za ta iya rayuwa na tsawon sa'o'i 72 a saman ƙasa.
Yana da mafi yawan kwayar cuta a cikin kwanaki uku na farko bayan bayyanar cututtuka, kodayake yana iya yaduwa a cikin bayyanar cututtuka da kuma a cikin matakan da suka gabata.
Ana ba da shawarar yin amfani da abin rufe fuska ga marasa lafiya da ake zargi da cutar, da kuma waɗanda suke kula da su.
Shawarwari game da amfani da abin rufe fuska na likita sun bambanta: wasu hukumomi sun bada shawarar kada a yi amfani da su, wasu sun bada shawarar yin amfani da su, wasu kuma sun bukaci a yi amfani da su.
A halin yanzu babu allurar rigakafi ko magani na musamman na cutar COVID-19.
An samu yaduwar cutar a mafi yawan ƙasashe a duk yankuna shida na WHO.
Waɗanda suka kamu da cutar ba su da wata alama ko kuma suna da alamun mura kamar zazzabi, tari, gajiya, da kuma rashin numfashi.
Alamun gaggawa sun haɗa da wahalar numfashi, ciwon zuciya ko ƙuntatawa, rikicewar hankali, wahalar farkawa, fuska ko lebe sun yi ja; idan akwai alamun da aka ambata a sama, ya kamata a nemi taimakon likita nan da nan.
Ba za a iya samun alamun ciwon na sama ba, kamar tari, hanci da ciwon makogwaro.
Ƙari ga haka, ana samun cututtuka na ciki da ciki kamar su rashin jin daɗi da amai da kuma zawo a wurare dabam dabam.
Wasu cututtuka da aka samu a ƙasar Sin sun nuna cewa suna jin ƙyar a ƙirjinsu da kuma bugun zuciya.
A wasu lokatai, cutar tana iya ci gaba zuwa ciwon huhu, rashin ƙarfi na gabobin jiki da yawa, kuma a ƙarshe mutuwa.
Ana kiran wannan lokacin lokacin da ake hawansa.
Lokacin da COVID-19 ke kwance yawanci kwana biyar zuwa shida ne, amma zai iya bambanta daga kwana biyu zuwa 14.
A cikin kashi 97.5 na mutane, alamun cutar na bayyana a cikin kwanaki 11.5 bayan kamuwa da cutar.
Ba a san ainihin matsayin waɗannan masu cutar ba a hanyar watsa cutar, amma binciken farko ya nuna cewa suna iya taimakawa wajen yaduwar cutar.
Ba a san yawan mutanen da ke kamuwa da cutar ba tare da bayyanar cutar ba, kuma ana ci gaba da bincike; yayin da Cibiyoyin Kula da Cututtuka da Cututtuka na Koriya (KCDC) suka ba da rahoton cewa kashi 20% na duk waɗanda aka tabbatar da su da kuma asibitocin da ke dauke da cutar ba su da alamun cutar.
Hukumar Lafiya ta Kasa ta kasar Sin ta fara hada wadanda ba su da alamun cutar a cikin rahoton ta na yau da kullum tun daga ranar 1 ga watan Afrilu; daga cikin mutane 166 da suka kamu da cutar a wannan rana, 130 (78%) sun ki su kasance marasa alamun cutar a lokacin gwajin.
Za a iya samun ƙwayoyin cuta a cikin hanci da kuma cikin hanci.
Sa'ad da ake magana da ƙarfi, ana fitar da ɗigo mai yawa fiye da sa'ad da ake magana da ƙarfi.
Wani bincike da aka yi a Singapore ya nuna cewa idan mutum ya yi tari a fili, raunin zai iya kaiwa nesa mai nisan mita 15.
Kwayar cutar ba ta yaduwa ta iska, amma National Academy of Sciences ta yi hasashen cewa ana iya yaduwar kwayar cutar ta hanyar bioaerosol, kuma gwajin iska da aka sarrafa ta hanyar masu tattara iska da ke cikin hanyoyin da ke wajen dakunan mutane ya nuna cewa akwai RNA na kwayar cutar.
Wasu hanyoyin kiwon lafiya kamar su intubation da kuma aikin numfashi na zuciya da huhu (CPR) na iya haifar da yayyafa abubuwan numfashi kuma, saboda haka, ya iya sa cutar ta yaɗu a cikin iska.
Akwai kuma fargabar cewa kwayar cutar za ta iya yaduwa ta hanyar najasa, duk da haka, ana ganin wannan hadarin ya yi kadan. Kwayar cutar ta fi yaduwa lokacin da mutane ke nuna alamun cutar; yaduwar kwayar cutar tana yiwuwa kafin bayyanar alamun cutar, amma wannan hadarin ba shi da yawa.
Ma'aikatan Cibiyar Kula da Cututtuka ta Turai (ECDC) sun ce ba a san yadda cutar ke yaduwa ba, amma an san cewa mutum ɗaya da ke da cutar yakan kamu da mutane 23 da suka kamu da ita.
Musamman, an gano cewa a kan takarda, kwayar cutar na iya rayuwa har tsawon yini guda, a kan filastik (polypropylene) da bakin karfe (AISI 304)  har zuwa kwana uku, kuma a kan kashi 99% na tagulla  har zuwa awanni 4.
Amma, waɗannan sun bambanta dangane da yanayin zafi da kuma zafin jiki.
Sabulu da kayan wanki idan aka yi amfani da su yadda ya kamata suna da amfani sosai wajen yaki da kamuwa da cuta: sabulu yana lalata fatar da ke kare kwayar cutar, ta haka yana kashe ta, kuma yana iya kawar da ita daga fatar fata da sauran wurare.
Wasu magunguna kamar su benzalkonium chloride da chlorhexidine gluconate (mai kashe cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan
A cikin marasa lafiya shida, biyar sun sami ƙwayoyin cuta mafi yawa a cikin jininsu a gwajin farko, kuma a cikin marasa lafiya shida, an samu ƙwayoyin cuta mafi yawa a cikin jinin su a rana ta biyu na gwajin.
Cutar coronavirus mai saurin kamuwa da cuta ta 2 (SARS-CoV-2)  sabuwar cuta ce ta coronavirus mai saurin kamuwa da cuta, wadda aka fara ganowa a cikin mutane uku da ke da ciwon huhu daga cikin mutanen da ke da cututtukan numfashi masu saurin kamuwa da cuta da aka samu a Wuhan.
Dukkanin alamun cutar SARS-CoV-2 na faruwa ne a cikin kwayar cutar korona da ke da nasaba da ita.
A waje da jikin mutum, ana kashe kwayar cutar ta hanyar sabulu da ake amfani da shi a gida, wanda ke buɗe garkuwar kariya. SARS-CoV-2 yana da alaƙa da asalin SARS-CoV.
Fuka-fukan  ne mafi saukin kamuwa da COVID-19, saboda kwayar cutar tana shiga cikin ƙwayoyin mahaifar ta hanyar enzyme mai canza angiotensin 2 (ACE2), wanda ya fi yawa a cikin ƙwayoyin alveolar na huhu na nau'in II.
Kwayar cutar tana haɗuwa da ACE2 kuma tana shiga cikin kwayar mai masaukin ta hanyar amfani da glikoprotein na sama  shipa (hawan ƙura).
Kashi 12 cikin 100 na mutanen da suka kamu da cutar da aka kwantar a asibiti a Wuhan, an gano su da ciwon zuciya mai tsanani, wanda ya fi faruwa a cikin mawuyacin hali.
Yawan cututtukan zuciya suna da yawa saboda tsarin kumburi da kuma rikicewar tsarin rigakafi da ake gani yayin ci gaban cutar, amma lalacewar myocardium na iya kasancewa tare da kasancewar masu karɓar ACE2 a cikin zuciya.
Ana samun masu karɓar ACE2 a cikin zuciya a adadi mai yawa domin suna da hannu a aikin wannan sashin.
An lura da yawan yawan kamuwa da jini (31%) da kuma yawan kamuwa da jini (25%) a cikin marasa lafiya da ke cikin OIT tare da COVID-19, kuma yana iya nuna rashin kyakkyawan hangen nesa. Autopsy na marasa lafiya da suka mutu daga COVID-19 ya nuna kasancewar lalacewar alveolar diffuse (DAD) da kuma lymphocyte-containing inflammatory infiltrates a cikin huhu.
Duk da cewa SARS-COV-2 yana da ƙarancin ƙarfi ga ƙwayoyin epithelial na numfashi waɗanda ke bayyana ACE2, marasa lafiya da ke da COVID-19 mai tsanani suna da alamun cutar mai saurin kumburi.
Musamman, an gano cewa kwayar cutar GM-KSF T-cell tana da alaƙa da daukar IL-6 mai ƙonewa da kuma mummunar cutar huhu a cikin marasa lafiya da COVID-19.
An kuma gano wasu ƙwayoyin cuta masu shiga cikin jiki a jikinsa.
Hukumar ta WHO ta kuma wallafa wasu takardun gwaji game da cutar.
Haɗin polymer na ainihin lokacin (RT-PCR)  shine daidaitaccen hanyar gwaji.
Ana yin gwajin ne a kan samfurin numfashi da aka samu daga hanci da hanci, amma ana iya yin amfani da samfurin hanci ko kuma ƙura.
Sakamakon zai kasance a shirye cikin sa'o'i da yawa zuwa kwana biyu.
Za ka iya yin gwajin jini, amma ana bukatar a yi gwajin jini sau biyu a mako biyu, kuma sakamakon ba shi da muhimmanci.
Masana kimiyya na kasar Sin sun gano kwayar cutar korona kuma sun wallafa jerin kwayoyinta domin masana kimiyya a dakunan gwaje-gwaje a duniya su samar da gwajin polymerase chain reaction (PCR) don gano cutar.
A ranar 4 ga Afrilu, 2020, ana kan samar da gwajin rigakafi da zai iya gano cutar a yanzu, da kuma yiwuwar kamuwa da cutar a baya, amma ba a riga an ba da shi ba.
Kwarewar kasar Sin ta nazarin sakamakon gwajin ya nuna cewa daidaito na kashi 60 zuwa 70 ne kawai.
A ranar 21 ga watan Maris na shekarar 2020, Hukumar Kula da Abinci da Magunguna ta Amurka (FDA) ta amince da gwajin farko na gano cutar a kan tabo, inda ta ba da izinin amfani da shi a karshen wannan watan.
Abubuwan da ke tattare da su na biyu na biyu na nau'in matate glass tare da rarrabawar gefen, asymmetric da kuma posterior  sune alamun bayyanar cututtuka da aka gano a farkon matakin cutar.
Subpleural domination, alamar alamar dutsen dutse (daɗaɗɗen tsayi na tsayi tare da canzawar alveolar cika) da kuma ƙarfafawa suna tasowa yayin da cutar ta ci gaba.
Ba a samu bayanai masu yawa game da cutar COVID-19 da kuma cutar.
Babban sakamakon binciken cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut
Maganin makirci: ciwon zuciya, ciwon zuciya, kumburi da kumburi
Za a iya lura da nau'o'i hudu na cutar huhu ta kwayar cuta:
nau'i mai sauƙi na ciwon huhu: kumburi na huhu, hyperplasia na pneumocytes, manyan atypical pneumocytes, interstitial kumburi tare da lymphocytic infiltration da kuma samuwar giant cell mai yawa
mummunar nau'in ciwon huhu: lalacewar alveolar diffuse (DAD) tare da ɓarkewar alveolar diffuse.
DAD ita ce sanadin cututtukan numfashi na gaggawa (ARDS) da kuma matsanancin rashin lafiya.
ciwon huhu mai warkewa: an samu ɓarna a cikin alveolar cavities da kuma ciwon huhu na interstitial fibrosis.
Jini: ƙuƙwalwar jijiyoyin jini (DVS-syndrome); halayen leukocytosis
Matakan rigakafi na rage yiwuwar kamuwa da cutar sun hada da zama a gida, guje wa wuraren jama'a, wanke hannuwanka da sabulu da ruwa na tsawon sakan 20, kiyaye tsaftace numfashi, da kuma guje wa taɓa idanu, hanci, ko baki da hannayen da ba a wanke ba.
CDC ta ba da shawarar rufe baki da hanci da tawul lokacin da kake tari ko hancinka, ko kuma idan babu tawul, rufe baki da hanci da ciki na cinya.
Ana ba da shawarar yin tsabtace hannu bayan tari ko hancin.
Cibiyar Kula da Cututtuka da Rigakafin Cutar (CDC) ta ba da shawarar yin amfani da abin rufe fuska a wuraren jama'a, musamman don iyakance yaduwar kamuwa da cutar daga mutanen da ba su da alamun cutar. Dabaru na nisantar da jama'a suna nufin rage hulɗa tsakanin marasa lafiya da manyan rukuni na mutane; a cikin waɗannan matakan an rufe makarantu da kamfanoni, an iyakance motsi na jama'a, kuma an soke manyan taron jama'a.
Shawarwarin nesa kuma sun nuna cewa mutane su kasance a nesa da juna na aƙalla ƙafa 6 (1.8 m).
Babu wani magani da aka tabbatar yana da tasiri akan COVID-19. Tun da ba a sa ran kammala aikin allurar rigakafin kafin shekarar 2021, yawancin matakan da ake dauka kan yaduwar COVID-19 sun ta'allaka ne ga rage yawan annobar da aka sani da "fitowa daga tudu".
CDC ta kuma ba da shawarar wanke hannaye da sabulu da ruwa aƙalla na dakika 20, musamman bayan zuwa bayan gida ko kuma idan hannayenka sun yi datti sosai, kafin cin abinci da kuma bayan yin hancinka, tari ko hancinka.
CDC ta kuma ba da shawarar yin amfani da maganin kashe wuka (abin da ke dauke da barasa  aƙalla 60%) don tsabtace hannu, amma kawai a lokuta da sabulu da ruwa ba su da wadatar. Ga yankunan da ba a sayar da irin waɗannan magungunan kashe wuka, WHO tana ba da takardun magani guda biyu don samar da gida.
Ana amfani da ethanol ko isopropanol a cikin waɗannan abubuwan da ke da tasirin ƙwayoyin cuta.
Ana amfani da hydrogen peroxide don kawar da ƙwayoyin cuta a cikin barasa kuma ba shi da kyau don maganin maganin maganin hannu.
Ana ƙara glycerol a matsayin mai danshi.
Ana ba marasa lafiya magani na tallafi, wanda zai iya haɗa da maganin jini, taimakon iskar oxygen, da kuma taimakon sauran gabobin da suka kamu da cutar.
CDC ta ba da shawarar cewa duk wanda ya yi zaton cewa yana da cutar ya sa abin rufe fuska na al'ada.
An yi amfani da maganin oxygen na waje da jiki (ECMO) don magance matsalar rashin numfashi, amma har yanzu ana binciken amfaninsa.
Don ƙarfafa rigakafi, ana ba da shawarar kiyaye ƙa'idodin tsabtar mutum, salon rayuwa mai kyau da abinci.
Za a iya ba da hanyoyin tallafi ga marasa lafiya da ke da alamun cutar a farkon matakan cutar. WHO da Hukumar Lafiya ta China sun wallafa shawarwari kan kula da marasa lafiya da ke asibiti da COVID-19.
A Amurka, likitocin kulawa mai tsanani da masu ilimin ciwon huhu sun tattara shawarwarin magani daga cibiyoyi daban-daban a cikin  IBCC.
Har zuwa watan Afrilu na shekarar 2020, babu wani magani na musamman na COVID-19.
Don magance alamun cutar a matsayin maganin farko, wasu ma'aikatan kiwon lafiya suna ba da shawarar zaɓar paracetamol (acetaminophen) maimakon ibuprofen.
Idan ana yin wani abu da zai iya sa mutum ya yi iska, kamar yin intubation ko bushe hannu, ya kamata a yi amfani da matakan tsaro don rage yiwuwar kamuwa da cutar, musamman a wuraren kiwon lafiya.
CDC ta ba da shawarar cewa ma'aikatan kiwon lafiya da ke kula da mutanen da ke da COVID-19 su sanya su a cikin keɓewar iska (AIIR)  ƙarin matakin ban da na yau da kullun na hulɗa da iska. CDC ta buga shawarwari kan amfani da kayan kariya na mutum (SIP) yayin annobar.
Abubuwan da ake ba da shawara na kariya na mutum: rigar kariya, na'urar numfashi ko abin rufe fuska, kayan kariya na ido da safofin hannu na likita. Daga cikin abubuwan da aka lissafa a sama, ya fi kyau a yi amfani da na'urar numfashi maimakon abin rufe fuska na likita.
An amince da masu numfashi na N95 don amfani a masana'antu, amma FDA ta ba da izinin amfani da waɗannan masu numfashi a ƙarƙashin izinin gaggawa don amfani (EUA).
An tsara su ne don su kāre su daga ƙwayoyin halittar iska kamar ƙura, amma idan ba a yi amfani da su yadda aka umurce su ba, ba a tabbatar da cewa za su iya kāre su daga wani takamaiman abu mai guba ba.
Idan ba a iya samun abin rufe fuska na likita ba, CDC ta ba da shawarar yin amfani da abin rufe fuska ko kuma a matsayin mafi muni, yin abin rufe fuska da kanka a gida.
A mafi yawan lokuta, nau'in COVID-19 ba shi da tsanani da zai sa a yi amfani da iska mai guba ko kuma wani abu dabam, amma akwai wasu lokuta da ake bukatar yin hakan.
Ana nazarin irin taimakon numfashi na marasa lafiya da ke asibiti da ke fama da rashin numfashi da ke da nasaba da COVID-19, tare da wasu shaidu da ke nuna cewa ana iya guje wa intubation ta hanyar amfani da oxygen na hanci tare da iska mai ƙarfi ko kuma matsin lamba mai kyau na biyu a cikin hanyoyin numfashi.
Ba a san ko ko ɗaya daga cikin waɗannan hanyoyin biyu yana da tasiri kamar yadda maganin IUD yake a cikin marasa lafiya masu ciwo mai tsanani ba.
Wasu likitoci suna yin zaɓi don yin amfani da iska mai guba na iska idan akwai, saboda wannan hanyar tana iyakance yaduwar ƙwayoyin cuta a cikin iska idan aka kwatanta da hanci mai zurfi. Hadarin mummunan nau'in cutar ga tsofaffi (waɗanda suka wuce shekaru 60, kuma musamman waɗanda suka wuce shekaru 80) sun fi girma.
Kasashe da yawa masu tasowa ba su da isassun gadajen asibiti a kowane mutum, kuma tsarin kiwon lafiya yana da iyakance don magance karuwar yawan kamuwa da cutar COVID-19 a cikin mawuyacin hali da ke buƙatar asibiti.
Wani bincike da aka yi a ƙasar Sin ya nuna cewa kashi biyar cikin ɗari na marasa lafiya da aka kwantar da su a asibiti suna bukatar kulawa sosai, kashi biyu bisa uku suna bukatar taimakon na'ura don su riƙa samun iska mai ƙarfi, kuma kashi ɗaya bisa huɗu sun mutu.
A China, kusan kashi 30 cikin dari na mutanen da aka kwantar da su a asibiti da COVID-19 suna zuwa asibiti na gaggawa.
Aikin samar da iska mai iska mai iska yana da wuya, saboda cutar COVID-19 da ke haifar da ciwon numfashi mai saurin ragewa (ARDS) da kuma iskar oxygen suna da matsala.
Ana buƙatar IVL tare da goyon bayan matsin lamba a numfashi da PDCV don isar da mafi yawan iskar oxygen zuwa huhu da kuma tabbatar da ƙarancin lalacewar su ta hanyar iska wanda zai iya haifar da pneumothorax.
A kan tsofaffin samfurin masu iska, ƙila ba za a iya samun babban ƙimar ƙarancin iska ba.
Binciken hanyoyin warkarwa ya fara ne a watan Janairun 2020, kuma a yanzu haka, an fara gwajin magungunan cutar da dama.
Remdesivir ne ke da amfani sosai.
Ana iya ci gaba da samar da sabbin magunguna har zuwa 2021, amma wasu daga cikin magungunan da ake gwadawa an riga an amince da su don wasu dalilai ko kuma suna cikin ƙarshen gwaji.
Ana iya gwada maganin rigakafin cutar a kan marasa lafiya da ke da ciwo mai tsanani.
Masu ba da gudummawa da WHO ta ba da shawarar suna shiga cikin gwajin inganci da amincin hanyoyin magani. FDA ta ba da izinin wucin gadi don amfani da plasma mai sakewa a matsayin magani na gwaji a lokuta inda rayuwar mutum ke cikin haɗari mai tsanani ko na kusa.
Ba a yi gwajin gwajin da ya kamata a yi don tabbatar da lafiyar magani ba.
A watan Fabrairun shekarar 2020, kasar Sin ta kaddamar da manhajar wayar salula da aka tsara don magance barkewar cutar.
Masu amfani suna bukatar su shigar da sunansu da lambar shaidarsu don shiga.
Aikace-aikacen zai iya gano "haɗuwa ta kusa" ta hanyar bayanan sa ido kuma, saboda haka, ƙayyade yiwuwar haɗarin kamuwa da cuta.
Kowane mai amfani zai iya duba matsayin wasu masu amfani uku.
Idan aka gano cewa akwai wata barazana, app ɗin ba wai kawai yana ba da shawarar keɓe kai ba ne, amma kuma yana aika da sanarwa ga hukumomin kiwon lafiya na gida. Ana amfani da nazarin manyan bayanai da aka tattara daga wayoyin hannu, fasahar gane fuska, bin diddigin wayoyin hannu da kuma ilimin kere kere  ana amfani da irin waɗannan kayan aikin don bin diddigin mutanen da ke da cutar da kuma mutanen da suka yi hulɗa da su a Koriya ta Kudu, Taiwan da Singapore.
A watan Maris na shekarar 2020, gwamnatin Isra'ila ta ba da izinin jami'an tsaro su bi bayanan wayar salula na mutanen da ake zargin suna dauke da cutar coronavirus.
An dauki matakai don samar da keɓewa da kariya ga mutanen da za su iya saduwa da mutanen da ke dauke da cutar.
Hakanan a watan Maris na shekarar 2020 don bincike da hana yaduwar kwayar cutar Deutsche Telekom ta ba da bayanan da aka tattara game da wurin da masu amfani da wayar salula suke a cikin gwamnatin tarayya ta Jamus da Cibiyar Robert Koch.
A Rasha, an gabatar da fasahar gane fuska don gano masu keta dokar keɓewa.
Jami'in kula da lafiyar yankin Italiya, Giulio Gallera ya ce masu samar da wayar salula sun ce 40% na mutane suna ci gaba da tafiya a yankin.
Gwamnatin Jamus ta gudanar da wani marathon na shirye-shiryen karshen mako na tsawon sa'o'i 48, inda mutane sama da 42,000 suka halarta.
Shugaban Estonia, Kersti Kaljulaid, ta kuma yi kira da a nemi hanyoyin magance cutar coronavirus.
Mutane na iya fuskantar matsi game da keɓewar kai, ƙuntatawa kan tafiye-tafiye, illa na magani, ko kuma tsoron kamuwa da cutar.
BBC ta nakalto Rory O'Connor: "Ƙarfafa keɓewa daga jama'a, kadaici, damuwa game da lafiya, damuwa da koma bayan tattalin arziki, yanayi ne mai kyau don cutar da lafiyar mutum da kuma jin daɗin mutum".
Cutar na iya zama mai sauƙi, ba tare da wata alama ko kuma babu wata alama ba, kamar sauran cututtukan da ke faruwa a cikin hanyar numfashi, kamar sanyi.
Marasa lafiya da ke da nau'in cutar sukan warke cikin makonni biyu, yayin da masu fama da nau'in cutar mai tsanani ko kuma mai tsanani na iya daukar makonni uku zuwa shida.
Mata masu juna biyu na iya samun babban haɗarin kamuwa da nau'in COVID-19 bisa ga bayanan wasu irin wannan ƙwayoyin cuta kamar SARS da MERS, kodayake babu irin wannan bayanan kan COVID-19. A wasu mutane COVID-19 na iya cutar da huhu kuma ya haifar da ciwon huhu a matsayin rikitarwa.
A cikin mutane masu cutar COVID-19 mai tsanani, cutar na iya saurin ci gaba zuwa ciwon numfashi mai saurin ragewa (ARDS) wanda ke haifar da rashin numfashi, tashin hankali ko rashin ƙarfi.
Rikicin COVID-19 ya haɗa da cututtukan jini, da kuma ciwon zuciya, koda, da kuma hanta.
An bayyana rashin daidaiton jini, musamman a cikin tsawon prothrombin, a cikin kashi 6 cikin dari na marasa lafiya da aka kwantar da su a asibiti da COVID-19, yayin da aka ga rashin aikin koda a cikin kashi 4 cikin dari na wannan rukuni.
Kimanin kashi 2030% na masu cutar COVID-19 suna da ƙwayoyin hanta (transaminases).
A wannan rahoton, an nuna cewa matsakaicin lokacin da mutum ya fara nuna alamun cutar har ya mutu kwanaki goma ne, kuma biyar daga cikinsu suna asibiti.
Amma, matsakaicin lokacin da aka kai marasa lafiya zuwa sashen kulawa mai tsanani zuwa asibiti da kuma lokacin da suka mutu, kwana bakwai ne.
Binciken da aka yi a kan farkon kamuwa da cutar ya nuna cewa matsakaicin lokaci daga bayyanar cututtuka zuwa ranar mutuwa kwanaki 14 ne, tare da cikakken zangon daga kwanaki shida zuwa 41.
Wani bincike da Hukumar Lafiya ta kasar Sin ta gudanar ya nuna cewa, mace-mace da maza suna mutuwa ne kashi 2.8 cikin dari.
Binciken cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut
An ga canje-canje na kwayar cutar a cikin ƙwayoyin cuta na huhu.
Fuskarsa ta yi kama da ciwon numfashi mai saurin rage numfashi (ORDS).
Kashi 11.8 na mutuwar da Hukumar Lafiya ta kasar Sin ta ruwaito, matsalar zuciya ta kasance ne saboda yawan troponin ko kuma rashin ciwon zuciya.
A cewar bayanan da Amurka ta bayar a watan Maris, kashi 89% na marasa lafiya da aka kwantar a asibiti sun riga sun sami matsalar rashin lafiya. Samun damar samun kiwon lafiya da kuma yanayin tattalin arziki da zamantakewa a yankin na iya shafar mutuwar.
Ƙididdigar mutuwar ta bambanta dangane da yanayin saboda irin wannan bambancin na yanki, da kuma saboda wahalar da ake samu.
Rashin ƙididdigar ƙwayoyin cuta mai sauƙi zai iya haifar da ƙaruwar yawan mutuwa.
Amma, gaskiyar cewa mutane suna mutuwa ne domin cututtuka da aka samu a dā na iya nuna cewa ba a kula da yawan mutuwar da ake yi a yau ba.
Masu shan sigari sun fi yawan ciwon COVID-19 sau 1.4 kuma sun fi yawan bukatar kulawa mai tsanani ko mutuwa sau 2.4 fiye da marasa shan sigari. An kuma nuna damuwa game da tasirin cutar a cikin dogon lokaci.
Wani asibiti a Hong Kong ya gano cewa wasu marasa lafiya da suka warke daga wannan cuta sun rage yawan huhu da kashi 20 zuwa 30 bisa dari, kuma an gano lalacewar a cikin binciken da aka yi.
Bayan warkewa, hakan zai iya sa a sami ciwo mai tsanani.
Har zuwa Maris na shekarar 2020 ba a san ko marasa lafiya da suka warke daga cutar suna samar da rigakafin da zai iya jurewa ba.
Bisa ga yadda sauran ƙwayoyin cuta na coronavirus suka gudana, ana ganin hakan na yiwuwa, amma an kuma samu rahoton cewa an sami gwajin cutar ta COVID-19 bayan an warke.
An yi imanin cewa a cikin waɗannan lokuta, an sami ciwon da ya daɗe ba a sake kamuwa da cutar ba.
An yi imanin cewa kwayar cutar ta halitta ce, ta samo asali ne daga dabbobi kuma cuta ce mai yaduwa.
Ba a san ainihin asalin kwayar cutar ba, amma a watan Disambar 2019 yaduwar cutar ta kasance kusan gaba ɗaya ta hanyar watsawa daga mutum zuwa mutum.
Binciken farko na 41 na tabbatar da cutar COVID-19, wanda aka buga a watan Janairun 2020 a cikin The Lancet, ya kira ranar 1 ga Disamba, 2019 ranar farko da aka fara gano cutar.
A cewar bayanan da WHO ta fitar, ranar 8 ga watan Disamba na shekarar 2019.
Ana amfani da hanyoyi da yawa wajen kimanta yawan mutuwa.
Dukkanin adadin sun bambanta dangane da yankin da lokacin da cutar ta bulla, kuma yawan gwajin, ingancin tsarin kiwon lafiya, hanyoyin jinya da aka yi amfani da su, tsawon lokacin da cutar ta bulla, da kuma yanayin jama'a kamar shekaru, jinsi da kuma yanayin lafiyar jama'a.
A ƙarshen 2019, WHO ta ba da lambar gaggawa ta ICB-10 ga cutar: U07.1  don mutuwar cutar ta tabbatar da gwajin gwaji ta SARS-CoV-2 da U07.2  don mutuwar COVID-19 da aka gano a asibiti ko ta hanyar annoba ba tare da tabbatar da gwajin gwaji na cutar SARS-CoV-2 ba.
Bisa ga kididdigar Jami'ar Johns Hopkins, a ranar 17 ga Afrilu, 2020, adadin mutuwar duniya da masu kamuwa da cutar ya kai kashi 6.9% (153 822/2 240 191).
Wasu hanyoyin sun hada da ƙididdigar mutuwar cutar (CFR), wanda ke nuna yawan marasa lafiya da aka gano sun mutu sakamakon cutar, da kuma ƙididdigar mutuwar cututtukan da aka ɗauka (IFR), wanda ke nuna yawan marasa lafiya masu kamuwa da cutar (duka waɗanda aka gano da waɗanda ba a gano su ba) waɗanda suka mutu sakamakon cutar.
Waɗannan ƙididdigar ba su da wani lokaci, kuma suna nuna yadda mutane suke a lokacin kamuwa da cutar har zuwa lokacin da ta ƙare.
Ko da yake ba a samar da kwayoyin cutar a dukan marasa lafiya da suka kamu da cutar ba, amma idan akwai kwayoyin cutar, za ka iya sanin yawan mutanen da suka kamu da cutar.
A tsakiyar annobar a Italiya, Castillone d'Adda, wani karamin ƙauye mai yawan mutane 4,600, mutane 80 (1.7%) sun mutu.
A Gangelt, cutar ta bazu a lokacin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin
Bugu da ƙari, ba a cika tsarin kiwon lafiya na Jamus da nauyi ba.
A ƙasar Netherlands, kashi uku cikin ɗari na yawan jama'a suna iya samun ƙwayoyin cuta, bisa ga yawan jinin da aka bayar.
COVID-19  shine sanadin mutuwar mutane 69 (0,004% na yawan jama 'a).
Tasirin annobar da kuma yawan mace-mace sun bambanta ga maza da mata.
Bincike da aka yi a ƙasar Sin da Italiya ya nuna cewa maza suna mutuwa fiye da mata.
Mutanen da suke da haɗari mafi girma  maza ne da suka wuce shekara 50; bambancin tsakanin maza da mata ya ragu ne kawai daga shekara 90.
A ƙasar Sin, adadin mace-macen da ke mutuwa ya kai kashi 2.8 na maza da kuma kashi 1.7 na mata.
Ba a san ainihin dalilin da ya sa ake samun irin wannan bambancin ba, amma ana iya danganta shi da kwayoyin halitta da kuma halayyar mutane.
Bambance-bambance na rigakafin jinsi, ƙananan shan sigari a tsakanin mata, cututtukan da ke tattare da su a cikin maza (misali, hawan jini wanda ke bayyana a cikin maza a cikin matasa fiye da mata) na iya zama dalilin mutuwar maza.
A Turai, kashi 57% na waɗanda suka kamu da cutar maza ne, kuma kashi 72% na waɗanda suka mutu daga COVID-19 maza ne.
Har zuwa watan Afrilu na shekarar 2020, gwamnatin Amurka ba ta gudanar da kididdigar jinsi game da COVID-19.
Binciken kimiyya ya nuna cewa cututtuka na ƙwayoyin cuta kamar su Ebola, HIV, mura, da kuma SARS suna da bambancin jinsi.
Ma'aikatan kiwon lafiya, musamman ma ma'aikatan jinya, mata ne, saboda haka suna da damar kamuwa da cutar.
A ranar 11 ga watan Fabrairun shekarar 2020, Hukumar Lafiya ta Duniya ta sanar da sunan cutar  COVID-19.
Shugaban WHO, Mista Tedros Adhanom Gebreyesus ya bayyana cewa: CO na nufin kora, VI virus, D  cuta, kuma 19  ne shekarar da aka fara gano cutar: 31 ga Disamba, 2019.
An zaɓi wannan sunan ne don kauce wa yin nuni ga takamaiman wuri (misali, China), nau'in dabbobi ko rukunin mutane, kamar yadda shawarwarin ƙasashen duniya ke buƙata don ba da suna don hana ƙyama. Ana kiran kwayar cutar da ke haifar da COVID-19 da mummunan cututtukan numfashi na coronavirus 2 (SARS-CoV-2).
A cikin sanarwar jama'a, WHO ta yi amfani da kalmomin  kwayar cutar COVID-19 da  kwayar cutar da ke da alhakin COVID-19.
An fi kiran cutar da kuma kwayar cutar coronavirus.
A lokacin da cutar ta fara bulla a Wuhan, China, an fi kiran cutar da cutar coronavirus da huhan coronavirus.
A watan Janairun 2020, bisa ga shawarwarin 2015 kan amfani da wurare a cikin sunayen cututtuka da ƙwayoyin cuta, WHO ta ba da shawarar yin amfani da sharuɗɗan Cutar numfashi mai tsanani 2019-nCov da 2019-nCoV a matsayin sunayen wucin gadi na ƙwayoyin cuta da cuta.
A ranar 11 ga Fabrairu, 2020, an buga sunayen hukuma   COVID-19 da SARS-CoV-2 .
Saboda ƙuntatawa na tsarin samar da kayayyaki na yau da kullum, wasu masu samar da kayayyakin dijital suna buga kayayyakin kiwon lafiya, kamar su takunkumin hanci da kuma kayan aikin IVL.
A wani yanayi, asibitin Italiya yana bukatar bawul na iska, kuma mai sayar da shi bai iya kawo shi a lokacin da ake bukata ba, sai aka sake tsara wani wurin da ake yin aikin kuma ya buga bawul 100 da ake bukata a dare.
Bayan barkewar cutar COVID-19, an fara yada ra'ayoyin makirci, da kuma bayanan karya game da asalin cutar, da girmanta, da rigakafinta, da magani, da sauran fannoni a cikin Intanet.
Wataƙila mutane za su iya yaɗa wannan cuta ga wasu dabbobi.
Sakamakon binciken bai tabbatar da yaduwar cutar a cikin aladu, da awaki da kaji ba.
A yanzu haka babu allurar rigakafin cutar ko magungunan da za a iya bi da ita.
A halin yanzu, kungiyoyin gwamnati, kungiyoyin ilimi, da masu bincike na masana'antu suna gudanar da bincike na duniya daban-daban kan alluran rigakafi da magunguna na COVID-19.
A watan Maris, WHO ta fara shirin SOLIDARITY Trial (Gwaji na Solidarity), wanda ke da manufar tantance tasirin maganin abubuwa huɗu da ake ganin sun fi tasiri a yau.
Har yanzu babu riga-kafin da aka shirya, amma kungiyoyi daban-daban suna aiki tukuru kan magungunan da za su iya yin rigakafin.
SARS-CoV da SARS-CoV-2 suna shiga cikin ƙwayoyin mutum ta hanyar mai karɓar ACE2, saboda haka ana amfani da sakamakon binciken SARS-CoV na baya a cikin binciken.
Akwai dabarun allurar rigakafi guda uku.
Na farko, masu bincike suna neman su samar da rigakafin da zai iya zama da kwayar cutar.
Amfani da irin wannan kwayar cutar, ko dai ta mutu ko kuma ta mutu, an yi shi ne don haifar da amsawar garkuwar jiki mai sauri ga sabon kamuwa da cutar COVID-19.
Dabara ta biyu, samar da allurar rigakafi ta ƙaramin rukuni, tana nufin samar da allurar rigakafi da ke ƙara ƙwarewar tsarin garkuwar jiki ga wasu ƙananan ƙwayoyin cuta.
A cikin yanayin SARS-CoV-2, irin wannan binciken yana nufin lalata furotin mai kama da S wanda ke taimakawa kwayar cutar ta shiga cikin mai karɓar enzyme ACE2.
Dabarar ta uku  ita ce samar da allurar rigakafi bisa tushen sinadarin nucleic acid (DNA ko RNA-vaccine, sabuwar hanyar samar da allurar rigakafi).
A ranar 16 ga Maris, 2020, an fara gwajin gwaji na farko a Seattle, a kan masu sa kai huɗu.
An nuna cewa maganin rigakafi na iya zama matsala wajen samar da maganin rigakafin SARS-COV-2, amma wannan zato yana da rikici.
A watan Afrilun 2020, an gudanar da gwaje-gwaje sama da 300.
An gwada magungunan da aka amince da su don maganin zazzabin cizon sauro a gwaje-gwaje bakwai, huɗu daga cikinsu sun kasance hydroxychloroquine ko chloroquine.
Sake fasalin magungunan cutar ya zama babban ɓangare na binciken Sin; a ƙarshen Afrilu an gudanar da binciken mataki na III tara a ƙasashe da dama game da remdesivir.
Ya zuwa watan Afrilu 2020, an gudanar da bincike mai zurfi kan ci gaban asibiti na alluran rigakafi da magungunan da aka zaɓa don maganin COVID-19. Hakanan ana yin la'akari da wasu magungunan rigakafin cutar da ke akwai don maganin COVID-19, gami da remdesivir, chloroquine da hydroxychloroquine, lopinavir / ritonavir, da lopinavir / ritonavir a hade tare da beta interferon, tare da wannan manufar.
A watan Maris na shekarar 2020 akwai bayanai na farko game da ingancin amfani da remdesivir.
An ga ci gaba a asibiti a cikin marasa lafiya da suka karɓi remdesivir a matsayin banda.
An riga an fara gwajin asibiti na mataki na uku a Amurka, China da Italiya. An yi nazarin amfani da chlorohydrate, wanda aka yi amfani da shi a baya don magance zazzabin cizon sauro a China a watan Fabrairun 2020, kuma an sami sakamakon farko.
Duk da haka, akwai bukatar a yi nazari a kan binciken.
Hukumar kiwon lafiya ta Koriya da ta Sin sun ba da shawarar yin amfani da chlorohydrate.
Cibiyar nazarin ƙwayoyin cuta ta Wuhan ta ba da shawarar a sha gram ɗaya a rana, amma ta ce ninka wannan adadin yana da haɗari kuma yana iya kaiwa ga mutuwa.
A ranar 28 ga Maris, 2020, FDA ta ba da izinin amfani da hydroxychloroquine da chloroquine na gaggawa a cikin shawarar likitoci da ke kula da marasa lafiya da COVID-19. A cikin littafin na 7 na jagororin kasar Sin, an kuma nuna interferon, ribavirin, ko kuma umfenovir a matsayin magungunan COVID-19.
Bayanai na farko sun nuna cewa ana bukatar manyan allurai na ribavirin don hana SARS-CoV-2 in vitro.
An ba da shawarar nitasoxaniid don ƙarin bincike a cikin vivo, yana nuna hana SARS-CoV-2 a ƙananan maida hankali. Bincike ya nuna cewa don shigar SARS-CoV-2 ta hanyar hulɗa tare da mai karɓar ACE2 yana buƙatar sulhunta furotin na spike tare da protease mai ɗaukar hoto na 2 (TMPRSS2).
Bincike kan amfani da chlorohine da hydroxychloroquine tare da ko ba tare da azithromycin ba yana da manyan ƙuntatawa waɗanda ke hana ƙungiyar likitanci amfani da waɗannan hanyoyin magani ba tare da ƙarin bincike ba. Ozeltamvir baya hana SARS-CoV-2 in vitro, kuma ba a san rawar da yake takawa wajen maganin COVID-19 ba.
Za a iya samun cutar hypercytokinemia a matsayin rikitarwa a lokacin da cutar ta COVID-19 ta yi tsanani.
Akwai tabbaci cewa hydroxychloroquine na iya samun halayen hypercytokinemia. A cikin wani karamin bincike da Hukumar Lafiya ta Kasa ta Sin ta gudanar, an hada da tocilizumab a cikin shawarar da aka bayar kan maganin coronavirus.
Wannan magani ya shiga gwaji na biyu wanda ba a yi amfani da shi ba, wanda ake gudanarwa a matakin kasa a Italiya, bayan an samu sakamako mai kyau a kan marasa lafiya da ke da mummunar cutar.
An haɗa shi da gwajin jini don gano ciwon cytokine don magance abubuwan da ake tsammanin suna haifar da mutuwa a wasu marasa lafiya.
A cikin 2017, FDA ta amince da mai adawa da mai karɓar mai karɓar interleukin-6 bisa ga nazarin binciken baya-bayan nan don magance cutar cutar cytokine ta steroidal ta haifar da wani dalili, maganin T-cell CAR.
A yau, babu wata hujja da aka tsara ta bazuwar da aka sarrafa cewa tocilizumab yana da tasiri wajen magance cutar cytokine.
A halin yanzu ana ganin bayar da rigakafin da aka tsabtace da kuma mai da hankali da tsarin garkuwar jikin marasa lafiya da suka warke daga COVID-19 ya samar wa mutanen da suke bukatar su, a matsayin hanyar rigakafin da ba rigakafi ba.
An gwada wannan dabarar a kan marasa lafiya da ke fama da cutar SARS, amma sakamakon ba shi da tabbaci.
Rashin cutar  wani sakamako ne da ake tsammani wanda maganin rigakafi na iya ba da kariya daga SARS-CoV-2.
Duk da haka, ana iya amfani da wasu hanyoyin, kamar su ƙwayoyin cuta masu ƙwayoyin cuta da ke dogara da antibody da / ko phagocytosis.
Sauran nau'ikan maganin rigakafi na wucewa, misali, ta amfani da ƙwayoyin cuta na monoclonal da aka ƙera, suna kan ci gaba.
Za a iya ƙara amfani da maganin jini mai sakewa, wanda ya ƙunshi ruwan jini daga marasa lafiya da suka warke kuma yana ɗauke da ƙwayoyin cuta da ke yaƙi da wannan cuta.
Cutar korona, rukuni na cututtuka masu kama da juna
Li Wenlian, likita a asibitin Wuhan na tsakiya, wanda daga baya ya kamu da cutar kuma ya mutu daga COVID-19 bayan ya ba da rahoton yaduwar cutar.
